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After a spinal cord injury (SCI), clinicians must quickly decide if they want to focus therapy 
towards gait training or wheeled mobility interventions to maximize an individual's functional 
mobility by discharge. Clinical prediction rules (CPRs) such as those that use age, strength, and 
sensation, can assist clinicians in making those difficult decisions, but for individuals with an 
incomplete SCI, these CPRs are often inaccurate. Additionally, these models only predict whether 
an individual can walk a short distance without physical assistance, which is not a sufficient 
description of functional ambulation. Limb accelerations (LA), captured unobtrusively and at a 
low cost from wearable accelerometers, may provide a responsive and informative movement 
biomarker of neuromuscular impairment that can be used to determine more accurate predictions 
of ambulatory ability among those who would benefit from them the most.  
Our long-term goal is to build a new CPR using LA that predicts functional ambulation 
after SCI, thus enabling appropriately targeted mobility training. As a first step towards this goal, 
we utilized a cross-sectional study to build a foundational knowledge of LA and its relationship to 
measures of neuromuscular impairment (Aim 1) and ambulatory ability (Aim 2) using machine 
learning techniques and a sample with chronic, motor incomplete SCI and known, diverse 
functional abilities. Using a longitudinal study consisting of individuals with acute, incomplete 
SCI, we established that LA is reliable when measured acutely at admission to inpatient 
rehabilitation (Aim 3a). We also investigated the changes in LA over time (Aim 3b) and in relation 
to clinical measures (Aim 4a) and explored the potential utility of LA measured at admission to 
 v 
inpatient rehabilitation to predict long-term ambulatory ability (Aim 4b) for those with acute, 
incomplete SCI. These results demonstrated that LA is a reliable and clinically-relevant metric that 
is likely to improve the prediction of ambulatory ability, thus improving long-term, functional 
outcomes for individuals with SCI. 
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1.0 Overview and Aims 
Ambulation is often a goal of individuals after spinal cord injury (SCI), and therefore, gait 
training is a common intervention during inpatient rehabilitation (IPR).1, 2 In the context of 
decreasing length of stays in IPR,3 clinicians must quickly make critical decisions regarding the 
focus of therapy: towards ambulatory or wheelchair-related interventions. Unfortunately, time 
spent on gait training may be detrimental if the individual does not become a functional ambulator, 
as demonstrated by decreased participation outcomes a year after injury.1 While there are clinical 
prediction rules (CPRs) that estimate the probability of becoming an independent ambulator, these 
rules struggle to delineate ambulators among the population that needs these rules the most, those 
with incomplete SCI.4-7 To predict walking, these rules generally use clinical tests of strength and 
sensation which have been shown to have limited responsiveness and inconsistent reliability.8, 9 
Additionally, because these models only predict the ability to walk versus not walk, they do not 
provide insight into gait quality or efficiency, which are important components of functional 
mobility.6  
Recent analyses of the shortcomings and inaccuracies of current CPRs for ambulation after 
SCI encouraged the use of alternative predictors and machine learning to provide improved 
predictions.6, 7 Recording limb movements using wearable accelerometers is likely to provide more 
insight into an individual’s strength, sensation, and spasticity than traditional physical examination 
measures. Limb accelerations (LA), defined as accelerations from any movement of the limbs 
during sleep at night, may be more responsive to identify differences in neuromuscular impairment 
and ambulatory ability compared to common clinical assessments. Also missing from current 
CPRs is any consideration of personal, psychosocial and environmental factors (PPEF) that 
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influence an individual’s ability to adjust to his or her SCI and thus impact rehabilitation outcomes. 
Successful adjustment to SCI relies on aspects such as an individual’s coping style, social support, 
socioeconomic status, and home and community accessibility, which should all be considered 
when predicting long-term functional outcomes such as ambulatory ability.10-12 
Our overall goal is to improve the prediction of ambulatory ability after SCI through 
establishing LA as a movement biomarker that will provide a more descriptive measure of 
neuromuscular impairment than traditional clinical tests and that can be measured reliably in the 
inpatient setting. This dissertation consists of the findings from 2 studies: one cross-sectional 
among those with chronic (≥ 1 year), primarily motor incomplete SCI (Aims 1 and 2) and one 
longitudinal over the first year post-injury among those with acute, incomplete SCI (Aims 3 and 
4). More specifically, Aim 1 will provide the foundational knowledge of LA by determining which 
LA features explain the greatest amount of variability in measures of neuromuscular impairment 
(lower extremity strength, sensation, and spasticity) among individuals with chronic SCI. In Aim 
2, we will target a sample with chronic, motor incomplete SCI and known, diverse functional 
abilities to evaluate the usefulness of novel predictors (LA and PPEF) and machine learning 
techniques to classify functional categories of ambulatory ability as defined by measures of gait 
speed and endurance. We will also evaluate LA measured longitudinally in a population with 
acute, incomplete SCI to determine which features of LA can be reliably measured from admission 
to IPR through the first 6-months post-discharge (Aim 3a) and which features remain stable over 
that time (Aim 3b). Lastly, utilizing that same sample with acute SCI, we will examine how LA 
changes in relation to measures of ambulatory ability over time (Aim 4a) and explore the utility of 
reliable LA features measured at admission to IPR to predict ambulatory ability at 6-months post-
discharge (Aim 4b).  
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Collectively, these findings will demonstrate the validity and reliability of LA as a clinical 
measure in both chronic and acute populations with SCI, establish the relationship between LA 
and measures of impairment and ambulatory ability, and provide evidence to support the future 
development of a CPR using acutely measured LA to predict long-term measures of functional 
ambulation. 
1.1 Specific Aim 1 
Determine the association between limb accelerations (LA) and clinical measures of 
neuromuscular impairment among individuals with chronic SCI. 
Hypothesis 1: Features of LA such as those related to amplitude and duration of movements 
will be related to clinical assessments of strength, sensation, and spasticity among individuals with 
chronic (≥ 1 year) SCI. 
1.2 Specific Aim 2 
Develop machine learning models to classify ambulatory ability using LA and PPEF among 
a population with chronic, motor incomplete SCI.  
Hypothesis 2: Random forest models including quantitative measures of LA and PPEF will 
produce higher classification accuracies for categories of functional ambulation (speed, endurance) 
than models including only clinical and demographic measures. 
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1.3 Specific Aim 3 
Determine a) which features of LA are reliable between nights when measured at admission 
to IPR and b) which remain stable over the first 6-months post-discharge among participants 
with acute, incomplete SCI. 
Hypothesis 3: A set of LA features can be identified that a) produce at least moderate 
reliability when examining intra-subject variance at admission to IPR and b) produce at least 
moderate stability between time points through 6-months post-discharge. 
1.4 Specific Aim 4 
a) Explore the how LA features which are not stable across the first 6- months following 
discharge (variable LA) change in relation to measures of ambulatory ability and 
impairment over time among participants with acute SCI. 
Hypothesis 4a: The change in variable LA features will be significantly correlated with the 
change in measures of ambulatory ability (need for assistance, speed, endurance) and impairment 
(strength, sensation) from admission through 6-months post-discharge from IPR. 
b) Explore the relationship between reliable LA features measured acutely at admission to 
IPR and ambulatory ability at 6-months post-discharge. 
Hypothesis 4b: Features of LA measured at admission to IPR will be significantly 
correlated or show clear visual separation of categories of ambulatory ability measured at 6-months 
post-discharge. 
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1.5 Overall Impact 
Information gained from these aims will provide insight to guide a future, multisite 
longitudinal study that will assess a new, more effective CPR for ambulatory ability in a larger 
population with acute, incomplete SCI. This new CPR will better aid clinical decision-making for 
individuals with SCI, allowing for optimally targeted therapies to be employed throughout the 
rehabilitation continuum. Additionally, this dissertation will provide a necessary understanding of 
the psychometric properties of LA in both chronic and acute populations with SCI, opening the 
door for many future uses of this metric. 
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2.0 Background 
2.1 Recovery and Rehabilitation after SCI 
Nearly 18,000 people in the United States sustain a spinal cord injury (SCI)a every year 
and almost 300,000 people in the United States are currently living with a SCI.3 An SCI is a life-
changing injury that often leaves an individual with strength and sensory deficits below their level 
of injury, in addition to many other changes such as bowel and bladder function. Once medically 
stable after a new SCI, patients often leave the acute care medical units to go to inpatient 
rehabilitation (IPR) for intensive physical, occupational, and speech therapy as needed, for 3 hours 
every day. It is in IPR that patients work to increase strength, balance, and motor control to restore 
function as much as possible. During this time, they also are learning new compensatory 
techniques and how to use assistive devices to maximize functional mobility and independence. 
Early after an SCI, one of the first questions an individual may ask is “Will I ever walk 
again?” The decision to pursue ambulation or wheelchair focused mobility is not a trivial one. 
Decreasing length of stays from a median of 98 days in the 1970’s to 30 days in 2021, force 
clinicians to quickly make critical decisions regarding the focus of therapy towards walking or 
wheelchair-based interventions.3, 13 Gait training following SCI can be both time and effort 
intensive and for those who regularly walk for mobility, this exertion is worthwhile. However, 
some individuals with the potential to walk may not be receiving gait training during this time 
while the potential for neurorecovery is the highest. Conversely, for someone who will primarily 
 
a All abbreviations are also defined in Appendix A and used consistently through the dissertation. 
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use a wheelchair following discharge, focusing on gait training can result in decreased time 
practicing transfers and wheelchair skills and lead to long-term negative consequences.1, 14-17 The 
challenge in deciding who should complete gait training is exacerbated by the fact that patients 
with new injuries often push for gait training regardless of the extent of injury.2 
Studies have shown that quality of life is more related to effective mobility and functional 
independence than the mode of locomotion.17, 18 Thus, it is important to consider not just if a person 
can walk, but how well and whether walking is likely to be functional. Achieving functional 
ambulation indicates that the individual can walk with minimal assistance and sufficient quality, 
speed, and endurance to be able to safely and efficiently complete their activities of daily living. 
Since the most rapid rate of neurological recovery occurs in the first 3 months and significantly 
declines by 12-18 months post-injury,19 it is critical that time in therapy is optimally utilized early 
after injury to maximize long-term functional mobility. 
2.2 Importance of Understanding Long-term Mobility Prognosis after SCI 
2.2.1 Positive Impacts of Ambulation 
If able to achieve long-term, functional ambulation after SCI, there are many benefits to 
returning to walking. Among individuals with SCI, non-ambulators were found to have increased 
cartilage atrophy and degradation compared to ambulators, which can lead to pain and functional 
limitations.20 Walking has also been associated with improved retention of bone mineral content, 
as up to half of the mineral content below the level of lesion can be lost in the first year after injury 
which significantly increases the risk of osteoporosis and fractures.21 Also, sitting in a wheelchair 
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for extended periods of time can lead to increased risk of joint contractures and decubitus ulcers, 
especially when decreased sensation is present. Standing and walking allows for greater variability 
in positioning, which may decrease the risk of deformities and pressure injuries, as well as decrease 
spasticity.22 Cardiovascular and respiratory benefits have also been noted when ambulating for 
exercise.23 Although gait training is often considered a frustrating experience filled with “ups and 
downs”, individuals with SCI who are ambulatory have also discussed relearning to walk as 
“powerful” and associated with “feeling extremely grateful.”24 Decreased depression and higher 
satisfaction with life scores have been shown among ambulatory individuals compared to those 
who use a wheelchair.17 
2.2.2 Negative Impacts of Ambulation 
While ambulation is achievable for some individuals during initial rehabilitation, only 25 
to 34% of all individuals with SCI become functional ambulators.17, 25 Factors such as spasticity, 
muscle weakness, pain severity, cognitive impairments, balance, proprioception deficits, and the 
need for assistance may limit the ability to ambulate.17, 19 A focus on gait training while in IPR 
may be related to negative outcomes for individuals who will primary be wheelchair users. Our 
analysis of the SCIRehab database, a multicenter study that documented interventions received by 
patients with SCI throughout IPR and at a one-year follow-up, showed that one-third of patients 
who were primarily using a wheelchair at one year after discharge received gait training in IPR.1 
As a percentage of their time in physical therapy, these individuals received significantly less 
transfer and wheeled mobility training, compared to those who used a wheelchair and did not 
receive gait training. In addition, the group of wheelchair users who received gait training reported 
significantly worse measures of Craig Handicap Assessment and Reporting Technique 
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participation at one year, in the domains of physical independence, mobility, and occupation than 
the group of wheelchair users who did not have gait training while in inpatient rehabilitation.1 
Unfortunately, even household or limited ambulators may be at risk for additional 
consequences. Marginal ambulation after SCI is associated with risks of musculoskeletal injury, 
pain, and physiological costs. Compared to wheelchair users, individuals with SCI who ambulate 
were more likely to report a fall, recurrent falls, and a fall-related injury, especially if they required 
assistance to ambulate.26-28 Individuals with SCI who require an assistive device to ambulate also 
reported increased shoulder pain and fatigue compared to both power and manual wheelchair 
users.15 This is likely resulting from the increased demands on a musculoskeletal system that 
already compensates for strength and sensory deficits, as forces of up 170% of an individual’s 
body weight have been measured at the shoulder when walking with crutches after SCI.29, 30 
When individuals with SCI are able to achieve functional ambulation, it is demonstrated to 
be far less efficient and more physiologically demanding than for able-bodied individuals. When 
compared to able-bodied controls, individuals with incomplete SCI were 200% less efficient while 
walking at their preferred velocity, demonstrated by increased oxygen use, heart rate, and lactate 
concentration. Additionally, even when ambulating at their maximal velocity, individuals with SCI 
were still walking 30% slower than able-bodied individuals walking at their preferred pace.31 Self-
selected gait speed in individuals with SCI is generally reported from 0.21 to 0.69 m/s, which is 
far below the able-bodied speed of 1.22 m/s and the average velocity to safely cross a street of 
1.06 m/s.31 Previous research demonstrated that people who walk at low speeds or high energy 
expenditure were limited in functional community ambulation and had poorer physical 
functioning.32 Thus, many of these individuals for whom walking is painful or inefficient may be 
more functional and active in their communities by using a wheelchair for mobility. 
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If an individual is primarily ambulating at discharge from IPR, but cannot sustain 
ambulation and transitions to wheelchair use by 1-year, they may also be prone to more negative 
outcomes. Riggins et al. evaluated 4 groups based upon the primary mode of mobility at discharge 
from IPR and one year later: transition from wheelchair to ambulation, transition from ambulation 
to wheelchair, ambulating at both time points or using a wheelchair at both time points.17 The 
group transitioning from ambulation to wheelchair use had significantly worse participation in the 
domains of mobility, occupation, and social integration, self-perceived health status, satisfaction 
with life, depressive symptoms, and pain severity scores of any mobility group, including the group 
who maintained wheelchair use at both time points.17 These negative effects may persist for up to 
10 years after injury.16 This emphasizes the importance of selecting the most effective mode of 
mobility during IPR in order to prevent the need to transition from ambulation to wheelchair use.  
2.3 Current Methods for Prediction of Ambulation after SCI 
The American Spinal Injury Association Impairment Scale (AIS) determined as part of the 
examination standardized by the International Standards for Neurological Classification of Spinal 
Cord Injury (ISNCSCI) was often used to guide the prognosis of ambulation. The AIS is a measure 
of impairment of a traumatic SCI from A (complete SCI) to E (normal), determined by light touch 
(LT) and pinprick sensation to all spinal levels from C2 to S4-5 and manual muscle test (MMT) 
motor scores from the upper (C5-T1) and lower (L2-S1) limbs. MMT consists of “the use of 
observation, palpation, and force application by an examiner to determine the strength of a muscle 
action”, while LT testing consists of the clinician touching a specific dermatome location while 
the individual’s eyes are closed and determining if they can feel the touch (Table 2.1).8, 9, 33 
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Table 2.1: Scoring of clinical tests 
Clinical Test Scoring 
Manual Muscle 
Test (MMT) to 
Assess 
Strength33 
0= Total paralysis 
1= Palpable or visible contraction 
2= Active movement, full range of motion with gravity eliminated 
3= Active movement, full range of motion against gravity 
4= Active movement, full range of motion against gravity and moderate resistance in a muscle 
specific position 
5= (Normal) active movement, full range of motion against gravity and full resistance in a 
functional muscle position expected from an otherwise unimpaired person 
Light Touch 











0= No increase in muscle tone 
1= Slight increase in muscle tone, manifested by either a catch and release or minimal 
resistance at the end of the range of motion when the affected part is moved in flexion or 
extension 
1+= Slight increase in muscle tone, manifested by a catch followed by minimal resistance 
throughout the remainder (less than half) of range of motion 
2= More marked increase in muscle tone but through most of the range of motion the affected 
part easily moved 
3= Considerable increase in muscle tone, passive movement difficult 
4= Affected part rigid in flexion or extension 
 
Individuals with complete SCI (AIS A) generally have a low likelihood of ambulating, as 
less than 8.5% typically regain functional ambulation.3, 19, 35, 36 Although individuals with 
diagnoses of AIS B SCI (sensory incomplete, motor complete) may not be ambulating initially at 
admission to IPR, approximately 18-33% will recovery the ability to functionally ambulate and 
this recovery maybe be related to better sensory preservation after injury.35, 36 Overall, about 52-
75% of individuals with AIS C SCI (motor incomplete with more than half of the motor levels 
below the level of injury unable to lift against gravity [MMT score < 3/5]) will regain ambulation, 
but this seems to vary dramatically by age as individuals less than 50 years of age have higher 
rates of recovering functional ambulation (71-91% of < 50 years vs 25-42% > 50 years).35, 36 While 
the vast majority of individuals with AIS D SCI (motor incomplete with at least half of the motor 
levels below the level of injury able to lift against gravity [MMT score ≥3/5]) are able to walk 
household distances (≥ 92%), approximately 20% cannot achieve community ambulation.3, 35, 37, 38 
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Factors that affect whether an individual recovers ambulation and the rate at which they do so 
include the level and severity of injury, lower extremity motor function, spasticity, trunk control, 
age, sensation, proprioception, balance, and cognitive impairments.19 
Clinicians primarily use clinical judgement to determine the ambulatory prognosis of a 
patient with a new SCI and plan their therapeutic interventions accordingly. One study showed 
that while clinicians were fairly accurate in predicting ambulatory ability of patients 3-months 
post-discharge, their mobility predictions were less accurate when only including participants with 
motor incomplete (AIS C and D) injuries.39 Another study evaluated the accuracy of both patient’s 
ambulatory prediction and the predictions of therapists and found that neither group was successful 
in predicting if the patient would walk 1-year after injury. About 66% of patients predicted that 
they would be able to walk household distances and 45% of therapists believed they could do so, 
but only 38% were actually able to ambulate a year later. Physicians of various specialties and 
years of experience were not able to accurately predict whether individuals would be able to walk 
household distances one year after injury. Specifically for individuals with AIS C injuries, 
physicians ranged from 42-84% accuracy with 4 of the 6 physicians (67%) incorrectly predicting 
more than 30% of patients.37  
CPRs are developed to help guide clinicians in critical decision-making regarding patient 
treatment and intervention selection. These tools can also be useful in providing education to 
patients about expected outcomes.40-42 Decision-making tools to improve the quality of care and 
efficiency of IPR for individuals with SCI have been evaluated with positive outcomes in clinical 
practice.42-44 
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2.3.1 van Middendorp CPR 
Although a number of CPRs exist regarding ambulation in the SCI population,5, 36, 45-48 the 
most cited rule in research and clinical settings for predicting ambulation in people with an acute, 
traumatic SCI is a logistic regression model created by van Middendorp et al. (“van Middendorp 
CPR”).4 This CPR uses LT sensation and MMT motor scores at L3 and S1, collected in the first 
15 days after injury and age (< 65 years, ≥ 65 years) to generate a score from -10 to 40 that is 
associated with the probability of walking independently at one year. The ability to walk 
independently was defined by the Spinal Cord Independence Measure item 12 as the ability to 
walk indoors, on an even surface less than 10 meters without physical assistance or supervision. 
In the derivation and validation models, the areas under the receiver operating characteristics 
curves (AUC) were .956 and .967, respectively, representing excellent discriminative ability in 
predicting individuals with SCI as walking or not walking (AUC= 1 is perfect discrimination, .5 
is unable to detect any difference between the 2 groups).4 Additionally, the van Middendorp CPR 
was demonstrated high accuracies when externally validated in other samples with traumatic SCI 




Figure 2.1: Validation group plot from the van Middendorp CPR4 displaying 95% confidence interval as 
vertical bars. Vertical stripes at the horizontal borders represent those who could (top) and could not 
(bottom) walk independently.b 
 
2.3.2 Clinical Utility of the van Middendorp CPR 
Recently, researchers have begun to assess how the van Middendorp CPR compares to 
ambulatory predictions by clinicians based on clinical judgement and the overall clinical utility of 
this CPR in affecting clinical decision-making and outcomes. The van Middendorp CPR slightly 
 
b Reprinted from The Lancet, 377, van Middendorp JJ, Hosman AJ, Donders AR, Pouw MH, Ditunno JF Jr., Curt A, 
Geurts AC, Van de Meent H, EM-SCI Study Group, A clinical prediction rule for ambulation outcomes after traumatic 
spinal cord injury: a longitudinal cohort study, 1004-1010, Copyright (2011), with permission from Elsevier. 
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outperformed physician predictions by 81% vs. 79% accuracy, but the difference was not 
significant. Particularly when predicting ambulation for individuals with AIS C injuries, the 
differences between the van Middendorp CPR and predictions from physician ranged from 32% 
higher predictions using the van Middendorp CPR to 10% lower.37 
In our medical center, the van Middendorp CPR was also assessed to determine the clinical 
utility of this CPR. This was done by sharing the van Middendorp CPR score with the primary 
therapist after the initial evaluation in IPR for individuals with SCI whose ambulation prognosis 
was judged by the therapist to be difficult to determine (n=52).42 The majority of the sample 
included in the study had AIS C and D injuries, further highlighting the challenges of predicting 
walking outcomes in this population. Therapists reported knowing the probability of walking was 
useful for 88% of cases for patients with non-traumatic SCI for establishing prognosis or setting 
goals. However, for individuals with moderate impairments whose CPR scores ranged from 10-17 
(predicted probability of independent ambulation from 35-78%), 50% of therapists did not find the 
CPR prediction useful. Since the individuals in this range are often the most difficult group to 
determine a mobility prognosis based upon clinical judgement, this finding emphasizes the 
weakness of the van Middendorp CPR for predictions with this population. Compared to therapists 
with greater than 10 years of experience, newer therapists were more likely to find the CPR results 
useful (68% vs 18%, p= 0.001) and more likely to share the CPR results with the patient (50% vs 
14%, p= 0.011).42 Thus, an improved CPR may be particularly useful to new therapists and for 
patients with motor incomplete SCI. 
This analysis also found that ambulation goals as described by the Functional 
Independence Measure (FIM), were not related to CPR probability of independent ambulation. 
Even among participants with very high probabilities of ambulating (98-99%), there was a wide 
 18 
range of FIM goals from ambulating with total assistance to modified independent.42 This suggests 
that factors beyond just clinical impairment and age are incorporated into clinical judgement 
regarding a patient’s mobility prognosis. The FIM score is based on an individual’s level of 
assistance to walk 150 feet (45.7 meters), while the van Middendorp CPR is only predicting an 
individual’s ability to walk 32.8 ft (10 meters). Thus, the lack of relation between van Middendorp 
CPR predictions and FIM goal setting or goal achievement may emphasize that the van 
Middendorp CPR’s outcome is not a sufficient measure of functional ambulation and that other 
factors that are not accounted for in the van Middendorp CPR may influence functional, 
community ambulation more than household ambulation. Therefore, CPRs for long-term 
ambulation after SCI are useful in clinical settings especially for less experienced therapists, but 
would likely be improved by more descriptive predictors than only clinical measures of 
impairment, more accurate CPR predictions for individuals with incomplete injuries, and a CPR 
outcome that better captures functional ambulation. 
2.3.3 Additional CPRs for Ambulation 
Additional CPRs for ambulation that are simpler52 or use a sample with only motor 
incomplete SCI,53 a variety of predictors,53 more functional descriptions of impairment,36 or 
improved model building and analysis techniques36, 53 are described in Appendix B. However, each 
of these CPRs also present with methodological or clinical application flaws that are further 
discussed in the appendix. 
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2.4 Areas for Improvement in Current CPRs for Ambulation 
As touched upon in the previous sections, many models have been developed for the 
prediction of ambulation after SCI, but they suffer from a variety of methodological issues that 
could be addressed in future CPRs to improve the accuracy and clinical utility. Multiple recent 
publications have highlighted 4 major areas of improvement for CPRs: uninformative predictors, 
biased sample populations, non-functional ambulatory outcomes, and suboptimal model 
evaluation and validation.6, 37, 42, 51, 54 The following sections describe the issues that have led to 
the identification of each area of improvement and propose solutions to resolve them in future 
CPRs. 
2.4.1 Uninformative and Unresponsive Predictors 
2.4.1.1 Characteristics of a Useful Predictor 
For a predictor to be useful in a CPR, it must be demonstrated to be valid, meaning that it 
is measuring what it is supposed to be measuring.55-57 Face validity is the intuitive “feeling” that a 
measurement seems to be valid at its “face value”. Face validity is difficult to quantify, but is 
demonstrated based upon the understanding of how the predictor is measured.57 Construct validity 
is the demonstrated relationship that a measurement is comparable to a different measure assessing 
a similar concept and not similar to unlike measures. Likewise, concurrent validity quantifies the 
relationship between the novel measure and the “gold standard” or another previously validated 
measure of the construct that is intended to be measured. For example, if a predictor is intended to 
measure strength, then it would demonstrate concurrent validity if it is related to other measures 
of strength, such as MMT scores, but not to measures such as sex and age that may affect an 
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individual’s strength, but are not direct measures of it. To demonstrate concurrent validity, the 
predictor should be related to Biodex dynamometry which is generally considered the gold 
standard measure of strength.57 Predictive validity is a form of criterion validity and determines if 
the measure has the ability to accurately predict a future outcome. In the case if CPRs, the CPR 
itself would provide evidence of predictive validity, but preliminary analyses such as correlations 
can also demonstrate this domain.57 
A predictor must also be reliably measured such that the same measurements result in the 
same predictions consistently even if measured under slightly different circumstances or at 
different times. While there are many domains of reliability, the primary areas that are important 
for use in a CPR are consistent measurements within each researcher or clinician (intra-rater 
reliability) and between different raters while measuring the same participant (inter-rater 
reliability), and consistency of repeated measurements (test-retest reliability).55-57 When a 
researcher or clinician is performing a clinical test manually (e.g., MMT and LT assessments), 
there is a level of subjectivity in scoring as well as differences in how the individual performs the 
test (e.g., due to the tester’s strength or experience). These may result in different scores when an 
individual is measured by the same tester (low intra-subject reliability), when different testers 
score the same subject (low inter-rater reliability), or when multiple measurements are performed 
without any other changes (low test-retest reliability). Using objective measures that are calculated 
algorithmically and without any bias from the tester ensure that whoever is performing the 
measurement is not influencing the outcome.55-57 
Intra-subject reliability (or variability) is also important for a predictor to ensure that 
changes within the participant do not unduly influence the CPR results (Figure 2.2).55-57 A 
predictor should have high intra-subject reliability, meaning that each time you measure the 
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predictor in a relatively short time frame and given the same conditions, the measurement should 
produce the same results. In this instance, having high intra-subject reliability would be effectively 
the same as high test-retest reliability. If a predictor had low intra-subject reliability, then the CPR 
may produce vastly different results each time it is calculated even within the same participant 
when no other characteristics have changed that should influence the CPR findings.55-57  
 
Figure 2.2: Examples of a predictor with high (left, good) and low (middle, bad) intra-subject reliability and 
high inter-subject variability (right, good) between 2 participants (black and blue) and multiple collection 
times (nights). 
 
In contrast to intra-subject reliability, a predictor should have high inter-subject variability 
which indicates that the value of the predictor changes considerably between different participants 
with different presentations. If the predictor had low inter-subject variability, then every 
participant would have approximately the same values and the predictor would not be very 
informative of different abilities in the CPR.55-57 Inter-subject variability is a measure of 
responsiveness which is defined as “the ability of the instrument, device, tool, test, or scale to 
accurately detect meaningful changes”.57 In the case of a CPR for ambulation, predictors must be 
 22 
able to differentiate between different ambulatory abilities when measured early after injury, such 
as soon after admission to IPR. Measures such as sensitivity and specificity (or precision and recall 
in multiclass cases) are often used to calculate responsiveness in classification situations. 
Understanding how a predictor is responsive to changes over time is also useful, though 
not critical, to understand when building a CPR. A measure that is stable, or does not considerably 
change over time, provides the ability to use it as a predictor at any time after injury and would 
produce the same results. These predictors represent stable characteristics that are not likely to be 
influenced by changes in neurorecovery, therapy, or other external factors. Most common 
predictors used in previous CPRs are clinical measures that are expected to change over time in 
someone who experiences neurorecovery and may be more likely to ambulate, such as strength 
and sensation.4, 5, 53, 58-63 Since someone’s strength soon after an SCI may be predictive of future 
motor recovery,47, 59, 64, 65 measures of strength may be useful as a predictor and as a clinical 
outcome measure of neurorecovery. Although these factors are not time invariant like the stable 
predictors, they change in a predictable fashion over time and may be more responsive to changes 
than other clinical measures. 
2.4.1.2 Common Clinical Measures May Not Be the Best Predictors 
The most common predictors used in CPRs are clinical measures such as MMT and LT 
scores to assess strength and sensation at specific spinal levels. These measures have the benefit 
of being able to be performed quickly and without any additional equipment and are routinely 
available in electronic health records for retrospective analyses since they are included in the 
ISNCSCI exam. However, these clinical measures of strength and sensation lack sufficient 
reliability, validity, and responsiveness to be optimal predictors of ambulatory ability. 
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Since MMT has a significant reliance on the tester’s experience, applied resistance, and 
strength, it can be an inaccurate representation of the actual strength of the muscle group.8 This 
has also led to substantial variability in the test-retest and inter-rater reliability, especially among 
muscle groups that are capable of providing larger forces, like the knee extensors and 
plantarflexors.8 This is particularly problematic since the knee extensors (L3) and plantarflexors 
(S1) are frequently included in CPRs.4, 52 
Additionally, MMT has demonstrated limited responsiveness and is prone to ceiling 
effects, which can mask small differences in strength that may be clinically relevant to detect, and 
are especially important in the application of prediction models.8, 66 For example, studies have 
shown that clinicians commonly scored an MMT as 5 (“normal”) when other measurements have 
shown muscle strength to only be 50% of the maximal contraction. Similarly, a muscle groups 
scored as of 4 (“good”) using MMT have been shown to be generating as little as 10% of their 
maximal output during the MMT.8, 67, 68 While there are other options to record an individual’s 
strength such as hand-held and Biodex dynamometry, MMT is often preferred due to its quick ease 
of use with no additional equipment, space, or expenses required.8, 69 
Due to only having a 3 point scoring scale and only assessing one domain of sensation, LT 
sensation tests have shown limited responsiveness and validity when examining neurological 
changes.9 Similar to the strength assessments, it has been shown that the tester’s experience can 
have a large influence on the test-retest reliability and that there is a positive correlation between 
the amount of tester training and the reliability.9 As LT scores are included in the most used CPRs,4, 
52 the inability to reliably assign a responsive sensory score is likely a limiting factor in the 
predictive ability of the current models. 
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Lastly, spasticity is often not included in the most common CPRs for ambulation, yet it has 
been reported as a common barrier to achieving ambulation.19, 42 In multiple populations, the 
amount of spasticity has had a significant relationship with the ability to walk70 and spasticity has 
been reported as one of the top three therapist-reported factors that interfere with therapy post-
SCI.71-74 The Modified Ashworth Scale (MAS) assigns a score based upon the resistance to passive 
movement of a joint by a clinician. The validity of this measure to quantify spasticity among 
individuals with SCI as well as limited inter-rater reliability, significant changes in reliability 
depending on the muscle being assessed and amount of tester training have brought the usefulness 
of this measure into question.75-77 Thus, the need for a more accurate measure is needed to assess 
spasticity and provide additional information for a predictive model for ambulation. 
2.4.1.2.1 Novel Predictors: LA and PPEF 
If a more responsive measure of neuromuscular impairment could be utilized early after a 
new SCI, it may give insight into the potential neurological and functional recovery that has not 
been well predicted previously.59 In multiple animal models, slight movement of a hind-limb joint 
after SCI has been found to be an early indicator of neuroplasticity that may lead to significant 
improvement in function, including the recovery of ambulation.64, 65 In humans, Waters et al. found 
that slight motor recovery soon after injury was predictive of functional motor recovery later on.59 
Inexpensive accelerometers allow for the collection of vast amounts of objective movement 
data with minimal administrative burden and have previously been used with individuals with SCI 
to quantify ambulation,78 wheelchair propulsion,79 physical activity,80, 81 sleep characteristics,82 
and activities of daily living.83 We define LA as accelerations from any limb movements occurring 
while asleep at night and may include periodic limb movements, spasms, positional shifts, rolling, 
and turning. We will focus our initial analysis on LA while asleep at night as there may be many 
 25 
factors that influence the amount of daytime LA such as an individual’s occupation and leisure 
time activities. While asleep, an individual most likely moves mostly subconsciously for comfort, 
pressure relief, or in response to other sensations.84, 85 These movements encompass aspects of 
sensation to cue the individual to move and strength to perform the movement. Additionally, it has 
been shown that supine positioning may increase spasticity, thus, spasticity may be more prevalent 
while laying down to sleep at night.86, 87 Therefore, we believe that measuring LA at night will 
provide the least biased measure of LA that is most likely to be related to impairment and 
ambulatory ability. It is important to note that when sleep studies were compared between the 
hospital and home settings, characteristics of sleep were improved at home, but the periodic limb 
movements were similar in both settings.88 This indicates that while sleep may improve once an 
individual is discharged home, the movements may not significantly change. Additionally, since 
an individual’s sleep quality may affect the intra-subject variability of LA and factors such as 
alcohol and caffeine consumption and exercise can affect sleep quality, it is important to include 
these factors in analyses including LA. 
In a population of children with Duchenne muscular dystrophy an activity monitor was 
used to calculate the frequency and amplitude of movements over the course of a week at baseline 
and one year and compared to measures of functional capacity. A moderate to good relationship 
was found between the intensity of movements and both knee extension strength and the 6-minute 
walk test (6MWT, measure of walking endurance), demonstrating the strong potential for LA to 
be related to neuromuscular impairment and functional mobility.89 
Also missing from current models that predict ambulation after SCI is any consideration 
for PPEF that may impact training, challenge, and/or enhance the sustainability of walking for 
functional mobility. Many factors may influence whether an individual may walk such as 
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resilience, self-efficacy, coping strategies, social support, home and community 
accessibility/barriers, socioeconomic status, comorbidities, pain, and sleep quality, and none of 
these factors are included in current CPRs.10-12, 90, 91 While studies have evaluated the influence of 
PPEF in the SCI population,92-97 how PPEF affect mobility outcomes has not been examined.  
Aim 1 evaluated the association between LA and neuromuscular impairment (strength, 
sensation, and spasticity) in a sample with chronic SCI to establish that LA is a clinically 
meaningful measure. Aim 2 evaluated the use of LA and PPEF to classify categories of functional 
ambulation among a sample with chronic, motor incomplete SCI. Aims 3 and 4 established the 
reliability and stability of LA when measured acutely (Aim 3) and explore the utility of LA 
collected at admission to IPR as related to ambulatory ability at 6-months post-discharge (Aim 4). 
Although it was not assessed in a longitudinal sample in this dissertation, PPEF was also collected 
and is planned to be included in a future CPR using both PPEF and LA measured at admission to 
IPR to predict long-term functional ambulation. 
2.4.2 Biased Sample Populations 
As previously mentioned, predictions using clinical judgment are most inaccurate for 
individuals with motor incomplete SCI and the van Middendorp CPR does not substantially 
improve predictions or clinical utility for this population.37, 42, 48 An analysis of the van Middendorp 
CPR by Phan et al. found that the disproportionately high number of individuals with low (AIS A, 
49% of derivation population) or high (AIS D, 22% of derivation population) probabilities of 
walking included in those CPRs led to the misleadingly high predictive accuracies when all AIS 
classes were presented as a single cohort.6 However, when a new cohort of 675 patients were 
predicted using the van Middendorp CPR the AUC were .730, .691, .850, and .516 for AIS classes 
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A, B, C, and D, respectively. The drastic decrease in AUC values compared to those reported by 
van Middendorp et al., demonstrates the bias of previous CPRs. This has caused a misperception 
that these models will produce accurate results for individuals with any AIS grade injury, when it 
appears its accuracy largely depends on the AIS class and is often not accurate for those with 
incomplete SCI.  
2.4.2.1 Targeted Sample Population 
Individuals with incomplete injuries present with varying degrees of strength and sensation 
initially and are most likely to experience neurologic recovery, thus making prediction of 
ambulation difficult.19, 37, 39, 98 Therefore, individuals with incomplete SCI would most benefit from 
a better understanding of ambulatory prognosis.19, 98 We carefully targeted individuals for all aims 
with a variety of impairment levels and functional abilities such that our analyses are not biased 
towards only those with AIS A or D injuries. Additionally, while most CPRs only include 
individuals with traumatic SCI, the clinical utility of the van Middendorp CPR was highest when 
used among a sample with non-traumatic SCI.42 Therefore, participants with both traumatic and 
non-traumatic non-progressive SCI will be included in the studies. Those with progressive SCI 
(e.g., spinal tumor) were not included because their level of impairment can change over time 
which results in CPRs not being clinically useful in this population. 
For Aims 1 and 2, a sample with chronic SCI was utilized because these participants can 
be recruited in larger numbers, tested cross-sectionally, and ensure a diverse range of functional 
abilities are collected. For Aim 1, participants were enrolled regardless of level of injury to ensure 
that we captured the full range of impairment. To ensure the distribution of impairment scores in 
Aim 1 was not overly skewed by the low scores from the motor complete SCI population, we 
enrolled those participants in lower proportions than the motor incomplete SCI sample. For Aim 
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2, the sample consisted of motor incomplete SCI as those with motor complete injuries were not 
likely to be walking and a future CPR would only focus on those with incomplete SCI.99, 100  
For the longitudinal study (Aims 3 and 4), only participants with incomplete SCI (AIS B, 
C, or D) or for whom a walking prognosis was not clear were included. Additionally, the current 
analysis of the longitudinal study is a pilot analysis as part of a larger study. Data collection of this 
population is still ongoing to enroll enough participants to build a CPR that is only targeting the 
those with incomplete SCI who would benefit from improved mobility prediction the most. 
2.4.3 Non-functional Ambulatory Outcome 
Another area for improvement in current models is that they only provide a binary 
assessment of the ability to ambulate short distances independently and do not predict important 
characteristics of gait such as need for assistance, speed, or endurance.4, 5, 36, 45-47, 53 The van 
Middendorp CPR and others that attempt to predict household ambulation (short distances of 32-
150 feet indoors) are inherently flawed, as community mobility is generally of greater importance 
to individuals with SCI and clinicians.37 This could lead to negative psychological consequences 
for individuals if they are not able to achieve community ambulation.19, 101 Previous CPRs may be 
misleading and may guide the focus of therapy towards gait training and away from more 
functional wheelchair-based interventions. If an individual is only able to ambulate a short distance 
with a slow gait speed or requires significant bracing or assistive devices to walk, then walking 
may not be the most efficient mode of mobility, despite the potential to ambulate independently 
(i.e., without physical assistance or supervision from another person). Phan et al. noted that using 
a binary instead of a continuous outcome may not be truly indicative of an individual’s recovery 
and reduces the subtleties in differences between the two functional abilities.6 Therefore, CPR 
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outcomes should give a more thorough, non-binary description of an individual’s ability to achieve 
functional ambulation in terms of the need for assistance, gait speed, and walking endurance. 
2.4.3.1 Functional Ambulatory Outcomes 
Three measures of ambulatory ability were used to provide a comprehensive understanding 
of the likelihood of gaining functional ambulation, including the need for assistance (devices, 
bracing, or hands-on assistance from a caregiver), speed, and endurance. We used a triad of 
measures to capture these constructs, as the Walking Index for SCI II (WISCI-II), 10 meter Walk 
Test (10mWT), and 6MWT which have collectively been reported as the most comprehensive 
ambulatory assessments for individuals with SCI.102-104 Although keeping the measures as 
continuous outcomes is ideal for providing the most thorough prediction possible, continuous 
outcomes are likely too variable to be able to predict accurately without an extremely large sample 
population that was not feasible for the current studies. Therefore, we were mindful when 
categorizing the ambulatory outcomes to ensure that the categories still increased resolution over 
current binary CPR outcomes and provided a comprehensive description of functional 
ambulation.2, 105, 106 
2.4.4 Suboptimal Model Evaluation and Validation 
Most current CPRs could benefit from more advanced analytical methods to build and 
evaluate the prediction model. Logistic regression is commonly used to produce a mathematical 
equation that can predict the probability of walking (binary outcome).4, 5 This standard statistical 
technique is generally the only algorithm assessed, has difficulty handling large or high 
dimensional datasets without additional regularization, and requires statistical assumptions to be 
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met.107 Phan et al. noted that using logistic regression models and small numbers of clinical 
variables as predictors may not be sufficient to produce an effective CPR and that new variables 
and machine learning models may be useful.6  
Additionally, most CPRs use only AUC and/or OCA as the primary metrics to evaluate the 
predictions. It has been suggested that AUC may be a misrepresentation of the model performance 
and that it should only be presented in combination with other measures such as sensitivity and 
specificity for binary outcomes or precision and recall for multiclass outcomes.6, 108 Both AUC 
and OCA can also be significantly affected by imbalanced data. For example, as explained in 
Section 2.4.2, the van Middendorp CPR appeared to perform accurately for all participants when 
viewing the AUC for the entire sample. When each AIS class was examined individually, it was 
found that the portion of the sample that had AIS A injuries skewed the overall results due to that 
portion of the sample being much larger and better predicted than the other AIS grades.109 
Reporting a variety of metrics that evaluate different aspects of the results including group-level 
classifications will provide a more accurate and comprehensive understanding of performance. 
While the van Middendorp CPR was validated with a separate test set, many of the other 
CPRs were not. If a model is intended for use in the prediction of unseen data, then you cannot 
fully understand how it is expected to perform until it is assessed using a held-out test set that was 
not included in building the model. Methods such as cross-validation can estimate this 
performance, but all model building steps must be performed inside each cross-validation fold 
(nested cross-validation) or the model will be biased. Issues such as model overfitting may result 
in overly-favorable training set performances. Without sufficient validation from a held-out test 
set of data, biased or overfit models may lead to reporting overly-optimistic results when the model 
is unlikely to perform as well in practice with new samples.4, 53, 109 
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2.4.4.1 Machine Learning and Model Evaluation 
Machine learning is a field of computer science in which patterns and predictions occur by 
learning from data. This “learning” occurs by unveiling possible hidden structure or regularity 
patterns in an automated manner. Machine learning is useful for large data sets or when the data 
set has a wide number of attributes that cannot be efficiently analyzed using traditional statistical 
techniques.107 Machine learning techniques are often used in the analysis of accelerometer data to 
detect and classify activities with high degrees of accuracy (often >90%).110-114 Accelerometer data 
has been analyzed using machine learning techniques in the SCI population specifically.83, 115, 116 
Generalization is often pursued empirically through training and testing datasets, making the 
prediction robust on unseen data. Since we are using small datasets or many more potential features 
than samples, we can use machine learning methods that reduce dimensionally and assess our 
results on unseen data in an unbiased fashion. Additionally, we will report outcomes per-class as 
appropriate using multiple metrics to provide a comprehensive view of model performance and 
accuracy. 
2.5 Impact of Improved CPRs for Ambulation on Clinical Practice 
The ultimate innovation of this proposal comes from applying the aforementioned 
techniques to a clinical problem that is directly impacting patient care and outcomes for individuals 
with SCI. This dissertation aims to provide essential knowledge about LA to support the future 
development of a CPR to assist clinicians in planning care and helping to ensure individuals with 
SCI are provided with evidence-based and patient-centered interventions. These measures of 
ambulatory ability can help clinicians to set real-world expectations for patients by comparison 
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with easily understood constructs like the time it takes to cross the street, average able-bodied 
walking speed, and the need for bracing and equipment. This added information can serve to 
bolster patient motivation when walking is achievable and set realistic expectations when other 
mobility interventions like wheelchair skills are more appropriate. 
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3.0 General Experimental Methods 
Portions of this chapter are reprinted from Archives of Physical Medicine and 
Rehabilitation, In Press Journal Pre-Proof, Rigot SK, Boninger ML, Ding D, McKernan G, Field-
Fote EC, Hoffman J, Hibbs R, Worobey LA, Towards Improving the Prediction of Functional 
Ambulation after Spinal Cord Injury Through the Inclusion of Limb Accelerations During Sleep 
and Personal Factors, Copyright (2021), with permission from Elsevier. 
 
Although the analyses and subject populations differ between the cross-sectional (Aims 1 
and 2) and longitudinal (Aims 3 and 4) studies, the data collection was largely the same. At each 
time point, participants completed questionnaires, clinical measures, ambulatory assessments as 
able, and wore accelerometers continuously for up to 1 week. The cross-sectional study 
participants completed this process once, while for the longitudinal study data was collected upon 
admission to IPR, just prior to discharge, and 3-, 6- and 12-months post-discharge. For the 
longitudinal study, the admission and discharge collections were targeted to occur in the first and 
last weeks of the IPR stay, respectively, with the questionnaires, clinical, and ambulatory 
assessments occurring as close to beginning or end of the week as possible. Follow-up collections 
for the longitudinal study began within 3 weeks before or after the target date. The cross-sectional 
study utilized participants with chronic SCI (any severity for Aim 1, motor incomplete for Aim 2), 
while the longitudinal study (Aim 3 and 4) was among individuals with acute, incomplete SCI. 
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3.1 Questionnaires 
Participants self-reported demographic characteristics and PPEF using questionnaires. 
Table 3.1 describes the questionnaires used in the cross-sectional study and which variables were 
extracted from each questionnaire. Similar questionnaires were collected at each time point in the 
longitudinal study. Since these questionnaires were not used in the current analyses, they are not 
described specifically.  
PPEF assessed included personal and health characteristics,33, 54, 97 socioeconomic 
status,117-119 pain,120, 121 environmental facilitators/barriers,122 physical and mental health,123 social 
support,124 self-efficacy,125 and resilience.126 These factors represent physical and psychological 
domains that may influence walking outcomes. For the pain questionnaire, Craig Hospital 
Inventory of Environmental Factors- Short Form, and Pittsburgh Sleep Quality Index (PSQI), 
having a higher score is associated with a less favorable outcome, while for the Medical Outcomes 
Study 36-Item Short-Form Health Survey (SF-36), Medical Outcome Study Social Support 
Survey, Moorong Self-efficacy Scale, and Spinal Cord Injury- Quality of Life Resilience Short 
Form a higher score is associated with a more favorable outcome. These factors were selected as 
they are stable and unlikely to change substantially after an acute SCI, making them more likely 
to be useful in a longitudinal CPR.117, 122, 126-131  
To evaluate other factors that may contribute to nighttime movements, participants were 
asked to complete a questionnaire each night that asks about medication use,132 alcohol and 
caffeine consumption,133-135 amount of daily activity, participation in sports,134 and fatigue level.136 
Participants could also record times that the accelerometers were removed during the day to 
improve compliance monitoring and analysis. For each morning of accelerometer data collection, 
participants completed a sleep log that records the time they went to sleep and woke up, the self-
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reported quality of sleep that night, and if they considered that night to be “typical” of how they 
normally sleep.137 Participants were called, emailed, or checked on in-person most days during 
their data collection to assist in completing the daily questionnaire and sleep log as needed. In 
combination, these measures will allow us accurately determine times asleep and capture external 
factors that may influence movements during sleep. 
Table 3.1: Self-reported demographic and PPEF questionnaire variables used in the analyses. Variables that 
are commonly found in an elctronic health record are shown in grey and questionnaire-specific PPEF 
variables are shown in white. 
Measure Description Components Included in Analyses 
Demographics33, 54, 97, 117-
119 
Personal, health, and SCI 
characteristics, measures of 
socioeconomic status 
• Age 
• Annual household income 
• Body mass index (BMI) 
• Comorbidities (if present): 
o Any 
o Cardiopulmonary 
o Depression or Anxiety 
• Highest education completed 
• Household size 
• Marital status 
• Medical insurance type 
• Metropolitan classification 
• Race/ethnicity 
• SCI level of injury (tetraplegia/ paraplegia) 
• Sex 
• Veteran status 
• Years since injury 
Pain Questionnaire120, 121 Pain intensity over the last week 
using components from the 
International SCI Pain Basic 
Dataset and Brief Pain Index 
• If pain present 
• Average pain intensity  
• Number of pain locations 
Pain Questionnaire120, 121 Pain interference over the last 
week using components from the 
International SCI Pain Basic 
Dataset and Brief Pain Index 
• Pain interference with respect to: 




o Social activity 
Craig Hospital Inventory 
of Environmental 
Factors- Short Form122 
Barriers and facilitators to 
participation (accessibility, 
accommodation, resource 
availability, social support) 
• Frequency score 
• Magnitude score 




Table 3.1 Continued 
Measure Description Components Included in Analyses 
Medical Outcomes Study 
36-Item Short-Form 
Health Survey (SF-36)123  
Assessment of physical and 
mental health 
• Domain scores: 
o Emotional role limitations 
o Energy/fatigue 
o General health perceptions 
o Mental health 
o Pain 
o Physical functioning 
o Physical role limitations 
o Social functioning 
Medical Outcome Study 
Social Support Survey124 
Assessment of various 
dimensions of social support  
• Overall support index 
• Subscales: 
o Affectionate  
o Emotional/informational 




Belief in an individual’s ability to 
achieve desired outcomes 
Converted to percent of maximum score: 
• Total score 
• Subscales: 
o General 
o Personal function  
o Social function 
Pittsburgh Sleep Quality 
Index (PSQI)138  
Subjective sleep characteristics 
over the past month  
• Global score (sum of 7 components) 
• Overall sleep quality (global score >5 [poor 
sleep quality] or ≤5) 
• Components: 





o Sleep quality 
Sleep/Activity Log132-134, 
136, 137 
Log of factors that are known to 
affect sleep that is completed 
each day of the data collection 
• Dichotomized to if it occurred over the 
collection period (yes/no): 
o Alcohol use (in 6 hours prior to sleep) 
o Caffeine use (in 6 hours prior to sleep) 
o Exercise 
o Sleep medication use 
• Averaged over nights collected (score 0-10) 
o Fatigue rating 
o Sleep rating 
Spinal Cord Injury- 
Quality of Life 
Resilience Short Form126 
An individual’s ability to 
psychologically adapt to their 
SCI 
• Total t score 
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3.2 Clinical and Ambulatory Assessments 
3.2.1 Clinical Assessments 
Clinical measures included MMT, LT, and MAS scores, to assess strength, sensation, and 
spasticity, respectively (Table 3.2).33, 34 Scoring for each clinical assessment is described in Table 
2.1. The strength and sensation assessments were completed as described by the ISNCSCI for 
Aims 3 and 4; for the cross-sectional study due to setup constraints, they were completed with the 
participant in a seated position. 
Table 3.2: Clinical variables used in the analyses 
Assessment Description Components Included in Analyses 
MMT Motor and LT 
Sensation scores33 
Clinical measures of 
strength and sensory 
impairment 
• Key muscles/sensory points from each level from L2-S1  
• Knee flexion (MMT only) 
• Lower extremity score (sum of scores from L2-S1) 
• Upper extremity score (sum of scores from C5-T1) 
• SCI severity (AIS A, B, C or D calculated from clinical exam) 
MAS34 Clinical measure of 
spasticity (score of 
1+ treated as 1.5) 
• Ankle plantarflexors  
• Knee flexors 
 
3.2.2 Ambulatory Assessments 
Participants who self-reported the ability to walk completed WISCI-II, 10mWT, and 
6MWT, to assess their need for assistance (physical assistance, bracing, or AD), speed, and 
endurance, respectively.102, 104 Participants were able to use their normal bracing and equipment. 
The WISCI-II is a hierarchical scale with the minimal score of 0 indicating “unable to stand and/or 
participate in assisted walking” and a maximal score of 20 indicating “ambulates with no devices, 
no braces and no physical assistance, 10m.”102, 104 For the 10MWT, participants were instructed to 
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walk 10 meters at their preferred pace while their speed was timed. For the 6MWT, participants 
were instructed to ambulate as far as possible on a level, straight surface for 6 minutes (inclusive 
of standing rest breaks) and the total distance walked was recorded.102, 104 Participants received a 
score of 0 on all 3 tests if they were non-ambulatory. Participants were allotted as many breaks as 
needed between tests to ensure the clinical and ambulatory assessments were minimally affected 
by fatigue. All 3 ambulatory ability assessments have demonstrated excellent inter- and intra-rater 
reliability and good responsiveness to detect changes in locomotion.102-104 Additionally, the 
10mWT and 6MWT have often demonstrated strong correlations to each other, however they have 
been found to capture different aspects of ambulatory ability and are both important to include.103 
When possible, the measures of ambulatory ability were kept as continuous outcomes. 
(Aim 4). However, at times to maximize the clinical utility of the models and to avoid overfitting 
while still providing increased resolution over current binary CPR outcomes, we categorized the 
WISCI-II, 10mWT, and 6MWT into 3 clinically relevant divisions based on current literature 
(Table 3.3, Aims 2 and 4b).2, 103, 105, 106  
Table 3.3: Categorical measures of ambulatory ability 
Measure Category Description 
Walking Index for SCI II (WISCI-II) Requires physical assistance (or non-ambulatory) 
Requires an AD, but no physical assistance 
Requires no AD or physical assistance 
10 meter Walk Test (10mWT)103, 105 Non-ambulatory (0 m/s) 
Household ambulator (0.01 - 0.44 m/s) 
Community ambulator (> 0.44 m/s) 
6 Minute Walk Test (6MWT)2, 106 Non-ambulatory (0 m) 
Household ambulator (1 - 204 m) 
Community ambulator (> 204 m) 
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3.2.3 Assessors for Clinical and Ambulatory Measures 
For the cross-sectional study, nearly all clinical and ambulatory assessments were 
completed by one of two physical therapists on the research team. For the longitudinal study, the 
inpatient clinical and ambulatory assessments were extracted from the electronic health record 
when available to decrease participant burden and because these same measures utilized in the 
study are routinely collected in our IPR unit. Research staff were able to monitor some of these 
assessments to ensure they were being completed and recorded correctly.  
Due to the COVID-19 pandemic and restrictions placed on in-person research, the follow-
up data collections for the longitudinal study were collected remotely for many participants. If 
participants were attending physical therapy (home health or outpatient) and provided permission, 
then we coordinated the collection of the clinical and ambulatory assessments with the 
participant’s physical therapist. If the participant was not attending physical therapy, then they 
were given the option to self-assess the ambulatory tests. Participants were provided with a pre-
measured string with markers to ensure that the distance and portions measured were correct. They 
were also provided ample verbal and written instructions including pictures and examples. Due to 
the excellent reliability of the ambulatory measures, differences in raters were not likely to 
substantially impact the consistency of the assessments.102-104 When completing a remote data 
collection, if the participant was not attending physical therapy or had a recent medical visit where 
these measures were recorded, then we were not able to obtain the strength, sensation, and 
spasticity measurements as they cannot be self-assessed.  
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3.3 Measuring LA 
3.3.1 Wearable Sensors 
ActiGraph GT9X Link tri-axial accelerometers were worn on the non-dominant wrist and 
both ankles continuously for 1-7 days (Figure 3.1 and Figure 3.2).139, 140 Bilateral ankle monitors 
were used to account for asymmetric impairments, while upper limb accelerations were measured 
to account for whole-body movements such as rolling. The non-dominant wrist was used to 
minimize the noise from non-purposeful movements that may affect the measurement of activities 
such as counting steps during the daytime. 
 For the cross-sectional study, the ankle accelerometers are worn on the lateral sides of the 
ankles and secured by a padded, adjustable velcro strap. Although not utilized in the present 
analysis, a Modus StepWatch activity monitor was also used in the longitudinal study to measure 
steps and other walking-related metrics. The StepWatch must be worn on the lateral side of the 
ankle of the stronger (or dominant if equal strength) lower limb the for best accuracy. For the 
longitudinal study, the ActiGraphs were worn on the medial side of both ankles and adjustments 
were made to the axis orientation in the analysis to account for the different positioning.  
The accelerometers were only to be removed for periods of water exposure and participants 
were not to modify any of their normal activities. Participants were instructed in safe use and 
donning/doffing of the devices and were provided with printed instructions to ensure skin integrity 
and proper placement. Additionally, for the longitudinal study, clinical staff working on the IPR 
unit where inpatient data collection occurred were trained on proper use and placement of all study 
devices to assist participants as needed. All study materials were returned at the end of the data 
collection period in-person or via a pre-paid USPS envelope. 
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a)  
b)  c)  
Figure 3.1: Examples of proper accelerometer placement on a) the non-dominant wrist for both studies, b) 
the lateral ankles for the cross-sectional study (Aims 1 and 2), and c) the medial ankle for the longitudinal 
study (Aims 3 and 4, lateral ankle shows StepWatch activity monitor that was not used in the current 
analysis). The ankle accelerometers are marked by yellow velcro for easier identification of proper 
placement.  
a) b)  
Figure 3.2: Examples of the gravitational vector orientation for the ActiGraph GT9X Link accelerometer for 
the right ankle of a participant when laying a) supine and b) sidelying on the left side with his or her head on 
the left side of the page and feet on the right side. The accelerometers are worn and computationally adjusted 
as needed such that, the x axis runs anterior-posterior, the y axis runs superior-inferior, and the z axis runs 
medial-lateral. 
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In the SCI population, ActiGraph sensors have been safely used to assess physical activity 
and energy expenditure among wheelchair users81, 141 and sleep assessment among individuals with 
tetraplegia.142 ActiGraph accelerometers were also shown to have excellent agreement with 
manually counted steps during physical therapy sessions in IPR among individuals with 
incomplete SCI.143 Additionally, the ActiGraph sensors have been shown to be accurate in 
predicting in-lab versus at-home activity in ambulatory participants with incomplete SCI.115  
For these analyses, only the period while the participant was asleep at night was analyzed 
to minimize biases that might be present in daytime data based on the individual’s therapy, 
interests, or occupation and not their actual abilities. Due to the nature of SCI and the spasticity 
that often is associated, participants presented with extreme variation in the number of movements 
per night with some participants having several hundred and some having very few.140 This 
variation often caused substantial under or over-estimates of sleep times when automatically 
detected by algorithms. Therefore, the sleep logs were utilized as the primary method to determine 
when the participants were asleep, while sleep detection algorithms and visual analyses were used 
to manually adjust times if needed.140 To account for any changes to sleep patterns from 
participants not being in their home environment or otherwise having unusual sleep, only nights 
identified as “typical” on the sleep log were included in the analysis. 
3.3.2 Pre-processing and Feature Extraction 
Drawing from previous analyses,89, 111, 112, 144-163 we identified LA as accelerations from 
any limb movements occurring while asleep, which could include rolling, turning, periodic limb 
movements, spasms, and positional shifts. LA pre-processing and feature extraction steps are 
described in (Figure 3.3). Using Matlab 2020a, raw accelerations (sampled at 30 Hz, Figure 3.4) 
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from all limb accelerometers were band-pass filtered (0.25-10 Hz) to analyze only accelerations 
that are likely due to human movements (i.e. removing gravitational accelerations and high 
frequency noise) and the vector magnitude was calculated from each monitor over the collection 
period.111, 162, 163 The start and end of each movement was identified as when the standard deviation 
(SD) of the magnitude in a moving window was greater or less than pre-defined thresholds (Figure 
3.5). Thresholds were determined by visually identifying the values that corresponded to the initial 
increase in acceleration magnitude (SD > 0.03 m/s2) and return to baseline (SD < 0.02 m/s2). To 
ensure the movement was not artifact, the SD had to be above the thresholds for at least 0.5 
seconds.144 The movement was discarded if the root mean square (RMS) of the movement 
magnitude was not at least equivalent to the local RMS of the noise plus two SD as accelerations 
that are this small may not represent true movement. Movements were combined if they occurred 
within 2 seconds of each other.112, 144 
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Figure 3.3: Flowchart showing the analysis steps for LA feature extraction from raw accelerations. 
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Figure 3.4: Raw accelerations from 1 ankle across portions of 3 days with green and red lines indicating the 
start and end of each night of sleep, respectively. 
 
 
Figure 3.5: An example of acceleration magnitude for 1 movement indicated by the start (green) and end 
(red) lines. 
 
Features were calculated from each identified movement episode based upon features 
previous used in PLM, gait, sleep assessment, and other accelerometer analyses.89, 111, 112, 144-163 
This resulted in 98 LA features being extracted from each movement measured from each 
accelerometer throughout the night for each “typical” night collected. Although some machine 
learning analyses can utilize many related samples per participant, these models are likely to 
overfit given our sample size and are not applicable to all of the planned analyses.164-167  
Based on preliminary analyses, we determined that the best method to result in 1 set of 
representative, yet stable features per participant was to use the median and interquartile range 
(IQR) of each feature across all movements from either lower limb per night then across all 
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“typical” nights per collection to result in 196 features per participant. We assessed the use of only 
the stronger/weaker or dominant/non-dominant limbs, but found the best preliminary results when 
combining the limbs such that all movements identified by either lower limb per night had LA 
features extracted before being condensed into 1 set of representative movement features per night 
using the median and IQR. Other methods assessed to combine individual movements into 1 
feature set per participant were to take the mean and SD across all movements per night and then 
across all typical nights or to take the median/IQR or mean/SD of all movements across the 
collection without separating by night. Additionally, we also counted the number of movements 
that fell into sized bins per category (e.g., short, moderate, and long duration movements), but due 
to the arbitrary nature of assigning the cutoff values for many features, this was not utilized.  
Features that were visually examined to have high within-subject variability (indicating an 
unreliable feature) or low between-subject variability (uninformative feature) when examined 
visually using boxplots were excluded. Some of the features provided detailed information 
regarding the direction and type of movement being performed were likely not reliably measured 
due small variations in the accelerometer position on the ankle throughout the night or occasional 
misplacements of the accelerometers noted mostly in the acute setting for the longitudinal analysis. 
Thus, the positional features that remained in the analysis were ones that related to overall changes 
in position and were robust to small fluctuations in accelerometer positioning. For example, the 
features quantifying the pre-movement angles with respect to each axis were initially calculated to 
provide information regarding a participant’s position (e.g., supine, side-lying, etc.). However, if 
the accelerometer is moved slightly on the limb, then this information was inaccurate or 
inconsistent. Thus, these features were removed, but features that measured the total change in the 
angle or gravitational vectors remained since those features were not as sensitive to the exact start 
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and end positions. Additionally, some features were removed that were found to be repetitive with 
another feature (highly correlated, but not identical features were still included at this stage). This 
all resulted in the exclusion of 63 features and a final LA feature set of 133 features being included 
in further analyses. Those 133 LA features are described in Table 3.4. The “Feature Short Name” 
is the name used to reference the LA feature throughout the dissertation.
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Table 3.4: Descriptions and abbreviation key of LA features extracted and included in the analysis. “Feature Short Name” is the name used to reference 
the LA feature throughout the dissertation. All features are calculated per ankle accelerometer and per movement and combined by taking the median 
and IQR across nights unless otherwise noted (* indicates a feature calculated per night, † indicates maximum across nights also calculated). 
Feature 





Net Angle Net Change Change from the start and end position angles Larger net change in body position 
Rate Angle Rate Change Total change in position divided by duration of 
movement 
Faster positional changes 




154, 159, 162 
x Grav Change X Describes changes in body positions with 
respect to the gravitational (DC) vector 
Larger change in proportion of 
gravitational vector in each direction y Grav Change Y 




154, 160, 162 
x-y Corr XY Describes the relationship between axes during 
a movement 
Movements occurring in more 
consistent directions x-z Corr XZ 




Bandwidth Bandwidth Range of frequencies that contain 95% of the 
total power 
Movements use a larger range of 
frequencies 
Centroid frequency Centroid Freq Frequency that divides the spectral power 
distribution into two equal parts 
Higher frequency movements 
1st dominant frequency Dom Freq 1 Frequency at maximum spectral power 
2nd dominant frequency Dom Freq 2 Frequency at 2nd highest peak of spectral 
power 
Dominant frequency in low 
frequency range 
Dom Low Freq Isolating just frequencies most likely to 
contain human movements (0.6-2.5 Hz) 
Mean/Median frequency Mean Freq, Med Freq Estimate of mean/median normalized 
frequency 
Ratio power at dominant 
frequency to total 
Power Dom Freq 1/ Total Proportion of the total power that occurs at the 
dominant frequency 
Higher proportion of the total energy 
occurred at the dominant frequency 
Power at 1st dominant frequency Power Dom Freq 1 Maximum power More powerful movements 
Power at 2nd dominant frequency Power Dom Freq 2 Max power at 2nd highest peak of power 
spectrum 
Power at dominant frequency in 
low frequency range 
Power Dom Low Freq Power at frequencies most likely to contain 
human movement (0.6 - 2.5 Hz) 
Ratio of high frequency power to 
total 
Power High Freq/Total Proportion of power that may likely be noise 
and not produced from movement (> 3.5 Hz) 
More noisy movement signals 




Table 3.4 Continued 
Feature Category Feature Feature Short Name Feature Description Larger value indicates… 
Limb movement 
percentages 
Bilateral ankle Bilat Ankle % Proportion of movements where both 
ankles are moving simultaneously 
Possible increased synergistic 
movements or lack of motor control to 
isolate limbs independently 
Unilateral ankle Unilat Ankle % Proportion of movements where only the 
unilateral ankle is moving 
Possible increased spasticity or strength 
on one lower limb 
Wrist and bilateral ankles Whole Body % Proportion of whole body movements (i.e., 
rolling) 
More whole body movements 
Wrist and unilateral ankle Wrist Ankle % Proportion of movements where both the 
ankle and wrist are moving simultaneously 
Possible increased strength on one side of 
the body 
Median crossings 
89, 149, 150 
Number of crossings Num Med Crossings, 
Num Med Crossings Norm 
Measure of movement smoothness Less smooth movements 
Periodic limb 
movements 
(PLM) 112, 152 
* Number of series Num PLM Norm Total number of movements meeting 
approximate criteria to be defined as PLM 
More series of short, repetitive 
movements (likely spastic or PLM) 
* Index PLM Index Total number of movements meeting 
approximate criteria to be defined as PLM 
divided by the number of hours asleep 
(>15 events/hour is indicative of possible 
dysfunction) 
* Percentage of movements PLM % Percent of all movements occurring during 
the night that could be classified as PLM 
Higher proportion of total movements are 
occurring in short, repetitive series (likely 




147, 149, 160, 162 
Dominant frequency in last 90s Dom Freq Last 90s Frequency of recent movement series More movements occurring in series 
Cross-correlation/ covariances 
in last 90s 
Close Cross Cov/Corr Peak, 
Max Cross Cov/Corr, 
Mean Cross Cov/Corr Peaks 
Num Cross Cov/Corr Peaks 
Similarity between recent movement 
(calculates: maximum value, closest and 
mean peak values, number of peaks) 
More similar/repetitive recent movements 
Number of movements in last 
90s 
Move Last 90s Quantifies if movement occurred as part of 
a series 
More short, frequent movements are part 
of a series 




Entropy rate Entropy Rate Measure of signal regularity More regular movement accelerations 
(samples within a movement are more 
related and less random) 
Lempel-Ziv complexity Lempel-Ziv Comp Measure of complexity-probability Less predictable, more complex 
accelerations 
Maximum Lyapunov exponent Lyapunov Exp Measure of local dynamic stability 
(sensitivity to perturbations) 
More chaos/divergent accelerations, less 
stable 
Wavelet energy Wave Approx, 
Wave Energy 1, Wave 
Energy 2, Wave Energy 3 
Approximation, 1st - 3rd details of the 
wavelet transform to evaluate the relative 
energy in each time-frequency band 
Higher energy concentration 
Wavelet entropy Wave Entropy Measure of signal disorder More random process/more disorder 
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Table 3.4 Continued 
Feature 
Category Feature Feature Short Name Feature Description Larger value indicates… 
Statistical 146, 147, 
149-153, 162 
Area under the curve AUC Acc, 
AUC Acc Norm 
Total change in velocity Larger total change in speed 
Signal magnitude area SMA Acc 
Duration † Duration How long each movement lasts Longer movements 
Kurtosis Kurtosis Describes weight of the movement's tails 
relative to the center of the movement 
More widely spread accelerations (less 
distinguishable max value) 
Maximum to RMS Max-RMS Acc Measure of movement smoothness More jerky movements 
Maximum Max Acc Measure of acceleration magnitude Larger changes in speed 
Range Range Acc Maximum to minimum acceleration 
Median Med Acc Median of acceleration magnitude Larger magnitude movements 
Root mean square (RMS) RMS Acc RMS of acceleration magnitude 
SD SD Acc Variability of acceleration magnitude Larger variation within movements 
Skewness Skewness Describes the symmetry of the temporal 
spread of a movement 
Positively skewed movements: largest 
acceleration for movements occur early 
and then there are longer slow-down 
periods 
Timing 112, 156, 162 * Number of movements Move/night, Move/hour Number of movements (calculates: 
movements per night, movements per hour) 
More movements 
When movements occurred in 
night 
Start Move %, 
End Move % 
Determine if movement are clustered in a 
certain portion of the night or well 
distributed 
Movements occur later in the night 
* Time asleep Time Asleep Hours asleep Longer time asleep 
Velocity and 
distance 155, 156 
Median velocity Med Vel Movement speed Faster movements 
RMS velocity RMS Vel 
Total distance Total Dist Total meters traveled Further distance moved 
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4.0 Cross-Sectional Study Among Individuals with Chronic SCI 
4.1 Study Population 
Participants were recruited locally using a research registry as well as at the 2018 and 2019 
National Veterans Wheelchair Games and the 2019 National Disabled Veterans Winter Sports 
Clinic. Participants were enrolled if they were at least 18 years of age, had a chronic (≥ 1 year), 
non-progressive SCI. Participants were excluded if they had a medical diagnosis of a condition 
that may affect sleep (e.g., sleep apnea or restless leg syndrome), were unable to wear activity 
monitor devices on wrist and ankles continuously for up to 1 week (e.g., due to autonomic 
dysreflexia or sores), or had an injury to the legs that would significantly impair ambulation (e.g., 
amputation or severe trauma). If the individual had a lower extremity motor score (LEMS) of zero 
(no voluntary movement) they were classified into the motor complete SCI group, otherwise if 
some voluntary lower limb movement is present, they were classified into the motor incomplete 
SCI group. All participants completed informed consent as approved by the VA Pittsburgh 
Healthcare System Institutional Review Board.  
4.2 Sample Size Considerations 
Traditional statistical models can be used as a conservative method for estimating power 
with machine learning approaches. This is especially true when considering that machine learning 
techniques tend not to require as large of sample sizes to produce accurate results.168 Since Aims 
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1 and 2 have overlapping samples, we identified the number of individuals with chronic, motor 
complete SCI from Aim 1 and the number of individuals with motor incomplete SCI from Aim 2, 
as this resulted in the largest samples needed to complete all analyses.  
For the original analysis for Aim 1, we had planned to compare LA between individuals 
with able-bodied controls and motor complete and incomplete SCI. We estimated sample size for 
Aim 1 using a one-way ANOVA with three impairment groups which required a total sample size 
of 66 participants (n= 22 in each group) to detect a significance level of α= 0.05 with power= 0.8 
and an effect size of 0.40. Using a regression model based on the analysis for Aim 2, we would 
need an estimated 58 subjects to detect a significant R2 increase (from 0) for each individual 
predictor with acceptable power (≥ 0.8), assuming small to moderate effect sizes (f2 = 0.11; alpha= 
0.1; G*Power 3.1.9.2). To ensure a final sample size of 22 participants with motor complete SCI 
and 58 with motor incomplete SCI and accounting for a 15% rate of missing or non-usable data, 
we had planned to recruitment a goal of 25 and 68 participants with motor complete and incomplete 
SCI, respectively.  
Due to funding delays, restrictions on research from the COVID-19 pandemic, and other 
recruiting difficulties, we did not achieve these goals. We were able to recruit 36 participants with 
motor incomplete SCI and 13 with motor complete SCI. Based upon preliminary results, we 
estimated the actual effect size for the analyses would be much larger (0.39 - 1.13) than was used 
for the sample size calculations, and thus our power analysis was likely conservative. Thus, we 
implemented more strict forms of cross-validation and other machine learning methods to account 
for the smaller sample size and continued the analysis with the 49 total participants with chronic 
SCI.  
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4.3 Aim 1: Association Between LA and Neuromuscular Impairment 
4.3.1 Introduction 
For decades researchers have been trying to understand which clinical variables are related 
to or able to predict long-term ambulatory ability after a new SCI. Although many different clinical 
variables have been assessed as predictors of ambulation, such as AIS/Frankel Grades,45, 48, 53, 63, 
169 demographic information such as age and sex,4, 5, 45, 58 and somatosensory evoked potentials,53 
the most common predictors are simple clinical measures of strength and sensation.4, 5, 53, 58-63 
Clinical measures such as MMT, LT, and the MAS to assess strength, sensation, and spasticity, 
respectively, are performed frequently after an SCI. These measures have the advantages of being 
quick to perform, requiring no additional equipment, and the MMT and LT are included in the 
ISNCSCI exam. 
Despite the many attempts to use strength and sensation as predictors of ambulation, 
studies have shown that these predictors are not able to consistently produce accurate predictions 
of ambulatory ability, especially among those with incomplete SCI.7, 51, 109 While these tests may 
be sufficient for clinical use, they likely lack the reliability and responsiveness needed to provide 
adequate predictions for individuals with incomplete SCI. Additionally, spasticity is not generally 
included in prediction models, despite being one of the top three therapist-reported factors that 
interfere with therapy post-SCI and its known relationship to pain and function.71-74 Spasticity can 
at times be helpful for mobility, but it can also often increase pain, lead to contractures, and 
destabilize balance which negatively affect ambulatory ability.170, 171 
We proposed that measuring an individual’s actual movement would be a more sensitive 
and responsive measure of an individual’s level of impairment than traditional clinical tests. Since 
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daytime activity can be biased by an individual’s interests, occupation, participation in 
rehabilitative therapy, and activity level, measuring movement characteristics at night may be less 
affected by these external factors. For example, a movement at night may be triggered by the tactile 
sensation of pressure building in an area of the body and then an individual must possess the 
strength to be able to voluntarily adjust their positioning.84, 85 Additionally, it has been shown that 
supine positioning may increase spasticity, thus, spasticity may be more prevalent while laying 
down to sleep at night.86, 87 Therefore, LA, defined as accelerations from any movement occurring 
while asleep at night, may be able to capture more responsive information about an individual’s 
neurological impairment than clinical measures, such as MMT, LT, and the MAS. 
To provide foundational knowledge of LA as a meaningful clinical metric, we aim to 
determine the association between LA and current clinical measures of neuromuscular impairment 
among individuals with chronic SCI. We hypothesize that features of LA such as those related to 
amplitude and duration of movements will be most strongly related to clinical assessments of 
strength, sensation, and spasticity among individuals with chronic SCI. Determining the 
relationship between clinical measures of impairment and LA will provide evidence of face, 
construct, and concurrent validity for LA and support the clinical use of LA as a predictor of 
ambulation (additional information about validity in Section 2.4.1.1). 
4.3.2 Methods 
Individuals with chronic, motor complete and incomplete SCI were included in this 
analysis as described in Sections 4.1 and 4.2. Since individuals with motor complete SCI will have 
a LEMS= 0, they were intentionally enrolled in a smaller proportion in comparison to the number 
of participants with motor incomplete SCI and LEMS > 0. Each participant completed 
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questionnaires, clinical, and ambulatory assessments as applicable during 1 in-person visit and 
then wore the ActiGraph GT9X Link accelerometers for 1-5 days as described in Section 3.0. 
4.3.2.1 Analysis 
4.3.2.1.1 Input Variables: LA and Covariates 
The raw accelerations were processed as described in Section 3.3.2 to extract 133 LA 
features per participant (Table 3.4). Since both LA and each impairment outcome were measured 
bilaterally, analyses were performed to assess independence between sides (Appendix D.1). Due 
to the high correlation between LA features and impairment outcomes between the stronger and 
weaker lower limbs and covariates assessed once per participant, only 1 sample was calculated per 
participant by combining the LA features from each limb as described in Section 3.3.2. 
Three feature sets were produced during the analysis that contain: the LA features alone, 
LA features and other possible covariates/confounders, and the covariates/confounders alone (just 
referred to as “covariates” for simplicity). Since the impairment outcomes were measured cross-
sectionally, the measurement of both impairment and LA could be affected by factors such as pain, 
demographics, sleep quality, exercise, sleep medication, or consumption of caffeine or alcohol.120, 
121, 123, 132-134, 136-138 For example, if an individual has slept poorly, they may be less able to exert 
themselves during the strength measurements, less focused during the sensation assessment which 
may introduce more error, and have atypical movements during their sleep the following night 
(e.g., less movements if sleeping more soundly). Therefore, it is important to assess how these 
covariates may affect the relationship between LA and impairment, and how much additional 
variance in impairment is explained by adding LA to the covariates. All covariates included in the 
models are listed in Appendix Table D.1.  
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All features were normalized so that all LA and covariate features carried equal weight in 
the machine learning model. Since LA needs to be reproducible for clinical use even if new 
samples are added, we scaled each feature such that the minimum value was recorded as 0 and the 
maximum as 1. 
4.3.2.1.2 Output Variables: Strength, Sensation, and Spasticity 
Measures of strength, sensation, and spasticity were used as the dependent variables in 
models as an estimate of neuromuscular impairment. Strength was quantified by the LEMS which 
sums the MMT motor scores from the L2 to S1 myotomes across both lower limbs for a score 
between 0 (total paralysis) to 50 (normal, Table 2.1, Table 3.2). Lower limb LT sensation was 
similarly calculated by summing the individual LT sensation scores from each dermatome across 
the lower limbs (L2-S1) for a total score between 0 (no sensation) and 20 (full sensation).33 
Strength and sensation scores were used as continuous outcomes.  
Spasticity was measured by the MAS for the knee flexors and ankle plantarflexors of both 
lower limbs. Since MAS had a skewed distribution in our sample with many participants having 
no spasticity, it was categorized into 3 groups: no, mild, and moderate spasticity. Participants were 
categorized as “no spasticity” if they had a MAS score of zero for all lower limb areas assessed. 
Participants were categorized as “mild spasticity” if they had some spasticity (MAS > 0) recorded, 
but all MAS scores were less than 2 for both lower limbs. Participants were categorized as having 
“moderate spasticity” if any MAS score was 2 or higher. The cutoff score of 2 was used based 
upon the finding by Baunsgaard et al., that about 80% of MAS scores reported in a sample with 
SCI had a score of 0, 1, or 1+. Therefore, if a participant had a score of 2 or higher it was above 
average and could be considered as moderate to severe spasticity.77  
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4.3.2.1.3 Machine Learning Models 
A three-step process was used to 1) determine the optimal LA and covariate features using 
algorithms with built-in feature selection, 2) reestablish the baseline model performance for just 
the selected features using algorithms without feature selection, and 3) add the selected LA features 
to the covariates model to determine the additional explained variance in each impairment outcome 
(Figure 4.1). The least absolute shrinkage and selection operator (LASSO) implemented with least 
angle regression (LARS) and logistic regression with ℓ1 regularization algorithms were utilized to 
select the important features for the continuous outcomes (strength and sensation) and categorical 
outcome (spasticity), respectively. The full description of the algorithms is provided in Appendix 
D.1. These models were chosen based upon their efficiency, ability to perform feature selection as 
part of the model building process, and ability to determine the relative strength of each selected 
feature to the impairment outcome. The coefficient values and features selected by the models can 
provide information about the relative importance of each feature as related to the impairment 
outcome. Approaches using a LASSO or similar machine learning models have been used to assess 
improvements lower limb rehabilitation using accelerometers after anterior cruciate ligament 
reconstruction.172, 173 Specifically among individuals with SCI, similar methods have been used to 
predict neurological recovery from MRI findings,174 classifying activities in-lab versus at-home 
among ambulatory participants,115 and determining the association between an unsupervised home 
sleep apnea test and sleep-disordered breathing and nocturnal hypercapnia.175  
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Figure 4.1: Impairment algorithms used for each analysis step in Aim 1 
 
For both the LASSO LARS and logistic regression with ℓ1 regularization models, 10-fold 
cross-validation was used to determine the regularization parameters and then the model was 
trained and evaluated on the full dataset. The features selected by the LASSO LARS and logistic 
regression models for each impairment outcome when including only LA or covariate features 
were recorded. To assess the variance explained by the selected covariate features and then by the 
addition of LA features, linear regression models were used for the strength and sensation 
outcomes and logistic regression without regularization was used for spasticity. Due to slight 
differences in the analysis methods, the models built using the algorithms with or without feature 
selection produce slightly different results when the same final feature sets are used. Therefore, 
models were assessed using linear regression and logistic regression without regularization and 
only the selected features from the previous models to ensure that an accurate baseline model 
performance was recorded. Those baselines would then be compared to the model performance 
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when selected LA and covariate features were combined to determine the additional amount of 
variance in each impairment outcome that was explained by adding LA compared to the model 
with covariates alone. 
4.3.2.1.4 Model Evaluation 
For the continuous strength and sensation outcomes, the coefficient of determination (R2) 
was used to determine the model’s ability to explain the variability of the impairment outcome.176 
The adjusted R2 was also assessed as a correction to the R2 for the number of features included in 
the model so that models with different numbers of features can be compared more equitably. 
Other evaluation metrics included mean and median absolute error which are calculated by taking 
the absolute value of the difference between each predicted and measured impairment score and 
then taking the average or median across the sample. Mean squared error (average of the squared 
difference between the predicted and measured score) was also included as it weighs larger errors 
more heavily. Lastly, root mean squared error was calculated as this evaluates the standard 
deviation of the prediction errors by taking the square root of the mean squared error. For each of 
the measures of error, a lower score is preferable. 
The OCA, precision, recall, and F1-score were used to describe the spasticity multinomial 
model performance (Appendix B). OCA represents the percentage of participants that were 
correctly classified. Precision represents the accuracy of the true classifications (i.e., positive 
predictive value) while recall represents the fraction of the correctly identified positive 
classifications (i.e., true positive rate, equivalent to sensitivity for binary classification). The F1-
score is the weighted average of precision and recall.177, 178 For all classification metrics, a higher 
score (range=0-1) is indicative of higher accuracy and better model performance. Additionally, the 




Thirty-six participants with motor incomplete SCI and 13 with motor complete SCI 
completed the data collection. Eight participants (n= 6 motor incomplete and n=2 complete SCI) 
were excluded because they self-reported that they had no “typical” nights recorded during the 
collection period. One additional participant with complete SCI was excluded because the 
accelerometers were likely removed at night and no movements were recorded. Data collection 
was completed for 2 participants before the spasticity measures were added to the study, so the 
spasticity analysis has 38 participants included, while the strength and sensation analyses have 40 
participants. The demographics for participants that were included in the analysis are shown in 
Table 4.1. Participants were primarily male, non-Hispanic White, Veterans, with paraplegia who 
used a manual wheelchair as their primary mode of mobility.  
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Table 4.1: Participant demographics 
Categorical Demographics 
Motor Incomplete 
n (% of group) 
Motor Complete  
n (% of group) Total N (%) 
Sex    
Female 4 (13.3) 2 (20.0) 6 (15.0) 
Male 26 (86.7) 8 (80.0) 34 (85.0) 
Race/Ethnicity    
Non-Hispanic White 14 (46.7) 6 (60.0) 20 (50.0) 
Non-Hispanic Black 10 (33.3) 3 (30.0) 13 (32.5) 
Non-Hispanic Other Race 3 (10.0) 0 (0.0) 3 (7.5) 
Hispanic (Any Race) 3 (10.0) 1 (10.0) 4 (10.0) 
Veteran    
Not Veteran 5 (16.7) 0 (0.0) 5 (12.5) 
Veteran 25 (83.3) 10 (100) 35 (87.5) 
Annual Household Income    
<$25,000 9 (30.0) 2 (20.0) 11 (27.5) 
$25,000-$49,999 3 (10.0) 5 (50.0) 8 (20.0) 
$50,000-$74,999 5 (16.7) 2 (20.0) 7 (17.5) 
≥$75,000 9 (30.0) 1 (10.0) 5 (12.5) 
Decline to Answer or Unknown 4 (13.3) 0 (0.0) 4 (10.0) 
Education    
High School Diploma/GED 17 (56.7) 2 (20.0) 19 (47.5) 
Associate's Degree 7 (23.3) 4 (40.0) 11 (27.5) 
Bachelor's Degree 4 (13.3) 2 (20.0) 6 (15.5) 
Graduate Degree 2 (6.7) 2 (20.0) 4 (10.0) 
SCI Injury Level    
Paraplegia 19 (63.3) 9 (90.0) 28 (70.0) 
Tetraplegia 11 (36.7) 1 (10.0) 12 (30.0) 
SCI AIS Classification (Calculated)    
A 0 (0.0) 6 (60.0) 6 (15.0) 
B 0 (0.0) 4 (40.0) 4 (10.0) 
C 15 (50.0) 0 (0.0) 15 (37.5) 
D 15 (50.0) 0 (0.0) 15 (37.5) 
Data Collection Location    
Local 8 (22.2) 0 (0.0) 8 (20.0) 
Adapted Sporting Event 22 (73.3) 10 (100) 32 (80.0) 
Primary Mode of Mobility    
Walk 5 (16.7) 0 (0.0) 5 (12.5) 
Manual Wheelchair 20 (73.5) 8 (80.0) 28 (70.0) 
Power Wheelchair/Scooter 4 (8.8) 2 (20.0) 6 (15.0) 
Equally Walk and Wheel 1 (3.3) 0 (0.0) 1 (2.5) 
Continuous Demographics 
Motor Incomplete 
Mean ± SD (Range) 
Motor Complete 
Mean ± SD (Range) 
Total Mean ± SD 
(Range) 
Age 54.0 ± 10.5 (25-70) 52.9 ± 14.2 (34-77) 53.7 ± 11.4 (25-77) 
Body Mass Index (BMI) 28.2 ± 5.4 (18.5-38.7) 24.4 ± 3.7 (18.7-30.4) 27.2 ± 5.2 (18.5-38.7) 
Years Since Injury 18.8 ± 12.5 (3.0-48.7) 16.0 ± 9.5 (5.6-28.9) 18.1 ± 11.8 (3-48.7) 
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4.3.3.2 Impairment Scores 
Impairment scores for all participants are shown in Table 4.2. Participants with motor 
incomplete SCI had LEMS scores spanning nearly the entire possible range from 2 to 49. Similarly, 
both motor complete and incomplete SCI groups had participants spanning the entire range of LT 
sensation scores, though those with motor complete SCI had lower scores on average than those 
with motor incomplete SCI. Ten (25%), 7 (17.5%) and 15 (39.5%) of participants had strength, 
sensation, and spasticity scores of 0, respectively. The 60.5% of individuals in this study presenting 
with spasticity is slightly lower than other studies that have found approximately 65-78% of 
individuals with SCI having symptoms of spasticity.74, 77, 179 
Table 4.2: Strength, sensation, and spasticity impairment scores 
Continuous Impairment Outcomes 
Motor Incomplete Motor Complete All Participants 
Mean ± SD (Range) Mean ± SD (Range) Mean ± SD (Range) 
Strength (LEMS) 26.9 ± 15.0 (2-49) 0.0 ± 0.0 8.2 ± 8.1 (0-49) 
Sensation (Lower Limb Summed LT) 10.9 ± 6.5 (0-20) 3.8 ± 6.6 (0-20) 9.1 ± 7.2 (0-20) 
Categorical Impairment Outcomes n (% of group) n (% of group) n (%) 
Spasticity (Lower Limb Categorized MAS)    
No Spasticity (MAS=0) 13 (46.4) 2 (20.0) 15 (39.5) 
Mild Spasticity (MAS all < 2) 9 (32.1) 5 (20.0) 14 (36.8) 
Moderate Spasticity (≥1 location with MAS ≥ 2) 6 (21.4) 3 (30.0) 9 (23.7) 
 
4.3.3.3 Strength (LEMS) 
Sixteen LA and 19 covariate features were selected using the LASSO LARS models which 
independently explained 67.0% and 49.2% of the variance (adjusted R2) in lower limb strength, 
respectively (Table 4.3). When LA features were combined with covariates, an additional 35.5% 
of the variance in strength could be explained (adjusted R2= 0.847), as compared to the model with 
only covariates. The features with the greatest association with higher strength scores from the 
models with LA features were larger variations in energy (Wave Approx- IQR) and local dynamic 
stability (Lyapunov Exp- IQR, variations in the response to perturbations), fewer variations in the 
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similarity between recent movements (Max Cross Cov- IQR), smoother movements (Num Med 
Crossings Norm- Med), and faster rotational movements (Angle Rate Change- Med, Appendix 
Table D.4 and Appendix Table D.5). When only covariates were included in the model, having 
more pain (SF-36: Pain), a higher BMI, and fewer pain locations were among the features most 
related to greater strength. However, when LA and covariate features were combined, the LA 
features maintained a similar order of association, while the covariate features that were most 
related to strength in the LA + covariates model were amongst the features that had the lowest 
associations with strength for the covariate model (more years since injury, more sleep 
disturbances generally [PSQI: Sleep Disturbance], and better average sleep rating during 
collection). 






















1. LASSO LARS for 
feature selection 
LA 15 (133) 0.469 0.687 8.17 7.87 93.56 9.67 
Covariates 19 (24) 0.394 0.689 8.08 7.67 92.86 9.64 
2. Linear regression to 
reestablish baseline 
LA 15 0.670 0.805 6.71 6.61 58.13 7.62 
Covariates 19 0.492 0.740 7.52 7.32 77.75 8.82 
3. Linear regression 
for additional variance 
explained by LA 
LA + 
Covariates 
34 0.847 0.984 1.68 1.18 4.68 2.16 





















1. LASSO LARS for 
feature selection 
LA 15 (133) 0.566 0.733 2.91 2.50 13.32 3.65 
Covariates 2 (24) 0.111 0.157 5.70 5.44 42.07 6.49 
2. Linear regression to 
reestablish baseline 
LA 15 0.717 0.826 2.21 1.88 8.68 2.95 
Covariates 2 0.222 0.262 5.11 5.25 36.83 6.07 
3. Linear regression 




17 0.714 0.839 2.03 1.69 8.05 2.84 
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4.3.3.4 Sensation (LT) 
The sensation model containing only LA features explained more of the variance in lower 
limb sensation (adjusted R2= 0.717) than just covariates (adjusted R2= 0.222, Table 4.3). When 
combined, LA explained an additional 49.2% of the variance in sensation (adjusted R2= 0.714) 
compared to the model with covariates alone. The features selected per model are shown in 
Appendix Table D.6 and Appendix Table D.7. Only 2 covariates were associated with higher 
sensation scores: fewer pain locations and better sleep efficiency (PSQI: Sleep efficiency). 
Additional analyses were performed to minimize the chance that the much lower model 
performance for the covariates model was due to a data irregularity (Appendix D.3) and no 
irregularity was identified. Having a less variable time between movements (Time Since Prev- 
IQR), more consistent movement directions (Corr YZ- Med), lower frequency movements (Dom 
Freq 1- Med), and less variability in the similarity between recent movements (Num Cross 
Cov/Corr Peaks- IQR) were most strongly associated with more intact sensation.  
4.3.3.5 Spasticity (MAS) 
Spasticity categories were more accurately classified using 7-10 selected LA features (F1-
Score= 0.765) than 5-6 covariate features (F1-Score= 0.668). When combined, the LA + covariates 
model achieved nearly 90% accuracy in classifying spasticity categories, including increases in 
F1-score and OCA of 0.228 and 13.2%, as compared to the model using only covariates. For all 
models, no participants were falsely predicted as having moderate spasticity (precision= 1). Recall 
was generally the highest for the mild spasticity category, indicating that those who actually had 
mild spasticity were more likely to be correctly classified than those with no or moderate spasticity. 
For the LA + covariates model, the moderate spasticity group had the highest F1-score (0.941), 
while the mild spasticity group had the lowest F1-score (0.875, no spasticity F1-score= 0.889). 
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In the model with only LA features, the features most associated with having no spasticity 
included less power at the second dominant frequency (Power Dom Freq 2- Med), lower 
percentage of movements that met PLM criteria (PLM %), moving in more variable directions 
(Corr YZ- Med), more variable energy (Wave Approx- IQR), and more variability in the similarity 
to recent movements (Num/Close Cross Corr/Cov Peak- IQR, Appendix Table D.8 and Appendix 
Table D.9). LA features associated with moderate spasticity include less variable movement 
disorder (Wave Entropy- IQR), lower and less variable energy (Wave Energy 2- Med, Wave 
Approx- IQR) and, moving in more consistent directions (Corr YZ- Med), less variable symmetry 
of movements (Skewness- IQR), more frequent movements (Move/hour), and more movements 
that met PLM criteria (PLM Index). For the covariates, having a longer time since injury, not using 
sleep medication during the data collection, and having more pain interference with sleep (Pain 
Interfere: Sleep) were associated with having no spasticity while using sleep medication, having 
worse nightly sleep ratings (Ave Sleep Rating), sleeping for shorter durations (PSQI: Sleep 
Duration) and having fewer sleep disturbances (PSQI: Sleep Disturbances) were associated with 
having moderate spasticity. 
Table 4.4: Spasticity logistic regression analysis results* 
Analysis Step Feature Set 
Number of Features 
Selected (Initial) F1-Score Precision Recall OCA 
1. Logistic regression with ℓ1 
regularization for feature 
selection 
LA 7-10 (133) 0.814 0.833 0.816 0.816 
Covariates 5-6 (24) 0.764 0.790 0.763 0.763 
2. Logistic regression to 
reestablish baseline for selected 
covariates model 
LA 7-10 0.765 0.820 0.763 0.763 
Covariates 5-6 0.668 0.741 0.684 0.684 
3. Logistic regression for 




12-16 0.896 0.918 0.895 0.895 




By demonstrating that machine learning models consisting of only LA features were able 
to explain approximately 67% of the variance in measures of lower limb strength and 72% of the 
variance in sensation as well as an F1-score of 0.765 when classifying participants into spasticity 
categories, we have provided evidence of face and construct validity for LA as a measure of 
impairment. Further, the adjusted R2 increased by 72% and 222% for the strength and sensation 
models, respectively, when LA was added to the covariate features, as compared to using the 
covariates alone. Similarly, the F1-score for the spasticity classification was 34% higher when 
including LA, as compared to when only using covariate features. This shows that LA provides 
additional, unique information that is related to measures of strength, sensation, and spasticity 
beyond what could be measured using covariate and confounding variables. The models that only 
included covariates consistently had the poorest performance, thus emphasizing the additional 
utility and information that LA can provide beyond what is available through demographic 
information and questionnaires. This further supports that LA features are directly related to 
measures of impairment, not just a proxy for sleep quality or another related metric. 
Although an R2 of 1 would explain 100% of the variance in the outcome and would be 
considered a perfect result for a model, we would not expect or want LA to explain that much 
variance in this case. As explained in Section 2.4.1, the clinical measures used as the outcomes in 
this analysis have inherent weaknesses and lack the responsiveness required to differentiate 
between individuals for prediction models, especially among motor incomplete SCI.8, 9, 34 Since 
all features of LA are continuous and there are 133 features available, LA is able to provide 
variability and detailed information about impairment that clinical measures may currently lack. 
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Thus, the finding of LA having a strong, yet imperfect relationship to each impairment outcome is 
supporting the aim of the analysis and clinical use of LA as a measure of impairment.  
It was hypothesized that LA features such as those measuring amplitude and duration of 
movements would be most related to the measures of impairment, which is somewhat supported 
by the findings. Although movement duration was not selected for any of the models, other features 
such as the percentage of movements that meet the criteria for PLM were selected. By definition, 
PLM must be short duration movements that occur in series.112, 152 Therefore, having a higher 
percentage or larger number of movements that meet the criteria for PLM or PLM indices, being 
related to better sensation, greater strength, and less spasticity provides support for this hypothesis.  
Although more intuitive statistical LA features such as the RMS and maximum movement 
acceleration were not related to any of the impairment measures, multiple features evaluating the 
spectral power and energy of movements in the frequency domain were related to each measure 
of impairment (e.g., Power Dom Freq 2- Med, Power Dom Freq 1/Total- IQR, Wave Approx- 
IQR, etc.). Additionally, these features often had some of the strongest associations with the 
measures of impairment. Both the statistical and frequency domain features consist of similar 
information about the intensity of movements, but the statistical features are with respect to time 
while features like power and energy are with respect to the movement frequency or both time and 
frequency. Therefore, it makes intuitive sense that higher energy movements may be associated 
with greater strength and worse spasticity. Similar features have also been found to be related to 
improvements in the lower limb after rehabilitation148 and have been able to differentiate between 
healthy controls and individuals with Parkinson’s Disease and peripheral neuropathy, further 
indicating the clinical relevance of these measures.146 
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The finding of moderate spasticity being associated with more frequent, less variable, 
lower energy movements supports visual findings seen during the analysis (Figure 4.2). For some 
participants, very frequent, low amplitude movements would be observed while they were asleep 
and these findings were thought to be associated with PLM or spastic movements.180-184 These 
findings support that individuals presenting with these movements are more likely to have more 
severe spasticity. Alternatively, participants with less consistent movements (lower Corr YZ- Med, 
higher Num Cross Cov Peaks- IQR, Close Cross Cov/Corr Peaks- IQR), higher and more variable 
energy movements (Wave Energy 2- Med, Wave Approx- IQR) and a smaller proportion of 
movements meeting the criteria for PLM (PLM %) were more likely to have no spasticity. Since 
both voluntary and subconscious movements are more likely to occur in variable directions and 
with variable timing (e.g., when rolling or adjusting positioning periodically throughout the night), 
it is logical to infer that participants with more frequent, consistent, repetitive movements may 
have more spasticity while those with more variable, less consistent movements have little to no 
spasticity. 
 
Figure 4.2: Example of potential spastic movements in the acceleration magnitude vs time plot from 1 
participant’s ankle across the whole night and zoomed in for additional detail. This participant had a T7 AIS 
C injury and MAS scores of 2 at the knee flexors and 1 at the plantarflexors for each lower limb. 
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Movement consistency also played a large role in the estimation of strength and sensation 
scores. Seven of the 16 LA features (43.8%) selected for strength and 6 of 15 (40.0%) of the LA 
features selected for sensation were associated with movement consistency or related 
characteristics. Having less consistent movements and wider variability of movements overall, but 
less variable recent movements were associated with greater strength. Someone with limited 
strength may also be limited in the types or directions of movements they can perform; thus, they 
may have a more limited variety of movements as compared to someone with greater strength. For 
example, if an individual has a low LEMS due to only having motor function of the knee extensors, 
they may be able to voluntarily straighten their knee during the night, but not be able to move their 
leg in other directions. This would result in movements consistently occurring in a particular 
direction and likely presenting with similar characteristics, as opposed to someone with greater 
strength that could move in a variety of directions. 
 Additional measures of movement consistency that were related to greater strength include 
having a wider range of local dynamic stability and chaos (higher Lyapunov Exp- IQR), smoother 
movements (lower Num Med Crossings Norm- Med), and more negatively skewed movements 
(lower Skewness- Med). These findings are supported by previous studies that have shown that 
healthy controls generally had smoother movements and more negative skewness than individuals 
with Parkinson’s disease146 and Lyapunov exponent being related to improvements in lower limb 
rehabilitation.148 
Limb movement percentages and velocity and distance features were not selected in any 
of the impairment models using LA. Features associated with the change in the angle of inclination 
or gravitational acceleration were also infrequently selected. This may infer that the distribution 
of which limbs are moving and the exact amounts and directions may not be as related to 
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impairment, which further supports that the consistency and variety of movements may be more 
meaningful than the specifics of the movements being performed. Velocity and distance features 
are calculated through integration of the acceleration of each movement and are highly correlated 
with other features that statistically describe the acceleration (Med Acc, AUC Acc, SMA, etc.) and 
frequency characteristics (Power). Since frequency and time-frequency features were frequently 
chosen in the models and the LASSO LARS algorithm is intended to minimize collinearity, it may 
not be that the velocity and distance features are not related to impairment, but just that they were 
less in informative than other related features. 
Although LA features were specifically extracted to be clinically meaningful individually, 
they provide the most beneficial and comprehensive information when interpreted together.146 
Additionally, since all LA features are extracted using the same data set and the computational 
time to extract additional features is minimal, there is no additional burden to extract one versus 
many LA features. Therefore, in addition to providing support for LA as a clinical metric, this 
analysis demonstrates the potential benefits of having versatile set of detailed features related to 
impairment available from one data collection with minimal burden the to the participant. 
4.3.4.1 Limitations 
Especially in small sample sizes, attention must be paid to machine learning models to 
ensure that overfitting does not occur and that the results are an appropriate estimation for the goal 
of the analysis. For prediction models, it is critical that the model is assessed using a separate, 
unseen test set. If this does not occur, the model performance will appear inappropriately favorable 
as compared to when it is used in practice, since the model was assessed with the same data that 
was used in building it. A nested, leave-one-out cross-validation model was initially considered to 
estimate the performance of the LA and covariate features in calculating estimates for each 
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outcome. This model uses all participants but 1 for an inner-loop cross-validation to calculate 
model parameters and then tests the model built using those optimal parameters on the 1 held-out 
sample. It then iterates until each participant is used as an independent test set in the outer-loop. 
This method is able to estimate the model performance on unseen data while maximizing the size 
of the training set and without inducing bias.185-187 However, for the current analysis, we only 
aimed to determine the association between the measures of impairment and LA in a cross-
sectional sample and do not intend to use LA as a predictor of impairment, as this is not clinically 
useful. Thus, holding out a separate test set of samples or using a computationally intensive 
analysis such as nested cross-validation to assess the model performance on unseen data was not 
deemed necessary. Additionally, due to the large variability inherent to continuous outcomes (e.g., 
the LEMS 0-50 range of outcomes for strength), very large sample sizes are frequently required to 
obtain an adequate prediction and was logistically not possible for the current analysis.  
For the strength model with both LA + covariates, 35 features were included which is a 
large number given the sample of 40 participants. This large number of features combined with 
the unadjusted R2 for that model of 0.984 likely indicate that this model is overfit and would not 
generalize well to unseen data. As this analysis is only aimed at assessing the relationship between 
LA, covariates, and impairment and is not intended for prediction, this is not a critical issue. 
Despite the overfitting, there is still clearly additional variance explained by adding LA to the 
covariate features with respect to the strength outcome. Overfitting is not apparent in the sensation 
and spasticity models. Therefore, the results from this analysis are valid for estimating the 
relationship between LA and measures of impairment in our sample and additional steps were 
taken (cross-validation for feature selection parameters, targeted participant recruitment, etc.) to 
minimize the bias in the analysis and maximize the generalizability of the findings.  
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Although efforts were made to recruit a diverse sample particularly with respect to AIS 
grade, ambulatory ability, and the impairment outcomes, it is still possible that the sample does 
not fully capture the demographic characteristics of the whole SCI population.3 In addition to the 
model validation, the specific distribution of demographic characteristics among our sample 
population should be considered when generalizing the findings from this study to the wider 
population with SCI. 
Although only nights “typical” to how the participant normally sleeps were included in the 
analysis, it is possible that LA was affected by unusual sleep patterns, especially for the portion of 
the sample that had data collected while participating in adaptive sports events. Covariates that 
were likely to affect the LA data collection such as exercising, consuming alcohol, and daily and 
overall sleep quality were included in the models to ensure that these factors were accounted for 
in the analysis. The minimal change or decreased performance of the models when covariates were 
included supports that LA was not substantially affected by these factors.  
Although preliminary analyses to visually evaluate the intra- and inter-subject variance 
using boxplots were performed to improve the reliability and usefulness of LA and resulted in the 
core set of 133 features (described in Section 3.3.2), a formal reliability analysis has not been 
performed. LA features must be found to be reliable to ensure that the current findings represent 
the true relationship between LA and impairment and are not the result of chance from inconsistent 
LA features. 
Lastly, although we want LA to capture information that clinical tests lack, using those 
clinical measures as the outcome of the models limits extent to which the relationship between LA 
and impairment can be quantified. This limitation is because we cannot be sure how much of the 
variance in each impairment outcome that was not explained by the LA models is due to variance 
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induced by other sources not captured in this study or is due to the outcome not providing a 
sufficient measure of impairment. In the latter case, if an improved measure of impairment was 
used for each outcome, it is possible that LA would explain more of the variance than was reported 
in the current analysis. Although using alternative methods for assessing strength and tactile 
sensation would have been preferred such as using Biodex Dynamometry and monofilaments,8, 9, 
188 due to logistical constraints that was not possible. Using summed measures of strength and 
sensation over the whole lower limbs and a categorized measure of lower limb spasticity and only 
two clinicians for all assessments should minimize the effect of the limitations in reliability and 
responsiveness seen in the individual MMT, LT, and MAS measurements.56, 189, 190 
While determining the relationship between LA and impairment is important to understand 
the clinical relevance of this metric, measures of function, participation, and quality of life are 
more meaningful outcomes for individuals with SCI. The relationship between LA and ambulation 
with and without the inclusion of personal, psychosocial, and environmental factors (PPEF) was 
assessed in Aim 2. The finding that LA is moderately to strongly related to measures of impairment 
provides sufficient evidence of the validity of this measure, despite possible limitations associated 
with the strength, sensation, and spasticity outcomes. 
4.3.5 Conclusions 
These findings provide evidence of face, construct, and concurrent validity that LA 
measured from movements during sleep are related to measures of strength, sensation, and 
impairment among a sample with chronic SCI. This demonstrates that LA is a clinically 
meaningful metric of neuromuscular impairment that could be useful in many future applications 
including CPRs for ambulation after an acute SCI. 
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4.4 Aim 2: Use of LA and PPEF to Classify Ambulatory Ability 
Reprinted from Archives of Physical Medicine and Rehabilitation, In Press Journal Pre-
Proof, Rigot SK, Boninger ML, Ding D, McKernan G, Field-Fote EC, Hoffman J, Hibbs R, 
Worobey LA, Towards Improving the Prediction of Functional Ambulation after Spinal Cord 
Injury Through the Inclusion of Limb Accelerations During Sleep and Personal Factors, Copyright 
(2021), with permission from Elsevier. 
 
4.4.1 Introduction 
Of the nearly 18,000 people in the United States who sustain a SCI each year, about half 
are likely to regain ambulation with one-third likely to ambulate in the community.191, 192 Although 
walking is often a primary goal of patients,2, 193 there are negative consequences of attempting gait 
training if the person does not become a long-term functional ambulator.194-196 Similarly, there 
may be missed opportunities from not attempting gait training during the period with the highest 
possibility of neurorecovery if a person will likely ambulate in the future.197-200 CPRs have the 
potential to aid clinicians by determining a patient’s likelihood of ambulation early in the rehab 
stay so that therapies and expectations can be adjusted appropriately, which is especially important 
in the context of decreasing length of stays.43, 191, 201 
The most cited CPR for ambulation after SCI is by van Middendorp et al. which uses age, 
strength and sensation to predict the probability of walking 10m independently one year post-
injury.4, 5 This CPR demonstrated high accuracies in the original publication,4 external 
validations,5, 49, 50 and among a group with nontraumatic SCI (area under the curve=0.889-0.967).51 
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When used clinically, the van Middendorp CPR was found to be useful for patient motivation and 
setting realistic expectations.42 Variations of this CPR have also been published that include fewer 
predictors5 and different age cut offs.54 
However, recent publications have highlighted shortcomings of existing CPRs.6, 51, 54 
Outcomes are more poorly predicted for those with an incomplete SCI, the cohort for whom a 
better understanding of ambulatory prognosis would be most useful.19, 98 Further, most CPRs only 
predict whether or not an individual is likely to walk a short distance without assistance, but this 
may not be representative of whether the individual will walk functionally.4, 5, 58, 202 Rather, 
measures of speed and endurance can provide a more comprehensive view of functional 
ambulation and help to guide therapeutic interventions and patient expectations.102, 104 
Additionally, recent studies have highlighted the benefits of leveraging machine learning 
techniques to include a larger number of predictors and identify complex, non-linear relationships 
between predictors.58, 202, 203 
PPEF such as resilience, social support, accessibility, socioeconomic status, and pain can 
influence one’s ability to ambulate but have not been included in previous CPRs.10-12, 90, 91 Further, 
measures of actual movement, which can be collected through low-cost wearable accelerometers, 
may be more reliable, objective, and responsive following SCI than clinical measures.8, 9, 68, 75-77 
In humans and animals, it has been found that slight motor recovery soon after injury was 
predictive of functional motor recovery.59, 64, 65 In a pediatric population with muscular dystrophy, 
a moderate to good relationship was found between the intensity of movements measured with an 
activity monitor and both knee extension strength and the 6MWT, demonstrating the strong 
potential for LA to be related to functional mobility.204 Activity during sleep may encompass 
aspects of sensation to cue the individual to move and strength to perform the movement, as well 
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as other extraneous movements such as those triggered by spasticity.205-209 Since therapy may bias 
daytime activity early after SCI, LA is defined as movements during sleep at night. 
The objective of the current study was to assess the ability of LA and PPEF to classify 
functional measures of ambulation using random forest machine learning models among 
individuals with chronic, motor incomplete SCI. Evaluating this relationship in a cross-sectional 
study is a first step towards the development of a more accurate CPR that can be used early in 
acute rehabilitation to predict long-term functional ambulation after a new SCI. 
4.4.2 Methods 
4.4.2.1 Study Population 
In addition to the study criteria described in Section 4.1, participants were only included if 
they had voluntary leg movement (LEMS > 0). Those with motor complete injuries were not 
included, as they were not likely to be ambulating.99, 100 
4.4.2.2 Questionnaires, Clinical and Ambulatory Assessments 
All questionnaires, clinical and ambulatory assessments were collected as described in 
Section 3.0. Each clinical measure described in Table 3.2 to assess strength, sensation, and 
spasticity was included in the analysis both as the “best” limb (better of scores from right and left) 
and “bilateral” limb scores (sum of limb scores). For spasticity scores, the “worst” limb (higher 
limb spasticity score) was also included.  
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4.4.2.3 Analysis 
4.4.2.3.1 Model Input Variables 
LA features were collected and extracted from raw accelerations as described in Section 
3.2.3. Four sets of features were used to assess the classification accuracy of ambulatory outcomes: 
1) clinical/demographic, 2) LA and clinical/demographic, 3) PPEF and clinical/demographic, and 
4) all features (LA, PPEF, clinical/demographics, Figure 4.3). Clinical/demographic features are 
widely available in clinical settings and include a larger selection than just from the ISNCSCI 
exam that are generally used in previous CPRs.4, 5, 33  
 




4.4.2.3.2 Model Outcome Variables 
To maximize the clinical utility of the model and to avoid overfitting while still providing 
increased resolution over current binary CPR outcomes, we categorized ambulatory ability into 3 
clinically relevant divisions based on literature (Table 3.3).2, 103, 105, 106 Due to an insufficient 
distribution of WISCI-II scores, only 10mWT and 6MWT were included in this analysis. 
4.4.2.3.3 Model Selection and Tuning 
Random forest models were used to classify each of the ambulation outcomes in Python 
3.8.178 Random forest is an ensemble method that uses subsets data to build many decision trees 
and then determines final predictions from the majority classifications of the individual trees. This 
results in a robust prediction that is often considered one of the most effective methods for handling 
high-dimensional data due to the ability to automatically handle interactions, ignore uninformative 
features, and resist overfitting.210, 211  
A nested, 4-fold inner-loop and leave-one-out (27-fold) outer-loop cross-validation 
procedure was used to avoid overfitting (Figure 4.4). Within each outer-loop fold, we 
simultaneously performed hyperparameter tuning and feature selection using a grid search 
algorithm with a 4-fold cross-validation using the inner-loop data and then applied the best 
parameters to a model made from the whole inner-loop dataset. This model is then applied to the 
individual, held-out, outer-loop test sample which is classified into 1 of the 3 ambulatory ability 
classes. Due to never pooling the full train and test sets, even with small sample sizes, this method 
produces a nearly unbiased estimate of the true error expected, instead of the overly-optimistic 
results expected without this method.185, 187 While it is possible for the inner-loop to choose 
suboptimal parameters due to overfitting, this would result in more misclassifications when applied 
to the test set and poorer overall model performance. Thus, by utilizing this strict cross-validation 
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method, our small sample would produce a conservative estimate of the possible performance 
expected in a larger sample, unlike other validation methods which would erroneously increase 
the test set accuracy.185-187  
Within in the inner-loop, the random forest models were tuned for the number of features 
to include by selecting between 3-20 features with the highest information gained with respect to 
the ambulatory outcome. Information gain is a feature selection algorithm that measures the 
amount of information gained (reduction in entropy) from the outcome variable by observing a 
given feature. A feature with more information gained provides a greater reduction in outcome 
unpredictability and is therefore more useful as a predictor of the given outcome than a feature 
with less information gained. Only the features that provided the most information about the 
ambulatory outcomes would be included in the final feature set for each outcome. Additionally, 
the random forest models were tuned for the number of features to be included per tree (20-75% 
of number of features selected), number of trees (50-500), and maximum depth of each tree (3-5). 
The ranges for each hyperparameter and which hyperparameters were chosen for tuning were 
based off preliminary analysis and to further minimize the risk of overfitting. Model performance 
was evaluated by overall classification accuracy (OCA), precision, recall, and F1-score that were 
calculated overall and per-class as described in Appendix C. 
 80 
 
Figure 4.4: Flowchart showing leave-one-out nested cross-validation, with 27 outer-loop folds to estimate 




Thirty-four participants completed the study; 6 were excluded from the analysis because 
they self-reported no “typical” nights of sleep during the collection period and 1 was excluded 
because he reported the ability to ambulate but required bracing that wasn’t available during the 
study period. Two additional participants with motor incomplete SCI that were included in the 
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analysis Aim 1 were not included here, as they had been enrolled after this analysis was completed. 
The majority of analyzed participants (n=27, Table 4.5) were male, non-Hispanic White, Veterans, 




Table 4.5: Ambulatory outcomes and demographic information from participants with motor incomplete SCI 
included in the analysis (n=27). 
Ambulatory Outcomes N (%) 
10m Walk Test (10mWT) 103, 212   
Non-ambulatory (0 m/s) 11 (40.7) 
Household ambulator (0.01-.44 m/s) 9 (33.3) 
Community ambulator (>.44 m/s) 7 (25.9) 
6-Minute Walk Test (6MWT) 213, 214   
Non-ambulatory (0 m) 11 (40.7) 
Household ambulator (1-204 m) 11 (40.7) 
Community ambulator (> 204 m) 5 (18.5) 
Categorical Demographics N (%) 
Sex  
Female 4 (14.8) 
Male 23 (85.2) 
Race/Ethnicity  
Non-Hispanic White 14 (51.9) 
Non-Hispanic Black 8 (29.6) 
Non-Hispanic Other Race 3 (11.1) 
Hispanic (Any Race) 2 (7.4) 
Veteran  
Not Veteran 4 (14.8) 
Veteran 23 (85.2) 
Annual Household Income  
<$25,000 8 (29.6) 
$25,000-$49,999 3 (11.1) 
$50,000-$74,999 5 (18.5) 
≥$75,000 8 (29.6) 
Decline to Answer or Unknown 3 (11.1) 
Education  
High School Diploma/GED 14 (51.9) 
Associate's Degree 7 (25.9) 
Bachelor's Degree 4 (14.8) 
Graduate Degree 2 (7.4) 
SCI Injury Level  
Paraplegia 17 (63.0) 
Tetraplegia 10 (37.0) 
SCI AIS Classification (Calculated)  
C 13 (48.1) 
D 14 (51.9) 
Data Collection Location  
Local 6 (22.2) 
Adapted Sporting Event 21 (77.8) 
Primary Mode of Mobility  
Walk 4 (14.8) 
Manual Wheelchair 19 (70.4) 
Power Wheelchair/Scooter 3 (11.1) 
Equally Walk and Wheel 1 (3.7) 
Continuous Demographics Mean ± SD (Range) 
Age 53.4 ± 10.9 (25-70) 




The random forest model using LA and clinical/demographic features resulted in the 
highest classification accuracy (OCA= 0.704), while the clinical/demographics only model had 
the lowest accuracy (OCA= 0.593, Table 4.6, Appendix Table E.2). The model using LA and 
clinical/demographic features correctly classified non-ambulatory participants 82% of the time 
(F1-score= 0.900), while household (F1-score= 0.632) and community ambulators (F1-score= 
0.533) were more frequently misclassified.  
The model using LA and clinical/demographic features selected 3 LA features that were 
representative of movement smoothness (Num Med Crossings- IQR/Med) and variation in local 
dynamic stability (Lyapunov Exp- IQR, Appendix Table E.3). Similarly, when given the 
opportunity to select any available features (“All” feature set), the 2 LA features describing 
movement smoothness were chosen slightly more frequently. PPEF features related to exercise, 
sleep medication, sleep quality, alcohol consumption, emotional role limitations, and pain 
interference with social activity were also chosen from the “All” model. Other features such as 
sensation at L2 and L4, knee flexors and L3 strength, having pain, and being a Veteran were 
frequently chosen in all models. 
 Table 4.6: Random forest model ambulatory ability classification accuracy for each feature set and 
ambulatory outcome. *† 
Feature Set 
10mWT 6MWT 
OCA Precision Recall F1-Score OCA Precision Recall F1-Score 
Clinical & Demographics 0.593 0.576 0.593 0.581 0.667 0.670 0.667 0.667 
LA, Clinical & Demographics 0.704 0.737 0.704 0.715 0.815 0.824 0.815 0.817 
PPEF, Clinical & Demographics 0.667 0.689 0.667 0.669 0.741 0.744 0.741 0.740 
All 0.630 0.637 0.630 0.626 0.741 0.739 0.741 0.739 
* Model with the highest classification accuracy is highlighted grey per ambulatory outcome.  




The 6MWT also produced the highest classification accuracy with the LA and 
clinical/demographics feature set (OCA= 0.815, Table 4.6, Appendix Table E.2). Community 
ambulators were classified well (F1-score= 0.889); 2 participants each in the non-ambulatory (F1-
score= 0.818) and household ambulator (F1-score= 0.783) groups were misclassified.  
LA features of movement smoothness were frequently selected, while variations in local 
dynamic stability (Lyapunov Exp- IQR), movement timing (Start/End Move %- IQR/Med), and 
variation in positioning changes were selected less frequently (Grav Change Z- IQR, Appendix 
Table E.4). Commonly selected PPEF features from the “All” model included sleep medication 
use, exercise, and sleep quality. Frequently selected clinical/demographic features were similar to 
the 10mWT with the addition of presence of comorbidities. 
4.4.4 Discussion 
By including novel LA features in combination with clinical/demographic measures, 
random forest models exhibited higher classification accuracies, as compared to models that 
included only clinical/demographic features. Adding PPEF also enhanced the model, and may 
further increase model accuracy in a larger, more diverse sample with greater variability of 
responses. These findings indicate a likely benefit to using LA and potentially PPEF to improve 
prognosis for individuals with acute, incomplete SCI, a group whose mobility outcomes are 
currently not well predicted. Further, there is a demonstrated relationship between these features 
and functional measures of mobility. The added level of granularity from classifying multiple 
categories of each functional ambulation measure may increase clinical utility compared to CPRs 
that target only a binary walking/wheeling outcome.  
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Random forest models for the 10mWT exhibited higher accuracies when classifying non-
ambulators, while the 6MWT models were slightly better at classifying community ambulators. 
This demonstrates that the current features selected to classify each outcome are sufficient for 
some groups, but may need further refinement to better differentiate others. Since household 
ambulators are likely to use a wheelchair for community mobility, require additional assistance, 
and/or have worse long-term outcomes than community ambulators, these groups are important to 
distinguish.18 Previous work among individuals with SCI demonstrated differences in walking 
capacity can be detected using the 10mWT versus 6MWT and our results may further support the 
importance of using both outcome measures.103 
For both the 10mWT and 6MWT, the feature set that produced the highest classification 
accuracy included LA and clinical/demographic features. LA features were more prominently 
selected for the 6MWT versus the 10mWT. Measures of movement smoothness (Num Med 
Crossings- IQR/Med) were the most commonly selected LA features for both outcomes. When an 
individual has decreased motor control over a limb or increased spasticity, movements may more 
frequently change speed as opposed to a smoother movement performed by someone who has 
better strength, motor control, and likely better ambulatory ability. A similar measure was found 
to be negatively correlated to 6MWT distances among children with muscular dystrophy, 
indicating that more frequent and less smooth movements were related to poorer walking 
endurance.89 Greater smoothness has also been associated with improved gait quality when 
comparing health controls to those with Parkinson’s disease and peripheral neuropathy.146 
A benefit of using LA over common clinical predictors is the continuous nature of most 
LA features allows for a large amount of variability between participants, which provides greater 
responsiveness and ability to differentiate between ambulatory abilities. However, given the small 
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sample, some LA features may have been too variable to provide enough information about the 
ambulatory outcome to be useful in the models. Since unobtrusively wearing the accelerometers 
overnight allows for many LA features to be calculated with minimal data collection burden or 
computational cost, future analyses should not just be limited to the LA features selected in this 
analysis. LA features may be even better predictors in a larger sample or an acutely injured 
population.  
PPEF features related to exercise, sleep medication use, and sleep quality were most 
frequently selected. Previous studies among those with SCI have shown the benefit that exercise 
can have in improving walking outcomes,215, 216 even when walking was not included in the 
exercise program.217 However, ambulatory individuals with SCI have been shown to participate in 
less and have more negative attitudes towards physical activity than manual wheelchair users.218 
Additionally, both exercise and sleep have been related to gait and physical functioning in other 
populations.219-222 Thus, it can be inferred that individuals who have poorer sleep quality, and 
potentially rely on sleep medications, may have poorer ambulatory outcomes. 
Frequently selected clinical features for both ambulatory outcomes included variables used 
in previous CPRs like sensation and strength at L3, and also variables that were not selected in 
previous models such as sensation at L2 and L4.4, 5 Interestingly, knee flexors strength was 
consistently one of the most frequently selected features, but has not been included in previous 
prediction models since it isn’t measured in the standard ISNCSCI. Sufficient quadriceps (L3) and 
plantarflexors (S1) strength are important for ambulation; although, weaknesses can be overcome 
through bracing. However, knee flexors strength needed during the swing phase of gait is difficult 
to compensate for weaknesses and should be considered as a predictor in future models.  
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4.4.4.1 Limitations 
The present study utilized a cross-sectional cohort of individuals with chronic SCI. 
Although a study following individuals longitudinally after acute SCI is needed for future CPR 
development, collecting novel features and measuring mobility long-term is time and resource 
intensive. The current analysis was used as a preliminary step to determine which features are 
likely to be meaningful in a future CPR and the results are not intended to be used directly for 
longitudinal prediction. Since PPEF collected were stable over time and LA is likely to change in 
relation to neurological recovery, we expect that the results of this study are likely to be applicable 
when used with an acute SCI sample measured longitudinally.  
Since many participants completed the study while at sporting events, several steps were 
taken to control for any abnormal activity or sleep. Participants recorded exercise, alcohol and 
caffeine use on a daily log and these covariates were included in the analysis. Additionally, only 
nights reported as “typical” to how the participant would sleep in their normal environment were 
used. It is possible that the demographics of our sample aren’t representative of the population of 
people with SCI which may limit generalizability of the findings. 
Although likely important in the description of functional ambulation, the WISCI-II that 
assesses an individual’s need for assistance through the use of physical assistance, bracing, and 
assistive devices was not included as an outcome in the current analysis due to an insufficient 
distribution based upon our original categorization of the WISCI-II (using bracing as the 
determinant for individuals being classified into the middle category instead of assistive devices). 
The categorization used for the WISCI-II was changed after the completion of this. Given the 
improved classification of the 10mWT and 6MWT when utilizing LA features, we would expect 
that the WISCI-II would have improved results as well, but this should be further assessed.  
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Usually, small sample sizes could lead to model overfitting and inaccurately favorable 
results. Random forest algorithms have consistently demonstrated adequate classification 
accuracies in high-dimensional feature spaces with small samples containing complex, non-linear 
data.223 Additionally, the nested, leave-one-out cross-validation technique was utilized to eliminate 
this risk and produce an unbiased estimate of the true performance, regardless of the small sample 
size.185-187 Despite selecting ranges for feature selection and hyperparameter tuning to minimize 
the likelihood of overfitting, it’s possible that the training set models overfit during the inner-loop 
cross-validation, but this would result in the current findings being a conservative estimate of the 
possible improved performance given a larger sample. Future studies could include the use of 
multiple machine learning algorithms, potentially combined using ensemble methods, to improve 
accuracy and further reduce bias and overfitting. Similarly, there may be additionally predictors 
that are beneficial to include in future prediction models, but were not captured here.98, 203 
4.4.5 Conclusions 
Models including diverse feature sets (LA/PPEF) better classified participants into 
categories of functional ambulation than clinical/demographic features alone. Targeting functional 
categories of ambulatory ability, based on gait speed and endurance, may guide clinicians, patients, 
and families towards more optimal rehabilitation goals and manage expectations for recovery 
better than a binary outcome of walking/wheeling. Using novel predictors and machine learning 
may lead to a better CPR to guide clinicians towards the right mobility training for the right patients 
at the right time to maximize long-term outcomes and independence after SCI. 
 89 
4.5 Cross-sectional Study Conclusions 
Aims 1 and 2 established that LA is related to clinical measures of neuromuscular 
impairment (strength, sensation, spasticity) and beneficial in the classification of ambulatory 
abilities (speed, endurance) among those with chronic, motor incomplete SCI. A variety of features 
such as those related to energy and power of movements, movement timing, and consistency were 
most strongly related to measures of impairment. Measures of movement smoothness, timing, and 
stability were most commonly selected in relation to measures of ambulatory ability. Compared to 
impairment, fewer LA features were selected as related to each classification for ambulatory 
ability; however, similar features were selected in both the analysis of neuromuscular impairment 
and ambulatory ability (Table 6.1 and Table 6.2). Limitations in the analysis of LA and impairment 
that were reported in Aim 1, including less responsive outcomes and stringent model validation, 
did not affect Aim 2 in the classification of functional ambulation using a strict leave-one-out 
nested cross-validation random forest model. This strengthens the findings from both Aims that 
LA is related to impairment and ambulation. 
Lyapunov Exp is a measure of local dynamic stability or chaos which may be a measure 
of the motor system’s ability to diminish perturbations and continue along a trajectory.224, 225 This 
feature was found to be related to both measures of ambulatory ability assessed (10mWT, 6MWT) 
and 2 of the 3 measures of impairment (strength, sensation). This feature has been shown to be 
related to improvements in lower limb rehabilitation,173 gait stability and changes in gait speed,146, 
225 and fall risk from measurements during gait.224, 226 Thus, finding the Lyapunov Exp to be related 
to strength, sensation, and gait indicates that this features is strongly related to clinical measures 
and is likely useful in a CPR for ambulatory ability. 
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The Num Med Crossings which measures movement smoothness was also found to be 
related to both the 10mWT, 6MWT, and strength after being normalized by the movement 
duration. If an individual is frequently changing increasing or decreasing their rate of changes in 
speed throughout a movement, then they would have an increased number of times that the 
acceleration-time signal crosses the median acceleration for that movement (higher Num Med 
Crossings). A similar measure of acceleration crossings was found to be related to 6MWT and 
weakly correlated to knee extensor strength among a sample of children with Duchenne Muscular 
Dystrophy.89 Additionally, other measures of movement smoothness have been associated with 
improved gait.146 This also demonstrates that this feature has excellent potential to be useful in a 
future CPR among individuals with acute SCI. While they had weaker relationships, LA features 
describing movement timing (Move/hour, Time Asleep, Start Move %) and changes in positioning 
(Grav Change Z) were also shown to be related to both ambulatory and impairment measures.  
Across nearly all models built using LA features, the majority of features selected were 
representing the IQR of the metric and a minority represented the median value. The only 
exception was the model for moderate spasticity, which had an equal proportion of LA features 
representing the IQR of the metric and median values. This indicates that the actual value of the 
feature is valuable, but the ability to have variability in movement characteristics may be more 
important. 
These similarities in the findings between the measures of impairment and ambulatory 
ability among participants with chronic SCI lay the foundation for LA to be utilized in other 
contexts as a more descriptive measure of impairment. It also further emphasizes that LA would 
likely be a useful predictor of long-term ambulatory ability among those with acute SCI.  
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5.0 Longitudinal Study with Acute SCI Over the First Year Post-Injury 
5.1 Study Population 
Participants were approached during the first week of IPR at the UPMC Rehabilitation 
Institute Spinal Cord Injury Unit. We recruited adults (≥18 years) with a new, incomplete (AIS B, 
C, or D) SCI, based upon the neurological exam upon admission to IPR, or individuals for whom 
a mobility prognosis was unclear. At admission to IPR, individuals with AIS A injuries are unlikely 
to achieve ambulation; therefore, they were not included unless their primary physical therapist 
specifically noted that they had an unclear ambulatory prognosis (e.g. with a lower level of 
injury).35 Although individuals with an AIS B SCI are unlikely to begin gait training at admission 
to rehab, approximately 50% convert to AIS C or D injuries within the first year, 20-65% achieve 
some degree of ambulation, and 18-33% achieve functional ambulation, thus, this population is 
important to consider.4, 35, 36, 99, 109 Although we are not excluding individuals who have 
experienced a traumatic brain injury, we are excluding those with significant cognitive 
impairments as indicated by a score < 20/25 on the Modified Mini-Mental Status Exam (cutoff 
score was < 23/25 at the beginning of the study and was lowered mid-way through).227 Participants 
were excluded if they do not live a reasonable driving distance from one of our centers to allow 
for follow-up. However, to gather pilot data in preparation for the planned multi-site expansion of 
this longitudinal study, research at the University of Washington Harborview Medical Center and 
Shepherd Center were also trained to complete the same data collection as is performed in 
Pittsburgh. One participant was included in the analyses the University of Washington site and has 
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completed all follow-ups remotely. All participants completed informed consent as approved by 
the University of Pittsburgh institutional review board and the appropriate other site as needed. 
Follow-up data collections took place for approximately 1 week immediately prior to 
discharge from IPR and at 3-months, 6- months, and 1-year post-discharge from IPR. The 3-month 
follow-up was added mid-way through the study to increase the detail regarding changes over time 
and as such, limited data was collected at that time and it was not included in the analysis. 
Although, at admission to IPR, only participants with incomplete SCI or an unclear ambulatory 
prognosis were enrolled, participants with any severity of SCI could also be enrolled just prior to 
discharge from IPR as part of a separate analysis for a larger study; these participants are not be 
included in this dissertation. Data collection occurred during a 3-week window surrounding each 
follow-up time point (3-months, 6-months, and 1-year post-discharge). 
5.1.1 Sample Size Considerations 
This analysis was a pilot analysis as part of a larger study that aimed to enroll enough 
participants to build and evaluate a new clinical prediction model using LA and PPEF features 
collected at admission to IPR to predict 1-year ambulatory ability among a sample with acute, 
incomplete SCI. As such, these Aims were only intended to be exploratory and were not designed 
to be powered to detect statistical significance. We planned to recruit 25 participants for these 
analyses, assuming a 25% drop out rate and a final sample size of 20 participants that complete all 
time points through 1-year post-discharge from IPR.  
To date, we have enrolled 39 participants with incomplete SCI, of which, 33 completed the 
admission time point (Figure 5.1). Due to difficulties with data collection due to COVID-19 and 
the subsequent IRB restrictions such as the inability to follow-up with participants in skilled 
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nursing facilities and other difficulties (e.g., participants medical complications or passing away) 
the follow-up rates for the study were lower than anticipated. Additionally, 100% of the 3-month, 
68.8% of the 6-month, and 55.6% of the 1-year follow-ups were completed remotely due to 
COVID-19 restrictions, which resulted in collection of clinical and ambulatory measures being 
more sparse in those participants. To date, 23 participants have reached the 1-year time point, 
aligning with our original recruitment goals. The same overall sample is used in Aims 3 and 4, 
although for some analyses only a portion of the sample is utilized.  
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Figure 5.1: Flowchart of participant enrollment and follow-up from admission to IPR through 1-year post-
discharge 
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5.2 Longitudinal Study Analysis Overview 
Although still in the pilot phase, we were able to utilize the data from individuals with 
acute, incomplete SCI for multiple purposes with the goals to provide information about the 
psychometric properties of LA when measured acutely and determine which features of LA are 
most likely to be useful in a future CPR for ambulation. These goals were addressed over 4 
analyses that were grouped in to 2 Aims that assess the psychometric properties of LA (Aims 3a 
and 3b) and related LA to clinical measures (Aims 4a and 4b). For clarity, the reasoning behind 
each analysis and how it will benefit a future CPR will be briefly described here, with additional 
details and specific methodologies provided in later sections. 
For the purposes of a CPR, the most useful time point for prediction would be upon 
admission to IPR. Aim 3a assesses the reliability of LA features when measured within the first 
week after admission to IPR to determine the minimum number of typical nights needed to obtain 
a reliable, robust feature set. Only features that were determined to be reliable when measured at 
admission to IPR were used in the remainder of the analyses (Aims 3b, 4a and 4b). Additional 
information regarding validity, reliability, and responsiveness of predictors for use in a CPR was 
explained in Section 2.4.1.1). 
Aim 3b assesses the change in LA from admission to IPR through the first 6-months post-
discharge. Although LA features that are used in a CPR would be measured at admission to IPR, 
it is important to determine which features of LA are stable (Figure 5.2 a-c) or changing (“variable 
LA”) over time (Figure 5.2 d-f). Stable LA features provide the benefit of being time invariant; 
thus, there would be more flexibility in when LA was measured and utilized in a CPR if the CPR 
consisted of all stable LA features. Variable LA features that change over time in relation to 
measures of ambulatory ability or impairment may also be important to include in a CPR. These 
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features may capture changes in strength, sensation, and spasticity that affect the ability to walk 
and perform many other functional tasks (Figure 5.2e). The score of these variable LA features at 
admission to IPR might be predictive of the individual’s abilities and recovery potential. 
Additionally, variable LA may capture similar, but potentially more detailed and responsive, 
information to the clinical measures that CPRs frequently include currently.4, 5, 53, 58-63 LA features 
that change over time, but not in relation to clinical measures (Figure 5.2f), are not likely to be 
useful in a CPR. The association between changes in variable LA features and changes in 
ambulatory ability and impairment is evaluated in Aim 4a. However, this analysis found that the 
changes in LA compared to ambulatory ability and impairment may be better determined in a large 
sample, so these findings provide a preliminary assessment of the change LA compared to clinical 
measures over time, but further evaluation is needed. 
Aim 4b evaluates the relationship between LA measured at admission and ambulatory 
ability at 6-months to perform a preliminary assessment of which LA features are most likely to 
be beneficial in a future. Stable LA features may be useful as predictors in a CPR if they are able 
to differentiate between ambulatory abilities (Figure 5.2 b-c); thus, all stable LA features were 
evaluated. Variable LA may be useful if it changes over time in a clinically meaningful pattern, so 
variable LA features that were found to be related to ambulatory ability or impairment in Aim 4a 
were included. Because of the sample size limitations on the analysis for Aim 4a, variable LA 
features that were not significantly related to changes in ambulatory ability and impairment in Aim 
4a were still included in the analysis for Aim 4b. These 3 features were specifically noted and 
additional information for them is provided in Appendix H.1, as their usefulness in a future CPR 
is less clear. The features from admission to IPR that were identified as being related to 6-month 
ambulatory ability in Aim 4b are most likely to be beneficial to improve CPR accuracy when 
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predicting long-term ambulatory ability among those with acute, incomplete SCI. All LA features 
identified as meaningful in each analysis are summarized in Table 6.1 and Table 6.2. 
 
Figure 5.2: Examples of a-c) stable and d-f) variable LA features.a) Trajactoreies of a stable LA feature over 
time per participant; b) example of a stable LA feature that is visually different and c) not different between 
ambulatory ability groups. d) trajectories of each participant’s variable LA feature over time; e) example of a 
variable feature (red) that is related to and f) not related to an ambulatory outcome (6MWT, blue) over time 
for 3 participants (corresponding LA and 6MWT scores for the each participant have the same marker shape 
and line pattern). Stable features that are related to measures of ambulatory ability (b, green outline) or 
variable features that change in relation to ambulaotry ability or impairment (e) are most likely to be useful 
in a CPR for ambulation, while features with little variance between ambulatory groups (c, red outline) or 
inconsistient changes (f) are unlikely to be useful in a CPR. 
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One major limitation of these analyses should be noted in advance as it affects Aims 3b, 
4a, and 4b. In Aim 3a, it was found that measuring LA from the combination of 2 typical nights 
provided the best balance between obtaining numerous reliable LA features, minimizing collection 
burden to participants and clinicians, and maximizing clinical utility. However, due to sample size 
limitations in certain ambulatory ability groups, we decided to utilize any participants with at least 
1 typical night measured for the remaining exploratory analyses. Two participants (16.7%) that 
were included in Aims 3b, 4a, and 4b only had one typical night collected at admission to IPR. 
However, 10 of 12 participants at admission and all participants at discharge and 6-months post-
discharge had at least 2 typical nights included.  
5.2.1 Long-term outcome 
Although the longitudinal study outcome was intended to be 1-year post-discharge from 
IPR, only 23 participants reached the 1-year time point to date, of which only 8 participants 
completed the full collection. However, the rate of motor recovery has been shown to substantially 
decline by 6-months.59, 228, 229 When assessing the Spearman’s rank correlations between the 
ambulatory and impairment outcomes (strength, sensation) at 6-months and 1-year post-discharge 
(Table 5.1), we found that the outcomes were all highly correlated, except the sensation 
measurements. Due to restrictions from COVID-19, many of the follow-up collections occurred 
remotely and utilized the participant’s own physical therapist (if still attending and willing to 
assist), which limited the small sample size for that measure. The low likelihood for the ambulatory 
and impairment outcomes to substantially change from 6-months to 1-year post-injury and the high 
correlation between 6-months and 1-year in our data, compounded with the larger sample collected 
at 6 months, led to the use of the 6-month assessments as the final outcome in these analyses. 
 99 
Additional comparisons between the ambulatory categorization for each outcome (WISCI-II, 
10mWT, 6MWT) at each time are shown in Appendix Table F.1 for all participants in the study, 
and Appendix Table H.2 for all participants included in the sample for Aims 3b and 4a. 
Table 5.1: Spearman correlations between outcomes at 6 months and 1-year post -discharge 
Outcome n r p 
WISCI-II 8 1.000 0.001 
10mWT 8 0.952 0.001 
6MWT 8 0.833 0.015 
Strength (LEMS) 4 0.800 0.333 
Sensation (Lower Limb LT) 4 0.211 0.833 
 
5.3 Aim 3: Reliability and Stability of LA Measured Acutely 
5.3.1 Introduction 
In Aims 1 and 2, evidence was provided to support the validity of LA being related to 
neuromuscular impairment and ambulatory ability in a sample with chronic SCI. However, the 
primary proposed use for LA is in a CPR for a sample with acute SCI to predict ambulatory ability 
1-year later. In the initial days after a SCI, the spinal cord is in shock and the individual may 
experience substantial impairments including flaccidity, loss of all sensation, and loss of reflexes 
caudal to their level of injury.230 In the days to months that follow, an individual may experience 
substantial changes to their neurological system including the development of hyperreflexia and 
spasticity as well as possible motor and sensory recovery.230 Additionally, sleep-disordered 
breathing, such as obstructive sleep apnea, can be highly prevalent after SCI and develops in up to 
60% of individuals with a cervical SCI within 2 weeks after injury.231 All of these changes, 
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compounded with data collection challenges innate to the inpatient setting, could potentially affect 
the measurement of LA among those with an acute SCI. Therefore, the psychometric properties of 
LA when measured acutely must be assessed, as individuals with acute SCI often present with 
very different characteristics than those in the chronic phase. 
For a feature to be useful as a predictor in a CPR, one of the most important characteristics 
it must possess is being reliable.232 Reliability refers to the extent to which a measure yields the 
same results each time it is administered, all other things being equal.55, 233 As long as sleep 
characteristic are within the normal range for that participant and considered typical of how they 
have slept since their injury, we expect that features of LA across multiple days of data collection 
upon admission to IPR can be measured reliably. Understanding the intra-subject reliability of LA 
features between nights will also allow us to identify a minimum number of nights necessary for 
a reliable set of LA features to be collected. 
Although patients begin physical and occupational therapy while in the acute care setting, 
intensive rehabilitation generally does not begin until the individual is admitted in to IPR. Patients 
typically spend a median of 11 days on acute care after SCI before being admitted to IPR, however 
this may vary substantially based upon an individual’s injury level and other medical needs.3 For 
LA to be a successful predictor in a CPR, it must be able to produce consistent and accurate 
predictions regardless of if the participant is a few days or a few weeks post-injury.232, 234 Further, 
learning which LA features remain stable over time will provide a deeper understanding of how 
well the findings from Aims 1 and 2 in the sample with chronic SCI generalize to participants with 
acute injuries. 
Therefore, this analysis had the following goals: Aim 3a) to establish which features of LA 
can be reliably measured across nights when collected at admission to IPR and Aim 3b) to evaluate 
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which features of LA remain stable from admission to IPR through 6-months post-discharge. We 
hypothesized that a set of LA features could be identified that produced at least moderate reliability 
when examining intra-subject reliability at admission to IPR and stability between time points 
through 6-months post-discharge. 
5.3.2 Methods 
For Aim 3a, participants were included if they had at least 2 nights of accelerometer data 
recorded from admission to IPR that they self-reported on the sleep log as being “typical” to how 
they have slept since their injury. For Aim 3b, participants were included if they had at least 1 
typical night collected at admission to IPR, just prior to discharge, and 6-months post-discharge 
from IPR. Clinical and ambulatory assessments were collected and LA was pre-processed as 
described in Section 3.0 to extract 133 features (Table 3.4).  
5.3.2.1 Analysis 
5.3.2.1.1 LA Intra-subject Reliability at Admission to IPR (Aim 3a) 
Intraclass correlation coefficients (ICCs) were calculated to assess the level of agreement 
between the first two typical nights recorded from each participant. Pearson correlations that only 
assess the trend of the data and may be misleading if data shows the same pattern but not the same 
values. In contrast, ICCs are able to assess both the trend and absolute agreement between sets of 
data. ICCs are calculated from the mean squares from the repeated measures analysis of variance. 
To assess intra-subject reliability between nights, we utilized a 2-way mixed effects ICC for 
absolute agreement of single and average nights.234, 235 If the reliability is sufficient for single night 
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ICCs, then it would indicate that those LA features could be measured from any individual night 
collected during the first week of admission to IPR and be considered reliable when used in future 
applications. The average nights ICC was also included to compare the reliability if the first two 
typical nights when they were are combined. Although we utilized a median nights approach 
previously to combine the LA features from individual nights into one set of features per 
participant and collection (Section 3.3.2), our approach to using LA more closely resembles the 
average nights analysis. Both the single and average nights calculations are performed within the 
ICC model based upon the input data from individual nights collected per participant. We 
considered a feature to be “reliable” if had an intra-subject reliability defined as an ICC greater 
than 0.5.235 Additionally, ICC values from 0.75 - 0.9 indicate good reliability and greater than 0.9 
indicate excellent reliability.235 
Since ICC calculations require a consistent number of nights to be included for each 
participant, only the first 2 typical nights were used to maximize our sample size. However, most 
participants wore the accelerometers for 2 - 7 days and many recorded more than 2 typical nights. 
Additional analyses were performed using all participants that had at least 3 and 5 typical nights 
to compare between the ICCs when using the first 2 nights and these increased numbers of nights. 
This was done to ensure that even though only the first 2 nights were utilized in the primary 
analysis, there were not substantial differences between the first 2 nights and additional nights 
collected. This also improves our ability to identify a minimum number of nights necessary to 
collect to result in a reliable set of LA features. 
5.3.2.1.2 LA Stability Over Time (Aim 3b) 
LA from multiple typical nights were combined as one set of features per collection by 
taking the median and IQR across all typical nights per participant as described in Section 3.3.2. 
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ICCs were again used to quantify the agreement between time points for all LA features that were 
found to be reliably measured at admission to IPR in Aim 3a. Since each time point is a separate 
sample and there is limited clinical value to combining time points, ICCs were only assessed for a 
single collection using a 2-way mixed, absolute agreement ICC analysis.235 Additionally, boxplots 
of each LA feature across the collection times and line graphs of each participant’s LA feature 
values for each time point were visually assessed to confirm the ICC findings since the ICCs may 
be affected by the smaller sample size. The general trends of the line plots as well as the variation 
in the range, IQR, and median for discharge and 6-months as compared to admission for the 
boxplots were used to classify a feature’s stability over time (Figure 5.2). A LA feature was 
considered “stable” over time if it had a single collection ICC > 0.5 indicating moderate reliability 
and was visually confirmed to be stable when plotted. 
5.3.3 Results 
5.3.3.1 Participants 
Thirty-one of 33 (93.9%) participants who had data collected at admission to IPR had at 
least 2 typical nights recorded and were used for the intra-subject reliability analysis (Aim 3a). 
Additionally, 24 (72.7%) and 11 (33.3%) participants had at least 3 or 5 typical nights recorded at 
admission, respectively, and were included in the supplemental analysis. Thirteen participants 
completed the admission, discharge, and 6-month collections; of these one had no ankle 
movements recorded across any night during the collection and was excluded as his ankle 
accelerometers were likely removed each night. Therefore, 12 participants were included in the 
stability analysis (Aim 3b). Categorical and continuous demographic information for the 
participants included in each analysis are shown in Table 5.2 and Table 5.3, respectively.  
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For both analyses, participants were primarily male, Non-Hispanic White, non-Veterans, 
with a variety of annual incomes, educational levels, and insurance providers. There was one 
participant with AIS A (complete) paraplegia who was included due to his low level of injury (L2) 
and unclear ambulatory prognosis. That participant had improved to a L4 AIS B injury by 
discharge from IPR. All other participants had an incomplete SCI (AIS B, C or D) and the majority 
had cervical injuries. By discharge from IPR one participant used in Aim 3b improved from AIS 
B to AIS C paraplegia, while all others stayed in the same category.  
Demographics for participants who were included in the analysis and those who had 
reached the 6-month time point, but did not complete all necessary parts of the data collection to 
be included in the analysis for Aim 3b are described in Appendix Table G.1 and Appendix Table 
G.2. Compared to those who were included in the analysis, those who were excluded had a 
significantly longer length of stay in IPR (47 vs 34 days), and at discharge start the data collection 
later, have fewer individuals who could ambulate (7.7% could walk without physical assistance vs 
58.3%, 25% were at least household ambulators vs 54.5% who were included), and have a slower 
gait speed (0.1 m/s vs 0.4 m/s). 
For Aim 3b, by discharge, 3 (25%) participants were primarily ambulating for mobility and 
by 6-months post-discharge, 8 (66.7%) were primarily walking (1 additional participant was a 
limited ambulator and primarily used a manual wheelchair). 
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Table 5.2: Categorical participant demographics at admission to IPR for Aim 3 
Categorical Demographics 
Aim 3a Aim 3b 
N (% of total n=31) N (% of total n=12) 
Sex   
Female 10 (32.3%) 5 (41.7%) 
Male 21 (67.7%) 7 (58.3%) 
Race/Ethnicity 
  
Non-Hispanic White 23 (74.2%) 9 (75.0%) 
Non-Hispanic Black 4 (12.9%) 1 (8.3%) 
Non-Hispanic Other Race 1 (3.2%) 0 (0.0%) 
Hispanic (Any Race) 3 (9.7%) 2 (16.7%) 
Veteran 
  
Not A Veteran 27 (87.1%) 11 (91.7%) 
Veteran 4 (12.9%) 1 (8.3%) 
Annual Household Income 
  
< $25,000 7 (22.6%) 1 (8.3%) 
$25,000 - $49,999 7 (22.6%) 3 (25.0%) 
$50,000 -$74,999 4 (12.9%) 3 (25.0%) 
≥ $75,000 5 (16.1%) 1 (8.3%) 
Decline to Answer or Unknown 8 (25.8%) 4 (33.3%) 
Education 
  
Less Than High School 4 (12.9%) 2 (16.7%) 
High School Diploma/GED 13 (41.9%) 6 (50.0%) 
Associate's Degree 6 (19.4%) 2 (16.7%) 
Bachelor's Degree 3 (9.7%) 1 (8.3%) 
Graduate Degree 1 (3.2%) 0 (0.0%) 
Other 4 (12.9%) 1 (8.3%) 
Medical Insurance 
  
Private 14 (45.2%) 3 (25.0%) 
Medicaid 7 (22.6%) 3 (25.0%) 
Medicare 1 (3.2%) 1 (8.3%) 
VA 2 (6.5%) 0 (0.0%) 
No Insurance 1 (3.2%) 1 (8.3%) 
Other/Multiple 6 (19.4%) 4 (33.3%) 
SCI Neurological Category at Admission to IPR 
  
Motor Complete (AIS A or B) Tetraplegia 2 (6.5%) 1 (8.3%) 
Motor Complete (AIS A or B) Paraplegia 4 (12.9%) 3 (25.0%) 
AIS C Tetraplegia 10 (32.3%) 1 (8.3%) 
AIS C Paraplegia 2 (6.5%) 1 (8.3%) 
AIS D Tetraplegia 11 (35.5%) 5 (41.7%) 
AIS D Paraplegia 2 (6.5%) 1 (8.3%) 
Primary Mode of Mobility at Admission to IPR 
  
Power Wheelchair 27 (87.1%) 9 (75.0%) 






Table 5.3: Continuous participant demographics for Aim 3 
Continuous Demographics 
Aim 3a Aim 3b 
Mean ± SD (Range) 
(Total n=12) 
Mean ± SD (Range) 
(Total n=12) 
Age 51.0 ± 17.5 (18 - 82) 45.8 ± 17.8 (18 - 71) 
BMI 28.8 ± 6.9 (15 - 47) 27.8 ± 3.4 (23 - 35) 
LEMS (Strength) 22.5 ± 15.4 (0 - 47) 23.8 ± 16.0 (0 - 47) 
Lower Limb LT (Sensation) 10.1 ± 6.6 (0 - 20) 10.5 ± 7.1 (0 - 20) 
Number of Nights Collected 5.1 ± 2.1 (2 - 7) 4.6 ± 1.9 (2 - 7) 
Number of Typical Nights Collected 4.6 ± 2.0 (2 - 7) 3.5 ± 2.0 (1 - 7) 
Length of Stay in IPR (Days) 38.8 ± 11.2 (12 - 64) 32.6 ± 10.2 (12 - 43) 
Days from Injury to Start of IPR 14.6 ± 7.7 (5 - 30) 14.8 ± 16.0 (5 - 62) 
Days from Injury to Start of Data Collection 18.4 ± 8.5 (7 - 36) 17.5 ± 15.9 (9 - 65) 
5.3.3.2 LA Intra-subject Reliability at Admission (Aim 3a) 
An example of the consistency of LA between nights per participant is shown in Figure 5.3 
and additional examples are provided in Appendix Figure G.1 and Appendix Figure G.2. Of the 
133 LA features assessed, 72 (54.1%) features had at least moderate reliability and 6 (4.5%) had 
good reliability when averaged over the first 2 typical nights collected at admission to IPR (brief 
results in Table 5.5; full results shown in Appendix Table G.3). Using the single night ICCs, 25 
(18.8%) features had moderate reliability and none had good reliability.  
 
Figure 5.3: Example of LA across each accelerometer for 3 typical nights at admissionfor one participant 
with an L1 AIS D SCI 
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Table 5.4: ICCs of reliable LA features to assess intra-subject reliability (Aim 3a) and stability over time 
from admission to IPR through 6 months post-discharge (Aim 3b) 
    
LA Admission Intra-subject 
Reliability (Aim 3a) * 
LA Stability Over 
Time (Aim 3b) † 







Change in angle of 
inclination 
Angle Net Change-Med 0.662 0.495 0.495 
Angle Rate Change-IQR 0.595 0.424 0.482 
Angle Rate Change-Med 0.738 0.585 0.427 
Angle Total Change-IQR 0.576 0.404 0.502 
Angle Total Change-Med 0.816 0.689 0.559 
Change in gravitational 
acceleration 
Grav Change X-IQR 0.571 0.400 0.538 
Grav Change Y-IQR 0.604 0.433 0.087 
Grav Change Z-IQR 0.815 0.688 0.424 
Grav Change Z-Med 0.618 0.447 0.158 
Correlation coefficients 
between axes 
Corr YZ-IQR 0.687 0.523 0.043 
Frequency domain Bandwidth-Med 0.572 0.401 0.803 
Centroid Freq-Med 0.501 0.334 0.727 
Dom Freq 1-Med 0.597 0.426 0.653 
Med Freq-IQR 0.721 0.563 0.575 
Med Freq-Med 0.634 0.464 0.746 
Power Dom Freq 1/Total-Med 0.609 0.438 0.783 
Power Dom Freq 1-Med 0.585 0.414 0.615 
Power Dom Freq 2-IQR 0.614 0.443 0.436 
Power Dom Freq 2-Med 0.704 0.543 0.647 
Power Dom Low Freq-IQR 0.566 0.395 0.527 
Power Dom Low Freq-Med 0.669 0.503 0.662 
Power High Freq/Total-Med 0.588 0.416 0.663 
Power Total-IQR 0.554 0.384 0.523 
Limb movement 
percentages 
Bilat Ankle % 0.600 0.429 0.299 
Unilat Ankle % 0.600 0.429 0.299 
Median crossings Num Med Crossings Norm-Med 0.644 0.474 0.545 
Num Med Crossings-IQR 0.629 0.459 0.264 
Num Med Crossings-Med 0.619 0.448 0.260 
PLM Num PLM Norm 0.827 0.706 0.302 
PLM % 0.716 0.557 0.579 
PLM Index 0.740 0.587 0.101 
Relationship to recent 
movements 
Close Cross Corr Peak-IQR 0.652 0.483 0.756 
Dom Freq Last 90s-Med 0.673 0.508 0.762 
Max Cross Cov-Med 0.511 0.343 0.612 
Move Last 90s-Med 0.581 0.409 0.181 






Table 5.4 Continued 
    
LA Admission Intra-subject 
Reliability (Aim 3a) * 
LA Stability Over 
Time (Aim 3b) † 







Signal characteristics Entropy Rate-IQR 0.640 0.471 0.748 
Entropy Rate-Med 0.600 0.429 0.410 
Lempel-Ziv Comp-Med 0.534 0.364 0.553 
Lyapunov Exp-IQR 0.618 0.448 0.676 
Wave Approx-Med 0.688 0.525 0.297 
Wave Energy 2-IQR 0.637 0.467 0.417 
Wave Energy 2-Med 0.716 0.558 0.392 
Wave Energy 3-IQR 0.804 0.672 0.269 
Wave Energy 3-Med 0.720 0.563 0.165 
Wave Entropy-Med 0.668 0.502 0.343 
Statistical AUC Acc Norm-IQR 0.568 0.396 0.649 
AUC Acc Norm-Med 0.694 0.531 0.674 
AUC Acc-IQR 0.669 0.503 0.586 
AUC Acc-Med 0.654 0.486 0.701 
Duration-IQR 0.55 0.379 0.413 
Duration-Max 0.576 0.404 0.143 
Duration-Med 0.631 0.46 0.726 
Kurtosis-Med 0.58 0.409 0.577 
Max Acc-IQR 0.638 0.468 0.723 
Max-RMS Acc-Med 0.613 0.441 0.596 
Med Acc-IQR 0.553 0.382 0.543 
Med Acc-Med 0.782 0.642 0.646 
Range Acc-IQR 0.641 0.472 0.725 
RMS Acc-Med 0.577 0.406 0.643 
SD Acc-IQR 0.513 0.345 0.701 
Skewness-Med 0.593 0.421 0.612 
SMA Acc-IQR 0.617 0.447 0.66 
SMA Acc-Med 0.704 0.544 0.661 
Timing Move/hour 0.693 0.530 0.129 
Move/night 0.608 0.437 0.147 
Time Asleep 0.721 0.564 0.302 
Velocity and distance Med Vel-IQR 0.588 0.417 0.535 
Med Vel-Med 0.775 0.633 0.350 
RMS Vel-Med 0.590 0.418 0.475 
Total Dist-IQR 0.706 0.546 0.552 
Total Dist-Med 0.673 0.507 0.702 
* ICC values > 0.5 (moderate reliability) are highlighted grey and those > 0.75 (good reliability) are also bolded. 










≥ 2 Typical 
Nights (n=31) 
Participants with ≥ 3 Typical 
Nights (n=24) 
Participants with ≥ 5 Typical Nights 
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Appendix Table G.4 shows the ICC for average and single nights for participants with 2 
(n=31), 3 (n=24), and 5 (n=11) typical nights. When using 3 or 5 typical nights, the number of LA 
features that have at least moderate reliability increased compared to only using the first 2 nights 
with the same participants. Additionally, when examining the ICCs for each feature, 97 of 133 
(72.9%) LA features increased the average nights’ ICC when using 3 nights compared to 2. 
Similarly, 74 (55.6%) features increased their average nights reliability when using 5 nights 
compared to 2. The average of 5 nights also produced the most features with good reliability 
(48/133, 36.1%). Using the average of 3 nights and 5 nights produced nearly the same number of 
reliable LA features (97 and 98, respectively). However, the smaller sample of participants with 
at least 5 typical nights collected at admission is likely biased towards having more consistent 
nights, as seen by the increased reliability when just using the first 2 nights in that sample. The 
proportion of features that were reliable when used as a single night decreased with each additional 
night included in the analysis. 
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5.3.3.3 LA Stability Over Time (Aim 3b) 
The 72 LA features that had at least moderate reliability when measured using the average 
of the first 2 typical nights were assessed for stability from admission to IPR through 6-months 
post-discharge (Table 5.4 and full results in Appendix Table G.5). Forty-two (58.3%) LA features 
were initially classified as being stable due to having an ICC > 0.5. However, eight features were 
found to not be stable when assessed visually. Therefore, 34 (47.2%) LA features were determined 
by ICC and visual confirmation to be stable over time. Of the 38 features that were not stable over 
time (called “variable” features), 6 (15.8%) were consistently increasing, 4 (10.5%), were 
consistently decreasing, and 28 (73.7%) were changing inconsistently. 
Mean ± SD plots were initially used to show the trajectory of LA features for all 
participants averaged per time point, but these were found to be misleading at times compared to 
the per participant line graphs. It was noted that for variable, inconsistently changing LA features, 
participants may change over time in opposite directions which may lead to the mean ± SD 
appearing stable. For example, in Figure 5.4, a slight increase of 0.21 can be appreciated in the 
mean ± SD plot (a), but this feature still appears relatively stable over time. However, in Figure 
5.4b, it can be clearly seen that there are participants changing in various directions and in non-
negligible amounts.  
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Figure 5.4: Examples of a) mean±SD plots versus b) individual line graphs per participant to assess LA 
stability over time. For reference, the feature shown had an ICC= 0.427. 
 
After noting the misleading findings associated with the mean ± SD plots, the per 
participant line graphs and boxplots were used to guide visual analyses. An example of a visually 
classified stable and unstable feature are shown in Figure 5.5. Although some intra-subject 
variation is still noted in Figure 5.5a and the median of the boxplot for 6-months in Figure 5.5b is 
at the top of the 95% confidence interval for the median at admission, this feature was still noted 
to be stable since most participants showed little change over time. This is further confirmed by 
the very similar ranges and IQRs for each time point noted in the boxplots. Alternatively, for Power 
Dom Freq 1- Med the ICC values would have classified this feature as stable (ICC= 0.615), but 
the per participant line graphs (Figure 5.5c) demonstrate very large changes at each time for 4 
participants and moderate changes between discharge and 6-months for an additional 2 
participants. This inconsistency is also noted in the Figure 5.5d boxplot where the range of values 
substantially increases from admission to discharge and the median is just below of the 95% 
confidence interval at discharge and approaching the upper bound at 6-months. Although it is 




Figure 5.5: Examples of a visually stable feature (top) and a visually unstable feature (bottom) per 
participant line graphs (left) and per time point boxplots (right). The red dashed line on the boxplots shows 
the median and the black dotted lines are the 95% confidence interval of the median at admission. For 
reference the stable (Bandwidth- Med) and unstable (Power Dom Freq 1- Med) ICC values were 0.803 and 
0.615, respectively. 
 
Figure 5.5c also demonstrated another trend that was frequently seen during the analysis: 
the appearance of sub-grouped trajectories. As already mentioned, the Power Dom Freq 1- Med 
feature seems to consist of 3 groups that change in similar patterns to others in the group, but 
change differently than others not in the group. In Aim 4a, we will further explore these trajectories 
and how they relate to clinical measures of impairment and ambulation to see if participants with 
similar functional characteristics follow similar LA trajectories over time.  
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5.3.4 Discussion 
Of 133 initial LA features, a subset of 72 features were found to be reliable when measured 
at admission over the first 2 typical nights and 34 of those were stable from admission to IPR 
through 6-months post-discharge. The knowledge that LA can be reliably measured in the inpatient 
setting among individuals with acute, incomplete SCI provides evidence that LA would be useful 
in a CPR for ambulation. Additionally, trends were noticed in the variable LA features that may 
be related to changes in impairment and ambulation and will be further explored in Aim 4. 
When evaluating the intra-subject reliability of LA features measured at admission, it was 
found that the reliability increased when averaged across an increased number of nights, but the 
single night reliability decreased. This may indicate the LA can still be used reliably when 
measured over a single night, but the features available may be limited. Nearly the same number 
of features were reliably measured when using 3 or 5 nights; as such, using the combination of 3 
typical nights may optimize the number of reliable LA features while minimizing data collection 
burden. However, measuring 2 nights still found over half of the assessed features to be reliable. 
In the context of CPRs, patients and clinicians would most benefit from a prediction provided as 
early in the IPR stay as possible and the CPR has a higher likelihood of being utilized if it is 
minimal burden to collect the necessary data.236 Therefore, the 72 LA features collected over the 
first 2 typical nights with an at least moderately reliable average night ICC were utilized as the 
“reliable” features in further analyses in this dissertation. 
A wide variety of LA features from every feature category were found to be reliable. This 
ensures that diverse characteristics of participant’s movements would still be captured if only using 
reliable features in future analyses and this assortment of features should be more informative in a 
CPR than clinical measures primarily used in previous CPRs which represent single domains of 
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function.4, 5, 53, 58-63 This is reinforced by 17 of the 35 (48.6%) LA features associated with 
impairment among a sample with chronic SCI in Aim 1 were found to be reliable when measured 
in a sample with acute, incomplete SCI (Table 6.2). Likewise, 4 of the 6 (66.7%) LA features 
found to be associated with ambulation in the sample with chronic, motor incomplete SCI in Aim 
2 were also found to be reliable when measured acutely. The numerous features related to measures 
of impairment and ambulation in a sample with chronic SCI and able to be reliably measured in 
an acute population demonstrates versatility and the high potential for these features to be related 
to clinical measures and predictive of ambulation in an acute sample. These relationships will be 
further explored in Aim 4. 
Alternatively, our findings indicate that 51.4% of the features associated with impairment 
(Aim 1) and 33.3% associated with ambulation (Aim 2) in the sample with chronic, primarily 
motor incomplete SCI were not found to be reliable in the acute, incomplete population. Although 
preliminary analyses to evaluate the intra- and inter-subject variability were assessed in the sample 
with chronic SCI using visual analyses of boxplots for each feature (described in 3.3.2), we did 
not perform a structured reliability analysis as performed here for the acute SCI sample. Therefore, 
the reliability should be formally assessed among those with chronic SCI, especially for the 
features that were found to be related to impairment or ambulatory ability in Aims 1 and 2, but 
were not reliable in the sample with acute SCI.  
Another possible explanation for the discrepancy in reliability compared to the chronic SCI 
sample, is that some changes inherent to an acute SCI and the differences in data collection setting 
(IPR vs community setting) may have affected the ability to measure some LA features reliably at 
admission to IPR. For example, 5 of the 6 features representing the correlations between axes for 
each movement that describe the consistency of movement directions were associated with 
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impairment, but only 1 of those features was found to be reliable in the acute setting (Corr YZ- 
IQR). Since participants in an acute setting are more likely to be limited in their sleeping positions 
and may have less motor ability to voluntarily change positions within each night, these features 
may be too dependent on how the participant is initially positioned at night in the acute setting 
whereas participants with chronic SCI may have improved ability to vary their sleep positions 
throughout the night. Additionally, individuals with acute SCI are likely to be still developing 
spasticity at admission to IPR and may be in various stages of effectively managing the spasticity. 
Theses participants may present with more significant night-to-night fluctuations in the quantity 
and characteristics of spastic movements (Figure 4.2 and Section 4.3.4) and, thus, the consistency 
of movement directions, than we would expect in a chronic SCI population that is more likely to 
have consistent levels and treatments for spasticity.74, 237 Therefore, some degree of difference in 
the reliable features between the chronic and acute settings is expected but should be further 
evaluated.  
We have demonstrated that LA features can be reliably measured at admission to IPR 
which was anywhere from 7 to 36 days after injury in our sample. Nearly half of those reliable 
features from admission to IPR were found to be stable over the stay in IPR and through 6-months 
post discharge. The van Middendorp CPR was validated for when the predictor clinical measures 
were measured in the first 15 days post-injury.4 However, due to various medical and logistical 
complications, providing a prediction that early may not always be possible or clinically 
appropriate especially for patients with tetraplegia who often have longer acute stays before being 
admitted to IPR compared to those with paraplegia.3 Alternatively, some patients may be admitted 
to IPR within a few days after injury and it is important to have an accurate prediction available 
as soon as possible to maximize the clinical utility to inform decision-making and patient 
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expectations. If a new CPR exclusively utilized features that are stable over time, then this CPR 
will likely be useful when applied at any time after the initial injury has stabilized, generally 48-
72 hours after SCI.19, 238, 239 A CPR utilizing reliable and stable LA features may also be 
particularly useful because, since these LA features are not expected to change over time, it would 
likely be valid to re-predict a patient’s ambulatory ability after an unexpected change in status later 
in the sub-acute phase after SCI. 
5.3.4.1 Limitations 
The ICC analysis was limited by the need for the number of typical nights included to be 
consistent across participants. For the first few participants, we had only collected 2 nights of 
accelerometer data before increasing the length of data collection briefly to 4 and then to 7 nights. 
Thus, 2 nights was the primary time period analyzed to maximize our available sample size. As 
we would want to use the shortest data collection window possible for prediction to maximize the 
clinical utility while still ensuring accurate results, we believe 2 nights has been shown to be 
reliable enough for this purpose. Additionally, the “moderate reliability” cutoff of 0.5 is lower than 
what is used in some other studies.234, 235 Since this is a preliminary analysis as part of a larger 
study and we are still exploring the properties and uses of LA, it was thought that it would be more 
beneficial to include LA with potentially lower reliability for the present analyses and these 
features can be re-assessed with more stringent criteria in a future sample. Therefore, this study 
may also benefit from further assessment with a larger sample population with more typical nights 
recorded. 
The ICC analysis is beneficial in the ability to assess the reliability of the nights used 
individually and when they are averaged. However, during our preliminary analysis we found that 
taking the median and IQR across nights provided an informative, yet more stable description of 
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an individual’s LA across all of the nights collected that was less prone to outliers. It is then likely 
that the “average nights” ICC that was primarily utilized for the reliability analysis (Aim 3a) 
underestimated the reliability of LA features that may be more stable when the median analysis is 
implemented to combine nights. Other methods to assess reliability such as repeated measures 
analysis of variance or ICCs with a larger number of included nights and participants would 
improve the evaluation of reliability. 
The small sample size was a major limitation of this study, especially when examining the 
stability of LA features over time. Due to challenges from COVID-19 and increased medical and 
related barriers, our long-term follow-up was limited. Additionally, it was likely biased since 
participants who participated in the follow-ups tended to be more ambulatory with likely less 
impairments and medical complications than those who did not participate (Appendix Table G.1 
and Appendix Table G.2). Visual analyses were added to verify the ICC analyses and ensure that 
trends over time were captured appropriately.  
Only 1 typical night was required for participants to be included in the analysis for Aim 
3b, despite the knowledge that including more than one night improves reliability. All participants 
had 2 or more typical nights for the discharge and 6-month collections, but 2 participants only had 
1 typical night recorded at admission (out of 4 or 7 nights collected). Due to the already limited 
sample size, these participants were still included in the analysis, but it should be acknowledged 
that it is possible their inclusion could have affected the stability analysis. Additionally, further 
analysis should be performed to evaluate the quantitative differences or lack thereof between 
participant reported “typical” and “non-typical” nights. Follow-up in a larger, more heterogeneous 
sample could be beneficial to address many of these of these questions.  
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5.3.5 Conclusions 
LA features were identified that could be reliably measured in as little as 2 typical nights 
in an IPR setting among a population with acute, incomplete SCI and variable days since injury. 
Additionally, many of these features remained stable over time, allowing for them to be utilized 
nearly any time after injury with consistent results. Many of the features that were shown to be 
related to impairment or ambulatory ability in Aims 1 and 2 were also identified as being reliable 
when measured at admission, providing further support for the usefulness and clinical applicability 
of LA when measured acutely. 
5.4 Aim 4: Exploring Longitudinal LA in Relation to Ambulation and Impairment 
5.4.1 Introduction 
As described previously, characteristics of a good predictor for use in a CPR include being 
reliable, valid, and responsive. This allows the predictor to be utilized consistently to measure a 
clinically valuable metric and recognize subtleties between different participant presentations and 
characteristics.234, 235 LA features were found to be reliable in Aim 3a between nights when 
measured at admission to IPR and in Aim 3b, a subset of those features were identified as being 
stable over the first 6-months post-injury. Not yet investigated are “variable LA features” that 
change in relation to clinical measures of impairment and ambulation. These features may be more 
sensitive to neurorecovery and provide additional evidence of face, construct, and concurrent 
validity.  
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The primary purpose of our investigation of LA has been intended for use as a novel 
biomarker in a CPR to predict long-term ambulatory ability following incomplete SCI. As this 
study is only a pilot analysis as part of a larger, ongoing study we do not have a sufficient sample 
size to build and assess the machine learning model for prediction at this time. However, we do 
have sufficient pilot data to explore the predictive validity of LA as related to ambulatory ability 
at 6-months post-discharge from IPR. Findings from this analysis will support the continued 
longitudinal data collection and future plans to build and validate a CPR utilizing LA. 
Aim 4a explores how variable LA features change in relation to measures of ambulatory 
ability and impairment over the IPR stay and first 6-months post-discharge. We hypothesized the 
change in variable LA features will be significantly correlated with the change in measures of 
impairment (strength, sensation) and ambulation (need for assistance, speed, endurance) between 
admission to IPR and 6-months post-discharge. Aim 4b explores the relationship between reliable 
LA features measured acutely at admission to IPR and ambulatory ability at 6-months post-
discharge. We hypothesize that features of LA measured at admission to IPR will be significantly 
correlated or show clear visual relationships with ambulatory ability measured at 6-months post-
discharge. 
5.4.2 Methods 
LA features were included that were identified as reliable but not stable (n=38) in Aims 3a 
and 3b. These 38 features were described in Table 5.4 with the full results in Appendix Table G.5. 
Clinical and ambulatory assessments were also collected (Section 3.2). The WISCI-II, 10mWT, 
and 6MWT were used as measures of ambulatory ability at 6-months post-discharge from IPR to 
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assess the need for assistance, speed, and endurance during ambulation (Section 3.2.2). Impairment 
at 6-month was assessed by the LEMS and lower limb LT for strength and sensation, respectively.  
Participants were enrolled as described in Section 5.1. Participants were included in the 
analysis for Aim 4a if they had LA from at least 1 typical night and at least 1 outcome measure 
(WISCI-II, 10mWT, 6MWT, LEMS, lower limb LT) collected at admission to IPR, just prior to 
discharge from IPR, and 6-month post-discharge. Participants were included in Aim 4b if they had 
at least 1 typical night of LA collected from admission to IPR and at least 1 ambulatory ability 
outcome (WISCI-II, 10mWT, 6MWT) measured at 6-months post-discharge, but were not 
required to have LA or ambulatory outcomes from the remaining time points. As described 
previously (Sections 5.2 and 5.3.4.1), only including participants with at least 2 typical nights at 
admission would have been preferred given the results from Aim 3a, but due to sample size 
limitations, 2 participants were included that only had 1 typical night measured at admission. 
5.4.2.1 Analysis 
5.4.2.1.1 Change in Variable LA Related to Change in Outcomes (Aim 4a) 
Spearman’s rank correlations were used to quantify the relationship between the change in 
each variable LA feature and each ambulatory and impairment outcome between time points. 
Unlike Pearson correlations, Spearman correlations are more robust to outliers and do not require 
a normal distribution and were more appropriate for this exploratory analysis. The change in LA 
and the outcomes were calculated by subtracting the earlier time point from the later. Correlations 
were assessed separately for the change from admission to discharge from IPR and from discharge 
to 6-months post-discharge from IPR. Correlations were also assessed when combining both sets 
of changes to assess trends over the entire time period from admission to 6-months post discharge. 
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Correlations using the difference between admission and 6-months post-discharge were not used 
since this difference may mask the changes occurring at the discharge time point. Since this 
analysis is exploratory, correlations were considered to be significant if p< 0.1. Correlation 
coefficients were interpreted as: ρ from 0 - 0.3= negligible, 0.3 - 0.5= low, 0.5 - 0.7= moderate, 
0.7 - 0.9= high, 0.9 - 1.0= very high.240 Scatter plots were utilized to further evaluate the trends in 
the LA features with significant correlations.  
As a supplemental analysis, the same per participant line plots used in Aim 3b to evaluate 
LA stability over time were examined after color-coding participants by their ambulatory ability 
category at the 6-month time point (ambulatory ability categories shown in Table 3.3). For the 
impairment outcomes, participants were categorized based on if they improved their LEMS or 
lower limb LT sensation score from admission to 6-months post-discharge by 6.9 or 4.16 points, 
respectively. The score of 6.9 points is the repeatability threshold for the LEMS when used for 
participants with motor incomplete SCI.56 Similarly, a score of 23.3 (out of 112) was the 
repeatability threshold for the LT total score among those with motor incomplete SCI which was 
then scaled to 4.16 (out of 20) estimate the threshold for only the lower limb portion of the LT 
exam.56  
5.4.2.1.2 Relationship between Admission LA and 6-month Ambulation (Aim 4b) 
As in Aim 4a, a combination of correlations and visual analyses were used to explore the 
relationship between reliable LA features measured at admission to IPR and clinical assessments 
of ambulatory ability at 6-months post-discharge. Although stability over time affects the way the 
feature may be used in a CPR, it is possible for both stable and variable LA features to be 
beneficial. Since the results from Aim 4a would benefit from further assessment, variable LA 
features that were not related to changes in ambulatory ability or impairment were still included, 
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but it was noted that they may be less useful in a future CPR if the results of Aim 4a are confirmed 
in a larger, more diverse sample. Thus, all 72 LA features that were reliably measured at admission 
to IPR (Aim 3a) were included in this analysis, regardless of their stability over time.  
The Pearson correlation coefficient was calculated to assess the linear relationship between 
each LA feature and ambulatory outcome. Again, p< 0.1 was used to indicate significance since 
this is an exploratory analysis.  
A benefit of using machine learning algorithms to build a new CPR, is that relationships 
do not necessarily need to be linear to be useful. For example, the random forest classification 
model used in Aim 2 uses many decision trees to split the sample at nodes until all remaining 
samples at the bottom of each branch belong to the same class. The nodes that branch the samples 
are based on cutoff values from the features. Thus, if groups could be separated from each other 
by a threshold or hyperplane or samples within a group are otherwise distinctly identifiable from 
other groups, then they might be useful in a non-linear machine learning analysis (Figure 5.6). 
To estimate which LA features demonstrate a visual relationship, scatter plots showing the 
ambulatory outcome vs LA feature were assessed. Participants were categorized by each 
ambulatory outcome at 6-months and the mean and SD of each ambulatory category were also 
plotted for reference. For a feature to be potentially useful in non-linear analyses, at least 2 of the 
3 groups for each outcome had to be clearly separated from each other on the scatter plots. Features 
that either had a correlation p< 0.1, were visually confirmed to show a trend, or visually classified 
as being separable from other groups were recorded as being related to the ambulatory outcome. 
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Figure 5.6: Example of visual separation in the LA feature between the non-ambulatory and community 
ambulator groups of the 6MWT at 6-months post-discharge from IPR. The stars represent the mean and the 
shading represents 1 SD from the mean per ambulatory group. The black dashed line was added to 




The same 12 participants that were included in Aim 3b were also utilized for Aim 4a. An 
additional 2 participants are included in Aim 4b who had admission LA and 6-month ambulatory 
outcomes, but were missing 6-month LA thus excluding them from prior analyses. One of those 
participants did have accelerometer data collected at 6-months, but likely removed the devices for 
sleep each night which prevented the calculation of LA during sleep. Categorical demographics 
and ambulation assessments are shown in Table 5.6 for each time point and sample of participants. 
SCI Neurological category was only reported from admission and discharge because it was not 
formally assessed at 6-months. Continuous demographics, impairment, and data collection 
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measures from admission to IPR are shown in Table 5.7 and the measures from all times (including 
1-year for reference) are shown in Appendix Table H.1. By 6-months post-discharge, 
approximately 2/3 of participants were primarily ambulating, 35.7 (Aim 4a) - 41.7% (Aim 4b) did 
not require an AD or physical assistance to walk, and about half were community ambulators are 
defined by the 10mWT or 6MWT. Confusion matrices that show the group assignment for each 
participant between ambulatory outcome are shown in Appendix Table H.2. At 6-months, only 
one participant was assigned at community ambulator by the 10mWT, but a household ambulator 
from the 6MWT. 
The admission data collection began on average 18 days after injury, but ranged from 9 to 
65 days post-injury. Demographics for participants who were included in the analysis and those 
who had reached the 6-month time point, but did not complete all necessary parts of the data 
collection to be included in the analysis for Aim 4a are the same as 3b described previously 
(Appendix Table G.1 and Appendix Table G.2) and are described in Appendix Table H.3 and 
Appendix Table H.4 for the sample from Aim 4b. The participants who were excluded from the 
analysis for Aim 4b had a longer length of stay in IPR, were mostly power wheelchair users at 
discharge, and walked with slower gait speeds than those who were included. 
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Table 5.6: Categorical participant demographics and ambulation assessments for Aim 4 
  
Categorical Demographics 
Aim 4a N (%) 
(Total n=12)* 
Aim 4b N (%) 
(Total n=14)† 





Female 5 (41.7%) 6 (42.9%) 
Male 7 (58.3%) 8 (57.1%) 
Race/Ethnicity 
  
Non-Hispanic White 9 (75.0%) 11 (78.6%) 
Non-Hispanic Black 1 (8.3%) 1 (7.1%) 
Non-Hispanic Other Race 0 (0.0%) 0 (0.0%) 
Hispanic (Any Race) 2 (16.7%) 2 (14.3%) 
Veteran 
  
Not A Veteran 11 (91.7%) 12 (85.7%) 
Veteran 1 (8.3%) 2 (14.3%) 
Annual Household Income 
  
< $25,000 1 (8.3%) 2 (14.3%) 
$25,000 - $49,999 3 (25.0%) 3 (21.4%) 
$50,000 -$74,999 3 (25.0%) 3 (21.4%) 
≥ $75,000 1 (8.3%) 2 (14.3%) 
Decline to Answer or Unknown 4 (33.3%) 4 (28.6%) 
Education 
  
Less Than High School 2 (16.7%) 2 (14.3%) 
High School Diploma/GED 6 (50.0%) 7 (50.0%) 
Associate's Degree 2 (16.7%) 2 (14.3%) 
Bachelor's Degree 1 (8.3%) 1 (7.1%) 
Graduate Degree 0 (0.0%) 1 (7.1%) 
Other 1 (8.3%) 1 (7.1%) 
Medical Insurance 
  
Private 3 (25.0%) 5 (35.7%) 
Medicaid 3 (25.0%) 3 (21.4%) 
Medicare 1 (8.3%) 1 (7.1%) 
VA 0 (0.0%) 0 (0.0%) 
No Insurance 1 (8.3%) 1 (7.1%) 
Other/Multiple 4 (33.3%) 4 (28.6%) 
SCI Neurological Category 
      
Motor Complete (AIS A or B) 
Tetraplegia 
1 (8.3%) 1 (8.3%) 1 (7.1%) 1 (7.1%) 
Motor Complete (AIS A or B) 
Paraplegia 
3 (25.0%) 2 (16.7%) 4 (28.6%) 3 (21.4%) 
AIS C Tetraplegia 1 (8.3%) 1 (8.3%) 2 (14.3%) 1 (7.1%) 
AIS C Paraplegia 1 (8.3%) 2 (16.7%) 1 (7.1%) 2 (14.3%) 
AIS D Tetraplegia 5 (41.7%) 5 (41.7%) 5 (35.7%) 6 (42.9%) 
AIS D Paraplegia 1 (8.3%) 1 (8.3%) 1 (7.1%) 1 (7.1%) 
Primary Mode of Mobility 
      
Power Wheelchair 9 (75.0%) 4 (33.3%) 2 (16.7%) 11 (78.6%) 4 (28.6%) 2 (14.3%) 
Manual Wheelchair 3 (25.0%) 5 (41.7%) 2 (16.7%) 3 (21.4%) 7 (50.0%) 3 (21.4%) 





Table 5.6 Continued 
  
Categorical Demographics 
Aim 4a N (%) 
(Total n=12)* 
Aim 4b N (%) 
(Total n=14)† 
Admission Discharge 6-months Admission Discharge 6-months 
WISCI-II 
      
Requires Physical Assistance (or 
Non-Ambulatory) 
12 (100%) 5 (41.7%) 3 (25.0%) 14 (100%) 7 (50.0%) 4 (28.6%) 
Requires AD, but no Physical 
Assistance 
0 (0.0%) 5 (41.7%) 4 (33.3%) 0 (0.0%) 5 (35.7%) 5 (35.7%) 
Requires No AD or Physical 
Assistance 
0 (0.0%) 2 (16.7%) 5 (41.7%) 0 (0.0%) 2 (14.3%) 5 (35.7%) 
10mWT*† 
      
Non-ambulatory (0 m/s) 10 (83.3%) 5 (45.5%) 3 (25.0%) 12 (85.7%) 6 (46.2%) 4 (30.8%) 
Household Ambulator (0.01- 0.44 
m/s) 
2 (16.7%) 1 (9.1%) 2 (16.7%) 2 (14.3%) 2 (15.4%) 2 (15.4%) 
Community Ambulator (>0.44 m/s) 0 (0.0%) 5 (45.5%) 7 (58.3%) 0 (0.0%) 5 (38.5%) 7 (53.9%) 
6MWT† 
      
Non-ambulatory (0 m) 10 (83.3%) 5 (41.7%) 3 (25.0%) 12 (85.7%) 6 (42.9%) 4 (30.8%) 
Household Ambulator (1-204 m) 2 (16.7%) 4 (33.3%) 3 (25.0%) 2 (14.3%) 5 (35.7%) 3 (23.1%) 
Community Ambulator (> 204 m) 0 (0.0%) 3 (25.0%) 6 (50.0%) 0 (0.0%) 3 (21.4%) 6 (46.2%) 
* n=11 for the 10mWT at admission and discharge for Aim 4a 
† n=13 for the 10mWT at discharge and for the 10mWT and 6MWT at 6-months 
 
Table 5.7: Continuous participant demographics for Aim 4 from admission to IPR 
Continuous Demographics Aim 4a Mean ± SD (Range) Aim 4b Mean ± SD (Range) 
Age 45.8 ± 17.8 (18 - 71) 43.8 ± 17.5 (18 - 71) 
BMI 27.8 ± 3.4 (23 - 35) 27.9 ± 3.5 (23 - 35) 
LEMS (Strength) 23.8 ± 16.0 (0 - 47) 22.5 ± 16.1 (0 - 47) 
Lower Limb LT (Sensation) 10.5 ± 7.1 (0 - 20) 10.3 ± 7.5 (0 - 20) 
Number of Nights Collected 4.6 ± 1.9 (2 - 7) 4.4 ± 1.9 (2 - 7) 
Number of Typical Nights Collected 3.5 ± 2.0 (1 - 7) 3.4 ± 1.9 (1 - 7) 
Length of Stay in IPR (Days) 32.6 ± 10.2 (12 - 43) 35.0 ± 11.3 (12 - 51) 
Days from Injury to Start of IPR 14.8 ± 16.0 (5 - 62) 15.9 ± 15.1 (5 - 62) 
Days from Injury to Start of Data Collection 17.5 ± 15.9 (9 - 65) 19.0 ± 15.2 (9 - 65) 
 
5.4.3.2 Change in Variable LA Related to Change in Outcomes (Aim 4a) 
LA features with significant correlations between the change in the feature and the change 
in the ambulatory or impairment outcomes are shown in Table 5.8 and Table 5.9, respectively. 
Twenty-six of 38 (68.4%) variable LA features were found to have a significant correlation with 
at least one ambulatory or impairment outcome at least 1 set of collection times (e.g., admission 
to discharge from IPR). 
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Table 5.8: Significant correlations (ρ) between the change in variable LA features and the change in 


















LA Feature (n=12) (n=12) (n=24) (n=11) (n=11) (n=22) (n=12) (n=12) (n=24) 
Change in 
grav acc 
Grav Change Z-IQR 0.182 0.523 0.264 0.225 -0.193 -0.063 0.236 0.011 0.052 
Freq 
domain 
Power Dom Freq 1-
Med 
0.349 0.343 0.365 0.124 -0.183 -0.068 0.189 -0.155 0.012 
Power Dom Freq 2-
IQR 
0.388 0.285 0.348 0.048 -0.312 -0.179 0.029 -0.099 -0.023 
Power Dom Freq 2-
Med 
0.356 0.519 0.424 0.076 -0.092 -0.072 0.094 0.070 0.088 
Power Dom Low 
Freq-Med 
0.434 0.482 0.475 0.133 -0.092 -0.051 0.145 0.106 0.131 
Limb 
move % 
Bilat Ankle % 0.537 -0.102 0.192 0.434 -0.395 -0.037 0.424 -0.338 0.002 
Unilat Ankle % -0.537 0.102 -0.192 -0.434 0.395 0.037 -0.424 0.338 -0.002 
PLM PLM % -0.232 0.292 0.007 -0.029 0.459 0.184 -0.007 0.500 0.215 
Signal 
char 
Wave Approx-Med 0.623 0.117 0.315 0.715 -0.165 0.209 0.725 0.042 0.272 
Wave Energy 2-Med -0.481 -0.073 -0.195 -0.677 0.239 -0.126 -0.761 -0.007 -0.222 
Wave Energy 3-IQR -0.541 -0.073 -0.338 -0.543 0.266 -0.170 -0.544 0.081 -0.230 
Wave Energy 3-Med -0.651 0.110 -0.249 -0.763 0.385 -0.127 -0.725 0.169 -0.161 
Wave Entropy-Med -0.519 -0.139 -0.281 -0.597 0.138 -0.205 -0.628 -0.053 -0.270 
Statistical AUC Acc Norm-
Med 
0.502 0.431 0.476 0.305 -0.073 0.084 0.319 -0.056 0.120 
Duration-Max 0.306 0.380 0.251 0.019 0.275 0.151 0.036 0.500 0.283 
SMA Acc-Med 0.517 0.400 0.461 0.272 -0.078 0.042 0.287 -0.074 0.089 
Velocity, 
distance 
RMS Vel-Med 0.730 -0.068 0.367 0.474 -0.505 0.109 0.425 -0.391 0.117 
* Correlations with p< 0.1 are highlighted grey 
 
The WISCI-II had the most correlated features of any of the outcomes, particularly from 
admission to discharge from IPR. Most features for the WISCI-II had low to moderate correlation 
coefficients, while most features for the 10mWT and 6MWT had moderate to high correlations. 
Visually, there were a few features for the WISCI-II, primarily in the frequency domain and signal 
characteristics categories, that showed weak to moderate trends (Figure 5.7a). However, most 
other features for the WISCI-II and all features for the 10mWT and 6MWT showed weak visual 
correlations (Figure 5.7b) and at times conflicting trends (Figure 5.7c and Figure 5.7d).  
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Some interesting trends were noted when examining the per participant line graphs by 
ambulation or impairment outcome (Appendix Figure H.1), such as the participants with more 
prominent variability tended to have better ambulatory ability while those who had more stable 
measurements over time tended to be non-ambulatory or more limited ambulators. However, most 
of these trends were inconsistent and would be better assessed in a larger, more variable sample. 
a) b)  
c) d)  
Figure 5.7: Examples of significant, but relatively weak changes in LA features and ambulatory outcomes. a) 
Power Dom Freq 1- Med has a moderate visual trend with the WISCI-II particularly from admission to 
discharge. b) SMA Acc- Med has a weak-moderate visual trend with the WISCI-II that is stronger between 
discharge and 6-months. c) Wave Entropy- Med has a weak trend with the 10mWT that is negative form 
admission to discharge and positive from discharge to 6-months. d) Wave Approx- Med Change has a weak 
trend with the 6MWT that is positive from admission to discharge but negative from discharge to 6-months. 
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Table 5.9: Significant correlations (ρ) between the change in variable LA features and the change in 
impairment outcomes from admission to IPR to 6-months post-discharge* 










Feature Category LA Feature (n=12) (n=9) (n=21) (n=11) (n=7) (n=18) 
Change in angle of inclination Angle Net Change-Med -0.141 -0.333 -0.228 -0.055 0.883 0.213 
Angle Rate Change-Med -0.058 -0.067 -0.050 -0.097 0.829 0.249 
Angle Total Change-IQR 0.134 -0.167 -0.048 -0.220 0.685 0.189 
Angle Total Change-Med -0.042 -0.050 -0.014 -0.110 0.829 0.301 
Change in gravitational acceleration Grav Change Y-IQR -0.179 -0.267 -0.294 -0.046 0.883 0.232 
Grav Change Z-Med 0.095 -0.559 -0.193 0.468 0.645 0.493 
Correlation coefficients between axes Corr YZ-IQR -0.341 0.217 -0.076 -0.248 0.793 0.175 
Frequency domain Power Dom Freq 2-IQR 0.046 -0.250 -0.158 -0.105 0.739 0.166 
Power Dom Freq 2-Med 0.127 -0.267 -0.112 0.087 0.901 0.373 
Power Dom Low Freq-Med 0.105 -0.250 -0.109 0.027 0.901 0.363 
Median crossings Num Med Crossings-IQR 0.606 0.051 0.297 0.173 -0.075 0.063 
Statistical Duration-Max 0.545 0.183 0.353 0.430 0.018 0.235 
Velocity and distance Med Vel-Med 0.588 0.548 0.504 0.195 0.206 0.291 
* Correlations with p< 0.1 are highlighted grey 
 
Three LA features had significant correlations to LEMS, but only one of them (Num Med 
Crossings- IQR) had a moderate positive trend to the change in LEMS from admission to discharge 
(Figure 5.8a, Appendix Figure H.2). Only weak visual trends were found related to lower limb LT; 
however, one feature (Corr YZ- IQR, variability in movement directions) had an unusual 
difference in the direction of change with nearly all participants decreasing the variability of their 
movement directions from admission to discharge and then increasing from discharge to 6-months. 
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a) b)  
Figure 5.8: Examples of the change in LA features and impairment outcomes a) Moderate positive trend 
noted from admission to discharge between the Num Med Crossings- IQR and LEMS. b) Unusual finding 
with Corr YZ- IQR where from admission to discharge nearly all participants decreased their variability in 
movement directions, but from discharge to 6-months nearly all participants increased their variability in 
movement directions with a positive trend to lower limb LT sensation noted. 
5.4.3.3 Relationship between Admission LA and 6-month Ambulation (Aim 4b) 
Of the 72 features that were reliably measured at admission to IPR, 41 (56.9%) were related 
to one of the measures of ambulatory ability at 6-months post-discharge. Ten of the 25 (40%, 24% 
of the 41 related features) features that were reliable when measured using a single night at 
admission were also found to be related to ambulatory ability at 6-months.  
Table 5.10 summarizes the number of features found to be related to each ambulatory 
outcome, Table 5.11 summarizes the findings from the correlation, and visual analyses for each 
ambulatory outcome and the full results for all reliable features are shown in Appendix Table H.5. 
Most features that were related to each outcome had both significant correlations and a supporting 
visual relationship. Overall, 11 (15.3%) reliable LA features were related to only one ambulatory 
outcome, while 15 (20.8%) features each were associated with 2 and all 3 ambulatory outcomes. 
LA features from all categories were reliable and associated with 6-month ambulatory ability 
except change in gravitational acceleration, correlation coefficients between axes, and timing. 
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Twenty-five out of 34 (73.5%) features found to be stable over time in Aim 3b were also 
related to an ambulatory outcome at 6-months (Table 6.1). Of the 38 features that were variable 
over time in Aim 3b, 16 (42.1%) were associated with 6-month ambulation, with 13 (81.3%, 34.2% 
of 38 variable features) of those features also significantly changing with measures of ambulation 
or impairment over time in Aim 4a. The 3 variable LA features that were related to ambulatory 
ability at 6-months but not to changes in ambulatory ability or impairment over time from Aim 4a 
(Angle Rate Change-IQR, Wave Energy 2-IQR, Duration-IQR) were further visually examined in 
Appendix H.1. It is possible these features would have a significant association between change 
in the feature and change in ambulatory ability or impairment in a larger sample, but none had 
clear associations when visually examined. Angle Rate Change- IQR had one of the most distinct 
separation of groups for the 10mWT and 6MWT in the visual analyses of any admission feature. 
Wave Energy 2- IQR had a smaller separation between the non-ambulatory and household 
ambulator groups for the 6MWT and Duration- IQR showed a weak-moderate correlation between 
the admission LA feature and the 6-month WISCI-II and 10mWT outcomes. 
Table 5.10: Number of reliable admission LA features related to each measure of ambulatory ability at 6-
months post-discharge from IPR 
Association to 6-month Ambulatory Ability WISCI-II 10mWT 6MWT Total 
Significant Correlation Only 9 (12.5%) 1 (1.4%) 2 (2.8%) 12 (16.7%) 
Visual Association Only 0 (0.0%) 5 (6.9%) 9 (12.5%) 14 (19.4%) 
Both Correlation and Visual Association 25 (34.7%) 17 (23.6%) 17 (23.6%) 59 (81.9%) 
Total 34 (47.2%) 23 (31.9%) 28 (38.9%) 41 (56.9%) 
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Table 5.11: Reliable LA features measured at admission to IPR that are related to ambulation outcomes at 6-
months*†‡ 
Feature Category LA Feature WISCI-II 10mWT 6MWT 
Change in angle of inclination 
Angle Rate Change-IQR § 0.324 0.452 0.399 
Angle Rate Change-Med 0.513 0.421 0.460 
Angle Total Change-IQR 0.468 0.651 0.580 
Angle Total Change-Med 0.471 0.382 0.432 
Frequency domain 
Bandwidth-Med -0.662 -0.421 -0.424 
Centroid Freq-Med -0.657 -0.445 -0.491 
Power Dom Freq 1/Total-Med 0.499 0.305 0.386 
Dom Freq 1-Med -0.641 -0.506 -0.520 
Power Dom Freq 1-Med 0.489 0.277 0.292 
Power Dom Freq 2-IQR 0.652 0.755 0.651 
Power Dom Freq 2-Med 0.596 0.369 0.376 
Power Dom Low Freq-IQR 0.698 0.776 0.664 
Power Dom Low Freq-Med 0.547 0.332 0.334 
Power High Freq/Total-Med -0.511 -0.338 -0.359 
Power Total-IQR 0.712 0.768 0.614 
Limb movement percentages 
Bilat Ankle % -0.247 -0.300 -0.487 
Unilat Ankle % 0.247 0.300 0.487 
Median crossings Num Med Crossings Norm-Med -0.708 -0.570 -0.546 
Relationship to recent movements Close Cross Corr Peak-IQR 0.691 0.562 0.482 
Signal characteristics 
Lempel-Ziv Comp-Med -0.089 -0.090 0.041 
Lyapunov Exp-IQR 0.620 0.407 0.417 
Wave Energy 2-IQR § 0.378 0.092 0.079 
Statistical 
AUC Acc Norm-IQR 0.747 0.733 0.681 
AUC Acc-IQR 0.699 0.735 0.679 
AUC Acc-Med 0.537 0.424 0.426 
Duration-IQR § 0.517 0.569 0.465 
Duration-Max 0.622 0.425 0.503 
Duration-Med 0.521 0.546 0.529 
Max Acc-IQR 0.611 0.668 0.443 
Med Acc-IQR 0.703 0.673 0.701 
Med Acc-Med 0.391 0.282 0.344 
Range Acc-IQR 0.612 0.669 0.444 
RMS Acc-Med 0.472 0.256 0.230 
SD Acc-IQR 0.741 0.694 0.556 
SMA Acc-IQR 0.710 0.720 0.655 
SMA Acc-Med 0.504 0.340 0.327 
Velocity and distance 
Med Vel-IQR 0.699 0.672 0.701 
Med Vel-Med 0.358 0.256 0.302 
RMS Vel-Med 0.476 0.257 0.231 
Total Dist-IQR 0.687 0.776 0.701 
Total Dist-Med 0.574 0.448 0.468 
* Outcomes that had a correlation p< 0.1 are bolded 
† Outcomes found to have visual trends or at least 2 groups were visually separable are highlighted grey 
‡ LA features that were found to be stable over time in Aim 3b are italicized 
§ Indicates a feature that was variable over time in Aim 3b, but not related to changes in ambulatory ability or 




Figure 5.9: Examples of the relationship between 2 LA features from admission and each ambulatory 
outcome at 6-months post-discharge from IPR. The stars represent the mean values and the shading 
represents 1 SD from the mean per group. The LA features Med Acc- IQR (left) and Lyapunov Exp- IQR 
(right) demonstrate positive correlations that are most prominent for the 6MWT. Additionally, there is no 
overlap in the LA feature values between participants in the lowest and highest ambulatory groups for each 




Although exploratory in nature, these findings provide further evidence that LA is valid as 
a clinically meaningful metric when assessed in acute, incomplete SCI and would be likely to be 
successful if utilized in a CPR for functional, long-term ambulatory ability. 
More than 2/3 of the variable LA features were found to significantly change in relation to 
changes in impairment or ambulatory ability. However, when visually examined, many of these 
correlations were relatively weak. The small sample size, especially for the impairment measures, 
may have led to the LA features appearing more variable when in a larger sample the correlation 
may be stronger. Because of the many variable LA features with significant correlations but 
minimal visual trends, a larger sample is likely needed to confirm the results found in this 
exploratory analysis. Because of this, all variable features were included in the analysis for Aim 
4b with the understanding that features that are confirmed in a larger, more diverse sample are not 
likely to be useful in a CPR. Although the correlations may be weak in the current sample, these 
findings still provide evidence of face and construct validity of LA when measured acutely as well 
as demonstrating the responsiveness and robustness of this measure to still be able to detect trends 
in a small sample.  
The findings noted when examining the per participant changes in relation to ambulation 
and impairment groups indicate that there may be additional associations between LA and the 
outcomes that were not fully captured by the correlation analysis. For example, participants who 
are better ambulators may be extremely variable in a measure over time, while those who are non-
ambulatory may remain relatively stable. This finding would not be noticed by correlational 
analyses, but may still be helpful because the direction and amount of change between repeated 
measurements of that feature may provide information about future changes in ambulatory ability. 
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Understanding how these features change over time and the nuances in their associations to clinical 
measures of ambulation and impairment will assist in informing a future CPR and clinical 
outcomes. 
Care should be taken when utilizing the 3 LA features (Angle Rate Change-IQR, Wave 
Energy 2-IQR, Duration-IQR) that were found to be related to ambulatory ability at 6-months, but 
were variable and not related to changes in ambulatory ability or impairment over time. These 
features may be inconsistently measured in which case they may add noise to future models and 
increase the variability in LA in an unpredictable manor which would decrease prediction accuracy 
of the CPR. Additional analyses to further evaluate how these features change over time and ensure 
that they change in a predictable and meaningful way before including them in a CPR or other 
applications. 
Over 20% of the LA features measured at admission to IPR were related to all 3 ambulatory 
outcomes at 6-months post-discharge. An additional 15% were related to only outcome; these 
features may provide unique information about specific aspects of ambulatory ability that 
influence an individual’s performance in one assessment, but not another. As demonstrated by the 
participant classifications in Appendix Table F.1 (for all participants) and Appendix Table H.2 
(for only participants in Aim 4a), the WISCI-II provides unique that may inform clinical care 
differently than the 10mWT and 6MWT. Even though the majority of participants did fall in to the 
same categories for the 10mWT and 6MWT, the differences between these outcomes can still be 
recognized by not all participants be classified identically into these groups. This reinforces the 
importance of utilizing multiple non-dichotomous ambulatory outcomes to produce a 
comprehensive prediction of an individual’s functional abilities.102-104, 109 
 136 
Visually it was seen that the middle ambulatory ability category (uses AD but no physical 
assistance for WISCI-II, household ambulator for 10mWT and 6MWT) was less separable from 
the other two. This trend was also detected when classifying individuals with chronic SCI into 
those ambulatory categories in Aim 2. Since this group may possess characteristics of both the 
lowest and highest ambulatory groups, it makes sense that this group may have the most overlap 
and may be most differentiate in a population with acute, incomplete SCI. However, some LA 
features were able to show significant correlations or clear visual separation of this group (Figure 
5.6). Thus, it is possible that this group may have the lowest accuracy for the 3 groups for each 
outcome when predicted in a future CPR utilizing LA, but we believe that LA consists of enough 
unique features to cumulatively still differentiate this group well. This was supported by the 
findings from Aim 2 in the sample with chronic, motor incomplete where the household ambulator 
group was the most commonly misclassified of the 3 ambulatory groups, but still was correctly 
classified with an F1-score of 0.632 and 0.783 and is likely to improve in a larger, longitudinal 
sample.241 Further, the middle ambulatory ability groups generally had the smallest sample size of 
the 3 groups for each outcome, so the increased variability may be influenced by the smaller 
number of participants.  
Many traditional statistical models used in previous CPRs assess a predictor’s relationship 
to the outcome linearly or using log-odds,4-6 but machine learning models have the ability to 
identify non-linear associations between the predictor and outcome, as well as associations 
between predictors.210, 211, 223 Additionally, machine learning models can generally utilize many 
more features or autonomously identify sets of important features that traditional statistical models 
with the same sample size cannot.107 Phan et al. has suggested that including a greater number of 
predictors and using less traditional statistical analyses like logistic regression could improve the 
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accuracy of future prediction models.109 Our findings demonstrate that a wide variety of different 
movement characteristics captured by LA are related to ambulatory ability and a CPR would likely 
perform best by utilizing predictors that embody this diversity. 
Although the current sample was too small to use machine learning techniques, the use of 
both correlational and visual analyses to identify trends that are not easily captured by statistical 
techniques allowed for a deeper understanding of the relationship and potential predictive ability 
of LA for long-term ambulatory ability. This also provides increased confidence that these features 
would be useful in a CPR for ambulatory ability. Machine learning models may pick up additional 
or different non-linear relationships between LA features or the features and outcomes that could 
not be visually assessed. 
5.4.4.1 Limitations 
Nearly all of the challenges regarding the sample size and other limitations that were 
discussed in Aim 3 (Section 5.3.4.1) are applicable to Aim 4 as well. The decision to use 1 typical 
night despite the finding that 2 typical nights provide the best reliability was a substantial limitation 
of these analyses. Due to the exploratory nature of these analyses and the limited sample size and 
distribution of ambulatory abilities, participants were not excluded if they did not have at least 2 
typical nights collected at admission to IPR (all participants did have ≥2 typical nights for the 
follow-ups). Since 24% of the features that were related to 6-month outcomes in Aim 4b were 
reliable when using a single night of LA (Aim 3a), we believe these findings are accurate despite 
the inclusion of those 2 participants with less reliable LA. Future analyses should assess the 
differences between “typical” and “non-typical” nights, as well as ensure that only participants 
with reliable LA are included.  
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Limitations unique to is aim, include the clinical and ambulatory assessments not being 
consistently performed by clinicians trained by the research team which may decrease the 
reliability of these assessments. However, one of the reasons that these ambulatory and clinical 
outcomes were utilized, is that they are frequently performed, common assessments that most 
clinicians would previously have been trained to complete and utilize regularly.102, 104 
Additionally, the ambulatory assessments have demonstrated excellent test-retest and inter-rater 
reliability which indicates that these measures would likely still be consistently measured in these 
circumstances.102, 242   
For both impairment outcomes, but especially lower limb LT, the sample size decreased at 
6-months secondary to limitations from remote follow-up collections (assessments could not be 
completed for impairment outcomes if participants weren’t attending physical therapy and were 
not consistently collected from those attending therapy). This sample size limits the interpretation 
of the findings and likely led to the larger number of features with correlations to the change in 
lower limb LT from discharge to 6-months post-discharge. For these reasons and the large number 
of missing data, the MAS had limited follow-up measurements and could not be included in this 
analysis.  
Although the 3 ambulatory outcomes assessed provide a comprehensive understanding of 
an individual’s ability to walk (capacity), they do not provide a measure of how much the 
participants actually do walk (performance). A person may be more likely to functionally ambulate 
if they walk with a better quality and speed, but other factors may also affect their primary mode 
of mobility and daily activity. The current findings make it likely that LA would also be related to 
measures of walking performance such as daily steps.214, 243 Additionally, the relationship between 
person, psychosocial, and environmental factors (PPEF) such as an individual’s coping strategies, 
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pain, environmental barriers, and social support may all influence an individual’s ambulation 
capacity and performance.11, 12, 90, 91, 244 Measures of daily steps, time and use of a wheelchair 
versus ambulation, and PPEF were all collected in this longitudinal sample and should be assessed 
in future analyses. 
Lastly, the visual analyses performed for this aim were subjective to some extent, although 
efforts were made to minimize the effects of subjectivity. These efforts include, one researcher 
performed all of the analyses with predetermined guidelines and checked the findings a second 
time to ensure that all visual classifications were consistent. Because of the aforementioned efforts 
taken to decrease subjectivity, compounded with the fact that these analyses are exploratory with 
a small sample size, the findings are still meaningful and will be further evaluated in future 
analyses.  
5.4.5 Conclusions 
Changes over time in variable features of LA were significantly correlated with and may 
be related to changes over time in each measure of ambulatory ability and impairment, though 
further analysis is needed. Additionally, 41 features that were reliable when measured at admission 
to IPR among a sample with acute, incomplete SCI were found to be related to the need for 
assistance, speed, and endurance during ambulation at 6-months post discharge. These features 
capture a variety of different aspects of movements representing a diverse understanding of a 
participant’s movement characteristics and abilities. These findings provide evidence that LA 
measured at admission to IPR would likely be beneficial in a CPR to predict a comprehensive 
description of ambulatory ability among a sample with acute, incomplete SCI who would benefit 
from this prediction the most. 
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5.5 Longitudinal Study Conclusions 
In Aim 3a, LA were established as reliable when measured over the first two typical nights 
soon after admission to IPR (number of selected features=72). Further, we identified LA features 
that are stable over the first 6-months post-discharge (Aim 3b) as well as features that were not 
stable (variable) over time and were related to changes in ambulatory ability and impairment (Aim 
4a). LA features stable over time (n=25) may be able to differentiate between different levels of 
impairment and ambulatory ability using measurements from a few days to a several months after 
injury. LA features that are variable over time and related to ambulation or impairment (n=26) 
represent baseline measures of characteristics that would only substantially change if the 
individual’s level of impairment or functional abilities improve. These measures are similar to 
clinical predictors such as MMT and LT scores that are commonly used in current CPRs and are 
likely to change with neurorecovery.4, 5, 53, 58-63 But unlike those clinical measures, the LA features 
capture much more information about an individual’s movement and should be more useful in a 
CPR. 
This work culminates in Aim 4b which shows LA features (both stable and variable) are 
related to ambulatory ability at 6-months. Each of these features demonstrated either a significant 
correlation with or visual separation of long-term ambulatory groups based on LA measurements 
from admission to IPR. They indicate diverse movement characteristics are important including 
movement magnitude, power, energy distribution, frequency, smoothness, stability, duration, 
similarity to recent movements, directions, velocity, and distance traveled. Further, they show that 
it is important to consider both the actual values of the movement characteristics (median values) 
and the ability to produce a variety of movement characteristics (IQR).  
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While a machine learning model may identify features most useful for prediction 
differently than the current analyses, our results provide strong pilot data evidence that LA, 
measured acutely after injury, is related to ambulatory ability following SCI and important to 
consider in future CPRs. Collectively, these analyses provide evidence of reliability and face, 
construct, concurrent, and predictive validity of LA when measured in a sample with acute, 
incomplete SCI. This makes a strong case for the future use of LA as a measure of impairment and 




6.0 Overall Conclusions and Future Directions 
This dissertation established LA as a meaningful clinical metric that is related to measures 
of impairment (strength, sensation, spasticity; Aim 1) and ambulation (speed, endurance; Aim 2) 
in a cross-sectional analysis of individuals with chronic, primarily motor incomplete SCI. These 
findings established the face, construct, and concurrent validity of LA in a diverse sample. Then 
using a longitudinal analysis of individuals with acute, incomplete SCI from admission to IPR 
through 6-months post-discharge, we were able to evaluate the reliability, validity, and relationship 
to clinical outcomes. These results determined that LA can be reliably measured in an acute setting, 
includes features that can be identified as stable over time or changing in relation to measures of 
impairment and ambulation, and are likely predictive of 6-month ambulatory ability when 
measured at admission to IPR.  
Summary findings of which LA features were determined to be supportive of the goals for 
each aim (e.g., related to ambulatory ability, reliable, etc.) are shown in Table 6.1. Additionally, a 
summary table describing the number of features selected for each aim is shown in Table 6.2. 
While many LA features were selected for each aim that represent a diverse set of movement 
characteristics, the only feature that was selected in every applicable analysis was Lyapunov Exp- 
IQR. The Lyapunov exponent is a measure of local dynamic stability or chaos which may be a 
measure of the motor system’s ability to diminish perturbations and continue along a trajectory 
with higher values representing increased divergence/chaos and less stability.224, 225 It has been 
shown to prevuously be related to measues of sleep apnea, brain activity during sleep,245 gait,146, 
225 fall risk,224, 226 and improvements in lower limb rehabilitation.173 The variability in this measure 
may represent an individual’s ability to produce consistent, stable movements and unpredictable 
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movements. Individuals with limited strength or severe spasticity may have limited ability to move 
in a variety of directions and speeds, thus their movements are more likely to be predictable with 
less variability. Therefore, the finding that individuals with better strength and ambulatory ability 
would exhibit more variability in movement stability. 
Seven other features were selected in 4 of the analyses: speed of positional changes (Angle 
Rate Change-Med), variability of position changes (Grav Change Z-IQR), movement frequency 
(Dom Freq 1-Med), power (Power Dom Freq 2-Med), movement smoothness (Num Med 
Crossings Norm-Med), and variability in similarity of recent movements (Close Cross Corr Peak-
IQR). All of those features were found to be related to a measure of impairment among those with 
chronic SCI, were reliable to measure at admission to IPR in acute, incomplete SCI, and were 
related to 6-month ambulatory ability when measured at admission in acute, incomplete SCI 
(except Grav Change Z- IQR which was related to ambulatory ability in chronic SCI).  
Both Angle Rate Change-Med and Grav Change Z-IQR describe different aspects related 
to the changes in position throughout the night. Angle Rate Change-Med describes the total change 
in the angle of inclination (resultant angle between 3 gravitational axes) divided by the time to 
complete the movement as a measure of angular velocity.154, 159, 162 Having a faster rotational 
movements was associated with greater strength in Aim 1 and was positively correlated with both 
the WISCI-II and 6MWT at 6-months post-discharge in Aim 4b. The Z axis of the accelerometer 
runs medial-lateral (Figure 3.2) and would experience the greatest changes when the participant 
rotates side to side, such as when rolling from the right to the left side. Grav Change Z- IQR was 
associated with mild spasticity in Aim 1 and the 6MWT in Aim 2 among those with chronic SCI 
and was correlated with changes in the WISCI-II over time in participants with acute SCI in Aim 
4a. Participants who are able to rotate positions more quickly and complete a variety of rotational 
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position changes throughout the night likely have improved strength to perform such movements, 
which may be related to improved walking endurance and less assistance for ambulation. Thus, 
these features may capture reliable and useful measures of how an individual moves throughout 
the night and are related to measures of strength and ambulatory ability which could be useful in 
a CPR. 
Dom Freq 1-Med represents the dominant frequency of the signal (frequency at the 
maximum spectral power) and provides of measure of periodicity. Someone with a higher 
dominant frequency would likely have many fluctuations in their movements and a noisier signal 
compared to someone with a lower dominant frequency. Power Dom Freq 2-Med represents the 
power at the second local maxima and will be higher for movements with higher intensities. It also 
could be higher if a larger amount of the total power is at the second dominant frequency as 
compared to other movements where the power might be highly concentrated at the dominant 
frequency. A higher Dom Freq 1-Med was associated with worse sensation, worse spasticity, and 
worse ambulatory ability in all 3 outcomes. Higher Power Dom Freq 2- Med values were 
associated with having worse sensation, more spasticity and better ambulatory outcomes for the 
WISCI-II and 10mWT. It makes intuitive sense that having noisier, higher frequency movements 
may be associated with more spasticity and worse outcomes and more intense movements being 
associated with better walking outcomes. However, the association between power and worse 
sensation and spasticity warrant further investigation. 
Num Med Crossings Norm-Med is a measure of movement smoothness that is calculated 
by counting the number of times that the acceleration magnitude crosses the median of the 
acceleration over the whole movement normalized by the duration of the movement. A participant 
with many changes in acceleration per second of movement would have a higher Num Med 
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Crossings Norm-Med and less smooth movement and was associated with worse walking 
outcomes for the WISCI-II, 10mWT, and 6MWT at 6-months post-injury. It would be expected 
that someone with poorer motor control and strength would have more difficulty performing a 
movement smoothly, thus it makes sense that Num Med Crossings Norm-Med was also associated 
with lower strength among those with chronic SCI. A similar measure was also found to be 
negatively correlated to 6MWT distances among children with muscular dystrophy, and greater 
smoothness has also been associated with improved gait quality when comparing health controls 
to those with Parkinson’s disease and peripheral neuropathy.89, 146 
Having movements in series with similar characteristics was common of movements that 
were more likely spastic or PLM (Figure 4.2). This was demonstrated by the finding that lower 
Close Cross Corr Peak-IQR which is a measure of similarity to recent movements was associated 
with a lower probability of having no spasticity. Additionally, having more variable recent 
movements was associated with all 3 ambulatory outcomes at 6-months post-injury. 
These features are a likely to be useful in a CPR for ambulation and other potential purposes 
such as improved measures of impairment. With the exception of the 2 features from the frequency 
domain, these features all represent different categories of movement information, which 
emphasizes the benefits of a diverse feature set.  
Both Aims 1 and 2 utilize machine learning models to assess the relationship between LA 
and measures of impairment and ambulatory ability. A benefit from those analyses is that feature 
selection steps were embedded in the analysis to minimize bias and overfitting in the results. The 
feature selection is designed to choose features that are likely to improve model performance and 
decrease collinearity, which would likely result in only one feature out of a group of highly 
correlated feature to be included in the model. Thus, it is likely that other highly correlated features 
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to those described above that were reliable when measured acutely (Aim 3a) and related to a 6-
month measure of ambulatory ability (Aim 4b), are also likely to be particularly useful in future 
applications.  
Future work in this area should include evaluating the reliability of LA features in the 
chronic SCI population and further validation of the findings in Aims 3 and 4 should in a larger, 
more diverse sample. Additionally, the differences between participant reported “typical” and 
“non-typical” nights should be evaluated. It would be beneficial to have a better understanding of 
what makes a participant identify a night as “non-typical” and if non-typical nights can be utilized 
in analyses if similar LA can be extracted to self-reported “typical” nights. It would also be 
beneficial to assess LA in relation to an ambulatory outcome that evaluates performance, such as 
daily steps, as well as the use of personal, psychosocial, and environmental factors (PPEF) as a 
predictor of all outcomes. Further, LA may be applicable as a movement biomarker that could be 
used to predict the response to rehabilitation interventions in other populations and for other 
activities. 
Given the many diverse, informative, and reliable features that can be extracted from limb 
movements during sleep with low collection burden in both acute and chronic populations with 
incomplete SCI, LA has the potential to be a widely utilized clinical metric. LA that is reliably 
measured at admission to IPR and used in a machine learning model to accurately predict long-
term functional ambulation among those with acute, incomplete SCI may lead to optimized use of 
therapy time, more realistic patient expectations, and improved long-term outcomes for patients. 
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Table 6.1: Summary of LA features selected from each analysis*† 
Feature 












6m (Aim 3b) 
LA Change Related 
to Outcome Change 
(Aim 4a) 
Admission Related 








Angle Net Change-IQR    
   
0 
Angle Net Change-Med   ✓  ✓  2 
Angle Rate Change-IQR   ✓   ✓ 2 
Angle Rate Change-Med ✓  ✓  ✓ ✓ 4 
Angle Total Change-IQR   ✓  ✓ ✓ 3 




Grav Change X-IQR   ✓ ✓   2 
Grav Change X-Med    
   
0 
Grav Change Y-IQR ✓  ✓  ✓  3 
Grav Change Y-Med    
   
0 
Grav Change Z-IQR ✓ ✓ ✓  ✓  4 




Corr XY-IQR ✓      1 
Corr XY-Med ✓   
   
1 
Corr XZ-IQR ✓   
   
1 
Corr XZ-Med    
   
0 
Corr YZ-IQR   ✓  ✓  2 
Corr YZ-Med ✓      1 
Frequency 
domain 
Bandwidth-IQR       0 
Bandwidth-Med   ✓ ✓ ✓ 3 
Centroid Freq-IQR    
   
0 
Centroid Freq-Med   ✓ ✓ 
 
✓ 3 
Dom Freq 1-IQR ✓   
   
1 
Dom Freq 1-Med ✓  ✓ ✓ 
 
✓ 4 
Dom Freq 2-IQR ✓   
   
1 
Dom Freq 2-Med    
   
0 
Dom Low Freq-IQR    
   
0 
Dom Low Freq-Med    
   
0 
Mean Freq-IQR ✓   
   
1 
Mean Freq-Med    




Table 6.1 Continued 
Feature 












6m (Aim 3b) 
LA Change Related 
to Outcome Change 
(Aim 4a) 
Admission Related 







Med Freq-IQR ✓  ✓ ✓  3 
Med Freq-Med ✓  ✓ ✓ 
 
 3 
Power Dom Freq 1/Total-IQR ✓   
   
1 
Power Dom Freq 1/Total-Med   ✓ ✓ 
 
✓ 3 
Power Dom Freq 1-IQR ✓   
   
1 
Power Dom Freq 1-Med   ✓  ✓ ✓ 3 
Power Dom Freq 2-IQR   ✓  ✓ ✓ 3 
Power Dom Freq 2-Med ✓  ✓  ✓ ✓ 4 
Power Dom Low Freq-IQR   ✓ ✓ 
 
✓ 3 
Power Dom Low Freq-Med   ✓  ✓ ✓ 3 
Power High Freq/Total-IQR    
   
0 
Power High Freq/Total-Med   ✓ ✓ 
 
✓ 3 
Power Total-IQR   ✓ ✓ 
 
✓ 3 




Bilat Ankle %   ✓  ✓ ✓ 3 
Unilat Ankle %   ✓  ✓ ✓ 3 
Whole Body %    
   
0 
Wrist Ankle %       0 
Median 
crossings 
Num Med Crossings Norm-IQR       0 
Num Med Crossings Norm-Med ✓  ✓ ✓ ✓ 4 
Num Med Crossings-IQR  ✓ ✓  ✓  3 
Num Med Crossings-Med  ✓ ✓    2 
PLM Num PLM Norm   ✓    1 
PLM % ✓  ✓  ✓  3 





Table 6.1 Continued 
Feature 












6m (Aim 3b) 
LA Change Related 
to Outcome Change 
(Aim 4a) 
Admission Related 








Close Cross Corr Peak-IQR ✓  ✓ ✓  ✓ 4 
Close Cross Corr Peak-Med    
   
0 
Close Cross Cov Peak-IQR ✓   
   
1 
Close Cross Cov Peak-Med    
   
0 
Dom Freq Last 90s-IQR ✓   
   
1 
Dom Freq Last 90s-Med   ✓ ✓ 
 
 2 
Max Cross Corr-IQR    
   
0 
Max Cross Corr-Med    
   
0 
Max Cross Cov-IQR ✓   
   
1 
Max Cross Cov-Med   ✓ ✓ 
 
 2 
Mean Cross Corr Peaks-IQR    
   
0 
Mean Cross Corr Peaks-Med    
   
0 
Mean Cross Cov Peaks-IQR    
   
0 
Mean Cross Cov Peaks-Med    
   
0 
Move Last 90s-IQR    
   
0 
Move Last 90s-Med ✓  ✓    2 
Move Next 90s-IQR    
   
0 
Move Next 90s-Med   ✓    1 
Num Cross Corr Peaks-IQR ✓   
   
1 
Num Cross Corr Peaks-Med    
   
0 
Num Cross Cov Peaks-IQR ✓   
   
1 
Num Cross Cov Peaks-Med    
   
0 
Time Since Prev-IQR ✓   
   
1 




Entropy Rate-IQR   ✓ ✓   2 
Entropy Rate-Med   ✓    1 
Lempel-Ziv Comp-IQR    
   
0 
Lempel-Ziv Comp-Med   ✓ ✓ 
 
✓ 3 
Lyapunov Exp-IQR ✓ ✓ ✓ ✓ 
 
✓ 5 
Lyapunov Exp-Med ✓   
   
1 
Wave Approx-IQR ✓   
   
1 
Wave Approx-Med   ✓  ✓  2 
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Table 6.1 Continued 
Feature 












6m (Aim 3b) 
LA Change Related 
to Outcome Change 
(Aim 4a) 
Admission Related 








Wave Energy 1-IQR    
   
0 
Wave Energy 1-Med    
   
0 
Wave Energy 2-IQR   ✓   ✓ 2 
Wave Energy 2-Med ✓  ✓  ✓  3 
Wave Energy 3-IQR   ✓  ✓  2 
Wave Energy 3-Med   ✓  ✓  2 
Wave Entropy-IQR ✓   
   
1 
Wave Entropy-Med   ✓  ✓  2 
Statistical AUC Acc Norm-IQR   ✓ ✓  ✓ 3 
AUC Acc Norm-Med   ✓  ✓  2 
AUC Acc-IQR   ✓ ✓ 
 
✓ 3 
AUC Acc-Med   ✓ ✓ 
 
✓ 3 
Duration-IQR    
   
0 
Duration-Max   ✓ ✓ 
 
 2 
Duration-Med   ✓ ✓ 
 
✓ 3 
Kurtosis-IQR    
   
0 
Kurtosis-Med    
   
0 
Max Acc-IQR   ✓ ✓ 
 
 2 
Max Acc-Med   ✓ ✓ 
 
✓ 3 
Max-RMS Acc-IQR   ✓ ✓ 
 
✓ 3 
Max-RMS Acc-Med   ✓   ✓ 2 
Med Acc-IQR   ✓  ✓ ✓ 3 
Med Acc-Med   ✓ ✓ 
 
✓ 3 
Range Acc-IQR   ✓ ✓ 
 
✓ 3 
Range Acc-Med    
   
0 
RMS Acc-IQR    
   
0 
RMS Acc-Med   ✓ ✓ 
 
✓ 3 
SD Acc-IQR   ✓ ✓ 
 
✓ 3 
SD Acc-Med    
   
0 
Skewness-IQR    
   
0 




Table 6.1 Continued 
Feature 












6m (Aim 3b) 
LA Change Related 
to Outcome Change 
(Aim 4a) 
Admission Related 





Statistical SMA Acc-IQR   ✓ ✓ ✓ 3 
SMA Acc-Med   ✓  ✓ ✓ 3 
Timing End Move %-IQR       0 
End Move %-Med    
  
0 
Move/hour ✓  ✓    2 
Move/night   ✓    1 
Start Move %-IQR  ✓  
   
1 
Start Move %-Med  ✓  
   
1 
Time Asleep ✓  ✓    2 
Velocity and 
distance 
Med Vel-IQR   ✓ ✓  ✓ 3 
Med Vel-Med   ✓  ✓ ✓ 3 
RMS Vel-IQR    
   
0 
RMS Vel-Med   ✓  ✓ ✓ 3 
Total Dist-IQR   ✓ ✓ 
 
✓ 3 
Total Dist-Med   ✓ ✓  ✓ 3 
Total Number of LA Features Selected 35 (26.3%) 6 (4.5%) 72 (54.1%) 34 (47.2%) 26 (68.4%) 41 (56.9%) 92 (69.2%) 
* ✓ = Feature was chosen/related,  = Feature was not chosen/related, Blank= Feature was not applicable for analysis. † Feature names are highlighted grey if 




Table 6.2: Summary of the number of LA features selected from each analysis (% of maximum number of features included in anlaysis, % of maximum 












Admission to 6m 
(Aim 3b) 
LA Change Related 
to Outcome Change 
(Aim 4a) 
Admission Related 
to 6m Ambulation 
(Aim 4b) 
Related to Impairment 
(Aim 1) 
35 (26.3% of 133) 
2 (1.5% of 133, 
33.3% of 6) 
17 (12.8% of 133, 
48.6% of 35) 
7 (9.7% of 72, 
20.6% of 34) 
6 (15.8% of 38, 
23.1% of 26) 
6 (8.3% of 72, 
17.1% of 35) 
Related to Ambulation 
(Aim 2) 
2 (1.5% of 133, 
33.3% of 6) 
6 (4.5% of 133) 
4 (3.0% of 133, 
66.7% of 6) 
1 (1.4% of 72, 
16.7% of 6) 
2 (5.3% of 38, 
33.3% of 6) 
1 (1.4% of 72, 
16.7% of 6) 
Reliable at Admission 
(Aim 3a) 
17 (12.8% of 133, 
48.6% of 35) 
4 (3.0% of 133, 
66.7% of 6) 
72 (54.1% of 133) 
34 (47.2% of 72, 
100.0% of 34) 
26 (68.4% of 38, 
100.0% of 26) 
41 (56.9% of 72, 
100.0% of 41) 
Stable from Admission to 
6m (Aim 3b) 
7 (9.7% of 72, 
20.6% of 34) 
1 (1.4% of 72, 
16.7% of 6) 
34 (47.2% of 72, 
100.0% of 34) 
34 (47.2% of 72) N/A 
25 (34.7% of 72, 
73.5% of 34) 
LA Change related to 
Outcome Change (Aim 4a) 
6 (15.8% of 38, 
23.1% of 26) 
2 (5.3% of 38, 
33.3% of 6) 
26 (68.4% of 38, 
100.0% of 26) 
N/A 26 (68.4% of 38) 
13 (34.2% of 38, 
50.0% of 26) 
Admission Related to 6m 
Ambulation (Aim 4b) 
6 (8.3% of 72, 
17.1% of 35) 
1 (1.4% of 72, 
16.7% of 6) 
41 (56.9% of 72, 
100.0% of 41) 
25 (34.7% of 72, 
73.5% of 34) 
13 (34.2% of 38, 
50.0% of 26) 




Appendix A List of Abbreviations 
AD= Assistive device 
AIS= American Spinal Injury Association impairment scale 
AUC= Area under the curve 
BMI= Body mass index 
CPR= Clinical prediction rule 
FIM= Functional Independence Measure 
ICC= Intraclass correlation coefficient 
ISNCSCI= International Standards for Neurological Classification of Spinal Cord Injury  
IPR= Inpatient rehabilitation 
IQR= Interquartile range 
LA= Limb accelerations 
LARS= Least angle regression 
LASSO=Least absolute shrinkage and selection operator  
LEMS= Lower extremity motor score 
LT= Light touch 
MAS= Modified Ashworth Scale 
MMT= Manual muscle test 
OCA= Overall classification accuracy 
PLM= Periodic limb movement 
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PSQI= Pittsburgh Sleep Quality Index 
RMS= Root mean square 
SCI= Spinal cord injury 
SD= Standard deviation 
SF-36= Medical Outcomes Study 36-Item Short-Form Health Survey 
WISCI-II= Walking Index for Spinal Cord Injury II 
6MWT= 6 minute walk test 
10mWT= 10 meter walk test 
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Appendix B Additional CPRs for Ambulation 
Although the van Middendorp CPR is the most widely cited CPR, there are many others 
that have sought to improve upon this CPR or approach prediction from a different angle. The 
Hicks CPR was created as a simpler version of the van Middendorp CPR and uses only age (≥65 
years), the MMT motor score at L3, and LT sensation score at S1 to predict the probability of 
independent ambulation at 1-year post-injury as measured by the FIM.5 Like the van Middendorp 
CPR, it has demonstrated high accuracy (AUC= 0.866, overall classification accuracy= 84%), but 
also suffers from a biased sample population that may have led to overly-favorable results.52 
Belliveau at al. predicted the self-reported ability to walk 150 feet in their home, 1 street 
block outside, and 1 flight of stairs (with or without mobility aids) using artificial neural networks. 
Predictors included age ≥65 years, maximal motor scores for each myotome that were 
dichotomized into having against gravity strength or not (MMT ≥ 3), and lower and upper 
extremity motor scores.36 The artificial neural network prediction models using age and 
dichotomized motor scores from L2, L3, and S1 had AUC= .880 - .902 from OCA= 85 - 88% in 
the validation test set which were comparable to prediction accuracies from similar models made 
using logistic regression using the entire dataset (no validation).36 These models demonstrated that 
machine learning methods can be used for ambulatory prediction at least as well as traditional 
statistics. Additionally, this study was one of the first to use more functional ambulatory outcomes, 
but still limited those outcomes to dichotomized groups of those who could or could not complete 
the ambulation task. 
The prediction models by Zörner et al. were some of the only prediction models that 
focused only on individuals with motor incomplete SCI (AIS C and D) and used a variety of 
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predictors (gender, age, lower and upper extremity motor, LT, and pinprick sensation scores, AIS 
grade, tibial somatosensory evoked potentials) to predict more descriptive and functional outcome 
measures at 6-months after injury (dichotomized Walking Index for SCI II [WISCI-II] and 6 
Minute Walk Test [6MWT] scores into categories of independent or dependent and functional and 
non-functional ambulators, respectively).53 They found that the models performed best when 
calculated separately for individuals with tetraplegia and paraplegia. Lower extremity motor score 
(LEMS) was consistently included in all models. Although these models produced high 
classification accuracies among individuals with motor incomplete SCI (OCA= 82.1 - 92.2% for 
the WISCI-II and OCA= 84.2 - 100% for the 6MWT), the models were not validated, which, given 
the small sample size (n= 51 with tetraplegia, n= 39 with paraplegia) and feature selection steps 
prior to fitting the model, may lead to models that are not generalizable and perform poorly on 
unseen test sets. These models had much smaller proportions of individuals with paraplegia in the 
lower ambulatory groups that may have affected model performance. This is demonstrated by the 
lower prediction accuracies for individuals with paraplegia who were dependent walkers (n= 14, 
accuracy= 64.3% vs independent walkers n= 25, accuracy= 92.0%) and non-functional walkers 
(n=8, accuracy= 37.5% vs functional walkers n= 30, accuracy= 96.7%).53 These results also 
demonstrate the problematic use of only metrics such as OCA and AUC for model evaluation as 
skewed sample populations could cover up prediction inaccuracies among certain sub-populations 
that could be clinically useful to detect.109 This study addresses the importance of focusing CPRs 
for ambulation on individuals with motor incomplete injuries and using a combination of more 
descriptive and functional measures of ambulation as model outcomes, but is likely not as 
clinically useful due to flaws in the sample population and model building and validation. 
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Appendix C Model Evaluation Metrics 
The overall classification accuracy (OCA), precision, recall, and F1-score were used to 
describe classification model performance. For the present analyses, those performance metrics 
are defined as follows: 
 
𝑂𝐶𝐴 =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑟𝑡𝑖𝑐𝑖𝑝𝑎𝑛𝑡𝑠 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑙𝑦 𝑐𝑙𝑎𝑠𝑠𝑖𝑓𝑖𝑒𝑑
𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑟𝑡𝑖𝑐𝑖𝑝𝑎𝑛𝑡𝑠
 
 
Appendix Equation C.1: 
Overall Classification Accuracy 
(OCA) 
 
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 (𝑝𝑒𝑟 𝑐𝑙𝑎𝑠𝑠 𝑖) =  
𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 + 𝐹𝑎𝑙𝑠𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
=
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑟𝑡𝑖𝑐𝑖𝑝𝑎𝑛𝑡𝑠 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑙𝑦 𝑐𝑙𝑎𝑠𝑠𝑖𝑓𝑖𝑒𝑑 𝑎𝑠 𝑐𝑙𝑎𝑠𝑠 𝑖
𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑟𝑡𝑖𝑐𝑖𝑝𝑎𝑛𝑡𝑠 𝑐𝑙𝑎𝑠𝑠𝑖𝑓𝑖𝑒𝑑 𝑎𝑠 𝑐𝑙𝑎𝑠𝑠 𝑖 
 
Appendix Equation C.2: 
Precision 
 
𝑅𝑒𝑐𝑎𝑙𝑙 (𝑝𝑒𝑟 𝑐𝑙𝑎𝑠𝑠 𝑖) =  
𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 + 𝐹𝑎𝑙𝑠𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
=
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑟𝑡𝑖𝑐𝑖𝑝𝑎𝑛𝑡𝑠 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑙𝑦 𝑐𝑙𝑎𝑠𝑠𝑖𝑓𝑖𝑒𝑑 𝑎𝑠 𝑐𝑙𝑎𝑠𝑠 𝑖
𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑟𝑡𝑖𝑐𝑖𝑝𝑎𝑛𝑡𝑠 𝑎𝑐𝑡𝑢𝑎𝑙𝑙𝑦 𝑐𝑙𝑎𝑠𝑠 𝑖 
 
Appendix Equation C.3: Recall 
 




Appendix Equation C.4: F1-
Score 
 
Precision represents the proportion of an outcome class that was labeled as a given class 
and actually in that class (i.e., ability not to label a negative sample as positive, positive predictive 
value). Recall is defined as the proportion of classifications that were correct out of the total 
number of classifications for a given class (i.e., ability of the classifier to find all positive samples, 
true positive rate). Precision is focused on minimizing false positives, while recall is focused on 
minimizing false negatives. Recall can also be referred to as sensitivity when used in binary 
classification. Measures such as specificity (true negative rate) are not applicable for multiclass 
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classification. F1-score is able to provide a more comprehensive view of model performance by 
calculating the weighted harmonic mean of precision and recall and is particularly useful for 
imbalanced classification problems where accuracy may be misleading.177, 178 For all metrics, a 
higher score (range=0-1) is indicative of higher accuracy and better model performance. 
The macro and weighted averages of the precision, recall, and F1-scores across classes 
were calculated to best evaluate the model performance when all classes are treated equally or 
when each class contribution is adjusted for the relative number of samples in that class, 





𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑙𝑎𝑠𝑠𝑒𝑠
 
Appendix Equation 
C.5: Macro Average 
 
𝑊𝑒𝑖𝑔ℎ𝑡𝑒𝑑 𝐴𝑣𝑒𝑟𝑎𝑔𝑒 =
∑  𝑚𝑒𝑡𝑟𝑖𝑐𝑖𝑖 ∗  𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑎𝑟𝑡𝑖𝑐𝑖𝑝𝑎𝑛𝑡𝑠 𝑖𝑛 𝑐𝑙𝑎𝑠𝑠 𝑖







Appendix D Aim 1 Supplemental Material 
Appendix Table D.1: Description of covariates included in feature sets for Aim 1 
Covariate Type Covariates Included in Analysis 
Demographics54, 97 • Age 
• Sex 
• BMI 
• Years since injury 
Pain120, 121, 123 • If pain present 
• Average pain intensity  
• Number of pain locations 
• Pain Domain Score 
Sleep Quality138 • Global score (sum of 7 components) 
• Poor sleep quality (global score >5 [poor sleep quality] or ≤5) 
• Components: 





o Sleep quality  
• Averaged over nights collected (score 0-10) 
o Fatigue rating 
o Sleep rating 
Factors Affecting Sleep120, 121, 132-
134, 136, 137 
• Pain interference with sleep 
• Dichotomized to if it occurred over the collection period (yes/no): 
o Alcohol use (in 6 hours prior to sleep) 
o Caffeine use (in 6 hours prior to sleep) 
o Exercise 
o Sleep medication use 
Appendix D.1 Assessment of Limb Independence 
To increase the sample size, it was proposed to treat the right and left lower limbs as 
independent samples since LA and each impairment outcome are measured separately for each 
limb. Although SCI can often lead to asymmetric impairments, it was still assumed that there will 
be some level of relation between the sides. Therefore, Pearson correlations were calculated for 
each outcome and LA feature between the stronger and weaker lower limbs for each participant.  
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The impairment outcome correlations are shown in Appendix Table D.2 and the LA 
correlations are shown in Appendix Table D.3. For the participants with motor complete SCI, all 
strength scores were 0, so the correlation between sides was not applicable. For both the 
impairment outcomes and the LA features, participants with motor complete SCI generally had 
higher correlations than those with motor incomplete SCI. Due to these high correlations between 
both the input and output variables assessed in the analysis, the limbs were determined to be not 
independent and only one sample per participant was used that combined both limbs. 
Appendix Table D.2: Correlations coefficients (r) for each impairment outcome between the stronger and 
weaker lower limbs* 
Impairment Outcome 
Motor Incomplete 






(n=40, 38 for 
Spasticity) 
Strength (LEMS) 0.770 N/A 0.857 
Sensation (Lower Extremity LT) 0.810 1.00 0.884 
Spasticity (MAS from knee flexors and plantarflexors)† 0.530 0.832 0.625 
* Correlation coefficients ≥ 0.7 are bolded; Coefficients ≥ 0.9 are in grey 
† MAS was treated as continuous with a score of 1+ as 1.5 
 
Appendix Table D.3: Correlations coefficients (r) for each LA feature between the stronger and weaker lower 
limbs* 
Feature 







Change in angle 
of inclination 
Angle Net Change-IQR 0.497 0.980 0.543 
Angle Net Change-Med 0.343 0.629 0.377 
Angle Rate Change-IQR 0.353 0.938 0.438 
Angle Rate Change-Med 0.386 0.867 0.483 
Angle Total Change-IQR 0.603 0.976 0.662 




Grav Change X-IQR 0.599 0.873 0.640 
Grav Change X-Med 0.110 -0.067 0.025 
Grav Change Y-IQR 0.220 0.913 0.263 
Grav Change Y-Med 0.076 0.774 0.035 
Grav Change Z-IQR 0.352 0.349 0.356 




Corr XY-IQR 0.320 0.502 0.374 
Corr XY-Med -0.106 0.587 0.074 
Corr XZ-IQR 0.417 -0.006 0.414 
Corr XZ-Med 0.052 -0.149 0.007 
Corr YZ-IQR 0.555 0.462 0.526 
Corr YZ-Med -0.189 0.021 -0.206 
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Appendix Table D.3 Continued 
Feature 









Bandwidth-IQR 0.542 0.272 0.484 
Bandwidth-Med 0.593 0.867 0.687 
Centroid Freq-IQR 0.754 -0.242 0.673 
Centroid Freq-Med 0.641 0.840 0.695 
Dom Freq 1-IQR 0.510 0.874 0.607 
Dom Freq 1-Med 0.757 0.953 0.851 
Dom Freq 2-IQR 0.180 0.559 0.186 
Dom Freq 2-Med 0.582 0.947 0.483 
Dom Low Freq-IQR 0.080 0.804 0.307 
Dom Low Freq-Med 0.658 0.813 0.740 
Mean Freq-IQR 0.706 0.235 0.625 
Mean Freq-Med 0.693 0.778 0.734 
Med Freq-IQR 0.578 0.872 0.718 
Med Freq-Med 0.693 0.915 0.794 
Power Dom Freq 1/Total-IQR 0.708 0.828 0.716 
Power Dom Freq 1/Total-Med 0.700 0.663 0.698 
Power Dom Freq 1-IQR 0.327 0.968 0.373 
Power Dom Freq 1-Med 0.431 0.677 0.433 
Power Dom Freq 2-IQR 0.558 0.994 0.664 
Power Dom Freq 2-Med 0.353 0.891 0.366 
Power Dom Low Freq-IQR 0.610 0.952 0.663 
Power Dom Low Freq-Med 0.326 0.932 0.351 
Power High Freq/Total-IQR 0.679 0.837 0.700 
Power High Freq/Total-Med 0.576 0.708 0.621 
Power Total-IQR 0.419 0.976 0.467 
Power Total-Med 0.355 0.779 0.366 
Limb movement 
percentages 
Bilat Ankle % 0.590 -0.038 0.512 
Unilat Ankle % 0.590 -0.038 0.512 
Whole Body % 0.795 0.708 0.781 
Wrist Ankle % 0.734 0.757 0.749 
Median crossings Num Med Crossings Norm-IQR 0.641 0.743 0.652 
Num Med Crossings Norm-Med 0.697 0.956 0.759 
Num Med Crossings-IQR 0.516 0.931 0.605 




Num PLM Norm 0.571 0.921 0.745 
PLM % 0.780 0.927 0.811 




Close Cross Corr Peak-IQR 0.617 0.272 0.586 
Close Cross Corr Peak-Med 0.537 0.495 0.534 
Close Cross Cov Peak-IQR 0.616 0.175 0.549 
Close Cross Cov Peak-Med 0.739 0.919 0.725 
Dom Freq Last 90s-IQR 0.284 0.862 0.241 
Dom Freq Last 90s-Med 0.796 0.930 0.839 
Max Cross Corr-IQR 0.639 0.296 0.550 
Max Cross Corr-Med 0.728 0.786 0.732 
Max Cross Cov-IQR 0.696 0.463 0.643 
Max Cross Cov-Med 0.845 0.862 0.827 
Mean Cross Corr Peaks-IQR 0.468 0.629 0.496 
Mean Cross Corr Peaks-Med 0.644 0.714 0.650 
Mean Cross Cov Peaks-IQR 0.451 0.227 0.411 
Mean Cross Cov Peaks-Med 0.840 0.749 0.810 
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Appendix Table D.3 Continued 
Feature 










Move Last 90s-IQR 0.425 0.372 0.394 
Move Last 90s-Med 0.924 0.821 0.903 
Move Next 90s-IQR 0.425 0.372 0.394 
Move Next 90s-Med 0.924 0.821 0.903 
Num Cross Corr Peaks-IQR 0.416 0.308 0.434 
Num Cross Corr Peaks-Med 0.848 0.893 0.853 
Num Cross Cov Peaks-IQR 0.501 0.456 0.465 
Num Cross Cov Peaks-Med 0.787 0.869 0.809 
Time Since Prev-IQR 0.632 0.910 0.684 
Time Since Prev-Med 0.394 0.976 0.579 
Signal 
characteristics 
Entropy Rate-IQR 0.515 0.429 0.501 
Entropy Rate-Med 0.665 0.645 0.655 
Lempel-Ziv Comp-IQR 0.549 0.831 0.617 
Lempel-Ziv Comp-Med 0.618 0.757 0.631 
Lyapunov Exp-IQR 0.493 0.252 0.450 
Lyapunov Exp-Med 0.652 0.882 0.726 
Wave Approx-IQR 0.545 0.303 0.541 
Wave Approx-Med 0.673 0.606 0.661 
Wave Energy 1-IQR 0.633 0.546 0.606 
Wave Energy 1-Med 0.748 0.862 0.789 
Wave Energy 2-IQR 0.250 0.274 0.267 
Wave Energy 2-Med 0.507 0.765 0.554 
Wave Energy 3-IQR 0.465 0.808 0.569 
Wave Energy 3-Med 0.525 0.722 0.593 
Wave Entropy-IQR 0.490 0.018 0.488 
Wave Entropy-Med 0.664 0.636 0.657 
Statistical AUC Acc Norm-IQR 0.532 0.855 0.554 
AUC Acc Norm-Med 0.592 0.778 0.611 
AUC Acc-IQR 0.876 0.982 0.853 
AUC Acc-Med 0.535 0.851 0.574 
Duration-IQR 0.817 0.985 0.847 
Duration-Max 0.880 0.991 0.891 
Duration-Med 0.837 0.951 0.854 
Kurtosis-IQR 0.604 0.493 0.558 
Kurtosis-Med 0.431 0.568 0.447 
Max Acc-IQR 0.801 0.937 0.812 
Max Acc-Med 0.628 0.913 0.632 
Max-RMS Acc-IQR 0.706 0.775 0.684 
Max-RMS Acc-Med 0.683 0.760 0.686 
Med Acc-IQR 0.713 0.877 0.749 
Med Acc-Med 0.757 0.848 0.779 
Range Acc-IQR 0.801 0.937 0.812 
Range Acc-Med 0.630 0.911 0.633 
RMS Acc-IQR 0.517 0.847 0.537 
RMS Acc-Med 0.602 0.803 0.615 
SD Acc-IQR 0.529 0.866 0.551 
SD Acc-Med 0.540 0.794 0.558 
Skewness-IQR 0.349 0.675 0.439 
Skewness-Med 0.437 0.707 0.489 
SMA Acc-IQR 0.537 0.829 0.554 
SMA Acc-Med 0.583 0.792 0.605 
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Appendix Table D.3 Continued 
Feature 







Timing End Move %-IQR 0.571 0.482 0.553 
End Move %-Med 0.905 0.927 0.909 
Move/hour 0.940 0.991 0.949 
Move/night 0.945 0.961 0.946 
Start Move %-IQR 0.571 0.480 0.552 
Start Move %-Med 0.907 0.927 0.910 
Time Asleep 1.000 1.000 1.000 
Velocity and 
distance 
Med Vel-IQR 0.720 0.833 0.751 
Med Vel-Med 0.753 0.826 0.764 
RMS Vel-IQR 0.507 0.846 0.529 
RMS Vel-Med 0.611 0.807 0.624 
Total Dist-IQR 0.859 0.985 0.851 
Total Dist-Med 0.518 0.827 0.563 
* Correlation coefficients ≥ 0.7 are bolded; Coefficients ≥ 0.9 are in grey 
 
Appendix D.1.1 Machine Learning Algorithm Descriptions 
The LASSO algorithm is a linear regression model with embedded feature selection that 
favors more sparse solutions (fewer non-zero coefficients) using ℓ1 regularization. The ℓ1 
regularization uses coordinate descent which minimizes the objective function of the residual sum 
of squares plus the sum of the absolute value of the coefficients which creates a trade-off between 
accuracy and simplicity. The regularization parameter, λ, can be used to influence the simplicity 
of the solution, with larger values of λ decreasing the number of features included in the model.176, 
246, 247 
The LASSO model can be implemented using the LARS algorithm which determines the 
features to be included in the model for all values of λ along the regularization path. It does this 
by finding the feature with the highest correlation to the residual and then continuing along that 
regression line until another variable is found that has the same or a higher correlation. It then 
continues equiangular to those features until no more features are added. In this way it produces 
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an exact value for the optimal λ in as few steps as forwards stepwise regression. Thus, the LASSO 
LARS algorithm is particularly useful when there are many more features than samples and 
provides an efficient and more automated method for feature selection and model fitting.176, 246, 247 
To provide consistency between the models for the continuous and categorical outcomes, 
the ℓ1 regularization was also used in the multinomial logistic regression model. A range of 
regularization parameters were used to ensure an appropriate value was used. The saga solver in 
sklearn in Python248 is a variation of the stochastic average gradient descent and was used as it 
supports both ℓ1 regularization and multinomial logistic regression.
249 The output in multinomial 
logistic regression is separate equations that evaluate the probability that the sample belongs to a 
given class. The class with the highest probability is chosen as the predicted class. 
Appendix D.2 Impairment Models Full Results 
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Appendix Table D.4: Features included in the strength LASSO LARS models per feature set, sorted by the 
absolute value of the coefficient. 
LA Features (16 features) Covariates Features (19 features) 
Feature Name Coeff Feature Name Coeff 
Wave Approx- IQR 20.99 SF-36: Pain -29.98 
Num Cross Corr Peaks- IQR -19.81 BMI 23.66 
Lyapunov Exp- IQR 13.90 Number if Pain Locations -21.56 
Angle Rate Change- Med 13.22 PSQI: Poor Sleep Quality 17.00 
Power Dom Freq 1/Total- IQR 11.64 PSQI: Sleep Duration -15.20 
Corr XY- IQR 8.83 Pain Interference: Sleep -13.67 
Move Next 90s- Med 8.67 PSQI: Sleep Meds -11.26 
Med Freq- Med -6.08 Exercised During Collection 10.18 
Max Cross Cov- IQR -5.74 Sex 6.84 
Corr XY- Med -5.73 PSQI: Sleep Efficiency -6.36 
PLM % 5.42 Pain Present 2.40 
Time Since Prev- IQR -4.61 PSQI: Sleep Latency -1.65 
Time Asleep 2.09 Sleep Meds During Collection -1.05 
Mean Freq- IQR 0.70 Age 0.99 
Num Med Crossings Norm- Med -0.64 Ave Sleep Rating 0.83 
Skewness- Med -0.51 Alcohol During Collection -0.79   
Years Since Injury 0.56   
PSQI: Sleep Disturbance 0.40   
Caffeine During Collection 0.09 
Abbreviations: Coeff= Model Coefficient 













Appendix Table D.5: Features included in the strength linear regression models per feature set, sorted by the 





LA + Covariates Features 
(35 features) 
Feature Name Coeff Feature Name Coeff Feature Name Coeff 
Max Cross Cov- IQR -37.57 SF-36: Pain -35.30 Corr XY- IQR 77.84 
Wave Approx- IQR 30.98 BMI 31.97 Angle Rate Change- Med 71.32 
Num Med Crossings 
Norm- Med 
-30.33 Number if Pain Locations -30.44 Max Cross Cov- IQR -69.68 
Lyapunov Exp- IQR 26.42 PSQI: Poor Sleep Quality 21.94 Years Since Injury 59.43 
Num Cross Corr Peaks- 
IQR 
-23.93 PSQI: Sleep Duration -20.75 PSQI: Sleep Disturbance -54.71 
Angle Rate Change- Med 17.75 Pain Interference: Sleep -20.32 Ave Sleep Rating 51.83 
Corr XY- IQR 13.35 PSQI: Sleep Meds -16.48 Num Med Crossings Norm- 
Med 
49.94 
Time Asleep 11.20 Sex 11.74 Number if Pain Locations -44.14 
Mean Freq- IQR 11.16 Exercised During 
Collection 
11.54 Skewness- Med 32.20 
Time Since Prev- IQR -10.39 Pain Present 9.06 PSQI: Poor Sleep Quality 29.64 
PLM % 8.74 PSQI: Sleep Efficiency -5.43 Med Freq- Med -28.90 
Corr XY- Med -6.54 Age 5.19 PLM % 28.51 
Skewness- Med 4.82 Sleep Meds During 
Collection 
-4.48 Age -27.69 
Move Next 90s- Med 4.47 Years Since Injury 4.21 Lyapunov Exp- IQR 26.38 
Med Freq- Med -3.30 Ave Sleep Rating 4.18 Mean Freq- IQR -24.91 
Power Dom Freq 1/Total- 
IQR 




0.91 PSQI: Sleep Meds -23.91 
  




0.04 Wave Approx- IQR 15.51 
    
  Sleep Meds During 
Collection 
-12.67 
      Time Since Prev- IQR -12.50 
      BMI 11.57 
      PSQI: Sleep Duration -10.74 
      Time Asleep -9.58 
      PSQI: Sleep Latency -8.62 
      Pain Interference: Sleep -7.61 
      Alcohol During Collection 6.62 
      Sex 4.33 
      Caffeine During Collection 3.96 
      SF-36: Pain -3.38 
      Corr XY- Med 2.21 
      Exercised During Collection 1.96 
      Pain Present 0.93 
    
  Power Dom Freq 1/Total- 
IQR 
-0.82 
        PSQI: Sleep Efficiency 0.77 
Abbreviations: Coeff= Model Coefficient 
Covariates are in grey; LA features are in white. 
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Appendix Table D.6: Features included in the sensation LASSO LARS models per feature set, sorted by the 
absolute value of the coefficient. 
LA Features (15 features) Covariates Features (2 features) 
Feature Name Coeff Feature Name Coeff 
Time Since Prev- IQR -9.62 Number if Pain Locations -2.76 
Corr YZ- Med 8.34 PSQI: Sleep Efficiency -2.38 
Dom Freq 1- Med -8.10     
Num Cross Cov Peaks- IQR -7.15     
Time Asleep 6.92     
Wave Entropy- IQR 5.67     
Num Cross Corr Peaks- IQR -4.85     
Power Dom Freq 2- Med -3.72     
Dom Freq 1- IQR 3.48     
Grav Change Y- IQR 3.17     
Power Dom Freq 1/Total- IQR 2.08     
Mean Freq- IQR 1.18     
Lyapunov Exp- Med 1.12     
Corr XZ- IQR -0.59     
PLM Index 0.11     
Abbreviations: Coeff= Model Coefficient   
Covariates are in grey; LA features are in white. 
 
Appendix Table D.7: Features included in the sensation linear regression models per feature set, sorted by the 





LA + Covariates Features 
(17 features) 
Feature Name Coeff Feature Name Coeff Feature Name Coeff 
Time Since Prev- IQR -11.23 Number if Pain Locations -9.08 Dom Freq 1- Med -12.34 
Dom Freq 1- Med -10.89 PSQI: Sleep Efficiency -5.08 Power Dom Freq 2- Med -10.42 
Corr YZ- Med 10.39   
 
Time Since Prev- IQR -10.34 
Power Dom Freq 2- Med -10.19   
 
Corr YZ- Med 10.33 
Grav Change Y- IQR 9.90   
 
Grav Change Y- IQR 9.64 
Num Cross Cov Peaks- IQR -8.97   
 
Time Asleep 8.95 
Time Asleep 8.79   
 
Wave Entropy- IQR 8.06 
Wave Entropy- IQR 8.40   
 
Dom Freq 1- IQR 7.94 
Dom Freq 1- IQR 8.26   
 
Num Cross Cov Peaks- IQR -6.29 
Lyapunov Exp- Med 4.63   
 
PLM Index 4.72 
PLM Index 4.55   
 
Num Cross Corr Peaks- IQR -4.07 
Num Cross Corr Peaks- IQR -3.73   
 
Number if Pain Locations -3.43 
Corr XZ- IQR -3.21   
 
Power Dom Freq 1/Total- IQR 2.72 
Power Dom Freq 1/Total- IQR 3.06   
 
Corr XZ- IQR -2.42 
Mean Freq- IQR 1.62   
 
Mean Freq- IQR 2.13     
Lyapunov Exp- Med 1.52     
PSQI: Sleep Efficiency -0.56 
Abbreviations: Coeff= Model Coefficient       




Appendix Table D.8: Spasticity logistic regression with ℓ1 regularization model overall and per-class statistics 
per feature set.*  










Features Selected F1- Score Precision Recall 
No Spasticity 14 1 0 10 0.848 0.778 0.933 
Mild Spasticity 3 11 0 7 0.786 0.786 0.786 
Moderate Spasticity 1 2 6 10 0.800 1.000 0.667 
Macro Average 
Overall Classification Accuracy= 0.816 
0.854 0.795 0.811 
Weighted Average 0.833 0.816 0.814 










Features Selected F1- Score Precision Recall 
No Spasticity 13 2 0 5 0.765 0.684 0.867 
Mild Spasticity 4 10 0 5 0.741 0.769 0.714 
Moderate Spasticity 2 1 6 6 0.800 1.000 0.667 
Macro Average 
Overall Classification Accuracy= 0.763 
0.818 0.749 0.768 
Weighted Average 0.790 0.763 0.764 
* The number of participants correctly classified per ambulation category are bolded. 
 
Appendix Table D.9: Spasticity logistic regression without regularization model overall and per-class 











Features Selected F1- Score Precision Recall 
No Spasticity 9 6 0 10 0.765 0.684 0.867 
Mild Spasticity 1 13 0 7 0.741 0.769 0.714 
Moderate Spasticity 0 2 7 10 0.800 1.000 0.667 
Macro Average 
Overall Classification Accuracy= 0.763 
0.769 0.779 0.840 











Features in Model F1- Score Precision Recall 
No Spasticity 12 3 0 5 0.750 0.706 0.800 
Mild Spasticity 3 11 0 5 0.688 0.611 0.786 
Moderate Spasticity 2 4 3 6 0.500 1.000 0.333 
Macro Average 
Overall Classification Accuracy= 0.684 
0.640 0.646 0.772 
Weighted Average 0.684 0.668 0.741 










Features in Model F1- Score Precision Recall 
No Spasticity 12 3 0 15 0.889 1.000 0.800 
Mild Spasticity 0 14 0 12 0.875 0.778 1.000 
Moderate Spasticity 0 1 8 16 0.941 1.000 0.889 
Macro Average 
Overall Classification Accuracy= 0.895 
0.926 0.896 0.902 
Weighted Average 0.918 0.895 0.896 
* The number of participants correctly classified per ambulation category are bolded. 
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Appendix Table D.10: Features included in the spasticity logistic regression with ℓ1 regularization models per 
category and feature set, sorted by the absolute value of the coefficient. 
LA Features 
No Spasticity Mild Spasticity Moderate Spasticity 
Corr YZ- Med -0.95 Time Asleep 1.38 Wave Entropy- IQR -2.26 
Skewness- IQR 0.93 Num Cross Cov Peaks- IQR -0.74 Move/hour 1.70 
Power Dom Freq 2- Med -0.62 Power Dom Freq 1- IQR 0.48 Skewness- IQR -1.03 
Close Cross Cov Peak- 
IQR 
0.59 Grav Change Z- IQR -0.37 Wave Energy 2- Med -0.91 
Close Cross Corr Peak- 
IQR 
0.58 Corr XY- Med -0.27 Med Freq- Med 0.60 
Wave Energy 2- Med 0.54 Dom Freq Last 90s- IQR -0.06 Corr YZ- Med 0.38 
Dom Freq 2- IQR 0.39 Dom Freq 1- Med -0.04 Wave Approx- IQR -0.27 
PLM % -0.34   
 
Med Freq- IQR 0.17 
Wave Approx- IQR 0.15   
 
PLM Index 0.17 
Num Cross Cov Peaks- 
IQR 
0.06   
 
Dom Freq 1- Med 0.04 
Corr YZ- Med -0.95 Time Asleep 1.38 Wave Entropy- IQR -2.26 
Covariates Features 
No Spasticity Mild Spasticity Moderate Spasticity 
Feature Name Coeff Feature Name Coeff Feature Name Coeff 
PSQI: Sleep Quality 1.86 Ave Fatigue Rating 0.82 Ave Sleep Rating -1.40 
Years Since Injury 1.10 PSQI: Sleep Meds -0.63 PSQI: Sleep Duration 0.87 
PSQI: Poor Sleep Quality -0.87 Age -0.52 PSQI: Sleep Disturbance -0.72 
Pain Interfere: Sleep 0.81 Caffeine During Collection 0.38 Pain Present 0.70 






Sleep Meds During 
Collection 
0.30 






Abbreviations: Coeff= Model Coefficient  




Appendix Table D.11: Features included in the spasticity logistic regression without regularization models 
per category and feature set, sorted by the absolute value of the coefficient. 
LA Features 
No Spasticity Mild Spasticity Moderate Spasticity 
Feature Name Coeff Feature Name Coeff Feature Name Coeff 
Power Dom Freq 2- Med -2.50 Time Asleep 2.51 Wave Approx- IQR -2.26 
PLM % -2.38 Grav Change Z- IQR -1.95 Wave Entropy- IQR -2.07 
Corr YZ- Med -2.28 Power Dom Freq 1- IQR 1.87 Corr YZ- Med 2.07 
Wave Approx- IQR 2.18 Num Cross Cov Peaks- IQR -1.41 Skewness- IQR -1.55 
Num Cross Cov Peaks- IQR 1.60 Dom Freq Last 90s- IQR -1.13 Move/hour 1.40 
Skewness- IQR 1.49 Corr XY- Med -1.03 Wave Energy 2- Med -1.31 
Close Cross Cov Peak- IQR 1.35 Dom Freq 1- Med -0.67 PLM Index 1.07 
Dom Freq 2- IQR 1.27   
 
Med Freq- IQR 0.66 
Wave Energy 2- Med 1.18   
 
Dom Freq 1- Med 0.63 
Close Cross Corr Peak- IQR 0.98   
 
Med Freq- Med 0.59 
Covariates Features 
No Spasticity Mild Spasticity Moderate Spasticity 
Feature Name Coeff Feature Name Coeff Feature Name Coeff 
Years Since Injury 2.69 Ave Fatigue Rating 1.93 PSQI: Sleep Disturbance -2.22 
PSQI: Sleep Quality 1.64 Age -1.85 Ave Sleep Rating -2.11 
Sleep Meds During 
Collection 
-0.90 Exercised During 
Collection 
-1.02 Sleep Meds During 
Collection 
1.54 
PSQI: Poor Sleep Quality -0.79 Caffeine During Collection 0.96 Pain Present 1.02 






  PSQI: Sleep Duration 0.77 
LA + Covariates Features 
No Spasticity Mild Spasticity Moderate Spasticity 
Feature Name Coeff Feature Name Coeff Feature Name Coeff 
PLM % -2.08 Time Asleep 2.20 Wave Approx- IQR -1.57 
Years Since Injury 1.59 Ave Fatigue Rating 1.99 Wave Entropy- IQR -1.56 
Wave Approx- IQR 1.37 Age -1.83 Corr YZ- Med 1.48 
Corr YZ- Med -1.25 Grav Change Z- IQR -1.83 Sleep Meds During 
Collection 
1.30 
Skewness- IQR 1.24 Corr XY- Med -1.28 Skewness- IQR -1.29 
PSQI: Poor Sleep Quality -1.03 Power Dom Freq 1- IQR 1.18 Move/hour 1.28 
Power Dom Freq 2- Med -1.02 Num Cross Cov Peaks- IQR -0.89 Wave Energy 2- Med -1.25 
PSQI: Sleep Quality 0.97 Dom Freq Last 90s- IQR -0.85 Ave Sleep Rating -1.04 
Num Cross Cov Peaks- IQR -0.91 Dom Freq 1- Med -0.71 PSQI: Sleep Duration 1.01 
Sleep Meds During 
Collection 
0.79 Exercised During 
Collection 
-0.66 PLM Index 1.00 
Dom Freq 2- IQR 0.67 Caffeine During Collection 0.52 PSQI: Sleep Disturbance -0.98 
Close Cross Cov Peak- IQR 0.62 PSQI: Sleep Meds 0.14 Dom Freq 1- Med 0.57 
Close Cross Corr Peak- IQR 0.61     Caffeine During 
Collection 
-0.50 
Wave Energy 2- Med 0.58     Med Freq- IQR 0.44 
Pain Interfere: Sleep 0.47     Med Freq- Med 0.41 
        Pain Present 0.40 
Abbreviations: Coeff= Model Coefficient  
Covariates are in grey; LA features are in white. 
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Appendix D.3 Supplemental Analysis for Sensation Models 
When evaluating the relationship between the covariates feature set and lower limb LT 
sensation, it was found that higher sensation scores were associated with 2 covariates: fewer pain 
locations and better sleep efficiency (lower PSQI: Sleep efficiency). This model resulted in much 
lower R2 values than would have been expected (i.e., a slightly lower R2 than when using only LA 
as seen in the other models). Thus, further analysis was completed to assess if an irregularity in 
the data was leading to the overly reduced feature selection and model instability or whether the 
covariates truly had a poorer relationship than expected. 
The LASSO LARS model is effective in reducing multicollinearity by only including 1 of 
the highly correlated features in the model, which is in a beneficial characteristic. However, the 
model effectively chooses between highly correlated features at random which can introduce 
problems in the model.176, 246 Although some covariate features were expected to have high 
correlations to other covariates, only 2 features had a correlation coefficient greater than 0.7: PSQI: 
Poor Sleep Quality and PSQI: Sleep Duration (r= .729) and PSQI: Poor Sleep Quality and PSQI: 
Sleep Quality (r= 0.718; Poor Sleep Quality is the dichotomized version of the PSQI Sleep Quality 
measure of the PSQI). 
Although there was not evidence of substantial correlation between covariate features, 
models were assessed that manually removed features that either conceptually measured similar 
information or were highly correlated. When determining which features to remove, features were 
kept that were more clinically meaningful, decreased the number of other features that were highly 
correlated, and were easier to calculate. A set of 19 covariate features after the repetitive/correlated 
features were removed was assessed in the LASSO LARS models and compared to the original 
model with all covariate features (24 initial features). The model with the non-repetitive features 
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produced essentially the same results as when no prior feature selection was performed, with the 
R2= 0.157 and the 2 same covariate features (number of pain problems, PSQI: Sleep Efficiency) 
selected.  
Feature selection was also performed algorithmically so that features with the highest 
mutual information scores with respect to the outcome were included in the model while other 
highly correlated features were removed. Mutual information measures the dependency between 
the LA feature and the outcome using nonparametric methods based on entropy estimations from 
k-nearest neighbors distances. Higher mutual information values indicate higher dependency 
between the variables.250 In addition to using mutual information to remove repetitive features, it 
was also used for further feature selection. The model containing all original covariate features 
(All) was compared to models using the following feature sets: only non-repetitive features after 
repetitive features with lower mutual information scores removed, only features with mutual 
information scores greater than zero, the top 50% of features based off mutual information score, 
top 25% and top 10%. Model performance is the same or worse than when all features were used 
until the features were restricted to the top 25% or less. Since it was determined that this method 
introduces too much bias to select features based off their relationship to the outcome and restricts 
features too much prior to when feature selection should occur in the LASSO LARS model, these 
methods were not further used. 
These results indicate that highly correlated features were not affecting the results. Since 
any feature selection prior to the machine learning model introduces bias, all future models did not 
have any feature selection performed prior. 
It was still thought that there was an interaction between covariates that was interfering 
with proper model building. The LASSO LARS model was run with all LA features and 1 
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covariate at a time to attempt to isolate the problematic covariate. All models performed essentially 
as expected with R2= 0.706 – 0.839 and 15-22 features selected for each model. Of the 24 models, 
10 included the covariate in the model, 13 did not select the covariate and produced the same 
model as when LA features only were included, and 1 covariate (Caffeine During Collection) was 
not selected in the model but produced a different model than when only LA features were 
included. Thinking that this covariate could be the source of the model instability, another model 
was assessed that included all LA and covariate features except for caffeine during the collection, 
but this again resulted in only the same 2 covariate features being selected and a poor model 
performance. 
A similar analysis was performed by including all LA features and all covariates except 1 
at a time. Each of these models selected only the same 2 covariate features when they were both 
available. When PSQI: Sleep Efficiency was excluded then only number of pain problems 
remained (R2= 0.067). However, when number of pain problems or both the PSQI: Sleep 
Efficiency and number of pain problems were excluded, then no variables were selected for the 
model). 
Since this finding with the covariate features resulting in an over-reduction in the number 
of features included in the model was only occurring with respect to the sensation outcome and 
not strength, the distributions of the outcomes were more closely assessed. Although neither 
outcome exhibited a normal distribution, this is not required for machine learning models and 
neither was vastly skewed (Appendix Figure D.1). 
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Appendix Figure D.1: Histograms and scatter plots for the Aim 1 participant distribution for the strength 
(top) and sensation (bottom) outcomes. 
 
Therefore, after evaluating correlations between features, manual feature reduction, 
algorithmic feature reduction, and individual covariate models there was not strong support for a 
data irregularity to be the primary cause of the poor sensation model performance. While it is still 
possible that a data issue may be present, this potential issue is unlikely to affect the study results 
or interpretation and it was determined that it was more likely that the covariates are just not 
strongly associated with sensation.  
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Appendix E Aim 2 Supplemental Material 
Appendix Table E.1: 10mWT confusion matrices and per-class and overall evaluation metrics for each 
feature set.* 







Ambulator Precision Recall 
F1-
Score 
Non-Ambulatory (0 m/s) 9 1 1 0.750 0.818 0.783 
Household Ambulator (0.01-.44 m/s) 2 5 2 0.500 0.556 0.526 
Community Ambulator (>.44 m/s) 1 4 2 0.400 0.286 0.333 
Macro Average Overall Classification Accuracy= 0.593 0.550 0.553 0.547 
Weighted Average 0.576 0.593 0.581 







Ambulator Precision Recall 
F1-
Score 
Non-Ambulatory (0 m/s) 9 1 1 1.000 0.818 0.900 
Household Ambulator (0.01-.44 m/s) 0 6 3 0.600 0.667 0.632 
Community Ambulator (>.44 m/s) 0 3 4 0.500 0.571 0.533 
Macro Average Overall Classification Accuracy= 0.704 0.700 0.685 0.688 
Weighted Average 0.737 0.704 0.715 







Ambulator Precision Recall 
F1-
Score 
Non-Ambulatory (0 m/s) 9 2 0 0.900 0.818 0.857 
Household Ambulator (0.01-.44 m/s) 1 6 2 0.500 0.667 0.571 
Community Ambulator (>.44 m/s) 0 4 3 0.600 0.429 0.500 
Macro Average Overall Classification Accuracy= 0.667 0.667 0.638 0.643 
Weighted Average 0.689 0.667 0.669 







Ambulator Precision Recall 
F1-
Score 
Non-Ambulatory (0 m/s) 9 1 1 0.900 0.818 0.857 
Household Ambulator (0.01-.44 m/s) 1 6 2 0.500 0.667 0.571 
Community Ambulator (>.44 m/s) 0 5 2 0.400 0.286 0.333 
Macro Average Overall Classification Accuracy= 0.630 0.600 0.590 0.587 
Weighted Average 0.637 0.630 0.626 
* The feature set with the highest classification accuracy per outcome is highlighted grey. The number of 





Appendix Table E.2: 6MWT confusion matrices and per-class and overall evaluation metrics for each feature 
set. * 







Ambulator Precision Recall 
F1-
Score 
Non-Ambulatory (0 m) 9 2 0 0.818 0.818 0.818 
Household Ambulator (1-204 m) 2 6 3 0.600 0.545 0.571 
Community Ambulator (> 204 m) 0 2 3 0.500 0.600 0.545 
Macro Average Overall Classification Accuracy= 0.667 0.639 0.655 0.645 
Weighted Average 0.670 0.667 0.667 







Ambulator Precision Recall 
F1-
Score 
Non-Ambulatory (0 m) 9 2 0 0.818 0.818 0.818 
Household Ambulator (1-204 m) 2 9 0 0.750 0.818 0.783 
Community Ambulator (> 204 m) 0 1 4 1.000 0.800 0.889 
Macro Average Overall Classification Accuracy= 0.815 0.856 0.812 0.830 
Weighted Average 0.824 0.815 0.817 







Ambulator Precision Recall 
F1-
Score 
Non-Ambulatory (0 m) 9 2 0 0.818 0.818 0.818 
Household Ambulator (1-204 m) 2 8 1 0.667 0.727 0.696 
Community Ambulator (> 204 m) 0 2 3 0.750 0.600 0.667 
Macro Average Overall Classification Accuracy= 0.741 0.745 0.715 0.727 
Weighted Average 0.744 0.741 0.740 







Ambulator Precision Recall 
F1-
Score 
Non-Ambulatory (0 m) 9 2 0 0.750 0.818 0.783 
Household Ambulator (1-204 m) 3 7 1 0.700 0.636 0.667 
Community Ambulator (> 204 m) 0 1 4 0.800 0.800 0.800 
Macro Average Overall Classification Accuracy= 0.741 0.750 0.752 0.750 
Weighted Average 0.739 0.741 0.739 
* The feature set with the highest classification accuracy per outcome is highlighted grey. The number of 




Appendix Table E.3: Features selected per 10mWT model and feature set (features selected 27 times maximum per model). 
 
Clinical & Demographic Features LA, Clinical & Demographic Features PPEF, Clinical & Demographic Features 


















LT: L4 (Best) 25 LT: L4 (Best) 24 MMT: Knee Flexion (Bilateral) 26 LT: L4 (Best) 27 
MMT: Knee Flexion (Best) 21 MMT: Knee Flexion (Best) 24 LT: L4 (Bilateral) 23 MMT: Knee Flexion (Best) 23 
LT: L2 (Best) 17 LT: L2 (Best) 18 LT: L2 (Best) 22 LT: L2 (Best) 18 
LT: L3 (Best) 15 MMT: L3 (Best) 16 MMT: L3 (Best) 19 AIS Classification 16 
AIS Classification 15 MMT: L5 (Best) 15 LT: L5 (Best) 19 LT: L5 (Best) 12 
MMT: L5 (Best) 12 LT: L3 (Best) 12 MMT: S1 (Best) 18 MMT: L3 (Best) 11 
LT: S1 (Best) 12 AIS Classification 11 AIS Classification 17 MMT: S1 (Best) 9 
LT: L5 (Best) 12 LT: L5 (Best) 11 MMT: L5 (Best) 16 MMT: L5 (Best) 8 
MMT: S1 (Best) 10 LT: S1 (Best) 9 LT: S1 (Bilateral) 15 MMT: L4 (Best) 7 
MMT: L3 (Bilateral) 10 MMT: L4 (Best) 7 LT: L3 (Best) 15 LT: S1 (Best) 7 
MMT: L4 (Best) 9 LT: Lower Extremity Score (Best) 6 MMT: L4 (Best) 13 LT: L3 (Bilateral) 4 
LT: Lower Extremity Score (Best) 4 MMT: Upper Extremity Score 
(Best) 
4 LT: Lower Extremity Score (Best) 6 MMT: L2 (Best) 2 
MMT: Lower Extremity Score 
(Best) 
3 MMT: L2 (Best) 4 MMT: Lower Extremity Score (Best) 5 LT: Lower Extremity Score (Best) 1 
MMT: Upper Extremity Score 
(Bilateral) 
3 SCI Level of Injury 3 SCI Level of Injury 4 SCI Level of Injury 1 
MMT: L2 (Best) 3 MMT: Lower Extremity Score 
(Best) 
3 MMT: Upper Extremity Score 
(Bilateral) 
3 LT: Upper Extremity Score (Best) 1 
SCI Level of Injury 2 LT: Upper Extremity Score 
(Bilateral) 
1 LT: Upper Extremity Score 
(Bilateral) 
1 MMT: Upper Extremity Score 
(Bilateral) 
1 
LT: Upper Extremity Score (Best) 2   
 











Veteran 20 Pain Present 19 Pain Present 25 Veteran 16 
Pain Present 17 Veteran 14 Veteran 22 Pain Present 11 
Medical Insurance 12 Medical Insurance 8 Comorbidities Present 14 Medical Insurance 7 
Number of Pain Locations 6 Number of Pain Locations 6 Number of Pain Locations 12 Comorbidities Present 4 
Marital Status 4 Marital Status 4 Medical Insurance 12 Number of Pain Locations 3 
Comorbidities Present 3 Comorbidities Present 4 Marital Status 6   
 
Years Since Injury 1 Race/Ethnicity 1 Race/Ethnicity 3   
 










Num Med Crossings- Med 2 N/A 
 
Num Med Crossings- Med 4   
Num Med Crossings- IQR 1 
  
Num Med Crossings- IQR 1 
  
 







Appendix Table E.3 Continued 
 
Clinical & Demographic Features LA, Clinical & Demographic Features PPEF, Clinical & Demographic Features 





















Took Sleep Medication During 
Collection 










PSQI: Sleep Quality 19 PSQI: Poor Sleep Quality 7   
  
 






Consumed Alcohol During Collection 18 PSQI: Sleep Quality 5   
  
 
Pain Interference: Social Activity 11 SF-36: Emotional Role Limitations 2   
  
 
PSQI: Sleep Duration 5 Pain Interference: Social Activity 2   
  
 













Resilience 2   
 










Appendix Table E.4: Features selected per 6MWT model and feature set (features selected 27 times maximum per model). 
  Clinical & Demographic Features 
LA, Clinical & Demographic 
Features PPEF, Clinical & Demographic Features 
All Features (LA, PPEF, Clinical & 
Demographic) 















MMT: Knee Flexion (Bilateral) 27 MMT: Knee Flexion 
(Bilateral) 
27 MMT: Knee Flexion (Best) 27 LT: L4 (Best) 26 
LT: L4 (Best) 25 LT: L4 (Best) 26 LT: L4 (Best) 24 MMT: Knee Flexion (Best) 24 
MMT: L3 (Bilateral) 22 MMT: L3 (Bilateral) 19 MMT: L3 (Best) 23 MMT: L3 (Best) 21 
LT: L3 (Bilateral) 16 LT: L3 (Bilateral) 18 LT: L3 (Bilateral) 13 LT: L3 (Bilateral) 11 
MMT: Lower Extremity Score 
(Best) 
14 MMT: Lower Extremity 
Score (Best) 
12 MMT: Lower Extremity Score 
(Best) 
13 MMT: Lower Extremity Score 
(Best) 
9 
LT: Lower Extremity Score 
(Bilateral) 
11 LT: Lower Extremity Score 
(Best) 
10 MMT: L5 (Best) 12 MMT: L5 (Best) 9 
MMT: L2 (Bilateral) 10 MMT: S1 (Best) 10 LT: Lower Extremity Score 
(Best) 
11 MMT: S1 (Best) 7 
MMT: L5 (Best) 7 MMT: L5 (Best) 9 MMT: L4 (Best) 10 LT: Lower Extremity Score (Best) 7 
LT: S1 (Best) 6 MMT: L2 (Bilateral) 5 MMT: L2 (Bilateral) 8 MMT: L2 (Best) 6 
MMT: S1 (Best) 6 MMT: L4 (Best) 5 MMT: S1 (Best) 5 MMT: L4 (Best) 4 
LT: L2 (Best) 4 LT: Upper Extremity Score 
(Best) 
5 LT: Upper Extremity Score 
(Bilateral) 
4 LT: L5 (Best) 4 
MMT: L4 (Bilateral) 3 LT: S1 (Best) 2 LT: S1 (Best) 4 LT: Upper Extremity Score (Best) 3 
LT: L5 (Best) 2 AIS Classification 2 LT: L2 (Best) 3 LT: L2 (Best) 2 
LT: Upper Extremity Score 
(Best) 
1 LT: L2 (Best) 1 LT: L5 (Bilateral) 2   
 
MMT: Upper Extremity Score 
(Bilateral) 













Comorbidities Present 25 Comorbidities Present 20 Pain Present 21 Comorbidities Present 17 
Pain Present 19 Pain Present 17 Comorbidities Present 20 Pain Present 16 
Veteran 10 Race/Ethnicity 10 Veteran 12 Veteran 11 
Race/Ethnicity 9 Veteran 9 Race/Ethnicity 5 Race/Ethnicity 6 











Num Med Crossings- Med 18 N/A 
 
Num Med Crossings- Med 24   
Lyapunov Exp- IQR 7 
  
Lyapunov Exp- IQR 6   
Start Move %- Med 2 
  
End Move %- Med 2   
Start Move %- IQR 1 
  
End Move %- IQR 2 
  
 







Appendix Table E.4 Continued 
  Clinical & Demographic Features 
LA, Clinical & Demographic 
Features PPEF, Clinical & Demographic Features 
All Features (LA, PPEF, Clinical & 
Demographic) 

























Took Sleep Medication During 
Collection 










Consumed Caffeine During 
Collection 



















SF-36: Emotional Role 
Limitations 










Self-Efficacy 1   
 




Appendix F Longitudinal Ambulatory and Clinical Assessments 
Appendix Table F.1: Confusion matrices of ambulatory categoizations for all participants and time points  
Admission to IPR 
Ambulatory Ability Category 





No AD or 
Assist 



















 Non-Amb (0m/s) 31 0 0 31 (93.9%) 31 0 0 31 (93.9%) 
Household Amb (0.01-.44m/s) 2 0 0 2 (6.1%) 0 2 0 2 (6.1%) 
Community Amb (>0.44m/s) 0 0 0 0 (0.0%) 0 0 0 0 (0.0%) 











 Non-Amb (0m) 31 0 0 31 (93.9%)         
Household Amb (1-204m) 2 0 0 2 (6.1%) 
    
Community Amb (>204m) 0 0 0 0 (0.0%) 
    
Total (% of row) 33 (100%) 0 (0.0%) 0 (0.0%) 33 (100%)         
Discharge from IPR 
Ambulatory Ability Category 





No AD or 
Assist 



















 Non-Amb (0m/s) 19 0 0 19 (63.3%) 19 0 0 19 (63.3%) 
Household Amb (0.01-.44m/s) 3 1 0 4 (13.3%) 0 4 0 4 (13.3%) 
Community Amb (>0.44m/s) 0 5 2 7 (23.3%) 0 4 3 7 (23.3%) 











 Non-Amb (0m) 19 0 0 19 (57.6%)         
Household Amb (1-204m) 4 7 0 11 (33.3%) 
    
Community Amb (>204m) 0 1 2 3 (9.1%) 
    





Appendix Table F.1 Continued 
6-months Post-Discharge from IPR 
Ambulatory Ability Category 





No AD or 
Assist 



















 Non-Amb (0m/s) 4 0 0 4 (30.8%) 4 0 0 4 (30.8%) 
Household Amb (0.01-.44m/s) 0 2 0 2 (15.4%) 0 2 0 2 (15.4%) 
Community Amb (>0.44m/s) 0 2 5 7 (53.8%) 0 1 6 7 (53.8%) 











 Non-Amb (0m) 4 0 0 4 (30.8%)         
Household Amb (1-204m) 0 2 1 3 (23.1%) 
    
Community Amb (>204m) 0 2 4 6 (46.2%) 
    
Total (% of row) 4 (30.8%) 4 (30.8%) 5 (38.5%) 13 (100%)         
1-year Post-Discharge from IPR 
Ambulatory Ability Category 





No AD or 
Assist 



















 Non-Amb (0m/s) 2 0 0 2 (22.2%) 2 0 0 2 (22.2%) 
Household Amb (0.01-.44m/s) 0 0 0 0 (0.0%) 0 0 0 0 (0.0%) 
Community Amb (>0.44m/s) 0 3 4 7 (77.8%) 0 2 5 7 (77.8%) 











 Non-Amb (0m) 2 0 0 2 (22.2%)         
Household Amb (1-204m) 0 2 0 2 (22.2%) 
    
Community Amb (>204m) 0 1 4 5 (55.6%) 
    
Total (% of row) 2 (22.2%) 3 (33.3%) 4 (44.4%) 9 (100%)         
Abbreviations: AD= Assistive Device, Amb= Ambulatory/Ambulation 
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Appendix G Aim 3 Supplemental Material 
Appendix Table G.1: Categorical demographics from participants included and excluded from Aims 3b/4a* 
 Aims 3b and 4a N (%) 
Categorical Demographics 
Included in Analysis Excluded From Analysis t test 
Collected and Usable 
(n=12) 
Partially Collected/Not 
Usable (n=2) Missed (n=9) Not Eligible (n=2) 
Total Not Included 
(n=13) Sig 
Adm Dc Adm Dc Adm Dc Adm Dc Adm Dc Adm Dc 
Sex           0.319  
Female 7 (58.3%)  1 (50.0%)  8 (88.9%)  1 (50.0%)  10 (76.9%)    
Male 5 (41.7%)  1 (50.0%)  1 (11.1%)  1 (50.0%)  3 (23.1%)    
Race/Ethnicity           0.716  
Non-Hispanic White 9 (75.0%)  2 (100%)  5 (55.6%)  1 (50.0%)  8 (61.5%)    
Non-Hispanic Black 1 (8.3%)  0 (0.0%)  1 (11.1%)  1 (50.0%)  2 (15.4%)    
Non-Hispanic Other Race 0 (0.0%)  0 (0.0%)  1 (11.1%)  0 (0.0%)  1 (7.7%)    
Hispanic (Any Race) 2 (16.7%)  0 (0.0%)  2 (22.2%)  0 (0.0%)  2 (15.4%)    
Veteran           0.953  
Not A Veteran 11 (91.7%)  1 (50.0%)  9 (100%)  2 (100%)  12 (92.3%)    
Veteran 1 (8.3%)  1 (50.0%)  0 (0.0%)  0 (0.0%)  1 (7.7%)    
Annual Household Income           0.240  
< $25,000 1 (8.3%)  1 (50.0%)  4 (44.4%)  0 (0.0%)  5 (38.5%)    
$25,000 - $49,999 3 (25.0%)  0 (0.0%)  2 (22.2%)  0 (0.0%)  2 (15.4%)    
$50,000 -$74,999 3 (25.0%)  0 (0.0%)  1 (11.1%)  0 (0.0%)  1 (7.7%)    
≥ $75,000 1 (8.3%)  1 (50.0%)  2 (22.2%)  0 (0.0%)  3 (23.1%)    
Declined/ Unknown 4 (33.3%)  0 (0.0%)  0 (0.0%)  2 (100%)  2 (15.4%)    
Education           0.541  
Less Than High School 2 (16.7%)  0 (0.0%)  0 (0.0%)  0 (0.0%)  0 (0.0%)    
High School 
Diploma/GED 
6 (50.0%)  1 (50.0%)  3 (33.3%)  1 (50.0%)  5 (38.5%)    
Associate's Degree 2 (16.7%)  0 (0.0%)  3 (33.3%)  1 (50.0%)  4 (30.8%)    
Bachelor's Degree 1 (8.3%)  0 (0.0%)  1 (11.1%)  0 (0.0%)  1 (7.7%)    
Graduate Degree 0 (0.0%)  1 (50.0%)  0 (0.0%)  0 (0.0%)  1 (7.7%)    
Other 1 (8.3%)  0 (0.0%)  2 (22.2%)  0 (0.0%)  2 (15.4%)    
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Appendix Table G.1 Continued 
 Aims 3b and 4a N (%) 
Categorical Demographics 
Included in Analysis Excluded From Analysis t test 
Collected and Usable 
(n=12) 
Partially Collected/ 
Not Usable (n=2) Missed (n=9) Not Eligible (n=2) 
Total Not Included 
(n=13) Sig 
Adm Dc Adm Dc Adm Dc Adm Dc Adm Dc Adm Dc 
Medical Insurance           0.447  
Private 3 (25.0%)  2 (100%)  5 (55.6%)  0 (0.0%)  7 (53.8%)    
Medicaid 3 (25.0%)  0 (0.0%)  3 (33.3%)  0 (0.0%)  3 (23.1%)    
Medicare 1 (8.3%)  0 (0.0%)  0 (0.0%)  0 (0.0%)  0 (0.0%)    
No Insurance 1 (8.3%)  0 (0.0%)  0 (0.0%)  0 (0.0%)  0 (0.0%)    
Other/Multiple 4 (33.3%)  0 (0.0%)  1 (11.1%)  2 (100%)  3 (23.1%)    
SCI Neurological Category           0.387 0.620 
Motor Complete (AIS A/B) 
Tetraplegia 
1 (8.3%) 1 (8.3%) 0 (0.0%) 0 (0.0%) 1 (11.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (7.7%) 0 (0.0%)   
Motor Complete (AIS A/B) 
Paraplegia 
3 (25.0%) 2 (16.7%) 1 (50.0%) 1 (50%) 1 (11.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (15.4%) 1 (7.7%)   
AIS C Tetraplegia 1 (8.3%) 1 (8.3%) 1 (50.0%) 0 (0.0%) 4 (44.4%) 3 (33.3%) 1 (50.0%) 1 (50.0%) 6 (46.2%) 4 (30.8%)   
AIS C Paraplegia 1 (8.3%) 2 (16.7%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (11.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (7.7%)   
AIS D Tetraplegia 5 (41.7%) 5 (41.7%) 0 (0.0%) 1 (50%) 2 (22.2%) 4 (44.4%) 1 (50.0%) 1 (50.0%) 3 (23.1%) 6 (46.2%)   
AIS D Paraplegia 1 (8.3%) 1 (8.3%) 0 (0.0%) 0 (0.0%) 1 (11.1%) 1 (11.1%) 0 (0.0%) 0 (0.0%) 1 (7.7%) 1 (7.7%)   
Primary Mode of Mobility           0.055 0.090 
Power Wheelchair 9 (75.0%) 4 (33.3%) 2 (100%) 0 (0.0%) 9 (100%) 8 (88.9%) 2 (100%) 2 (100%) 13 (100%) 10 
(76.9%) 
  
Manual Wheelchair 3 (25.0%) 5 (41.7%) 0 (0.0%) 2 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (15.4%)   
Ambulation 0 (0.0%) 3 (25.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (11.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (7.7%)   
WISCI-II           N/A 0.023 
Physical Assistance (or Non-
Ambulatory) 
12 (100%) 5 (41.7%) 2 (100%) 2 (100%) 9 (100%) 8 (88.9%) 2 (100%) 2 (100%) 13 (100%) 12 
(92.3%) 
  
Requires AD, but no Physical 
Assistance 
0 (0.0%) 5 (41.7%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (11.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (7.7%)   
Requires No AD or Physical 
Assistance 
0 (0.0%) 2 (16.7%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)   
10mWT           0.125 0.029 
Non-ambulatory (0m/s) 10 (83.3%) 5 (45.5%) 2 (100%) 1 (50%) 9 (100%) 6 (75.0%) 2 (100%) 2 (100%) 13 (100%) 9 (75.0%)   
Household Ambulator (0.01-.44m/s) 2 (16.7%) 1 (9.1%) 0 (0.0%) 1 (50%) 0 (0.0%) 2 (25.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (25.0%)   
Community Ambulator (>.44m/s) 0 (0.0%) 5 (45.5%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)   
6MWT           0.125 0.128 
Non-ambulatory (0m) 10 (83.3%) 5 (41.7%) 2 (100%) 1 (50%) 9 (100%) 6 (66.7%) 2 (100%) 2 (100%) 13 (100%) 9 (69.2%)   
Household Ambulator (1-204m) 2 (16.7%) 4 (33.3%) 0 (0.0%) 1 (50%) 0 (0.0%) 3 (33.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 4 (30.8%)   
Community Ambulator (>204m) 0 (0.0%) 3 (25.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)   
Abbreviations: Adm= Admission, Dc= Discharge 
* Significant differences between those included and excluded from the analysis (p< 0.05) are highlighted grey 
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Appendix Table G.2: Continuous demographics from participants included and excluded from Aims 3b/4a* 
  Aims 3b and 4a Mean±SD (Range)  
Included in Analysis Excluded From Analysis t test 
Continuous 
Demographics 
Collected and Usable 
(n=12) 
Partially Collected/Not 
Usable (n=2) Missed (n=9) Not Eligible (n=2) Total Not Included (n=13) Sig 
Adm Dc Adm Dc Adm Dc Adm Dc Adm Dc Adm Dc 
Age 45.8±17.8 (18-71) 32.0±12.8 (23-41) 52.6±15.2 (36-82) 63.7±4.0 (61-67) 51.1±16.0 (23-82) 0.442 
 
BMI 27.8±3.4 (23-35) 28.8±5.4 (25-33) 29.2±9.9 (15-47) 30.4±4.3 (27-33) 29.3±8.3 (15-47)  0.549 
 
Length of Stay in 
IPR (Days) 
33.8±10.7 (17-53) 49.5±2.1 (48-51) 47.3±10.9 (30-64) 44.0±12.7 (35-53) 47.2±9.8 (30-64)  0.002 
 
Days from Injury 
to Start of IPR 
14.8±16.0 (5-62) 23.0±7.1 (18-28) 18.1±8.7 (8-30) 12.5±0.7 (12-13) 18.0±8.0 (8-30) 0.521 
 
Days from Injury 
to Start of Data 
Collection 
17.5 ± 15.9 
(9 - 65) 
39.7 ± 16.5 
(18 - 76) 
28.0 ± 5.7 
(24 - 32) 
63.0 ± 4.2 
(60 - 66) 
22.8 ± 9.8 
(10 - 36) 
57.2 ± 11.0 
(41 - 72) 
17.5 ± 2.1 
(16 - 19) 
53.0 ± 9.9 
(46 - 60) 
22.8 ± 8.8 
(10 - 36) 
57.5 ± 9.5 































































0±0 (0-0) 0.1±0.1 (0-
0) 
0±0 (0-0) 0.1±0.2 (0-
0) 
0±0 (0-0) 0±0 (0-0) 0±0 (0-0) 0.1±0.1 (0-
0) 
0.211 0.043 




0±0 (0-0) 32.3±45.7 
(0-65) 
0±0 (0-0) 37.2±60.6 
(0-161) 
0±0 (0-0) 0±0 (0-0) 0±0 (0-0) 30.7±53.0 
(0-161) 
0.273 0.087 
Abbreviations: Adm= Admission, Dc= Discharge 






Appendix Figure G.1: Examples of LA collected from the right ankle, left ankle, and wrist across 7 typical nights at admission to IPR. This participant 
had an C5 AIS B SCI and non-ambulatory at admission to IPR. 
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Appendix Figure G.2: Examples of LA collected from the right ankle, left ankle, and wrist across 7 typical nights at admission to IPR. This participant 
had an L2 AIS A and primarily power wheelchia user but also uses a manual wheelchair and walks up to 45.7m with moderate assistance, a wheeled 
walker, and bilateral bracing (1 AFO, 1 KAFO) ambulatory with at admission to IPR. 
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Appendix Table G.3: ICC between nights of collection from admission to IPR* 
Feature 
Category 
  Average Nights Single Night     
Feature Name ICC 
95% Confidence Interval 
ICC 




Bound Lower Bound 
Upper 
Bound F Value Sig 
Change in angle 
of inclination 
Angle Net Change-IQR 0.481 -0.083 0.751 0.317 -0.040 0.601 1.91 0.040 
Angle Net Change-Med 0.662 0.291 0.838 0.495 0.170 0.721 2.90 0.002 
Angle Rate Change-IQR 0.595 0.161 0.805 0.424 0.088 0.674 2.46 0.008 
Angle Rate Change-Med 0.738 0.453 0.874 0.585 0.293 0.776 3.74 <0.001 
Angle Total Change-IQR 0.576 0.124 0.795 0.404 0.066 0.660 2.35 0.011 




Grav Change X-IQR 0.571 0.107 0.794 0.400 0.056 0.658 2.31 0.013 
Grav Change X-Med 0.467 -0.104 0.743 0.305 -0.049 0.591 1.87 0.046 
Grav Change Y-IQR 0.604 0.180 0.809 0.433 0.099 0.679 2.51 0.007 
Grav Change Y-Med 0.439 -0.098 0.722 0.282 -0.047 0.565 1.86 0.047 
Grav Change Z-IQR 0.815 0.616 0.911 0.688 0.445 0.837 5.29 <0.001 




Corr XY-IQR 0.232 -0.494 0.618 0.131 -0.198 0.447 1.33 0.223 
Corr XY-Med 0.195 -0.646 0.609 0.108 -0.244 0.438 1.24 0.276 
Corr XZ-IQR 0.221 -0.628 0.626 0.124 -0.239 0.456 1.28 0.251 
Corr XZ-Med 0.223 -0.640 0.628 0.125 -0.242 0.458 1.28 0.251 
Corr YZ-IQR 0.687 0.346 0.849 0.523 0.209 0.738 3.13 0.001 
Corr YZ-Med 0.162 -0.777 0.600 0.088 -0.280 0.429 1.19 0.319 
Frequency 
domain 
Bandwidth-IQR -0.136 -1.436 0.461 -0.063 -0.418 0.300 0.88 0.631 
Bandwidth-Med 0.572 0.101 0.795 0.401 0.053 0.660 2.30 0.013 
Centroid Freq-IQR 0.135 -0.767 0.579 0.072 -0.277 0.408 1.16 0.345 
Centroid Freq-Med 0.501 -0.044 0.760 0.334 -0.021 0.614 1.98 0.033 
Dom Freq 1-IQR 0.272 -0.546 0.653 0.157 -0.214 0.485 1.36 0.201 
Dom Freq 1-Med 0.597 0.153 0.807 0.426 0.083 0.677 2.44 0.009 
Dom Freq 2-IQR 0.015 -0.962 0.515 0.007 -0.325 0.347 1.02 0.483 
Dom Freq 2-Med 0.469 -0.122 0.746 0.306 -0.057 0.595 1.86 0.048 
Dom Low Freq-IQR 0.340 -0.392 0.685 0.205 -0.164 0.520 1.50 0.135 
Dom Low Freq-Med -0.095 -1.278 0.472 -0.046 -0.390 0.309 0.91 0.598 
Mean Freq-IQR 0.286 -0.431 0.650 0.167 -0.177 0.481 1.42 0.173 
Mean Freq-Med 0.469 -0.111 0.745 0.306 -0.052 0.594 1.87 0.046 
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Appendix Table G.3 Continued 
Feature 
Category 
  Average Nights Single Night     
Feature Name ICC 
95% Confidence Interval 
ICC 




Bound Lower Bound 
Upper 
Bound F Value Sig 
Frequency 
Domain 
Med Freq-IQR 0.721 0.422 0.865 0.563 0.267 0.763 3.55 <0.001 
Med Freq-Med 0.634 0.231 0.824 0.464 0.131 0.701 2.68 0.004 
Power Dom Freq 1/Total-IQR 0.349 -0.297 0.680 0.211 -0.129 0.515 1.56 0.114 
Power Dom Freq 1/Total-Med 0.609 0.179 0.813 0.438 0.098 0.685 2.51 0.007 
Power Dom Freq 1-IQR 0.448 -0.112 0.730 0.289 -0.053 0.575 1.84 0.050 
Power Dom Freq 1-Med 0.585 0.132 0.801 0.414 0.071 0.668 2.38 0.010 
Power Dom Freq 2-IQR 0.614 0.208 0.813 0.443 0.116 0.684 2.60 0.005 
Power Dom Freq 2-Med 0.704 0.380 0.858 0.543 0.235 0.751 3.30 <0.001 
Power Dom Low Freq-IQR 0.566 0.132 0.787 0.395 0.071 0.649 2.41 0.009 
Power Dom Low Freq-Med 0.669 0.312 0.841 0.503 0.185 0.725 2.99 0.002 
Power High Freq/Total-IQR 0.079 -0.952 0.560 0.041 -0.322 0.389 1.08 0.414 
Power High Freq/Total-Med 0.588 0.143 0.802 0.416 0.077 0.669 2.40 0.010 
Power Total-IQR 0.554 0.088 0.784 0.384 0.046 0.645 2.26 0.014 
Power Total-Med 0.492 -0.071 0.757 0.327 -0.034 0.609 1.94 0.037 
Limb movement 
percentages 
Bilat Ankle % 0.600 0.196 0.804 0.429 0.108 0.673 2.72 0.004 
Unilat Ankle % 0.600 0.196 0.804 0.429 0.108 0.673 2.72 0.004 
Whole Body % 0.393 -0.166 0.696 0.245 -0.077 0.534 1.74 0.068 
Wrist Ankle % 0.122 -0.706 0.562 0.065 -0.261 0.391 1.15 0.354 
Median 
crossings 
Num Med Crossings Norm-IQR 0.441 -0.148 0.729 0.283 -0.069 0.574 1.79 0.058 
Num Med Crossings Norm-Med 0.644 0.265 0.828 0.474 0.153 0.706 2.80 0.003 
Num Med Crossings-IQR 0.629 0.250 0.819 0.459 0.143 0.693 2.79 0.003 
Num Med Crossings-Med 0.619 0.206 0.817 0.448 0.115 0.690 2.59 0.006 
PLM Num PLM Norm 0.827 0.643 0.917 0.706 0.474 0.846 5.72 <0.001 
PLM % 0.716 0.406 0.863 0.557 0.255 0.759 3.45 <0.001 




Close Cross Corr Peak-IQR 0.652 0.295 0.830 0.483 0.173 0.710 2.99 0.002 
Close Cross Corr Peak-Med 0.086 -0.777 0.545 0.045 -0.280 0.374 1.10 0.397 
Close Cross Cov Peak-IQR 0.450 -0.133 0.734 0.290 -0.062 0.580 1.82 0.053 
Close Cross Cov Peak-Med 0.247 -0.519 0.632 0.141 -0.206 0.462 1.34 0.216 
Dom Freq Last 90s-IQR -0.002 -1.074 0.516 -0.001 -0.349 0.348 1.00 0.502 
Dom Freq Last 90s-Med 0.673 0.332 0.841 0.508 0.199 0.726 3.10 0.001 
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Appendix Table G.3 Continued 
Feature 
Category 
  Average Nights Single Night     
Feature Name ICC 
95% Confidence Interval 
ICC 




Bound Lower Bound 
Upper 




Max Cross Corr-IQR 0.254 -0.587 0.645 0.145 -0.227 0.476 1.33 0.220 
Max Cross Corr-Med -0.019 -1.179 0.516 -0.009 -0.371 0.348 0.98 0.520 
Max Cross Cov-IQR 0.460 -0.140 0.742 0.299 -0.066 0.590 1.83 0.052 
Max Cross Cov-Med 0.511 -0.021 0.765 0.343 -0.010 0.619 2.03 0.029 
Mean Cross Corr Peaks-IQR 0.409 -0.205 0.713 0.257 -0.093 0.554 1.70 0.075 
Mean Cross Corr Peaks-Med -0.559 -2.142 0.238 -0.219 -0.517 0.135 0.63 0.896 
Mean Cross Cov Peaks-IQR 0.179 -0.689 0.602 0.098 -0.256 0.431 1.22 0.295 
Mean Cross Cov Peaks-Med 0.434 -0.136 0.722 0.277 -0.064 0.566 1.80 0.057 
Move Last 90s-IQR 0.225 -0.598 0.625 0.127 -0.230 0.455 1.29 0.244 
Move Last 90s-Med 0.581 0.146 0.796 0.409 0.079 0.661 2.42 0.009 
Move Next 90s-IQR 0.225 -0.598 0.625 0.127 -0.230 0.455 1.29 0.244 
Move Next 90s-Med 0.581 0.146 0.796 0.409 0.079 0.661 2.42 0.009 
Num Cross Corr Peaks-IQR 0.294 -0.490 0.663 0.173 -0.197 0.495 1.41 0.177 
Num Cross Corr Peaks-Med 0.398 -0.220 0.707 0.249 -0.099 0.546 1.68 0.081 
Num Cross Cov Peaks-IQR -0.042 -1.240 0.506 -0.021 -0.383 0.339 0.96 0.543 
Num Cross Cov Peaks-Med 0.471 -0.077 0.743 0.308 -0.037 0.591 1.91 0.041 
Time Since Prev-IQR -0.021 -1.137 0.510 -0.010 -0.363 0.342 0.98 0.522 
Time Since Prev-Med 0.029 -1.086 0.540 0.015 -0.352 0.369 1.03 0.469 
Signal 
characteristics 
Entropy Rate-IQR 0.640 0.272 0.824 0.471 0.158 0.701 2.97 0.002 
Entropy Rate-Med 0.600 0.167 0.808 0.429 0.091 0.677 2.47 0.008 
Lempel-Ziv Comp-IQR 0.171 -0.548 0.578 0.093 -0.215 0.406 1.23 0.285 
Lempel-Ziv Comp-Med 0.534 0.050 0.773 0.364 0.026 0.630 2.17 0.019 
Lyapunov Exp-IQR 0.618 0.201 0.817 0.448 0.112 0.690 2.58 0.006 
Lyapunov Exp-Med 0.319 -0.326 0.661 0.190 -0.140 0.494 1.51 0.133 
Wave Approx-IQR -0.010 -1.007 0.502 -0.005 -0.335 0.336 0.99 0.511 
Wave Approx-Med 0.688 0.352 0.850 0.525 0.214 0.739 3.57 <0.001 
Wave Energy 1-IQR 0.309 -0.406 0.663 0.182 -0.169 0.496 1.45 0.155 
Wave Energy 1-Med 0.209 -0.684 0.623 0.117 -0.255 0.453 1.26 0.268 
Wave Energy 2-IQR 0.637 0.240 0.826 0.467 0.136 0.703 2.71 0.004 
Wave Energy 2-Med 0.716 0.421 0.862 0.558 0.267 0.758 3.73 <0.001 
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Appendix Table G.3 Continued 
Feature 
Category 
  Average Nights Single Night     
Feature Name ICC 
95% Confidence Interval 
ICC 




Bound Lower Bound 
Upper 
Bound F Value Sig 
Signal 
Characteristics 
Wave Energy 3-IQR 0.804 0.598 0.905 0.672 0.426 0.826 5.22 <0.001 
Wave Energy 3-Med 0.720 0.402 0.867 0.563 0.252 0.765 4.06 <0.001 
Wave Entropy-IQR -1.117 -3.608 0.002 -0.358 -0.643 0.001 0.48 0.976 
Wave Entropy-Med 0.668 0.317 0.840 0.502 0.188 0.724 3.33 <0.001 
Statistical AUC Acc Norm-IQR 0.568 0.099 0.792 0.396 0.052 0.656 2.29 0.013 
AUC Acc Norm-Med 0.694 0.359 0.853 0.531 0.218 0.744 3.20 0.001 
AUC Acc-IQR 0.669 0.323 0.839 0.503 0.192 0.723 3.05 0.002 
AUC Acc-Med 0.654 0.282 0.833 0.486 0.164 0.714 2.86 0.003 
Duration-IQR 0.550 0.055 0.784 0.379 0.028 0.645 2.19 0.018 
Duration-Max 0.576 0.108 0.797 0.404 0.057 0.662 2.32 0.012 
Duration-Med 0.631 0.228 0.823 0.460 0.129 0.699 2.67 0.004 
Kurtosis-IQR 0.221 -0.321 0.579 0.124 -0.138 0.408 1.39 0.184 
Kurtosis-Med 0.580 0.160 0.794 0.409 0.087 0.658 2.55 0.006 
Max Acc-IQR 0.638 0.248 0.825 0.468 0.141 0.703 2.73 0.004 
Max Acc-Med 0.408 -0.239 0.715 0.256 -0.107 0.557 1.68 0.081 
Max-RMS Acc-IQR 0.161 -0.468 0.556 0.088 -0.190 0.385 1.24 0.280 
Max-RMS Acc-Med 0.613 0.220 0.810 0.441 0.124 0.681 2.75 0.004 
Med Acc-IQR 0.553 0.059 0.786 0.382 0.030 0.647 2.20 0.017 
Med Acc-Med 0.782 0.544 0.895 0.642 0.374 0.810 4.47 <0.001 
Range Acc-IQR 0.641 0.255 0.827 0.472 0.146 0.705 2.76 0.003 
Range Acc-Med 0.403 -0.249 0.714 0.253 -0.111 0.555 1.66 0.085 
RMS Acc-IQR 0.499 -0.048 0.759 0.332 -0.023 0.612 1.98 0.033 
RMS Acc-Med 0.577 0.110 0.798 0.406 0.058 0.663 2.32 0.012 
SD Acc-IQR 0.513 -0.016 0.766 0.345 -0.008 0.620 2.03 0.028 
SD Acc-Med 0.459 -0.137 0.741 0.298 -0.064 0.589 1.83 0.052 
Skewness-IQR 0.000 -0.757 0.472 0.000 -0.275 0.309 1.00 0.500 
Skewness-Med 0.593 0.184 0.800 0.421 0.101 0.667 2.61 0.005 
SMA Acc-IQR 0.617 0.203 0.816 0.447 0.113 0.689 2.58 0.006 
SMA Acc-Med 0.704 0.380 0.858 0.544 0.235 0.751 3.31 <0.001 
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Appendix Table G.3 Continued 
Feature 
Category 
  Average Nights Single Night     
Feature Name ICC 
95% Confidence Interval 
ICC 




Bound Lower Bound 
Upper 
Bound F Value Sig 
Timing End Move %-IQR 0.329 -0.390 0.676 0.197 -0.163 0.511 1.49 0.141 
End Move %-Med -0.623 -2.466 0.228 -0.237 -0.552 0.129 0.62 0.901 
Move/hour 0.693 0.358 0.853 0.530 0.218 0.743 3.19 0.001 
Move/night 0.608 0.175 0.812 0.437 0.096 0.684 2.50 0.007 
Start Move %-IQR 0.329 -0.391 0.676 0.197 -0.163 0.511 1.49 0.141 
Start Move %-Med -0.625 -2.470 0.227 -0.238 -0.553 0.128 0.62 0.902 
Time Asleep 0.721 0.419 0.866 0.564 0.265 0.764 3.52 <0.001 
Velocity and 
distance 
Med Vel-IQR 0.588 0.134 0.803 0.417 0.072 0.671 2.38 0.010 
Med Vel-Med 0.775 0.531 0.892 0.633 0.362 0.805 4.35 <0.001 
RMS Vel-IQR 0.488 -0.071 0.754 0.322 -0.034 0.605 1.93 0.038 
RMS Vel-Med 0.590 0.137 0.804 0.418 0.074 0.672 2.39 0.010 
Total Dist-IQR 0.706 0.396 0.858 0.546 0.247 0.751 3.41 <0.001 
Total Dist-Med 0.673 0.321 0.842 0.507 0.191 0.728 3.02 0.002 





Appendix Table G.4: ICCs for intra-subject reliability with 1-5 typical nights collected at admission to IPR 
    
Participants with ≥ 
2 Typical Nights 
(n=31) 
Participants with ≥ 3 Typical Nights 
(n=24) 
Participants with ≥ 5 Typical Nights 
(n=11) 
  Typical Nights 1-2 Typical Nights 1-2 Typical Nights 1-3 Typical Nights 1-2 Typical Nights 1-5 
Feature 
























Angle Net Change-IQR 0.481 0.317 0.417 0.263 0.552 0.292 0.747 0.597 0.609 0.237 
Angle Net Change-Med 0.662 0.495 0.698 0.536 0.759 0.512 0.336 0.202 0.238 0.059 
Angle Rate Change-IQR 0.595 0.424 0.675 0.509 0.560 0.298 0.818 0.692 0.609 0.237 
Angle Rate Change-Med 0.738 0.585 0.782 0.642 0.812 0.591 0.679 0.514 0.620 0.246 
Angle Total Change-IQR 0.576 0.404 0.562 0.391 0.535 0.277 0.822 0.697 0.632 0.256 




Grav Change X-IQR 0.571 0.400 0.623 0.452 0.636 0.368 0.498 0.331 0.201 0.048 
Grav Change X-Med 0.467 0.305 0.417 0.263 0.608 0.340 0.649 0.481 -1.170 -0.121 
Grav Change Y-IQR 0.604 0.433 0.588 0.417 0.726 0.469 0.795 0.660 0.489 0.161 
Grav Change Y-Med 0.439 0.282 0.443 0.284 0.469 0.227 -0.017 -0.009 0.599 0.230 
Grav Change Z-IQR 0.815 0.688 0.831 0.711 0.767 0.523 -0.404 -0.168 0.326 0.088 




Corr XY-IQR 0.232 0.131 0.174 0.095 -0.161 -0.049 0.360 0.220 -0.230 -0.039 
Corr XY-Med 0.195 0.108 0.501 0.334 0.442 0.209 0.265 0.153 -1.228 -0.124 
Corr XZ-IQR 0.221 0.124 0.359 0.219 0.433 0.203 0.312 0.185 0.441 0.136 
Corr XZ-Med 0.223 0.125 0.482 0.318 0.251 0.101 0.278 0.161 0.405 0.120 
Corr YZ-IQR 0.687 0.523 0.682 0.518 0.265 0.107 0.613 0.442 0.409 0.122 
Corr YZ-Med 0.162 0.088 -0.212 -0.096 0.312 0.131 -1.209 -0.377 0.702 0.320 
Frequency 
domain 
Bandwidth-IQR -0.136 -0.063 -0.276 -0.121 0.019 0.006 -2.650 -0.570 0.319 0.086 
Bandwidth-Med 0.572 0.401 0.644 0.475 0.649 0.381 0.587 0.415 0.595 0.227 
Centroid Freq-IQR 0.135 0.072 0.009 0.004 0.400 0.182 -2.073 -0.509 0.361 0.102 
Centroid Freq-Med 0.501 0.334 0.590 0.419 0.655 0.387 0.327 0.195 0.610 0.239 
Dom Freq 1-IQR 0.272 0.157 0.155 0.084 0.561 0.299 0.206 0.115 0.595 0.227 
Dom Freq 1-Med 0.597 0.426 0.604 0.433 0.629 0.361 0.614 0.443 0.763 0.391 
Dom Freq 2-IQR 0.015 0.007 0.049 0.025 0.189 0.072 0.052 0.026 0.706 0.325 
Dom Freq 2-Med 0.469 0.306 0.504 0.337 0.381 0.170 0.379 0.234 0.622 0.247 
Dom Low Freq-IQR 0.340 0.205 0.275 0.160 0.538 0.279 0.557 0.386 0.637 0.260 
Dom Low Freq-Med -0.095 -0.046 -0.283 -0.124 0.397 0.180 -0.419 -0.173 0.449 0.140 
Mean Freq-IQR 0.286 0.167 0.198 0.110 0.527 0.271 -0.979 -0.329 0.675 0.293 
Mean Freq-Med 0.469 0.306 0.496 0.330 0.557 0.295 0.287 0.167 0.553 0.199 
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Appendix Table G.4 Continued 
    
Participants with ≥ 
2 Typical Nights  Participants with ≥ 3 Typical Nights  Participants with ≥ 5 Typical Nights  
  Typical Nights 1-2 Typical Nights 1-2 Typical Nights 1-3 Typical Nights 1-2 Typical Nights 1-5 
Feature 























Med Freq-IQR 0.721 0.563 0.740 0.587 0.645 0.377 0.857 0.751 0.820 0.478 
Med Freq-Med 0.634 0.464 0.641 0.472 0.530 0.273 0.615 0.444 0.641 0.263 
Power Dom Freq 1/Total-
IQR 
0.349 0.211 0.359 0.219 0.570 0.306 0.756 0.608 0.718 0.337 
Power Dom Freq 1/Total-
Med 
0.609 0.438 0.404 0.253 0.663 0.396 0.065 0.034 0.636 0.259 
Power Dom Freq 1-IQR 0.448 0.289 0.402 0.251 0.619 0.352 0.879 0.785 0.791 0.432 
Power Dom Freq 1-Med 0.585 0.414 0.551 0.380 0.616 0.349 0.702 0.541 0.614 0.241 
Power Dom Freq 2-IQR 0.614 0.443 0.567 0.395 0.642 0.374 0.829 0.708 0.756 0.382 
Power Dom Freq 2-Med 0.704 0.543 0.727 0.571 0.648 0.380 0.590 0.418 0.619 0.245 
Power Dom Low Freq-IQR 0.566 0.395 0.544 0.373 0.695 0.431 0.883 0.790 0.778 0.413 
Power Dom Low Freq-Med 0.669 0.503 0.633 0.463 0.749 0.498 0.678 0.512 0.695 0.313 
Power High Freq/Total-IQR 0.079 0.041 -0.173 -0.079 0.491 0.243 -1.469 -0.423 0.162 0.037 
Power High Freq/Total-Med 0.588 0.416 0.700 0.538 0.739 0.486 0.356 0.217 0.423 0.128 
Power Total-IQR 0.554 0.384 0.556 0.385 0.708 0.448 0.910 0.835 0.835 0.504 




Bilat Ankle % 0.600 0.429 0.635 0.465 0.723 0.465 0.774 0.631 0.859 0.549 
Unilat Ankle % 0.600 0.429 0.635 0.465 0.723 0.465 0.774 0.631 0.859 0.549 
Whole Body % 0.393 0.245 0.362 0.221 0.636 0.368 0.512 0.344 0.736 0.357 
Wrist Ankle % 0.122 0.065 0.131 0.070 0.354 0.155 0.551 0.381 0.583 0.218 
Median 
crossings 
Num Med Crossings Norm-
IQR 
0.441 0.283 0.458 0.297 0.281 0.115 0.614 0.444 0.633 0.257 
Num Med Crossings Norm-
Med 
0.644 0.474 0.664 0.497 0.753 0.504 0.667 0.501 0.792 0.433 
Num Med Crossings-IQR 0.629 0.459 0.667 0.500 0.674 0.408 0.770 0.626 0.883 0.603 
Num Med Crossings-Med 0.619 0.448 0.726 0.569 0.584 0.318 0.828 0.706 0.897 0.636 
PLM Num PLM Norm 0.827 0.706 0.831 0.712 0.640 0.373 0.832 0.712 0.778 0.412 
PLM % 0.716 0.557 0.757 0.609 0.747 0.497 0.520 0.352 0.742 0.365 
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Participants with ≥ 
2 Typical Nights  Participants with ≥ 3 Typical Nights  Participants with ≥ 5 Typical Nights  
  Typical Nights 1-2 Typical Nights 1-2 Typical Nights 1-3 Typical Nights 1-2 Typical Nights 1-5 
Feature 
























Close Cross Corr Peak-IQR 0.652 0.483 0.613 0.442 0.396 0.179 0.347 0.210 0.657 0.277 
Close Cross Corr Peak-Med 0.086 0.045 0.491 0.326 0.512 0.259 0.552 0.381 0.624 0.249 
Close Cross Cov Peak-IQR 0.450 0.290 0.427 0.271 0.622 0.355 0.763 0.617 0.856 0.544 
Close Cross Cov Peak-Med 0.247 0.141 0.337 0.203 0.702 0.440 0.598 0.426 0.760 0.388 
Dom Freq Last 90s-IQR -0.002 -0.001 -0.004 -0.002 -0.035 -0.012 -0.456 -0.186 0.071 0.015 
Dom Freq Last 90s-Med 0.673 0.508 0.640 0.471 0.626 0.358 0.603 0.432 0.054 0.011 
Max Cross Corr-IQR 0.254 0.145 0.216 0.121 0.408 0.187 0.193 0.107 0.642 0.264 
Max Cross Corr-Med -0.019 -0.009 0.302 0.178 0.525 0.269 0.345 0.209 0.701 0.319 
Max Cross Cov-IQR 0.460 0.299 0.413 0.260 0.562 0.300 0.739 0.586 0.849 0.529 
Max Cross Cov-Med 0.511 0.343 0.685 0.521 0.765 0.520 0.821 0.697 0.830 0.495 
Mean Cross Corr Peaks-IQR 0.409 0.257 0.160 0.087 0.269 0.109 -0.096 -0.046 0.472 0.152 
Mean Cross Corr Peaks-Med -0.559 -0.219 -0.103 -0.049 0.382 0.171 0.246 0.140 0.703 0.321 
Mean Cross Cov Peaks-IQR 0.179 0.098 -0.115 -0.054 0.436 0.205 0.318 0.189 0.741 0.364 
Mean Cross Cov Peaks-Med 0.434 0.277 0.591 0.420 0.741 0.488 0.792 0.655 0.840 0.512 
Move Last 90s-IQR 0.225 0.127 0.334 0.200 0.388 0.175 0.309 0.183 0.413 0.123 
Move Last 90s-Med 0.581 0.409 0.629 0.459 0.746 0.495 0.473 0.310 0.617 0.244 
Move Next 90s-IQR 0.225 0.127 0.334 0.200 0.388 0.175 0.309 0.183 0.413 0.123 
Move Next 90s-Med 0.581 0.409 0.629 0.459 0.746 0.495 0.473 0.310 0.617 0.244 
Num Cross Corr Peaks-IQR 0.294 0.173 0.411 0.258 0.436 0.205 0.364 0.222 -0.091 -0.017 
Num Cross Corr Peaks-Med 0.398 0.249 0.276 0.160 0.516 0.262 -0.333 -0.143 0.333 0.091 
Num Cross Cov Peaks-IQR -0.042 -0.021 -0.214 -0.097 0.415 0.191 0.816 0.689 0.294 0.077 
Num Cross Cov Peaks-Med 0.471 0.308 0.401 0.251 0.549 0.289 -0.421 -0.174 0.293 0.077 
Time Since Prev-IQR -0.021 -0.010 -0.004 -0.002 0.597 0.331 0.391 0.243 0.694 0.312 
Time Since Prev-Med 0.029 0.015 0.245 0.139 0.488 0.241 -0.064 -0.031 0.616 0.243 
Signal 
characteristics 
Entropy Rate-IQR 0.516 0.348 0.495 0.329 0.650 0.383 0.568 0.397 0.789 0.428 
Entropy Rate-Med 0.517 0.349 0.587 0.416 0.585 0.319 0.795 0.659 0.839 0.510 
Lempel-Ziv Comp-IQR 0.171 0.093 0.192 0.106 0.536 0.278 0.549 0.379 0.861 0.554 
Lempel-Ziv Comp-Med 0.534 0.364 0.603 0.432 0.659 0.392 0.865 0.762 0.851 0.532 
Lyapunov Exp-IQR 0.618 0.448 0.685 0.521 0.620 0.352 0.612 0.441 0.515 0.175 
Lyapunov Exp-Med 0.319 0.190 0.294 0.172 0.536 0.278 0.546 0.375 0.803 0.449 
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Participants with ≥ 
2 Typical Nights  Participants with ≥ 3 Typical Nights  Participants with ≥ 5 Typical Nights  
  Typical Nights 1-2 Typical Nights 1-2 Typical Nights 1-3 Typical Nights 1-2 Typical Nights 1-5 
Feature 























Wave Approx-IQR -0.010 -0.005 0.105 0.055 0.315 0.133 0.108 0.057 0.735 0.357 
Wave Approx-Med 0.688 0.525 0.697 0.535 0.737 0.483 0.752 0.602 0.690 0.308 
Wave Energy 1-IQR 0.309 0.182 0.435 0.278 0.595 0.328 -0.177 -0.081 0.323 0.087 
Wave Energy 1-Med 0.209 0.117 0.385 0.239 0.584 0.318 0.313 0.186 0.348 0.097 
Wave Energy 2-IQR 0.637 0.467 0.661 0.493 0.650 0.382 0.857 0.750 0.763 0.392 
Wave Energy 2-Med 0.716 0.558 0.738 0.585 0.718 0.459 0.811 0.682 0.600 0.231 
Wave Energy 3-IQR 0.804 0.672 0.817 0.690 0.624 0.356 0.959 0.921 0.910 0.668 
Wave Energy 3-Med 0.720 0.563 0.749 0.599 0.736 0.481 0.755 0.606 0.762 0.391 
Wave Entropy-IQR -1.117 -0.358 -0.792 -0.284 0.043 0.015 -1.832 -0.478 0.500 0.167 
Wave Entropy-Med 0.668 0.502 0.679 0.514 0.727 0.471 0.790 0.653 0.658 0.278 
Statistical AUC Acc Norm-IQR 0.568 0.396 0.616 0.445 0.670 0.404 0.861 0.756 0.760 0.388 
AUC Acc Norm-Med 0.694 0.531 0.696 0.533 0.725 0.467 0.843 0.728 0.791 0.430 
AUC Acc-IQR 0.669 0.503 0.659 0.492 0.679 0.413 0.818 0.693 0.750 0.375 
AUC Acc-Med 0.654 0.486 0.659 0.492 0.726 0.469 0.833 0.714 0.802 0.448 
Kurtosis-IQR 0.221 0.124 0.248 0.142 0.363 0.160 0.199 0.111 0.371 0.106 
Kurtosis-Med 0.580 0.409 0.523 0.354 0.624 0.356 0.581 0.410 0.691 0.309 
Max Acc-IQR 0.638 0.468 0.700 0.539 0.782 0.545 0.924 0.859 0.865 0.562 
Max Acc-Med 0.408 0.256 0.503 0.336 0.683 0.418 0.865 0.762 0.851 0.534 
Max-RMS Acc-IQR 0.161 0.088 0.091 0.047 0.473 0.230 -0.365 -0.154 0.447 0.139 
Max-RMS Acc-Med 0.613 0.441 0.656 0.488 0.630 0.363 0.590 0.419 0.728 0.349 
Med Acc-IQR 0.553 0.382 0.567 0.395 0.560 0.298 0.655 0.487 0.506 0.170 
Med Acc-Med 0.782 0.642 0.767 0.622 0.692 0.428 0.771 0.628 0.790 0.430 
Duration-IQR 0.550 0.379 0.474 0.310 0.535 0.277 0.529 0.360 0.641 0.263 
Duration-Max 0.576 0.404 0.776 0.634 0.826 0.613 0.678 0.513 0.835 0.504 
Duration-Med 0.631 0.460 0.604 0.432 0.685 0.420 0.618 0.448 0.792 0.433 
Range Acc-IQR 0.641 0.472 0.704 0.543 0.784 0.548 0.926 0.862 0.867 0.565 
Range Acc-Med 0.403 0.253 0.499 0.333 0.683 0.417 0.868 0.767 0.852 0.536 
RMS Acc-IQR 0.499 0.332 0.547 0.376 0.701 0.439 0.872 0.773 0.817 0.471 
RMS Acc-Med 0.577 0.406 0.591 0.420 0.726 0.468 0.815 0.688 0.809 0.458 
SD Acc-IQR 0.513 0.345 0.562 0.391 0.729 0.472 0.929 0.867 0.849 0.529 
SD Acc-Med 0.459 0.298 0.486 0.321 0.676 0.410 0.856 0.748 0.821 0.479 
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Participants with ≥ 
2 Typical Nights  Participants with ≥ 3 Typical Nights  Participants with ≥ 5 Typical Nights  
  Typical Nights 1-2 Typical Nights 1-2 Typical Nights 1-3 Typical Nights 1-2 Typical Nights 1-5 
Feature 





















Statistical Skewness-IQR 0.000 0.000 -0.006 -0.003 0.240 0.095 -0.211 -0.095 0.310 0.082 
Skewness-Med 0.593 0.421 0.569 0.398 0.663 0.397 0.708 0.548 0.749 0.374 
SMA Acc-IQR 0.617 0.447 0.669 0.502 0.692 0.429 0.876 0.779 0.776 0.409 
SMA Acc-Med 0.704 0.544 0.736 0.583 0.731 0.475 0.853 0.744 0.778 0.412 
Timing End Move %-IQR 0.329 0.197 0.501 0.334 -0.444 -0.114 0.825 0.701 -0.031 -0.006 
End Move %-Med -0.623 -0.237 -0.820 -0.291 -0.301 -0.083 0.231 0.131 -0.233 -0.039 
Move/hour 0.693 0.530 0.896 0.812 0.814 0.594 0.945 0.896 0.751 0.376 
Move/night 0.608 0.437 0.796 0.662 0.811 0.588 0.771 0.627 0.672 0.291 
Start Move %-IQR 0.329 0.197 0.500 0.334 -0.445 -0.114 0.824 0.701 -0.033 -0.006 
Start Move %-Med -0.625 -0.238 -0.823 -0.291 -0.302 -0.084 0.230 0.130 -0.235 -0.040 
Time Asleep 0.721 0.564 0.710 0.551 0.775 0.535 0.618 0.447 0.681 0.299 
Velocity and 
distance 
Med Vel-IQR 0.588 0.417 0.618 0.447 0.589 0.323 0.647 0.478 0.507 0.170 
Med Vel-Med 0.775 0.633 0.748 0.597 0.677 0.412 0.805 0.673 0.792 0.432 
RMS Vel-IQR 0.488 0.322 0.531 0.362 0.695 0.431 0.862 0.757 0.815 0.468 
RMS Vel-Med 0.590 0.418 0.599 0.428 0.726 0.469 0.796 0.661 0.802 0.448 
Total Dist-IQR 0.706 0.546 0.728 0.572 0.725 0.468 0.811 0.682 0.751 0.377 
Total Dist-Med 0.673 0.507 0.674 0.508 0.722 0.464 0.807 0.676 0.788 0.426 







Appendix Table G.5: ICC for stability and direction of change for reliable LA features measured at admission, discharge, and 6-months 
      95% Confidence Interval F Test with True Value 0   
Feature Category Feature Name ICC Lower Bound Upper Bound F Value Sig Direction of Change 
Change in angle of 
inclination 
Angle Net Change-Med 0.495 0.127 0.797 3.704 0.004 Inconsistent 
Angle Rate Change-IQR 0.482 0.133 0.786 3.783 0.004 Inconsistent 
Angle Rate Change-Med 0.427 0.064 0.759 3.125 0.011 Inconsistent 
Angle Total Change-IQR 0.502 0.146 0.798 3.893 0.003 Inconsistent 
Angle Total Change-Med 0.559 0.216 0.827 4.681 0.001 Inconsistent 
Change in gravitational 
acceleration 
Grav Change X-IQR 0.538 0.180 0.818 4.244 0.002 Stable 
Grav Change Y-IQR 0.087 -0.224 0.518 1.269 0.304 Inconsistent 
Grav Change Z-IQR 0.424 0.051 0.759 3.033 0.013 Decreasing 
Grav Change Z-Med 0.158 -0.153 0.570 1.565 0.178 Decreasing 
Correlation coefficients 
between axes 
Corr YZ-IQR 0.043 -0.174 0.421 1.167 0.363 Inconsistent 
Frequency domain Bandwidth-Med 0.803 0.570 0.932 12.351 < 0.001 Stable 
Centroid Freq-Med 0.727 0.445 0.902 8.559 < 0.001 Stable 
Dom Freq 1-Med 0.653 0.335 0.871 6.364 < 0.001 Stable 
Med Freq-IQR 0.575 0.229 0.836 4.815 < 0.001 Stable 
Med Freq-Med 0.746 0.481 0.909 9.722 < 0.001 Stable 
Power Dom Freq 1/Total-Med 0.783 0.532 0.925 10.925 < 0.001 Stable 
Power Dom Freq 1-Med 0.615 0.296 0.852 6.024 < 0.001 Inconsistent 
Power Dom Freq 2-IQR 0.436 0.072 0.764 3.197 0.010 Inconsistent 
Power Dom Freq 2-Med 0.647 0.337 0.867 6.660 < 0.001 Inconsistent 
Power Dom Low Freq-IQR 0.527 0.185 0.809 4.363 0.002 Stable 
Power Dom Low Freq-Med 0.662 0.357 0.874 7.021 < 0.001 Inconsistent 
Power High Freq/Total-Med 0.663 0.351 0.875 6.657 < 0.001 Stable 
Power Total-IQR 0.523 0.169 0.810 4.131 0.002 Stable 
Limb movement 
percentages 
Bilat Ankle % 0.299 -0.032 0.672 2.339 0.043 Decreasing 
Unilat Ankle % 0.299 -0.032 0.672 2.339 0.043 Increasing 
Median crossings Num Med Crossings Norm-Med 0.545 0.206 0.819 4.609 0.001 Stable 
Num Med Crossings-IQR 0.264 -0.080 0.654 2.048 0.073 Inconsistent 
Num Med Crossings-Med 0.260 -0.065 0.644 2.097 0.067 Inconsistent 
PLM Num PLM Norm 0.302 -0.052 0.682 2.246 0.051 Inconsistent 
PLM % 0.579 0.248 0.836 5.171 < 0.001 Inconsistent 




Appendix Table G.5 Continued 
      95% Confidence Interval F Test with True Value 0   
Feature Category Feature Name ICC Lower Bound Upper Bound F Value Sig Direction of Change 
Relationship to recent 
movements 
Close Cross Corr Peak-IQR 0.756 0.498 0.914 10.199 < 0.001 Stable 
Dom Freq Last 90s-Med 0.762 0.508 0.916 10.607 < 0.001 Stable 
Max Cross Cov-Med 0.612 0.284 0.852 5.622 < 0.001 Stable 
Move Last 90s-Med 0.181 -0.162 0.599 1.614 0.163 Inconsistent 
Move Next 90s-Med 0.181 -0.162 0.599 1.614 0.163 Inconsistent 
Signal characteristics Entropy Rate-IQR 0.748 0.479 0.911 9.459 < 0.001 Stable 
Entropy Rate-Med 0.410 0.073 0.742 3.251 0.009 Increasing 
Lempel-Ziv Comp-Med 0.553 0.219 0.822 4.834 < 0.001 Stable 
Lyapunov Exp-IQR 0.676 0.369 0.881 6.960 < 0.001 Stable 
Wave Approx-Med 0.297 -0.037 0.672 2.306 0.046 Inconsistent 
Wave Energy 2-IQR 0.417 0.075 0.748 3.246 0.009 Inconsistent 
Wave Energy 2-Med 0.392 0.047 0.733 2.979 0.014 Inconsistent 
Wave Energy 3-IQR 0.269 -0.050 0.648 2.187 0.057 Increasing 
Wave Energy 3-Med 0.165 -0.113 0.557 1.683 0.144 Inconsistent 
Wave Entropy-Med 0.343 0.000 0.703 2.590 0.028 Increasing 
Statistical AUC Acc Norm-IQR 0.649 0.331 0.869 6.300 < 0.001 Stable 
AUC Acc Norm-Med 0.674 0.371 0.880 7.088 < 0.001 Inconsistent 
AUC Acc-IQR 0.586 0.246 0.840 5.052 < 0.001 Stable 
AUC Acc-Med 0.701 0.408 0.891 7.797 < 0.001 Stable 
Kurtosis-Med 0.577 0.228 0.837 4.799 < 0.001 Stable 
Max Acc-IQR 0.723 0.447 0.900 9.050 < 0.001 Stable 
Max-RMS Acc-Med 0.596 0.256 0.845 5.159 < 0.001 Stable 
Med Acc-IQR 0.543 0.201 0.818 4.536 0.001 Stable 
Med Acc-Med 0.646 0.328 0.867 6.285 < 0.001 Stable 
Duration-IQR 0.413 0.041 0.752 2.949 0.015 Decreasing 
Duration-Max 0.143 -0.128 0.537 1.575 0.176 Increasing 
Duration-Med 0.726 0.437 0.902 8.313 < 0.001 Stable 
Range Acc-IQR 0.725 0.451 0.901 9.142 < 0.001 Stable 
RMS Acc-Med 0.643 0.325 0.866 6.257 < 0.001 Stable 
SD Acc-IQR 0.701 0.413 0.891 8.054 < 0.001 Stable 
Skewness-Med 0.612 0.270 0.854 5.340 < 0.001 Stable 
SMA Acc-IQR 0.660 0.349 0.874 6.657 < 0.001 Stable 
SMA Acc-Med 0.661 0.352 0.874 6.745 < 0.001 Inconsistent 
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      95% Confidence Interval F Test with True Value 0   
Feature Category Feature Name ICC Lower Bound Upper Bound F Value Sig Direction of Change 
Timing Move/hour 0.129 -0.171 0.543 1.449 0.221 Inconsistent 
Move/night 0.147 -0.158 0.558 1.525 0.192 Inconsistent 
Time Asleep 0.302 -0.031 0.675 2.346 0.043 Inconsistent 
Velocity and distance Med Vel-IQR 0.535 0.180 0.816 4.244 0.002 Stable 
Med Vel-Med 0.350 0.015 0.705 2.711 0.022 Inconsistent 
RMS Vel-Med 0.475 0.142 0.779 4.254 0.002 Inconsistent 
Total Dist-IQR 0.552 0.203 0.824 4.510 0.001 Stable 
Total Dist-Med 0.702 0.412 0.892 7.923 < 0.001 Stable 
* If also visually confirmed, ICC values > 0.5 (moderate reliability) are highlighted grey and those > 0.75 (good reliability) are also bolded. 
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Appendix Table H.1: Continous impairment, ambulation, and data collection measures for Aim 4 from admission to IPR through 6-months post-




Admission Discharge 6-months 1-year 
n Mean ± SD (Range) n Mean ± SD (Range) n Mean ± SD (Range) n Mean ± SD (Range) 
LEMS (Strength) 12 23.8 ± 16.0 (0 - 47) 12 28.7 ± 16.0 (0 - 45) 9 38.9 ± 11.5 (15 - 50) 6 35.0 ± 18.1 (0 - 49) 
Lower Limb LT 
(Sensation) 
11 10.5 ± 7.1 (0 - 20) 11 10.7 ± 6.5 (0 - 18) 8 16.0 ± 5.6 (3 - 20) 6 17.8 ± 3.1 (13 - 20) 
WISCI-II 12 2.4 ± 4.9 (0 - 17) 12 8.2 ± 7.7 (0 - 20) 12 13.7 ± 8.8 (0 - 20) 8 15.6 ± 7.3 (0 - 20) 
10mWT (m/s) 12 0.03 ± 0.07 (0.00 - 0.22) 11 0.37 ± 0.43 (0.00 - 1.16) 12 0.63 ± 0.54 (0.00 - 1.80) 8 0.70 ± 0.36 (0.00 - 1.08) 
6MWT (m) 12 15.3 ± 46.1 (0.0 - 160.0) 12 112.3 ± 144.5 (0.0 - 457.2) 12 184.3 ± 145.3 (0.0 - 404.8) 8 262.1 ± 175.4 (0.0 - 614.5) 
Number of Nights 
Collected 
12 4.6 ± 1.9 (2 - 7) 12 5.3 ± 2.2 (2 - 7) 12 6.2 ± 1.3 (4 - 7) 8 6.6 ± 1.1 (4 - 7) 
Number of Typical 
Nights Collected 
12 3.5 ± 2.0 (1 - 7) 12 4.4 ± 2.1 (2 - 7) 12 4.8 ± 1.7 (2 - 7) 8 4.5 ± 1.8 (2 - 7) 
Days from Injury to Start 
of Data Collection 




Admission Discharge 6-months 1-year 
n Mean ± SD (Range) n Mean ± SD (Range) n Mean ± SD (Range) n Mean ± SD (Range) 
LEMS 14 22.5 ± 16.1 (0 - 47) 14 27.8 ± 17.3 (0 - 45) 10 39.0 ± 10.9 (15 - 50) 6 35.0 ± 18.1 (0 - 49) 
Lower Limb LT 13 10.3 ± 7.5 (0 - 20) 13 10.5 ± 7.0 (0 - 18) 8 16.0 ± 5.6 (3 - 20) 6 17.8 ± 3.1 (13 - 20) 
WISCI-II 14 2.1 ± 4.6 (0 - 17) 14 7.6 ± 7.4 (0 - 20) 14 12.9 ± 8.9 (0 - 20) 8 15.6 ± 7.3 (0 - 20) 
10mWT (m/s) 14 0.02 ± 0.06 (0.00 - 0.22) 13 0.33 ± 0.41 (0.00 - 1.16) 13 0.59 ± 0.54 (0.00 - 1.80) 8 0.70 ± 0.36 (0.00 - 1.08) 
6MWT (m) 14 13.1 ± 42.8 (0.0 - 160.0) 14 100.9 ± 136.6 (0.0 - 457.2) 13 170.1 ± 148.2 (0.0 - 404.8) 8 262.1 ± 175.4 (0.0 - 614.5) 
Number of Nights 
Collected 
14 4.4 ± 1.9 (2 - 7) 14 5.1 ± 2.3 (2 - 7) 13 6.2 ± 1.3 (4 - 7) 8 6.6 ± 1.1 (4 - 7) 
Number of Typical 
Nights Collected 
14 3.4 ± 1.9 (1 - 7) 14 4.4 ± 2.1 (2 - 7) 13 4.9 ± 1.7 (2 - 7) 8 4.5 ± 1.8 (2 - 7) 
Days from Injury to Start 
of Data Collection 
14 19.0 ± 15.2 (9 - 65) 14 43.0 ± 17.4 (18 - 76) 13 230.8 ± 23.9 (184 - 274) 8 414.5 ± 21.9 (390 - 448) 
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Appendix Table H.2: Confusion matrices of ambulatory categoizations for participants included in Aims 3b and 4a across each time point  
Admission to IPR 
Ambulatory Ability Category 





No AD or 
Assist 



















 Non-Amb (0m/s) 10 0 0 10 (83.3%) 10 0 0 10 (83.3%) 
Household Amb (0.01-.44m/s) 2 0 0 2 (16.7%) 0 2 0 2 (16.7%) 
Community Amb (>0.44m/s) 0 0 0 0 (0.0%) 0 0 0 0 (0.0%) 











 Non-Amb (0m) 10 0 0 10 (83.3%)         
Household Amb (1-204m) 2 0 0 2 (16.7%) 
    
Community Amb (>204m) 0 0 0 0 (0.0%) 
    
Total (% of row) 12 (100%) 0 (0.0%) 0 (0.0%) 12 (100%)         
Discharge from IPR 
Ambulatory Ability Category 





No AD or 
Assist 



















 Non-Amb (0m/s) 5 0 0 5 (45.5%) 5 0 0 5 (45.5%) 
Household Amb (0.01-.44m/s) 0 1 0 1 (9.1%) 0 1 0 1 (9.1%) 
Community Amb (>0.44m/s) 0 3 2 5 (45.5%) 0 2 3 5 (45.5%) 











 Non-Amb (0m) 5 0 0 5 (41.7%)         
Household Amb (1-204m) 0 4 0 4 (33.3%) 
    
Community Amb (>204m) 0 1 2 3 (25.0%) 
    
Total (% of row) 5 (41.7%) 5 (41.7%) 2 (16.7%) 12 (100%)         
6-months Post-Discharge from IPR 
Ambulatory Ability Category 





No AD or 
Assist 



















 Non-Amb (0m/s) 3 0 0 3 (25.0%) 3 0 0 3 (25.0%) 
Household Amb (0.01-.44m/s) 0 2 0 2 (16.7%) 0 2 0 2 (16.7%) 
Community Amb (>0.44m/s) 0 2 5 7 (58.3%) 0 1 6 7 (58.3%) 











 Non-Amb (0m) 3 0 0 3 (25.0%)         
Household Amb (1-204m) 0 2 1 3 (25.0%)     
Community Amb (>204m) 0 2 4 6 (50.0%)     
Total (% of row) 3 (25.0%) 4 (33.3%) 5 (41.7%) 12 (100%)         
Abbreviations: AD= Assistive Device, Amb= Ambulatory/Ambulation 
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Appendix Table H.3: Categorical demographics from participants included and excluded from Aim 4b*† 
 Aim 4b N (%) 
 Included in Analysis (n=14) Excluded From Analysis (n=11) t test Sig 
Categorical Demographics Admission Discharge Admission Discharge Admission Discharge 
Sex     0.189  
Female 8 (57.1%)  9 (81.8%)    
Male 6 (42.9%)  2 (18.2%)    
Race/Ethnicity     0.479  
Non-Hispanic White 11 (78.6%)  6 (54.5%)    
Non-Hispanic Black 1 (7.1%)  2 (18.2%)    
Non-Hispanic Other Race 0 (0.0%)  1 (9.1%)    
Hispanic (Any Race) 2 (14.3%)  2 (18.2%)    
Veteran     0.191  
Not A Veteran 12 (85.7%)  11 (100%)    
Veteran 2 (14.3%)  0 (0.0%)    
Annual Household Income     0.698  
< $25,000 2 (14.3%)  4 (36.4%)    
$25,000 - $49,999 3 (21.4%)  2 (18.2%)    
$50,000 -$74,999 3 (21.4%)  1 (9.1%)    
≥ $75,000 2 (14.3%)  2 (18.2%)    
Decline to Answer or Unknown 4 (28.6%)  2 (18.2%)    
Education     0.477  
Less Than High School 2 (14.3%)  0 (0.0%)    
High School Diploma/GED 7 (50.0%)  4 (36.4%)    
Associate's Degree 2 (14.3%)  4 (36.4%)    
Bachelor's Degree 1 (7.1%)  1 (9.1%)    
Graduate Degree 1 (7.1%)  0 (0.0%)    
Other 1 (7.1%)  2 (18.2%)    
Medical Insurance     0.771  
Private 5 (35.7%)  5 (45.5%)    
Medicaid 3 (21.4%)  3 (27.3%)    
Medicare 1 (7.1%)  0 (0.0%)    
No Insurance 1 (7.1%)  0 (0.0%)    




Appendix Table H.3 Continued 
 Aim 4b N (%) 
 Included in Analysis (n=14) Excluded From Analysis (n=11) t test Sig 
Categorical Demographics Admission Discharge Admission Discharge Admission Discharge 
SCI Neurological Category     0.509 0.311 
Motor Complete (AIS A or B) Tetraplegia 1 (7.1%) 1 (7.1%) 1 (9.1%) 0 (0.0%)   
Motor Complete (AIS A or B) Paraplegia 4 (28.6%) 3 (21.4%) 1 (9.1%) 0 (0.0%)   
AIS C Tetraplegia 2 (14.3%) 1 (7.1%) 5 (45.5%) 4 (36.4%)   
AIS C Paraplegia 1 (7.1%) 2 (14.3%) 0 (0.0%) 1 (9.1%)   
AIS D Tetraplegia 5 (35.7%) 6 (42.9%) 3 (27.3%) 5 (45.5%)   
AIS D Paraplegia 1 (7.1%) 1 (7.1%) 1 (9.1%) 1 (9.1%)   
Primary Mode of Mobility     0.102 0.006 
Power Wheelchair 11 (78.6%) 4 (28.6%) 11 (100%) 10 (90.9%)   
Manual Wheelchair 3 (21.4%) 7 (50.0%) 0 (0.0%) 0 (0.0%)   
Ambulation 0 (0.0%) 3 (21.4%) 0 (0.0%) 1 (9.1%)   
WISCI-II     N/A 0.086 
Requires Physical Assistance (or Non-Ambulatory) 14 (100%) 7 (50.0%) 11 (100%) 10 (90.9%)   
Requires AD, but no Physical Assistance 0 (0.0%) 5 (35.7%) 0 (0.0%) 1 (9.1%)   
Requires No AD or Physical Assistance 0 (0.0%) 2 (14.3%) 0 (0.0%) 0 (0.0%)   
10mWT     0.191 0.083 
Non-ambulatory (0 m/s) 12 (85.7%) 6 (46.2%) 11 (100%) 8 (80.0%)   
Household Ambulator (0.01-.44 m/s) 2 (14.3%) 2 (15.4%) 0 (0.0%) 2 (20.0%)   
Community Ambulator (>.44 m/s) 0 (0.0%) 5 (38.5%) 0 (0.0%) 0 (0.0%)   
6MWT     0.191 0.176 
Non-ambulatory (0 m) 12 (85.7%) 6 (42.9%) 11 (100%) 8 (72.7%)   
Household Ambulator (1-204 m) 2 (14.3%) 5 (35.7%) 0 (0.0%) 3 (27.3%)   
Community Ambulator (> 204 m) 0 (0.0%) 3 (21.4%) 0 (0.0%) 0 (0.0%)   
* Significant differences between those included and excluded from the analysis (p< 0.05) are highlighted grey 






Appendix Table H.4: Continuous demographics from participants included and excluded from Aim 4b*† 
  Aim 4b Mean ± SD (Range)  
Included in Analysis (n=14) Excluded From Analysis (n=11) t test Sig 
Continuous Demographics Admission Discharge Admission Discharge Admission Discharge 
Age 43.8 ± 17.5 (18 - 71) 43.8 ± 17.5 (18 - 71) 0.113 
 
BMI 27.9 ± 3.5 (23 - 35) 27.9 ± 3.5 (23 - 35) 0.610 
 
Length of Stay in IPR (Days) 36.1 ± 11.4 (17 - 53) 46.7 ± 10.6 (30 - 64) 0.021 
 
Days from Injury to Start of IPR 15.9 ± 15.1 (5 - 62) 17.1 ± 8.1 (8 - 30) 0.820 
 
Days from Injury to Data Collection 19.0 ± 15.2 (9 - 65) 43.0 ± 17.4 (18 - 76) 21.8 ± 9.1 (10 - 36) 56.1 ± 10.2 (41 - 72) 0.593 0.067 
LEMS 22.5 ± 16.1 (0 - 47) 27.8 ± 17.3 (0 - 45) 20.2 ± 13.7 (0 - 36) 28.5 ± 17.9 (0 - 48) 0.707 0.926 
LELTS 10.3 ± 7.5 (0 - 20) 10.5 ± 7.0 (0 - 18) 10.8 ± 6.0 (0 - 18) 10.4 ± 6.2 (0 - 20) 0.857 0.972 
WISCI-II 2.1 ± 4.6 (0 - 17) 7.6 ± 7.4 (0 - 20) 0.2 ± 0.4 (0 - 1) 3.5 ± 6.3 (0 - 17) 0.150 0.153 
10mWT (m/s) 0.0 ± 0.1 (0 - 0) 0.3 ± 0.4 (0 - 1) 0.0 ± 0.0 (0 - 0) 0.1 ± 0.1 (0 - 0) 0.209 0.044 
6MWT (m) 13.1 ± 42.8 (0 - 160) 100.9 ± 136.6 (0 - 457) 0.0 ± 0.0 (0 - 0) 30.4 ± 56.2 (0 - 161) 0.271 0.123 
* Significant differences between those included and excluded from the analysis (p< 0.05) are highlighted grey 
† Missing and not eligible participants are the same as in Appendix Table G.2, and not repeated here 
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a)  b)  
Appendix Figure H.1: Per participant line graphs of LA over time for Power Dom Freq 1-Med colored by a) WISCI-II  and b) 10mWT category by 6-
months post-discharge from IPR.  In a) it can be seen that participants who require physical assistance or are non-ambulatory do not change much over 
time, compared to those who can ambulate with or without an AD. In b) it can be seen that only community ambulators are widely variable over time, 




Appendix Figure H.2: Changes in Num Med Crossings- IQR over time categorized by if the participant increased their LEMS greater than the 
repeatability threshold of 6.9 points. This feature which was found to be significnatly correlated with the change in LEMS from admission to discharge 
(ρ= .606) but not from discharge to 6-months (likely influenced by outlier). From admission to discharge it can be seen that all participants who increase 
their LEMS score past the threshold (organge) also increased their variability in movement smoothness, however the participants that did not increase 
their LEMS past the repeatability threshold (blue) were the only participants to decrease their varaibility in movement smoothness. 
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Appendix Table H.5: Correlations between all reliable LA features measured at admission and ambulation 
outcomes at 6-months*†‡§ 
    WISCI-II 10mWT 6MWT 
Feature Category LA Feature r p r p r p 
Change in angle 
of inclination 
Angle Net Change-Med 0.318 0.268 0.369 0.214 0.324 0.281 
Angle Rate Change-IQR § 0.324 0.258 0.452 0.121 0.399 0.176 
Angle Rate Change-Med 0.513 0.061 0.421 0.152 0.460 0.114 
Angle Total Change-IQR 0.468 0.092 0.651 0.016 0.580 0.038 




Grav Change X-IQR -0.004 0.990 0.150 0.624 0.120 0.696 
Grav Change Y-IQR 0.103 0.727 0.326 0.278 0.184 0.548 
Grav Change Z-IQR 0.341 0.233 0.316 0.294 0.292 0.333 





0.204 0.485 -0.001 0.999 -0.128 0.677 
Frequency domain Bandwidth-Med -0.662 0.010 -0.421 0.152 -0.424 0.149 
Centroid Freq-Med -0.657 0.011 -0.445 0.128 -0.491 0.088 
Power Dom Freq 1/Total-Med 0.499 0.069 0.305 0.310 0.386 0.192 
Dom Freq 1-Med -0.641 0.013 -0.506 0.078 -0.520 0.069 
Med Freq-IQR 0.094 0.749 0.032 0.916 0.102 0.740 
Med Freq-Med -0.445 0.111 -0.387 0.192 -0.451 0.122 
Power Dom Freq 1-Med 0.489 0.076 0.277 0.359 0.292 0.333 
Power Dom Freq 2-IQR 0.652 0.011 0.755 0.003 0.651 0.016 
Power Dom Freq 2-Med 0.596 0.024 0.369 0.215 0.376 0.206 
Power Dom Low Freq-IQR 0.698 0.006 0.776 0.002 0.664 0.013 
Power Dom Low Freq-Med 0.547 0.043 0.332 0.267 0.334 0.264 
Power High Freq/Total-Med -0.511 0.062 -0.338 0.259 -0.359 0.228 
Power Total-IQR 0.712 0.004 0.768 0.002 0.614 0.025 
Limb movement 
percentages 
Bilat Ankle % -0.247 0.395 -0.300 0.320 -0.487 0.092 
Unilat Ankle % 0.247 0.395 0.300 0.320 0.487 0.092 
Median crossings Num Med Crossings Norm-Med -0.708 0.005 -0.570 0.042 -0.546 0.054 
Num Med Crossings-IQR 0.048 0.869 -0.160 0.602 -0.156 0.611 
Num Med Crossings-Med § 0.065 0.826 -0.096 0.755 -0.006 0.984 
PLM Num PLM Norm § 0.230 0.429 -0.047 0.879 0.067 0.829 
PLM % -0.066 0.824 -0.164 0.592 -0.109 0.722 
PLM Index § -0.208 0.476 -0.265 0.381 -0.220 0.470 
Relationship to 
recent movements 
Close Cross Corr Peak-IQR 0.691 0.006 0.562 0.046 0.482 0.095 
Dom Freq Last 90s-Med -0.151 0.607 -0.237 0.435 -0.072 0.816 
Max Cross Cov-Med 0.087 0.766 -0.018 0.952 0.039 0.899 
Move Last 90s-Med § -0.059 0.841 -0.164 0.591 -0.057 0.853 





Appendix Table H.5 Continued 
    WISCI-II 10mWT 6MWT 
Feature Category LA Feature r p r p r p 
Signal 
characteristics 
Entropy Rate-IQR 0.329 0.251 0.416 0.157 0.186 0.543 
Entropy Rate-Med § 0.382 0.178 0.184 0.548 0.134 0.663 
Lempel-Ziv Comp-Med -0.089 0.762 -0.090 0.771 0.041 0.895 
Lyapunov Exp-IQR 0.620 0.018 0.407 0.167 0.417 0.157 
Wave Approx-Med -0.185 0.526 -0.115 0.709 -0.021 0.946 
Wave Energy 2-IQR § 0.378 0.182 0.092 0.765 0.079 0.798 
Wave Energy 2-Med 0.270 0.350 0.184 0.548 0.089 0.772 
Wave Energy 3-IQR 0.025 0.932 -0.090 0.771 -0.192 0.530 
Wave Energy 3-Med 0.201 0.492 0.115 0.708 -0.010 0.973 
Wave Entropy-Med 0.103 0.726 0.072 0.815 -0.011 0.972 
Statistical AUC Acc Norm-IQR 0.747 0.002 0.733 0.004 0.681 0.010 
AUC Acc Norm-Med 0.455 0.102 0.268 0.376 0.245 0.420 
AUC Acc-IQR 0.699 0.005 0.735 0.004 0.679 0.011 
AUC Acc-Med 0.537 0.048 0.424 0.149 0.426 0.147 
Duration-IQR § 0.517 0.058 0.569 0.042 0.465 0.110 
Duration-Max 0.622 0.018 0.425 0.148 0.503 0.080 
Duration-Med 0.521 0.056 0.546 0.053 0.529 0.063 
Kurtosis-Med -0.008 0.978 0.172 0.575 0.039 0.899 
Max Acc-IQR 0.611 0.020 0.668 0.013 0.443 0.130 
Max-RMS Acc-Med 0.145 0.620 0.220 0.470 0.085 0.783 
Med Acc-IQR 0.703 0.005 0.673 0.012 0.701 0.008 
Med Acc-Med 0.391 0.167 0.282 0.351 0.344 0.250 
Range Acc-IQR 0.612 0.020 0.669 0.012 0.444 0.128 
RMS Acc-Med 0.472 0.089 0.256 0.399 0.230 0.450 
SD Acc-IQR 0.741 0.002 0.694 0.009 0.556 0.049 
Skewness-Med 0.003 0.992 0.155 0.614 0.014 0.963 
SMA Acc-IQR 0.710 0.004 0.720 0.006 0.655 0.015 
SMA Acc-Med 0.504 0.066 0.340 0.256 0.327 0.275 
Timing Move/hour § 0.163 0.578 -0.053 0.863 0.031 0.920 
Move/night § 0.141 0.631 -0.074 0.811 0.020 0.948 
Time Asleep § 0.268 0.354 0.099 0.748 0.132 0.668 
Med Vel-IQR 0.699 0.005 0.672 0.012 0.701 0.008 
Velocity and 
distance 
Med Vel-Med 0.358 0.209 0.256 0.398 0.302 0.316 
RMS Vel-Med 0.476 0.085 0.257 0.397 0.231 0.447 
Total Dist-IQR 0.687 0.007 0.776 0.002 0.701 0.008 
Total Dist-Med 0.574 0.032 0.448 0.125 0.468 0.107 
* Outcomes that had a correlation p< 0.1 are bolded 
† Outcomes where at least 2 groups could be visually well isolated when plotted are highlighted grey 
‡ LA features that were found to be stable over time in Aim 3b are italicized 
§ Indicates a feature that was variable over time in Aim 3b, but not related to changes in ambulatory ability or 
impairment in Aim 4a 
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Appendix H.1 Supplemental Visual Analyses for Features Significant in Aim 4b, but Not 
Aim 4a 
 
Appendix Figure H.3: Duration-IQR supplemental visual analysis (variable LA feature that was related to 6-
month WISCI-II and 10mWT when measured at admission [Aim 4b], but not change in any outcomes over 
time [Aim 4a]). a) Shows no trend to change in WISCI-II over time, b) admission feature has significant 
correlation to WISCI-II at 6-months, c) no trend to change in 10mWT over time, b) admission feature has 




Appendix Figure H.4: Angle Rate Change-IQR supplemental visual analysis (variable LA feature that was 
related to 6-month 10mWT and 6MWT when measured at admission [Aim 4b], but not change in any 
outcomes over time [Aim 4a]). a) Shows no trend to change in 10mWT over time, b) admission feature is 
visually separable between the household and community ambulator groups for the 10mWT at 6-months, c) 
no trend to change in 6MWT over time, b) admission feature is visually separable between the household and 






Appendix Figure H.5: Wave Energy 2-IQR supplemental visual analysis (variable LA feature that was 
related to 6-month 6MWT when measured at admission [Aim 4b], but not change in any outcomes over time 
[Aim 4a]). a) Shows no trend to change in 6MWT over time, b) admission feature is visually separable 




1.Rigot S, Worobey L, Boninger ML. Gait Training in Acute Spinal Cord Injury Rehabilitation—
Utilization and Outcomes Among Nonambulatory Individuals: Findings From the SCIRehab 
Project. Archives of Physical Medicine and Rehabilitation 2018;99(8):1591-8. 
2.Ditunno PL, Patrick M, Stineman M, Ditunno JF. Who wants to walk? Preferences for recovery 
after SCI: a longitudinal and cross-sectional study. Spinal Cord 2008;46(7):500-6. 
3.National Spinal Cord Injury Statistical Center. 2020 Annual Statistical Report for the Spinal 
Cord Injury Model Systems. Birmingham, Alabama; 2020. 
4.van Middendorp JJ, Hosman AJ, Donders AR, Pouw MH, Ditunno JF, Jr., Curt A et al. A clinical 
prediction rule for ambulation outcomes after traumatic spinal cord injury: a longitudinal cohort 
study. Lancet 2011;377(9770):1004-10. 
5.Hicks KE, Zhao Y, Fallah N, Rivers CS, Noonan VK, Plashkes T et al. A simplified clinical 
prediction rule for prognosticating independent walking after spinal cord injury: a prospective 
study from a Canadian multicenter spinal cord injury registry. Spine J 2017;17(10):1383-92. 
6.Phan P, Budhram B, Zhang Q, Rivers CS, Noonan VK, Plashkes T et al. Highlighting 
discrepancies in walking prediction accuracy for patients with traumatic spinal cord injury: an 
evaluation of validated prediction models using a Canadian Multicenter Spinal Cord Injury 
Registry. The Spine Journal 2019;19(4):703-10. 
7.Engel-Haber E, Zeilig G, Haber S, Worobey L, Kirshblum S. The effect of age and injury 
severity on clinical prediction rules for ambulation among individuals with spinal cord injury. 
Spine J 2020. 
8.Bohannon RW. Considerations and Practical Options for Measuring Muscle Strength: A 
Narrative Review. Biomed Res Int 2019;2019:8194537. 
9.Hales M, Biros E, Reznik JE. Reliability and Validity of the Sensory Component of the 
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI): A 
Systematic Review. Top Spinal Cord Inj Rehabil 2015;21(3):241-9. 
10.Peter C, Muller R, Cieza A, Geyh S. Psychological resources in spinal cord injury: a systematic 
literature review. Spinal Cord 2012;50(3):188-201. 
 214 
11.Waldron B, Benson C, O'Connell A, Byrne P, Dooley B, Burke T. Health locus of control and 
attributions of cause and blame in adjustment to spinal cord injury. Spinal Cord 2010;48(8):598-
602. 
12.Chevalier Z, Kennedy P, Sherlock O. Spinal cord injury, coping and psychological adjustment: 
a literature review. Spinal Cord 2009;47(11):778-82. 
13.National Spinal Cord Injury Statistical Center. Facts and Figures at a Glance. Birmingham, 
Alabama: University of Alabama at Birmingham; 2021. 
14.Øiestad B, Juhl C, Eitzen I, Thorlund J. Knee extensor muscle weakness is a risk factor for 
development of knee osteoarthritis. A systematic review and meta-analysis. Osteoarthritis and 
cartilage 2015;23(2):171-7. 
15.Jain NB, Higgins LD, Katz JN, Garshick E. Association of shoulder pain with the use of 
mobility devices in persons with chronic spinal cord injury. PM R 2010;2(10):896-900. 
16.Hiremath SV, Hogaboom NS, Roscher MR, Worobey LA, Oyster ML, Boninger ML. 
Longitudinal Prediction of Quality-of-Life Scores and Locomotion in Individuals With Traumatic 
Spinal Cord Injury. Arch Phys Med Rehabil 2017;98(12):2385-92. 
17.Riggins MS, Kankipati P, Oyster ML, Cooper RA, Boninger ML. The relationship between 
quality of life and change in mobility 1 year postinjury in individuals with spinal cord injury. Arch 
Phys Med Rehabil 2011;92(7):1027-33. 
18.Krause J, Carter RE, Brotherton S. Association of mode of locomotion and independence in 
locomotion with long-term outcomes after spinal cord injury. J Spinal Cord Med 2009;32(3):237-
48. 
19.Chay W, Kirshblum S. Predicting outcomes after spinal cord injury. Physical medicine and 
rehabilitation clinics of North America 2020;31(3):331-43. 
20.Hardin EC, Kobetic R, Triolo RJ. Ambulation and spinal cord injury. Phys Med Rehabil Clin 
N Am 2013;24(2):355-70. 
21.Biering-Sorensen F, Hansen B, Lee BS. Non-pharmacological treatment and prevention of bone 
loss after spinal cord injury: a systematic review. Spinal Cord 2009;47(7):508-18. 
22.Taghi MK. The Physiological Benefits and Problems Associated With Using Standing and 
Walking Orthoses in Individuals With Spinal Cord Injury—A Meta-analytic Review. Journal of 
Orthopaedics, Trauma and Rehabilitation 2012;16(1):37-40. 
 215 
23.Karimi MT. Evidence-based evaluation of physiological effects of standing and walking in 
individuals with spinal cord injury. Iranian journal of medical sciences 2011;36(4):242-53. 
24.Jannings W, Pryor J. The experiences and needs of persons with spinal cord injury who can 
walk. Disabil Rehabil 2012;34(21):1820-6. 
25.Kirshblum SC, Priebe MM, Ho CH, Scelza WM, Chiodo AE, Wuermser LA. Spinal cord injury 
medicine. 3. Rehabilitation phase after acute spinal cord injury. Arch Phys Med Rehabil 2007;88(3 
Suppl 1):S62-70. 
26.Brotherton SS, Krause JS, Nietert PJ. Falls in individuals with incomplete spinal cord injury. 
Spinal Cord 2007;45(1):37-40. 
27.Khan A, Pujol C, Laylor M, Unic N, Pakosh M, Dawe J et al. Falls after spinal cord injury: a 
systematic review and meta-analysis of incidence proportion and contributing factors. Spinal Cord 
2019;57(7):526-39. 
28.Cao Y, DiPiro N, Li C, Roesler J, Krause JS. Behavioral factors and unintentional injuries after 
spinal cord injury. Archives of Physical Medicine and Rehabilitation 2020;101(3):412-7. 
29.Saunders LL, Krause JS, DiPiro ND, Kraft S, Brotherton S. Ambulation and complications 
related to assistive devices after spinal cord injury. J Spinal Cord Med 2013;36(6):652-9. 
30.Haubert LL, Gutierrez DD, Newsam CJ, Gronley JK, Mulroy SJ, Perry J. A comparison of 
shoulder joint forces during ambulation with crutches versus a walker in persons with incomplete 
spinal cord injury. Arch Phys Med Rehabil 2006;87(1):63-70. 
31.Lapointe R, Lajoie Y, Serresse O, Barbeau H. Functional community ambulation requirements 
in incomplete spinal cord injured subjects. Spinal Cord 2001;39(6):327-35. 
32.Purser JL, Weinberger M, Cohen HJ, Pieper CF, Morey MC, Li T et al. Walking speed predicts 
health status and hospital costs for frail elderly male veterans. J Rehabil Res Dev 2005;42(4):535-
46. 
33.Kirshblum S, Waring W, 3rd. Updates for the International Standards for Neurological 
Classification of Spinal Cord Injury. Phys Med Rehabil Clin N Am 2014;25(3):505-17, vii. 
34.Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle 
spasticity. Phys Ther 1987;67(2):206-7. 
35.Scivoletto G, Tamburella F, Laurenza L, Torre M, Molinari M. Who is going to walk? A review 
of the factors influencing walking recovery after spinal cord injury. Front Hum Neurosci 
2014;8:141. 
 216 
36.Belliveau T, Jette AM, Seetharama S, Axt J, Rosenblum D, Larose D et al. Developing artificial 
neural network models to predict functioning one year after traumatic spinal cord injury. Archives 
of Physical Medicine and Rehabilitation 2016;97(10):1663-8.e3. 
37.Pelletier-Roy R, Richard-Denis A, Jean S, Bourassa-Moreau É, Fleury J, Beauchamp-Vien G 
et al. Clinical judgment is a cornerstone for validating and using clinical prediction rules: a head-
to-head study on ambulation outcomes for spinal cord injured patients. Spinal Cord 2021. 
38.Lee BA, Leiby BE, Marino RJ. Neurological and functional recovery after thoracic spinal cord 
injury. J Spinal Cord Med 2016;39(1):67-76. 
39.Chu J, Harvey LA, Ben M, Batty J, Avis A, Adams R. Physical therapists' ability to predict 
future mobility after spinal cord injury. Journal of Neurologic Physical Therapy 2012;36(1):3-7. 
40.Afzal M, Hussain M, Ali Khan W, Ali T, Lee S, Huh E-N et al. Comprehensible knowledge 
model creation for cancer treatment decision making. Computers in Biology and Medicine 
2017;82:119-29. 
41.Barlow T, Scott P, Griffin D, Realpe A. How outcome prediction could affect patient decision 
making in knee replacements: a qualitative study. BMC musculoskeletal disorders 2016;17:304. 
42.Everhart J, Somers M, Hibbs R, Worobey LA. Clinical Utility During Inpatient Rehabilitation 
of a Clinical Prediction Rule for Ambulation Prognosis Following Spinal Cord Injury. The Journal 
of Spinal Cord Medicine 2021:1-9. 
43.Boggenpoel B, Madasa V, Jeftha T, Joseph C. Systematic scoping review protocol for clinical 
prediction rules (CPRs) in the management of patients with spinal cord injuries. BMJ Open 
2019;9(1):e025076. 
44.Burns AS, Yee J, Flett HM, Guy K, Cournoyea N. Impact of benchmarking and clinical 
decision making tools on rehabilitation length of stay following spinal cord injury. Spinal Cord 
2013;51(2):165-9. 
45.Rowland T, Ohno-Machado L, Ohrn A. Comparison of multiple prediction models for 
ambulation following spinal cord injury. Proc AMIA Symp 1998:528-32. 
46.Winchester P, Smith P, Foreman N, Mosby JM, Pacheco F, Querry R et al. A prediction model 
for determining over ground walking speed after locomotor training in persons with motor 
incomplete spinal cord injury. J Spinal Cord Med 2009;32(1):63-71. 
47.Waters RL, Adkins R, Yakura J, Vigil D. Prediction of ambulatory performance based on motor 
scores derived from standards of the American Spinal Injury Association. Archives of physical 
medicine and rehabilitation 1994;75(7):756-60. 
 217 
48.Kay ED, Deutsch A, Wuermser LA. Predicting walking at discharge from inpatient 
rehabilitation after a traumatic spinal cord injury. Archives of physical medicine and rehabilitation 
2007;88(6):745-50. 
49.Malla R. External validation study of a clinical prediction rule for ambulation outcomes after 
traumatic spinal cord injury [THESIS.MASTER]. Texas Medical Center Dissertations (via 
ProQuest); 2013. 
50.van Silfhout L, Peters AE, Graco M, Schembri R, Nunn AK, Berlowitz DJ. Validation of the 
Dutch clinical prediction rule for ambulation outcomes in an inpatient setting following traumatic 
spinal cord injury. Spinal Cord 2016;54(8):614-8. 
51.Sturt R, Hill B, Holland A, New PW, Bevans C. Correction: Validation of a clinical prediction 
rule for ambulation outcome after non-traumatic spinal cord injury. Spinal Cord 2020;58(5):631. 
52.Hicks KE, Zhao Y, Fallah N, Rivers CS, Noonan VK, Plashkes T et al. A simplified clinical 
prediction rule for prognosticating independent walking after spinal cord injury: a prospective 
study from a Canadian multicenter spinal cord injury registry. The Spine Journal 
2017;17(10):1383-92. 
53.Zörner B, Blanckenhorn WU, Dietz V, Group E-SS, Curt A. Clinical algorithm for improved 
prediction of ambulation and patient stratification after incomplete spinal cord injury. Journal of 
Neurotrauma 2010;27(1):241-52. 
54.Engel-Haber E, Zeilig G, Haber S, Worobey L, Kirshblum S. The effect of age and injury 
severity on clinical prediction rules for ambulation among individuals with spinal cord injury. The 
Spine Journal 2020. 
55.Hays RD, Revicki D. Reliability and validity (including responsiveness). Assessing quality of 
life in clinical trials 2005;2:25-39. 
56.Marino RJ, Jones L, Kirshblum S, Tal J, Dasgupta A. Reliability and repeatability of the motor 
and sensory examination of the international standards for neurological classification of spinal 
cord injury. The Journal of Spinal Cord Medicine 2008;31(2):166-70. 
57.Gadotti IC, Vieira ER, Magee DJ. Importance and clarification of measurement properties in 
rehabilitation. Rev Bras Fisioter 2006;10(2):137-46. 
58.Belliveau T, Jette AM, Seetharama S, Axt J, Rosenblum D, Larose D et al. Developing 
Artificial Neural Network Models to Predict Functioning One Year After Traumatic Spinal Cord 
Injury. Arch Phys Med Rehabil 2016;97(10):1663-8 e3. 
 218 
59.Waters RL, Adkins RH, Yakura JS, Sie I. Motor and sensory recovery following incomplete 
paraplegia. Arch Phys Med Rehabil 1994;75(1):67-72. 
60.Crozier KS, Cheng LL, Graziani V, Zorn G, Herbison G, Ditunno JF, Jr. Spinal cord injury: 
prognosis for ambulation based on quadriceps recovery. Paraplegia 1992;30(11):762-7. 
61.Crozier KS, Graziani V, Ditunno JF, Jr., Herbison GJ. Spinal cord injury: prognosis for 
ambulation based on sensory examination in patients who are initially motor complete. Arch Phys 
Med Rehabil 1991;72(2):119-21. 
62.Hussey RW, Stauffer ES. Spinal cord injury: requirements for ambulation. Arch Phys Med 
Rehabil 1973;54(12):544-7. 
63.DeVries Z, Hoda M, Rivers CS, Maher A, Wai E, Moravek D et al. Development of an 
unsupervised machine learning algorithm for the prognostication of walking ability in spinal cord 
injury patients. Spine J 2020;20(2):213-24. 
64.Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after 
spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 
1996;139(2):244-56. 
65.Onifer SM, Smith GM, Fouad K. Plasticity after spinal cord injury: relevance to recovery and 
approaches to facilitate it. Neurotherapeutics 2011;8(2):283-93. 
66.Velstra IM, Curt A, Frotzler A, Abel R, Kalsi-Ryan S, Rietman JS et al. Changes in Strength, 
Sensation, and Prehension in Acute Cervical Spinal Cord Injury: European Multicenter 
Responsiveness Study of the GRASSP. Neurorehabil Neural Repair 2015;29(8):755-66. 
67.Beasley WC. Influence of method on estimates of normal knee extensor force among normal 
and postpolio children. Phys Ther Rev 1956;36(1):21-41. 
68.Dvir Z. Grade 4 in manual muscle testing: the problem with submaximal strength assessment. 
Clin Rehabil 1997;11(1):36-41. 
69.Le-Ngoc L, Jansse J. Validity and reliability of a hand-held dynamometer for dynamic muscle 
strength assessment. In: Kim CT, editor. Rehabilitation Medicine. InTech; 2012. 
70.Winchester P, Smith P, Foreman N, Mosby JM, Pacheco F, Querry R et al. A prediction model 
for determining over ground walking speed after locomotor training in persons with motor 
incomplete spinal cord injury. The journal of spinal cord medicine 2009;32(1):63-71. 
 219 
71.Dijkers MP, Zanca JM. Factors complicating treatment sessions in spinal cord injury 
rehabilitation: nature, frequency, and consequences. Archives of Physical Medicine and 
Rehabilitation 2013;94(4 Suppl):S115-24. 
72.Hammond FM, Lieberman J, Smout RJ, Horn SD, Dijkers MP, Backus D. Missed therapy time 
during inpatient rehabilitation for spinal cord injury. Archives of Physical Medicine and 
Rehabilitation 2013;94(4 Suppl):S106-14. 
73.Holtz KA, Lipson R, Noonan VK, Kwon BK, Mills PB. Prevalence and effect of problematic 
spasticity after traumatic spinal cord injury. Archives of Physical Medicine and Rehabilitation 
2017;98(6):1132-8. 
74.Sköld C, Levi R, Seiger A. Spasticity after traumatic spinal cord injury: nature, severity, and 
location. Archives of Physical Medicine and Rehabilitation 1999;80(12):1548-57. 
75.Scholtes VA, Becher JG, Beelen A, Lankhorst GJ. Clinical assessment of spasticity in children 
with cerebral palsy: a critical review of available instruments. Dev Med Child Neurol 
2006;48(1):64-73. 
76.Haas BM, Bergstrom E, Jamous A, Bennie A. The inter rater reliability of the original and of 
the modified Ashworth scale for the assessment of spasticity in patients with spinal cord injury. 
Spinal Cord 1996;34(9):560-4. 
77.Baunsgaard CB, Nissen UV, Christensen KB, Biering-Sorensen F. Modified Ashworth scale 
and spasm frequency score in spinal cord injury: reliability and correlation. Spinal Cord 
2016;54(9):702-8. 
78.Stevens SL, Fuller DK, Morgan DW. Leg strength, preferred walking speed, and daily step 
activity in adults with incomplete spinal cord injuries. Top Spinal Cord Inj Rehabil 2013;19(1):47-
53. 
79.Hiremath SV, Ding D. Evaluation of activity monitors in manual wheelchair users with 
paraplegia. J Spinal Cord Med 2011;34(1):110-7. 
80.Hiremath SV, Ding D, Farringdon J, Vyas N, Cooper RA. Physical activity classification 
utilizing SenseWear activity monitor in manual wheelchair users with spinal cord injury. Spinal 
Cord 2013;51(9):705-9. 
81.Warms CA, Belza BL. Actigraphy as a measure of physical activity for wheelchair users with 
spinal cord injury. Nurs Res 2004;53(2):136-43. 
82.Telles SC, Alves RC, Chadi G. Periodic limb movements during sleep and restless legs 
syndrome in patients with ASIA A spinal cord injury. J Neurol Sci 2011;303(1-2):119-23. 
 220 
83.Hiremath SV, Intille SS, Kelleher A, Cooper RA, Ding D. Detection of physical activities using 
a physical activity monitor system for wheelchair users. Med Eng Phys 2015;37(1):68-76. 
84.Lavigne G, Zucconi M, Castronovo C, Manzini C, Marchettini P, Smirne S. Sleep arousal 
response to experimental thermal stimulation during sleep in human subjects free of pain and sleep 
problems. Pain 2000;84(2-3):283-90. 
85.Kato T, Montplaisir JY, Lavigne GJ. Experimentally induced arousals during sleep: a cross-
modality matching paradigm. Journal of sleep research 2004;13(3):229-38. 
86.Phadke CP, Balasubramanian CK, Ismail F, Boulias C. Revisiting physiologic and psychologic 
triggers that increase spasticity. American Journal of Physical Medicine & Rehabilitation 
2013;92(4):357-69. 
87.Fleuren JF, Voerman GE, Snoek GJ, Nene AV, Rietman JS, Hermens HJ. Perception of lower 
limb spasticity in patients with spinal cord injury. Spinal Cord 2009;47(5):396-400. 
88.Bruyneel M, Sanida C, Art G, Libert W, Cuvelier L, Paesmans M et al. Sleep efficiency during 
sleep studies: results of a prospective study comparing home-based and in-hospital 
polysomnography. J Sleep Res 2011;20(1 Pt 2):201-6. 
89.Kimura S, Ozasa S, Nomura K, Yoshioka K, Endo F. Estimation of muscle strength from 
actigraph data in Duchenne muscular dystrophy. Pediatr Int 2014;56(5):748-52. 
90.Horn SD, Smout RJ, DeJong G, Dijkers MP, Hsieh CH, Lammertse D et al. Association of 
various comorbidity measures with spinal cord injury rehabilitation outcomes. Arch Phys Med 
Rehabil 2013;94(4 Suppl):S75-86. 
91.Tian W, Hsieh CH, DeJong G, Backus D, Groah S, Ballard PH. Role of body weight in therapy 
participation and rehabilitation outcomes among individuals with traumatic spinal cord injury. 
Arch Phys Med Rehabil 2013;94(4 Suppl):S125-36. 
92.Barclay L, Lentin P, McDonald R, Bourke-Taylor H. Understanding the factors that influence 
social and community participation as perceived by people with non-traumatic spinal cord injury. 
British journal of occupational therapy 2017;80(10):577-86. 
93.Livneh H, Martz E. Coping strategies and resources as predictors of psychosocial adaptation 
among people with spinal cord injury. Rehabilitation psychology 2014;59(3):329-39. 
94.Elfstrom ML, Kennedy P, Lude P, Taylor N. Condition-related coping strategies in persons 
with spinal cord lesion: a cross-national validation of the Spinal Cord Lesion-related Coping 
Strategies Questionnaire in four community samples. Spinal Cord 2007;45(6):420-8. 
 221 
95.Elfstrom ML, Ryden A, Kreuter M, Persson LO, Sullivan M. Linkages between coping and 
psychological outcome in the spinal cord lesioned: development of SCL-related measures. Spinal 
Cord 2002;40(1):23-9. 
96.Craig A, Nicholson Perry K, Guest R, Tran Y, Dezarnaulds A, Hales A et al. Prospective study 
of the occurrence of psychological disorders and comorbidities after spinal cord injury. Arch Phys 
Med Rehabil 2015;96(8):1426-34. 
97.Myaskovsky L, Gao S, Hausmann LRM, Bornemann KR, Burkitt KH, Switzer GE et al. How 
Are Race, Cultural, and Psychosocial Factors Associated With Outcomes in Veterans With Spinal 
Cord Injury? Arch Phys Med Rehabil 2017;98(9):1812-20 e3. 
98.Sharif S, Jazaib Ali MY. Outcome prediction in spinal cord injury: myth or reality. World 
neurosurgery 2020;140:574-90. 
99.Oleson CV, Marino RJ, Leiby BE, Ditunno JF. Influence of Age Alone, and Age Combined 
With Pinprick, on Recovery of Walking Function in Motor Complete, Sensory Incomplete Spinal 
Cord Injury. Arch Phys Med Rehabil 2016;97(10):1635-41. 
100.Kirshblum SC, Botticello AL, Dyson-Hudson TA, Byrne R, Marino RJ, Lammertse DP. 
Patterns of Sacral Sparing Components on Neurologic Recovery in Newly Injured Persons With 
Traumatic Spinal Cord Injury. Arch Phys Med Rehabil 2016;97(10):1647-55. 
101.Ames H, Wilson C, Barnett SD, Njoh E, Ottomanelli L. Does functional motor incomplete 
(AIS D) spinal cord injury confer unanticipated challenges? Rehabil Psychol 2017;62(3):401-6. 
102.Jackson AB, Carnel CT, Ditunno JF, Read MS, Boninger ML, Schmeler MR et al. Outcome 
measures for gait and ambulation in the spinal cord injury population. J Spinal Cord Med 
2008;31(5):487-99. 
103.Forrest GF, Hutchinson K, Lorenz DJ, Buehner JJ, Vanhiel LR, Sisto SA et al. Are the 10 
meter and 6 minute walk tests redundant in patients with spinal cord injury? Plos One 
2014;9(5):e94108. 
104.Bolliger M, Blight AR, Field-Fote EC, Musselman K, Rossignol S, Barthélemy D et al. Lower 
extremity outcome measures: considerations for clinical trials in spinal cord injury. Spinal cord 
2018;56(7):628-42. 
105.van Hedel HJ, Dietz V. Walking during daily life can be validly and responsively assessed in 
subjects with a spinal cord injury. Neurorehabil Neural Repair 2009;23(2):117-24. 
 222 
106.Altenburger PA, Dierks TA, Miller KK, Combs SA, Van Puymbroeck M, Schmid AA. 
Examination of sustained gait speed during extended walking in individuals with chronic stroke. 
Archives of Physical Medicine and Rehabilitation 2013;94(12):2471-7. 
107.Westreich D, Lessler J, Funk MJ. Propensity score estimation: neural networks, support vector 
machines, decision trees (CART), and meta-classifiers as alternatives to logistic regression. 
Journal of Clinical Epidemiology 2010;63(8):826-33. 
108.Lobo JM, Jiménez-Valverde A, Real R. AUC: a misleading measure of the performance of 
predictive distribution models. Global Ecology and Biogeography 2008;17(2):145-51. 
109.Phan P, Budhram B, Zhang Q, Rivers CS, Noonan VK, Plashkes T et al. Highlighting 
discrepancies in walking prediction accuracy for patients with traumatic spinal cord injury: an 
evaluation of validated prediction models using a Canadian Multicenter Spinal Cord Injury 
Registry. Spine J 2019;19(4):703-10. 
110.Schmid M, Riganti-Fulginei F, Bernabucci I, Laudani A, Bibbo D, Muscillo R et al. SVM 
versus MAP on accelerometer data to distinguish among locomotor activities executed at different 
speeds. Computational and mathematical methods in medicine 2013;2013:343084. 
111.Mannini A, Intille SS, Rosenberger M, Sabatini AM, Haskell W. Activity recognition using a 
single accelerometer placed at the wrist or ankle. Med Sci Sports Exerc 2013;45(11):2193-203. 
112.Sforza E, Johannes M, Claudio B. The PAM-RL ambulatory device for detection of periodic 
leg movements: a validation study. Sleep Medicine 2005;6(5):407-13. 
113.Jatesiktat P, Wei Tech A. An elderly fall detection using a wrist-worn accelerometer and 
barometer. Conf Proc IEEE Eng Med Biol Soc 2017;2017:125-30. 
114.Özdemir AT, Barshan B. Detecting falls with wearable sensors using machine learning 
techniques. Sensors Basel Sensors 2014;14(6):10691-708. 
115.Albert MV, Azeze Y, Courtois M, Jayaraman A. In-lab versus at-home activity recognition in 
ambulatory subjects with incomplete spinal cord injury. Journal of neuroengineering and 
rehabilitation 2017;14(1):10. 
116.Tsang K, Hiremath SV, Cooper RA, Ding D. Evaluation of custom energy expenditure models 
for SenseWear armband in manual wheelchair users. J Rehabil Res Dev 2015;52(7):793-803. 
117.Botticello AL, Chen Y, Cao Y, Tulsky DS. Do communities matter after rehabilitation? The 
effect of socioeconomic and urban stratification on well-being after spinal cord injury. Arch Phys 
Med Rehabil 2011;92(3):464-71. 
 223 
118.Centers for Disease Control and Prevention, National Center for Health Statistics. NCHS 
Urban-Rural Classification Scheme for Counties. In: U.S. Department of Health and Human 
Services, editor. https://www.cdc.gov/nchs/data_access/urban_rural.htm; 2017. 
119.Centers for Disease Control and Prevention, National Center for Health Statistics, Office of 
Analysis and Epidemiology. 2013 NCHS Urban–Rural Classification  Scheme for Counties. 
Hyattsville, MD: U.S. Department of Health and Human Services; 2014. 
120.Cleeland CS, Ryan K. The brief pain inventory. Pain Research Group 1991. 
121.Widerstrom-Noga E, Biering-Sorensen F, Bryce T, Cardenas DD, Finnerup NB, Jensen MP 
et al. The international spinal cord injury pain basic data set. Spinal Cord 2008;46(12):818-23. 
122.Craig Hospital. Craig Hospital Inventory of Environmental Factors, Version 3.0. Craig 
Hospital Research Department; 2001. 
123.Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. 
Conceptual framework and item selection. Med Care 1992;30(6):473-83. 
124.Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32(6):705-
14. 
125.Middleton JW, Tran Y, Lo C, Craig A. Reexamining the Validity and Dimensionality of the 
Moorong Self-Efficacy Scale: Improving Its Clinical Utility. Arch Phys Med Rehabil 
2016;97(12):2130-6. 
126.Victorson D, Tulsky DS, Kisala PA, Kalpakjian CZ, Weiland B, Choi SW. Measuring 
resilience after spinal cord injury: Development, validation and psychometric characteristics of the 
SCI-QOL Resilience item bank and short form. J Spinal Cord Med 2015;38(3):366-76. 
127.Middleton J, Tran Y, Craig A. Relationship between quality of life and self-efficacy in persons 
with spinal cord injuries. Arch Phys Med Rehabil 2007;88(12):1643-8. 
128.Whiteneck G, Meade MA, Dijkers M, Tate DG, Bushnik T, Forchheimer MB. Environmental 
factors and their role in participation and life satisfaction after spinal cord injury. Arch Phys Med 
Rehabil 2004;85(11):1793-803. 
129.Whiteneck GG, Harrison-Felix CL, Mellick DC, Brooks CA, Charlifue SB, Gerhart KA. 
Quantifying environmental factors: a measure of physical, attitudinal, service, productivity, and 
policy barriers. Arch Phys Med Rehabil 2004;85(8):1324-35. 
130.Post MWM, van Leeuwen CMC. Psychosocial issues in spinal cord injury: a review. Spinal 
Cord 2012;50(5):382-9. 
 224 
131.Kennedy P, Lude P, Elfström ML, Smithson EF. Psychological contributions to functional 
independence: a longitudinal investigation of spinal cord injury rehabilitation. Archives of 
Physical Medicine and Rehabilitation 2011;92(4):597-602. 
132.Ahn SH, Park HW, Lee BS, Moon HW, Jang SH, Sakong J et al. Gabapentin effect on 
neuropathic pain compared among patients with spinal cord injury and different durations of 
symptoms. Spine (Phila Pa 1976) 2003;28(4):341-6; discussion 6-7. 
133.LaVela SL, Burns SP, Goldstein B, Miskevics S, Smith B, Weaver FM. Dysfunctional sleep 
in persons with spinal cord injuries and disorders. Spinal Cord 2012;50(9):682-5. 
134.Schoenborn CA, Adams PF. Sleep Duration as a Correlate of Smoking, Alcohol Use, Leisure-
Time Physical Inactivity, and Obesity Among Adults: United States, 2004-2006. NCHS Health & 
Stats; 2008. 
135.Garcia AN, Salloum IM. Polysomnographic sleep disturbances in nicotine, caffeine, alcohol, 
cocaine, opioid, and cannabis use: A focused review. Am J Addict 2015;24(7):590-8. 
136.Hammell KW, Miller WC, Forwell SJ, Forman BE, Jacobsen BA. Fatigue and spinal cord 
injury: a qualitative analysis. Spinal Cord 2009;47(1):44-9. 
137.Usui A, Ishizuka Y, Obinata I, Okado T, Fukuzawa H, Kanba S. Validity of sleep log 
compared with actigraphic sleep-wake state II. Psychiatry and clinical neurosciences 
1999;53(2):183-4. 
138.Mollayeva T, Thurairajah P, Burton K, Mollayeva S, Shapiro CM, Colantonio A. The 
Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical 
samples: A systematic review and meta-analysis. Sleep Med Rev 2016;25:52-73. 
139.Migueles JH, Cadenas-Sanchez C, Ekelund U, Delisle Nyström C, Mora-Gonzalez J, Löf M 
et al. Accelerometer data collection and processing criteria to assess physical activity and other 
outcomes: A systematic review and practical considerations. Sports Med 2017;47(9):1821-45. 
140.Cole RJ, Kripke DF, Gruen W, Mullaney DJ, Gillin JC. Automatic sleep/wake identification 
from wrist activity. Sleep 1992;15(5):461-9. 
141.Garcia-Masso X, Serra-Ano P, Garcia-Raffi LM, Sanchez-Perez EA, Lopez-Pascual J, 
Gonzalez LM. Validation of the use of Actigraph GT3X accelerometers to estimate energy 
expenditure in full time manual wheelchair users with spinal cord injury. Spinal Cord 
2013;51(12):898-903. 
142.Spivak E, Oksenberg A, Catz A. The feasibility of sleep assessment by actigraph in patients 
with tetraplegia. Spinal Cord 2007;45(12):765-70. 
 225 
143.Albaum E, Quinn E, Sedaghatkish S, Singh P, Watkins A, Musselman K et al. Accuracy of 
the Actigraph wGT3x-BT for step counting during inpatient spinal cord rehabilitation. Spinal Cord 
2019. 
144.Moore Ht, Leary E, Lee SY, Carrillo O, Stubbs R, Peppard P et al. Correction: Design and 
Validation of a Periodic Leg Movement Detector. PLoS One 2015;10(9):e0138205. 
145.Mannini A, Sabatini AM. Machine learning methods for classifying human physical activity 
from on-body accelerometers. Sensors (Basel) 2010;10(2):1154-75. 
146.Sejdić E, Lowry KA, Bellanca J, Redfern MS, Brach JS. A comprehensive assessment of gait 
accelerometry signals in time, frequency and time-frequency domains. IEEE Trans Neural Syst 
Rehabil Eng 2014;22(3):603-12. 
147.Krishnan S, Athavale Y. Trends in biomedical signal feature extraction. Biomed Signal 
Process Control 2018;43:41-63. 
148.Tedesco S, Urru A, O'Flynn B. Spectral and time-frequency domains features for quantitative 
lower-limb rehabilitation monitoring via wearable inertial sensors. Proceedings of the 2017 IEEE 
Biomedical Circuits and Systems Conference (BioCAS): IEEE; 2017. 
149.Rosati S, Balestra G, Knaflitz M. Comparison of different sets of features for human activity 
recognition by wearable sensors. Sensors Basel Sensors 2018;18(12). 
150.Machado IP, Luísa Gomes A, Gamboa H, Paixão V, Costa RM. Human activity data discovery 
from triaxial accelerometer sensor: Non-supervised learning sensitivity to feature extraction 
parametrization. Information Processing & Management 2015;51(2):204-14. 
151.Mannini A, Intille SS, Rosenberger M, Sabatini AM, Haskell W. Activity recognition using a 
single accelerometer placed at the wrist or ankle. Medicine and Science in Sports and Exercise 
2013;45(11):2193-203. 
152.Athavale Y, Krishnan S, Dopsa DD, Berneshawi AG, Nouraei H, Raissi A et al. Advanced 
signal analysis for the detection of periodic limb movements from bilateral ankle actigraphy. 
Journal of sleep research 2017;26(1):14-20. 
153.Attal F, Mohammed S, Dedabrishvili M, Chamroukhi F, Oukhellou L, Amirat Y. Physical 
human activity recognition using wearable sensors. Sensors Basel Sensors 2015;15(12):31314-38. 
154.Twomey N, Diethe T, Fafoutis X, Elsts A, McConville R, Flach P et al. A comprehensive 
study of activity recognition using accelerometers. Informatics 2018;5(2):27. 
 226 
155.Choi S, Shin YB, Kim S-Y, Kim J. A novel sensor-based assessment of lower limb spasticity 
in children with cerebral palsy. Journal of neuroengineering and rehabilitation 2018;15(1):45. 
156.Tsao C-C, Mirbagheri MM. Upper limb impairments associated with spasticity in neurological 
disorders. Journal of neuroengineering and rehabilitation 2007;4:45. 
157.Noor MHM, Salcic Z, Wang KIK. Adaptive sliding window segmentation for physical activity 
recognition using a single tri-axial accelerometer. Pervasive Mob Comput 2017;38:41-59. 
158.van Hees VT, Sabia S, Anderson KN, Denton SJ, Oliver J, Catt M et al. A Novel, Open Access 
Method to Assess Sleep Duration Using a Wrist-Worn Accelerometer. Plos One 
2015;10(11):e0142533. 
159.Lugade V, Fortune E, Morrow M, Kaufman K. Validity of using tri-axial accelerometers to 
measure human movement - Part I: Posture and movement detection. Medical Engineering & 
Physics 2014;36(2):169-76. 
160.Wang X, Smith KA, Hyndman RJ. Dimension reduction for clustering time series using global 
characteristics. In: Sunderam VS, van Albada GD, Sloot PMA, Dongarra J, editors. Computational 
science – ICCS 2005. Berlin, Heidelberg: Springer Berlin Heidelberg; 2005. p 792-5. 
161.Zhang S, Rowlands AV, Murray P, Hurst TL. Physical activity classification using the 
GENEA wrist-worn accelerometer. Medicine and Science in Sports and Exercise 2012;44(4):742-
8. 
162.Bayat A, Pomplun M, Tran DA. A Study on Human Activity Recognition Using 
Accelerometer Data from Smartphones. Procedia Computer Science 2014;34:450-7. 
163.Mathie MJ, Coster ACF, Lovell NH, Celler BG. Accelerometry: providing an integrated, 
practical method for long-term, ambulatory monitoring of human movement. Physiological 
measurement 2004;25(2):R1-20. 
164.Carbonneau M-A, Granger E, Gagnon G. Bag-Level Aggregation for Multiple-Instance 
Active Learning in Instance Classification Problems. IEEE Trans Neural Netw Learn Syst 
2019;30(5):1441-51. 
165.Che Z, Purushotham S, Cho K, Sontag D, Liu Y. Recurrent Neural Networks for Multivariate 
Time Series with Missing Values. Scientific Reports 2018;8(1):6085. 
166.Kim HB, Lee WW, Kim A, Lee HJ, Park HY, Jeon HS et al. Wrist sensor-based tremor 
severity quantification in Parkinson's disease using convolutional neural network. Computers in 
biology and medicine 2018;95:140-6. 
 227 
167.Tilmanne J, Urbain J, Kothare MV, Wouwer AV, Kothare SV. Algorithms for sleep-wake 
identification using actigraphy: a comparative study and new results. Journal of sleep research 
2009;18(1):85-98. 
168.Theodoridis S, Koutroumbas K. Pattern Recognition. Academic Press; 2008. 
169.van Middendorp JJ, Hosman AJ, Pouw MH, Van de Meent H. ASIA impairment scale 
conversion in traumatic SCI: is it related with the ability to walk? A descriptive comparison with 
functional ambulation outcome measures in 273 patients. Spinal Cord 2009;47(7):555-60. 
170.Strommen JA. Management of spasticity from spinal cord dysfunction. Neurol Clin 
2013;31(1):269-86. 
171.Krawetz P, Nance P. Gait analysis of spinal cord injured subjects: effects of injury level and 
spasticity. Archives of Physical Medicine and Rehabilitation 1996;77(7):635-8. 
172.Tedesco S, O'Flynn B. LASSO regression for monitoring patients progress following ACL 
reconstruction via motion sensors: A case study. International Journal on Advances in Life 
Sciences 2019;11(1&2):23-32. 
173.O'Flynn B, Dagini N, Bottone S, Urru A, Tedesco S. Metrics for monitoring patients progress 
in a rehabilitation context: a case study based on wearable inertial sensors. Proceedings of the 
HEALTHINFO 2018: The Third International Conference on Informatics and Assistive 
Technologies for Health-Care, Medical Support and Wellbeing: IARIA; 2018. 
174.Martineau J, Goulet J, Richard-Denis A, Mac-Thiong J-M. The relevance of MRI for 
predicting neurological recovery following cervical traumatic spinal cord injury. Spinal Cord 
2019. 
175.Bauman KA, Kurili A, Schotland HM, Rodriguez GM, Chiodo AE, Sitrin RG. Simplified 
Approach to Diagnosing Sleep-Disordered Breathing and Nocturnal Hypercapnia in Individuals 
With Spinal Cord Injury. Archives of Physical Medicine and Rehabilitation 2016;97(3):363-71. 
176.Januaviani TMA, Gusriani N, Joebaedi K, Supian S, Subiyanto S. The best model of LASSO 
with the LARS (least angle regression and shrinkage) algorithm using Mallow’s Cp. World 
Scientific News 2019;116:245-52. 
177.Hossin M, Sulaiman M. A review on evaluation metrics for data classification evaluations. 
International Journal of Data Mining & Knowledge Management Process 2015;5(2):1. 
178.Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O et al. Scikit-learn: 
Machine learning in Python. the Journal of machine Learning research 2011;12:2825-30. 
 228 
179.Akpinar P, Atici A, Ozkan FU, Aktas I, Kulcu DG, Sarı A et al. Reliability of the Modified 
Ashworth Scale and Modified Tardieu Scale in patients with spinal cord injuries. Spinal Cord 
2017;55(10):944-9. 
180.Athavale Y, Krishnan S, Dopsa DD, Berneshawi AG, Nouraei H, Raissi A et al. Advanced 
signal analysis for the detection of periodic limb movements from bilateral ankle actigraphy. 
Journal of sleep research 2017;26(1):14-20. 
181.de Mello MT, Lauro FA, Silva AC, Tufik S. Incidence of periodic leg movements and of the 
restless legs syndrome during sleep following acute physical activity in spinal cord injury subjects. 
Spinal Cord 1996;34(5):294-6. 
182.Plante DT. Leg actigraphy to quantify periodic limb movements of sleep: a systematic review 
and meta-analysis. Sleep Medicine Reviews 2014;18(5):425-34. 
183.Yokota T, Hirose K, Tanabe H, Tsukagoshi H. Sleep-related periodic leg movements 
(nocturnal myoclonus) due to spinal cord lesion. J Neurol Sci 1991;104(1):13-8. 
184.Levy J, Hartley S, Mauruc-Soubirac E, Leotard A, Lofaso F, Quera-Salva MA et al. Spasticity 
or periodic limb movements? Eur J Phys Rehabil Med 2018;54(5):698-704. 
185.Cawley GC, Talbot NL. On over-fitting in model selection and subsequent selection bias in 
performance evaluation. J Mach Learn Res 2010;11:2079-107. 
186.Vabalas A, Gowen E, Poliakoff E, Casson AJ. Machine learning algorithm validation with a 
limited sample size. Plos One 2019;14(11):e0224365. 
187.Varma S, Simon R. Bias in error estimation when using cross-validation for model selection. 
BMC Bioinformatics 2006;7:91. 
188.Felix ER, Widerstrom-Noga EG. Reliability and validity of quantitative sensory testing in 
persons with spinal cord injury and neuropathic pain. J Rehabil Res Dev 2009;46(1):69-83. 
189.Field-Fote EC, Yang JF, Basso DM, Gorassini MA. Supraspinal Control Predicts Locomotor 
Function and Forecasts Responsiveness to Training after Spinal Cord Injury. Journal of 
Neurotrauma 2017;34(9):1813-25. 
190.Marino RJ, Graves DE. Metric properties of the ASIA motor score: subscales improve 
correlation with functional activities. Archives of Physical Medicine and Rehabilitation 
2004;85(11):1804-10. 
191.National Spinal Cord Injury Statistical Center. Annual Statistical Report for the Spinal Cord 
Injury Model Systems. Birmingham, Alabama; 2019. 
 229 
192.National Spinal Cord Injury Statistical Center. Facts and Figures at a Glance. Birmingham, 
Alabama: University of Alabama at Birmingham; 2020. 
193.Simpson LA, Eng JJ, Hsieh JT, Wolfe DL. The health and life priorities of individuals with 
spinal cord injury: a systematic review. J Neurotrauma 2012;29(8):1548-55. 
194.Hiremath SV, Hogaboom NS, Roscher MR, Worobey LA, Oyster ML, Boninger ML. 
Longitudinal Prediction of Quality-of-Life Scores and Locomotion in Individuals With Traumatic 
Spinal Cord Injury. Arch Phys Med Rehab 2017;98(12):2385-92. 
195.Riggins MS, Kankipati P, Oyster ML, Cooper RA, Boninger ML. The relationship between 
quality of life and change in mobility 1 year postinjury in individuals with spinal cord injury. Arch 
Phys Med Rehab 2011;92(7):1027-33. 
196.Rigot SK, Worobey L, Boninger ML. Gait Training in Acute Spinal Cord Injury 
Rehabilitation-Utilization and Outcomes Among Nonambulatory Individuals: Findings From the 
SCIRehab Project. Arch Phys Med Rehabil 2018;99(8):1591-8. 
197.Hylin MJ, Kerr AL, Holden R. Understanding the Mechanisms of Recovery and/or 
Compensation following Injury. Neural Plast 2017;2017:7125057. 
198.Barbeau H, Nadeau S, Garneau C. Physical determinants, emerging concepts, and training 
approaches in gait of individuals with spinal cord injury. Journal of Neurotrauma 2006;23(3-
4):571-85. 
199.Burns AS, Marino RJ, Kalsi-Ryan S, Middleton JW, Tetreault LA, Dettori JR et al. Type and 
timing of rehabilitation following acute and subacute spinal cord injury: A systematic review. 
Global spine journal 2017;7(3 Suppl):175S-94S. 
200.Fouad K, Tetzlaff W. Rehabilitative training and plasticity following spinal cord injury. 
Experimental Neurology 2012;235(1):91-9. 
201.Tetreault L, Le D, C⊚ té P, Fehlings M. The Practical Application of Clinical Prediction 
Rules: A Commentary Using Case Examples in Surgical Patients with Degenerative Cervical 
Myelopathy. Global spine journal 2015;5(6):457-65. 
202.DeVries Z, Hoda M, Rivers CS, Maher A, Wai E, Moravek D et al. Development of an 
unsupervised machine learning algorithm for the prognostication of walking ability in spinal cord 
injury patients. The Spine Journal 2020;20(2):213-24. 
203.Khan O, Badhiwala JH, Wilson JRF, Jiang F, Martin AR, Fehlings MG. Predictive modeling 
of outcomes after traumatic and nontraumatic spinal cord injury using machine learning: review 
of current progress and future directions. Neurospine 2019;16(4):678-85. 
 230 
204.Kimura S, Ozasa S, Nomura K, Yoshioka K, Endo F. Estimation of muscle strength from 
actigraph data in Duchenne muscular dystrophy. Pediatrics International 2014;56(5):748-52. 
205.Ferri R, Proserpio P, Rundo F, Lanza A, Sambusida K, Redaelli T et al. Neurophysiological 
correlates of sleep leg movements in acute spinal cord injury. Clin Neurophysiol 2015;126(2):333-
8. 
206.Lee MS, Choi YC, Lee SH, Lee SB. Sleep-related periodic leg movements associated with 
spinal cord lesions. Movement Disorders 1996;11(6):719-22. 
207.Proserpio P, Lanza A, Sambusida K, Fratticci L, Frigerio P, Sommariva M et al. Sleep apnea 
and periodic leg movements in the first year after spinal cord injury. Sleep Medicine 
2015;16(1):59-66. 
208.McCall WV, Boggs N, Letton A. Changes in sleep and wake in response to different sleeping 
surfaces: a pilot study. Applied Ergonomics 2012;43(2):386-91. 
209.Giganti F, Ficca G, Gori S, Salzarulo P. Body movements during night sleep and their 
relationship with sleep stages are further modified in very old subjects. Brain Res Bull 
2008;75(1):66-9. 
210.Lebedev AV, Westman E, Van Westen GJP, Kramberger MG, Lundervold A, Aarsland D et 
al. Random Forest ensembles for detection and prediction of Alzheimer's disease with a good 
between-cohort robustness. Neuroimage Clin 2014;6:115-25. 
211.Hajjem A. Mixed Effects Trees and Forests for Clustered Data. ProQuest LLC: University of 
Montreal; 2010. 
212.van Hedel HJ, Emsci Study Group. Gait speed in relation to categories of functional 
ambulation after spinal cord injury. Neurorehabilitation and neural repair 2009;23(4):343-50. 
213.Altenburger PA, Dierks TA, Miller KK, Combs SA, Van Puymbroeck M, Schmid AA. 
Examination of sustained gait speed during extended walking in individuals with chronic stroke. 
Arch Phys Med Rehabil 2013;94(12):2471-7. 
214.Fulk GD, He Y, Boyne P, Dunning K. Predicting home and community walking activity 
poststroke. Stroke 2017;48(2):406-11. 
215.Gaspar R, Padula N, Freitas TB, de Oliveira JPJ, Torriani-Pasin C. Physical exercise for 
individuals with spinal cord injury: systematic review based on the international classification of 
functioning, disability, and health. J Sport Rehabil 2019;28(5):505-16. 
 231 
216.Liu H, Li J, Du L, Yang M, Yang D, Li J et al. Short-term effects of core stability training on 
the balance and ambulation function of individuals with chronic spinal cord injury: a pilot 
randomized controlled trial. Minerva Med 2019;110(3):216-23. 
217.DiPiro ND, Embry AE, Fritz SL, Middleton A, Krause JS, Gregory CM. Effects of aerobic 
exercise training on fitness and walking-related outcomes in ambulatory individuals with chronic 
incomplete spinal cord injury. Spinal Cord 2016;54(9):675-81. 
218.Martin Ginis KA, Papathomas A, Perrier M-J, Smith B, Group S-SR. Psychosocial factors 
associated with physical activity in ambulatory and manual wheelchair users with spinal cord 
injury: a mixed-methods study. Disability and rehabilitation 2017;39(2):187-92. 
219.Chasens ER, Sereika SM, Weaver TE, Umlauf MG. Daytime sleepiness, exercise, and 
physical function in older adults. Journal of sleep research 2007;16(1):60-5. 
220.Goldman SE, Stone KL, Ancoli-Israel S, Blackwell T, Ewing SK, Boudreau R et al. Poor 
sleep is associated with poorer physical performance and greater functional limitations in older 
women. Sleep 2007;30(10):1317-24. 
221.Alessi CA, Martin JL, Webber AP, Alam T, Littner MR, Harker JO et al. More daytime 
sleeping predicts less functional recovery among older people undergoing inpatient post-acute 
rehabilitation. Sleep 2008;31(9):1291-300. 
222.Beveridge C, Knutson K, Spampinato L, Flores A, Meltzer DO, Van Cauter E et al. Daytime 
Physical Activity and Sleep in Hospitalized Older Adults: Association with Demographic 
Characteristics and Disease Severity. J Am Geriatr Soc 2015;63(7):1391-400. 
223.Qi Y. Random forest for bioinformatics. In: Zhang C, Ma Y, editors. Ensemble Machine 
Learning. Boston, MA: Springer US; 2012. p 307-23. 
224.Mehdizadeh S. The largest Lyapunov exponent of gait in young and elderly individuals: A 
systematic review. Gait & Posture 2018;60:241-50. 
225.England SA, Granata KP. The influence of gait speed on local dynamic stability of walking. 
Gait & Posture 2007;25(2):172-8. 
226.Toebes MJP, Hoozemans MJM, Furrer R, Dekker J, van Dieën JH. Local dynamic stability 
and variability of gait are associated with fall history in elderly subjects. Gait & Posture 
2012;36(3):527-31. 
227.Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J 
Am Geriatr Soc 1992;40(9):922-35. 
 232 
228.Steeves JD, Kramer JK, Fawcett JW, Cragg J, Lammertse DP, Blight AR et al. Extent of 
spontaneous motor recovery after traumatic cervical sensorimotor complete spinal cord injury. 
Spinal Cord 2011;49(2):257-65. 
229.Waters RL, Adkins RH, Yakura JS, Sie I. Motor and sensory recovery following incomplete 
tetraplegia. Arch Phys Med Rehabil 1994;75(3):306-11. 
230.D'Amico JM, Condliffe EG, Martins KJB, Bennett DJ, Gorassini MA. Recovery of neuronal 
and network excitability after spinal cord injury and implications for spasticity. Front Integr 
Neurosci 2014;8:36. 
231.Berlowitz DJ, Brown DJ, Campbell DA, Pierce RJ. A longitudinal evaluation of sleep and 
breathing in the first year after cervical spinal cord injury. Archives of Physical Medicine and 
Rehabilitation 2005;86(6):1193-9. 
232.Balasubramanian V, Ho S-S, Vovk V. Conformal prediction for reliable machine learning: 
theory, adaptations and applications. Newnes; 2014. 
233.Taherdoost H. Validity and reliability of the research instrument; how to test the validation of 
a questionnaire/survey in a research. How to test the validation of a questionnaire/survey in a 
research (August 10, 2016) 2016. 
234.Atkinson G, Nevill AM. Statistical methods for assessing measurement error (reliability) in 
variables relevant to sports medicine. Sports Med 1998;26(4):217-38. 
235.Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for 
reliability research. J Chiropr Med 2016;15(2):155-63. 
236.Kennedy G, Gallego B. Clinical prediction rules: A systematic review of healthcare provider 
opinions and preferences. Int J Med Inform 2019;123:1-10. 
237.Burns AS, Lanig I, Grabljevec K, New PW, Bensmail D, Ertzgaard P et al. Optimizing the 
Management of Disabling Spasticity Following Spinal Cord Damage: The Ability Network-An 
International Initiative. Arch Phys Med Rehabil 2016;97(12):2222-8. 
238.Burns AS, Lee BS, Ditunno JF, Tessler A. Patient selection for clinical trials: the reliability 
of the early spinal cord injury examination. Journal of Neurotrauma 2003;20(5):477-82. 
239.Brown PJ, Marino RJ, Herbison GJ, Ditunno JF, Jr. The 72-hour examination as a predictor 
of recovery in motor complete quadriplegia. Arch Phys Med Rehabil 1991;72(8):546-8. 
240.Mukaka MM. Statistics corner: A guide to appropriate use of correlation coefficient in medical 
research. Malawi Med J 2012;24(3):69-71. 
 233 
241.Rigot SK, Boninger ML, Ding D, McKernan G, Field-Fote EC, Hoffman J et al. Towards 
Improving the Prediction of Functional Ambulation after Spinal Cord Injury Through the Inclusion 
of Limb Accelerations During Sleep and Personal Factors. Archives of Physical Medicine and 
Rehabilitation 2021. 
242.Ditunno JF, Jr., Barbeau H, Dobkin BH, Elashoff R, Harkema S, Marino RJ et al. Validity of 
the walking scale for spinal cord injury and other domains of function in a multicenter clinical 
trial. Neurorehabil Neural Repair 2007;21(6):539-50. 
243.Saraf P, Rafferty MR, Moore JL, Kahn JH, Hendron K, Leech K et al. Daily stepping in 
individuals with motor incomplete spinal cord injury. Physical therapy 2010;90(2):224-35. 
244.Peter C, Müller R, Cieza A, Geyh S. Psychological resources in spinal cord injury: a 
systematic literature review. Spinal Cord 2012;50(3):188-201. 
245.Fell J, Röschke J, Beckmann P. Deterministic chaos and the first positive Lyapunov exponent: 
a nonlinear analysis of the human electroencephalogram during sleep. Biological cybernetics 
1993;69(2):139-46. 
246.Efron B, Hastie T, Johnstone I, Tibshirani R. Least angle regression. Ann Statist 
2004;32(2):407-99. 
247.Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via 
Coordinate Descent. J Stat Softw 2010;33(1):1-22. 
248.Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O et al. Scikit-learn: 
Machine Learning in Python. J Mach Learn Res 2011;12:2825-30. 
249.Defazio A, Bach F, Lacoste-Julien S. SAGA: A fast incremental gradient method with support 
for non-strongly convex composite objectives. arXiv preprint arXiv:14070202 2014. 
250.Kraskov A, Stögbauer H, Grassberger P. Estimating mutual information. Physical Review E, 
Statistical, Nonlinear, and Soft Matter Physics 2004;69(6 Pt 2):066138. 
 
